.
zoledronic acid - Ontology Report - Rat Genome Database

Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term:zoledronic acid
go back to main search page
Accession:CHEBI:46557 term browser browse the term
Definition:An imidazole compound having a 2,2-bis(phosphono)-2-hydroxyethane-1-yl substituent at the 1-position.
Synonyms:exact_synonym: [1-hydroxy-2-(1H-imidazol-1-yl)ethane-1,1-diyl]bis(phosphonic acid)
 related_synonym: (1-hydroxy-2-(1H-imidazol-1-yl)ethylidene)bisphosphonic acid;   (1-hydroxy-2-imidazol-1-ylethylidene)diphosphonic acid;   Formula=C5H10N2O7P2;   InChI=1S/C5H10N2O7P2/c8-5(15(9,10)11,16(12,13)14)3-7-2-1-6-4-7/h1-2,4,8H,3H2,(H2,9,10,11)(H2,12,13,14);   InChIKey=XRASPMIURGNCCH-UHFFFAOYSA-N;   Reclast;   SMILES=OC(Cn1ccnc1)(P(O)(O)=O)P(O)(O)=O;   ZOL
 xref: Beilstein:9205049;   CAS:118072-93-8;   Chemspider:61986;   DrugBank:DB00399;   Drug_Central:2868;   Gmelin:2609374;   KEGG:D08689
 xref_mesh: MESH:C088658
 xref: PDBeChem:ZOL;   PMCID:PMC8090009;   PMID:12183663;   PMID:15161327;   PMID:15324309;   PMID:16414486;   PMID:17691952;   PMID:18982915;   PMID:19751105;   PMID:33908127;   PMID:33984339;   PMID:34081204;   PMID:34157824;   PMID:34324430;   PMID:34341833;   PMID:34393156;   PMID:34413050;   PMID:34435997;   PMID:34447747;   PMID:34475752;   PMID:34560734;   PMID:34585443;   Patent:US4939130;   Wikipedia:Zoledronic_Acid

 Loading Annotations... 
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
X
Y

show annotations for term's descendants           Sort by:
zoledronic acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G A4GALT alpha 1,4-galactosyltransferase (P1PK blood group) increases expression EXP zoledronic acid results in increased expression of A4GALT mRNA CTD PMID:24714768 NCBI chr22:42,692,121...42,721,301
Ensembl chr22:42,692,121...42,721,298 		JBrowse link
G AADAT aminoadipate aminotransferase decreases expression EXP zoledronic acid results in decreased expression of AADAT mRNA CTD PMID:24714768 NCBI chr 4:170,060,222...170,094,292
Ensembl chr 4:170,060,222...170,091,699 		JBrowse link
G AARS1 alanyl-tRNA synthetase 1 decreases expression EXP Zoledronic Acid results in decreased expression of AARS1 mRNA CTD PMID:25596134 NCBI chr16:70,252,298...70,289,506
Ensembl chr16:70,251,983...70,289,707 		JBrowse link
G ABCA12 ATP binding cassette subfamily A member 12 increases expression EXP zoledronic acid results in increased expression of ABCA12 mRNA CTD PMID:24714768 NCBI chr 2:214,931,542...215,138,626
Ensembl chr 2:214,931,542...215,138,626 		JBrowse link
G ABCA4 ATP binding cassette subfamily A member 4 increases expression EXP zoledronic acid results in increased expression of ABCA4 mRNA CTD PMID:20977926 PMID:24714768 NCBI chr 1:93,992,834...94,121,148
Ensembl chr 1:93,992,834...94,121,148 		JBrowse link
G ABCB6 ATP binding cassette subfamily B member 6 (LAN blood group) decreases expression EXP zoledronic acid results in decreased expression of ABCB6 mRNA CTD PMID:24714768 PMID:25596134 NCBI chr 2:219,209,772...219,218,958
Ensembl chr 2:219,209,772...219,218,994 		JBrowse link
G ABCC5 ATP binding cassette subfamily C member 5 decreases expression EXP zoledronic acid results in decreased expression of ABCC5 mRNA CTD PMID:24714768 NCBI chr 3:183,919,934...184,017,884
Ensembl chr 3:183,919,934...184,017,939 		JBrowse link
G ABCG2 ATP binding cassette subfamily G member 2 (JR blood group) increases expression EXP zoledronic acid results in increased expression of ABCG2 mRNA CTD PMID:18225567 NCBI chr 4:88,090,264...88,231,626
Ensembl chr 4:88,090,150...88,231,628 		JBrowse link
G ABHD17C abhydrolase domain containing 17C, depalmitoylase decreases expression EXP zoledronic acid results in decreased expression of ABHD17C mRNA CTD PMID:24714768 NCBI chr15:80,695,310...80,755,621
Ensembl chr15:80,679,684...80,755,621 		JBrowse link
G ABI3BP ABI family member 3 binding protein decreases expression EXP zoledronic acid results in decreased expression of ABI3BP mRNA CTD PMID:24714768 NCBI chr 3:100,749,156...100,993,421
Ensembl chr 3:100,749,156...100,993,515 		JBrowse link
G ABTB3 ankyrin repeat and BTB domain containing 3 decreases expression EXP Zoledronic Acid results in decreased expression of ABTB3 mRNA CTD PMID:24714768 NCBI chr12:107,318,434...107,659,642
Ensembl chr12:107,318,421...107,659,642 		JBrowse link
G ACAA1 acetyl-CoA acyltransferase 1 decreases expression ISO zoledronic acid results in decreased expression of ACAA1 mRNA CTD PMID:28871336 NCBI chr 3:38,122,715...38,137,127
Ensembl chr 3:38,103,129...38,137,242 		JBrowse link
G ACADL acyl-CoA dehydrogenase long chain decreases expression ISO zoledronic acid results in decreased expression of ACADL mRNA CTD PMID:28871336 NCBI chr 2:210,187,923...210,225,447
Ensembl chr 2:210,187,126...210,225,447 		JBrowse link
G ACADM acyl-CoA dehydrogenase medium chain decreases expression ISO zoledronic acid results in decreased expression of ACADM mRNA CTD PMID:28871336 NCBI chr 1:75,724,709...75,763,679
Ensembl chr 1:75,724,431...75,787,575 		JBrowse link
G ACAT2 acetyl-CoA acetyltransferase 2 increases expression EXP zoledronic acid results in increased expression of ACAT2 mRNA CTD PMID:24714768 NCBI chr 6:159,762,045...159,779,112
Ensembl chr 6:159,762,045...159,779,112 		JBrowse link
G ACBD4 acyl-CoA binding domain containing 4 decreases expression EXP zoledronic acid results in decreased expression of ACBD4 mRNA CTD PMID:20977926 NCBI chr17:45,131,597...45,144,176
Ensembl chr17:45,132,600...45,144,181 		JBrowse link
G ACMSD aminocarboxymuconate semialdehyde decarboxylase decreases expression EXP zoledronic acid results in decreased expression of ACMSD mRNA CTD PMID:24714768 NCBI chr 2:134,838,616...134,902,034
Ensembl chr 2:134,838,616...134,902,034 		JBrowse link
G ACOX1 acyl-CoA oxidase 1 decreases expression
multiple interactions 		ISO
EXP 		zoledronic acid results in decreased expression of ACOX1 mRNA
Fenofibrate inhibits the reaction [zoledronic acid results in decreased expression of ACOX1 mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in decreased expression of ACOX1 mRNA]
zoledronic acid results in decreased expression of ACOX1 mRNA; zoledronic acid results in decreased expression of ACOX1 protein 		CTD PMID:28871336 NCBI chr17:75,941,507...75,979,166
Ensembl chr17:75,941,507...75,979,177 		JBrowse link
G ACOX2 acyl-CoA oxidase 2 multiple interactions
decreases expression 		ISO Fenofibrate inhibits the reaction [zoledronic acid results in decreased expression of ACOX2 mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in decreased expression of ACOX2 mRNA] CTD PMID:28871336 NCBI chr 3:58,505,136...58,537,190
Ensembl chr 3:58,505,136...58,537,283 		JBrowse link
G ACP3 acid phosphatase 3 decreases expression EXP Zoledronic Acid results in decreased expression of ACP3 mRNA CTD PMID:24714768 NCBI chr 3:132,317,407...132,368,302
Ensembl chr 3:132,317,369...132,368,302 		JBrowse link
G ACSL1 acyl-CoA synthetase long chain family member 1 decreases expression EXP Zoledronic Acid results in decreased expression of ACSL1 mRNA; Zoledronic Acid results in decreased expression of ACSL1 protein CTD PMID:25596134 PMID:28871336 NCBI chr 4:184,755,595...184,826,594
Ensembl chr 4:184,755,595...184,826,818 		JBrowse link
G ACSL3 acyl-CoA synthetase long chain family member 3 decreases expression EXP zoledronic acid results in decreased expression of ACSL3 protein CTD PMID:28871336 NCBI chr 2:222,861,036...222,944,639
Ensembl chr 2:222,860,942...222,944,639 		JBrowse link
G ACSL5 acyl-CoA synthetase long chain family member 5 increases expression EXP zoledronic acid results in increased expression of ACSL5 mRNA CTD PMID:24714768 NCBI chr10:112,374,116...112,428,376
Ensembl chr10:112,374,116...112,428,379 		JBrowse link
G ACSM3 acyl-CoA synthetase medium chain family member 3 decreases expression EXP zoledronic acid results in decreased expression of ACSM3 mRNA CTD PMID:24714768 NCBI chr16:20,674,405...20,797,581
Ensembl chr16:20,610,243...20,797,581 		JBrowse link
G ACSS2 acyl-CoA synthetase short chain family member 2 increases expression EXP zoledronic acid results in increased expression of ACSS2 mRNA CTD PMID:24714768 NCBI chr20:34,874,989...34,927,959
Ensembl chr20:34,872,146...34,927,962 		JBrowse link
G ACTA2 actin alpha 2, smooth muscle increases expression
multiple interactions 		ISO
EXP 		zoledronic acid results in increased expression of ACTA2 protein
Fenofibrate inhibits the reaction [zoledronic acid results in increased expression of ACTA2 protein]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in increased expression of ACTA2 protein]
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [zoledronic acid results in increased expression of ACTA2 protein] 		CTD PMID:28871336 NCBI chr10:88,935,074...88,991,337
Ensembl chr10:88,934,822...88,991,339 		JBrowse link
G ACTBL2 actin beta like 2 increases expression EXP zoledronic acid results in increased expression of ACTBL2 mRNA CTD PMID:24714768 NCBI chr 5:57,480,018...57,482,811
Ensembl chr 5:57,480,018...57,482,811 		JBrowse link
G ACTG2 actin gamma 2, smooth muscle decreases expression EXP zoledronic acid results in decreased expression of ACTG2 mRNA CTD PMID:24714768 NCBI chr 2:73,893,008...73,919,865
Ensembl chr 2:73,892,314...73,919,865 		JBrowse link
G ACTN1 actinin alpha 1 decreases expression EXP zoledronic acid results in decreased expression of ACTN1 protein CTD PMID:28871336 NCBI chr14:68,874,128...68,979,302
Ensembl chr14:68,874,123...68,979,440 		JBrowse link
G ACTN4 actinin alpha 4 decreases expression EXP zoledronic acid results in decreased expression of ACTN4 protein CTD PMID:28871336 NCBI chr19:38,647,649...38,731,589
Ensembl chr19:38,647,649...38,731,589 		JBrowse link
G ADAM17 ADAM metallopeptidase domain 17 multiple interactions
increases expression
decreases activity 		EXP ADAM17 protein promotes the reaction [zoledronic acid results in decreased expression of TNFSF11 protein]
zoledronic acid results in increased expression of ADAM17 protein
zoledronic acid results in decreased activity of ADAM17 protein 		CTD PMID:14753746 NCBI chr 2:9,488,486...9,555,830
Ensembl chr 2:9,488,486...9,556,732 		JBrowse link
G ADAM19 ADAM metallopeptidase domain 19 decreases expression EXP zoledronic acid results in decreased expression of ADAM19 mRNA CTD PMID:24714768 NCBI chr 5:157,477,304...157,575,775
Ensembl chr 5:157,395,534...157,575,775 		JBrowse link
G ADAM28 ADAM metallopeptidase domain 28 increases expression EXP zoledronic acid results in increased expression of ADAM28 mRNA CTD PMID:24714768 NCBI chr 8:24,294,069...24,359,014
Ensembl chr 8:24,294,069...24,359,014 		JBrowse link
G ADAMTS1 ADAM metallopeptidase with thrombospondin type 1 motif 1 increases expression EXP zoledronic acid results in increased expression of ADAMTS1 mRNA CTD PMID:24714768 NCBI chr21:26,835,755...26,845,409
Ensembl chr21:26,835,755...26,845,409 		JBrowse link
G ADAMTS9 ADAM metallopeptidase with thrombospondin type 1 motif 9 increases expression EXP zoledronic acid results in increased expression of ADAMTS9 mRNA CTD PMID:24714768 NCBI chr 3:64,515,654...64,688,000
Ensembl chr 3:64,515,654...64,688,000 		JBrowse link
G ADAMTSL3 ADAMTS like 3 decreases expression EXP zoledronic acid results in decreased expression of ADAMTSL3 mRNA CTD PMID:24714768 NCBI chr15:83,654,123...84,039,842
Ensembl chr15:83,654,088...84,039,842 		JBrowse link
G ADGRF1 adhesion G protein-coupled receptor F1 increases expression EXP zoledronic acid results in increased expression of ADGRF1 mRNA CTD PMID:24714768 NCBI chr 6:46,997,708...47,042,332
Ensembl chr 6:46,997,708...47,042,350 		JBrowse link
G ADGRG1 adhesion G protein-coupled receptor G1 decreases expression EXP zoledronic acid results in decreased expression of ADGRG1 mRNA CTD PMID:24714768 NCBI chr16:57,619,738...57,665,567
Ensembl chr16:57,610,652...57,665,580 		JBrowse link
G ADGRL1 adhesion G protein-coupled receptor L1 decreases expression EXP zoledronic acid results in decreased expression of ADGRL1 mRNA CTD PMID:20977926 NCBI chr19:14,147,743...14,206,169
Ensembl chr19:14,147,743...14,206,187 		JBrowse link
G ADGRV1 adhesion G protein-coupled receptor V1 increases expression EXP zoledronic acid results in increased expression of ADGRV1 mRNA CTD PMID:24714768 NCBI chr 5:90,558,797...91,164,437
Ensembl chr 5:90,529,344...91,164,437 		JBrowse link
G ADH1A alcohol dehydrogenase 1A (class I), alpha polypeptide decreases expression EXP zoledronic acid results in decreased expression of ADH1A mRNA CTD PMID:24714768 NCBI chr 4:99,276,369...99,290,985
Ensembl chr 4:99,276,369...99,291,003 		JBrowse link
G ADH6 alcohol dehydrogenase 6 (class V) decreases expression EXP zoledronic acid results in decreased expression of ADH6 mRNA CTD PMID:24714768 NCBI chr 4:99,202,639...99,219,246
Ensembl chr 4:99,202,638...99,219,537 		JBrowse link
G ADM2 adrenomedullin 2 decreases expression EXP zoledronic acid results in decreased expression of ADM2 mRNA CTD PMID:24714768 NCBI chr22:50,481,543...50,486,437
Ensembl chr22:50,481,543...50,486,440 		JBrowse link
G ADSL adenylosuccinate lyase decreases expression EXP zoledronic acid results in decreased expression of ADSL mRNA CTD PMID:20977926 NCBI chr22:40,346,500...40,387,527
Ensembl chr22:40,346,461...40,390,463 		JBrowse link
G AFP alpha fetoprotein increases expression EXP zoledronic acid results in increased expression of AFP protein CTD PMID:28871336 NCBI chr 4:73,436,221...73,456,174
Ensembl chr 4:73,431,138...73,456,174 		JBrowse link
G AGPAT5 1-acylglycerol-3-phosphate O-acyltransferase 5 increases expression EXP zoledronic acid results in increased expression of AGPAT5 mRNA CTD PMID:24714768 NCBI chr 8:6,708,642...6,761,503
Ensembl chr 8:6,708,642...6,761,503 		JBrowse link
G AGR2 anterior gradient 2, protein disulphide isomerase family member decreases expression EXP zoledronic acid results in decreased expression of AGR2 mRNA CTD PMID:24714768 NCBI chr 7:16,791,811...16,804,999
Ensembl chr 7:16,791,811...16,833,433 		JBrowse link
G AGRN agrin increases expression EXP zoledronic acid results in increased expression of AGRN protein CTD PMID:28871336 NCBI chr 1:1,020,120...1,056,116
Ensembl chr 1:1,020,120...1,056,119 		JBrowse link
G AHNAK2 AHNAK nucleoprotein 2 decreases expression EXP zoledronic acid results in decreased expression of AHNAK2 mRNA CTD PMID:24714768 NCBI chr14:104,937,253...104,978,374
Ensembl chr14:104,937,244...104,978,374 		JBrowse link
G AHR aryl hydrocarbon receptor affects activity EXP zoledronic acid affects the activity of AHR protein CTD PMID:25596134 NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152 		JBrowse link
G AHSG alpha 2-HS glycoprotein increases expression EXP zoledronic acid results in increased expression of AHSG protein CTD PMID:28871336 NCBI chr 3:186,613,060...186,621,318
Ensembl chr 3:186,613,060...186,621,318 		JBrowse link
G AK3 adenylate kinase 3 decreases expression EXP zoledronic acid results in decreased expression of AK3 mRNA CTD PMID:25596134 NCBI chr 9:4,709,556...4,742,043
Ensembl chr 9:4,709,556...4,742,043 		JBrowse link
G AK5 adenylate kinase 5 decreases expression EXP zoledronic acid results in decreased expression of AK5 mRNA CTD PMID:24714768 NCBI chr 1:77,282,019...77,559,966
Ensembl chr 1:77,282,019...77,559,966 		JBrowse link
G AKAP7 A-kinase anchoring protein 7 decreases expression EXP zoledronic acid results in decreased expression of AKAP7 mRNA CTD PMID:24714768 NCBI chr 6:131,125,627...131,283,532
Ensembl chr 6:131,135,467...131,283,535 		JBrowse link
G AKIP1 A-kinase interacting protein 1 increases expression EXP zoledronic acid results in increased expression of AKIP1 mRNA CTD PMID:24714768 NCBI chr11:8,911,189...8,920,079
Ensembl chr11:8,911,139...8,920,084 		JBrowse link
G AKIRIN2 akirin 2 decreases expression EXP zoledronic acid results in decreased expression of AKIRIN2 mRNA CTD PMID:20977926 NCBI chr 6:87,674,860...87,702,233
Ensembl chr 6:87,674,860...87,702,233 		JBrowse link
G AKR1A1 aldo-keto reductase family 1 member A1 increases expression EXP zoledronic acid results in increased expression of AKR1A1 mRNA CTD PMID:24714768 NCBI chr 1:45,550,826...45,570,049
Ensembl chr 1:45,550,543...45,570,049 		JBrowse link
G AKR1B1 aldo-keto reductase family 1 member B increases expression EXP zoledronic acid results in increased expression of AKR1B1 mRNA CTD PMID:24714768 NCBI chr 7:134,442,350...134,459,239
Ensembl chr 7:134,442,356...134,459,284 		JBrowse link
G AKR1C2 aldo-keto reductase family 1 member C2 decreases expression EXP zoledronic acid results in decreased expression of AKR1C2 mRNA CTD PMID:25596134 NCBI chr10:4,987,775...5,018,000
Ensembl chr10:4,987,775...5,018,031 		JBrowse link
G AKT1 AKT serine/threonine kinase 1 multiple interactions EXP CCN1 protein affects the reaction [Zoledronic Acid results in decreased phosphorylation of and results in decreased activity of AKT1 protein]; Zoledronic Acid results in decreased phosphorylation of and results in decreased activity of AKT1 protein CTD PMID:19530242 NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,759 		JBrowse link
G AKT1S1 AKT1 substrate 1 increases expression EXP zoledronic acid results in increased expression of AKT1S1 mRNA CTD PMID:20977926 NCBI chr19:49,869,033...49,878,356
Ensembl chr19:49,869,033...49,878,459 		JBrowse link
G ALB albumin increases expression EXP zoledronic acid results in increased expression of ALB protein CTD PMID:28871336 NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482 		JBrowse link
G ALDH18A1 aldehyde dehydrogenase 18 family member A1 decreases expression EXP zoledronic acid results in decreased expression of ALDH18A1 mRNA CTD PMID:25596134 NCBI chr10:95,605,941...95,656,711
Ensembl chr10:95,605,941...95,656,711 		JBrowse link
G ALDH1A3 aldehyde dehydrogenase 1 family member A3 increases expression EXP zoledronic acid results in increased expression of ALDH1A3 mRNA CTD PMID:24714768 PMID:25596134 NCBI chr15:100,879,831...100,916,626
Ensembl chr15:100,861,924...100,916,626 		JBrowse link
G ALDH3A2 aldehyde dehydrogenase 3 family member A2 decreases expression EXP zoledronic acid results in decreased expression of ALDH3A2 mRNA CTD PMID:24714768 NCBI chr17:19,648,136...19,677,596
Ensembl chr17:19,648,136...19,685,760 		JBrowse link
G ALDH8A1 aldehyde dehydrogenase 8 family member A1 increases expression EXP zoledronic acid results in increased expression of ALDH8A1 mRNA CTD PMID:24714768 NCBI chr 6:134,917,393...134,950,101
Ensembl chr 6:134,917,393...134,950,115 		JBrowse link
G ALOX5 arachidonate 5-lipoxygenase increases expression EXP zoledronic acid results in increased expression of ALOX5 mRNA CTD PMID:24714768 NCBI chr10:45,374,216...45,446,117
Ensembl chr10:45,374,176...45,446,119 		JBrowse link
G ALOX5AP arachidonate 5-lipoxygenase activating protein increases expression EXP zoledronic acid results in increased expression of ALOX5AP mRNA CTD PMID:20977926 PMID:24714768 NCBI chr13:30,713,485...30,764,426
Ensembl chr13:30,713,478...30,764,426 		JBrowse link
G ALPK2 alpha kinase 2 increases expression EXP zoledronic acid results in increased expression of ALPK2 mRNA CTD PMID:24714768 NCBI chr18:58,481,247...58,629,091
Ensembl chr18:58,481,247...58,629,091 		JBrowse link
G ALPL alkaline phosphatase, biomineralization associated decreases activity
multiple interactions 		ISO zoledronic acid results in decreased activity of ALPL protein
TNFRSF11B protein affects the reaction [zoledronic acid results in decreased activity of ALPL protein] 		CTD PMID:18496637 NCBI chr 1:21,508,984...21,578,410
Ensembl chr 1:21,509,397...21,578,410 		JBrowse link
G ALS2CL ALS2 C-terminal like increases expression EXP zoledronic acid results in increased expression of ALS2CL mRNA CTD PMID:24714768 PMID:25596134 NCBI chr 3:46,668,995...46,693,679
Ensembl chr 3:46,668,995...46,693,704 		JBrowse link
G ANK2 ankyrin 2 decreases expression EXP zoledronic acid results in decreased expression of ANK2 mRNA CTD PMID:24714768 NCBI chr 4:112,705,622...113,383,736
Ensembl chr 4:112,818,032...113,384,221 		JBrowse link
G ANKEF1 ankyrin repeat and EF-hand domain containing 1 increases expression EXP zoledronic acid results in increased expression of ANKEF1 mRNA CTD PMID:20977926 NCBI chr20:10,034,987...10,058,303
Ensembl chr20:9,986,126...10,058,303 		JBrowse link
G ANKRA2 ankyrin repeat family A member 2 increases expression EXP zoledronic acid results in increased expression of ANKRA2 mRNA CTD PMID:25596134 NCBI chr 5:73,552,190...73,565,639
Ensembl chr 5:73,552,190...73,565,667 		JBrowse link
G ANKRD10 ankyrin repeat domain 10 increases expression EXP zoledronic acid results in increased expression of ANKRD10 mRNA CTD PMID:20977926 NCBI chr13:110,878,540...110,915,069
Ensembl chr13:110,878,540...110,915,069 		JBrowse link
G ANKRD22 ankyrin repeat domain 22 increases expression EXP zoledronic acid results in increased expression of ANKRD22 mRNA CTD PMID:24714768 NCBI chr10:88,819,896...88,851,844
Ensembl chr10:88,819,896...88,851,844 		JBrowse link
G ANLN anillin, actin binding protein decreases expression EXP zoledronic acid results in decreased expression of ANLN mRNA CTD PMID:24714768 NCBI chr 7:36,389,862...36,453,791
Ensembl chr 7:36,389,821...36,453,791 		JBrowse link
G ANPEP alanyl aminopeptidase, membrane increases expression EXP zoledronic acid results in increased expression of ANPEP mRNA CTD PMID:24714768 NCBI chr15:89,784,895...89,814,852
Ensembl chr15:89,784,895...89,815,401 		JBrowse link
G ANXA2 annexin A2 decreases expression EXP zoledronic acid results in decreased expression of ANXA2 protein CTD PMID:28871336 NCBI chr15:60,347,151...60,397,986
Ensembl chr15:60,347,134...60,402,883 		JBrowse link
G AP1S2 adaptor related protein complex 1 subunit sigma 2 increases expression EXP zoledronic acid results in increased expression of AP1S2 mRNA CTD PMID:24714768 NCBI chr  X:15,825,806...15,854,813
Ensembl chr  X:15,825,806...15,854,931 		JBrowse link
G AP1S3 adaptor related protein complex 1 subunit sigma 3 increases expression EXP zoledronic acid results in increased expression of AP1S3 mRNA CTD PMID:20977926 NCBI chr 2:223,755,326...223,837,582
Ensembl chr 2:223,667,680...223,838,027 		JBrowse link
G AP4B1 adaptor related protein complex 4 subunit beta 1 increases expression EXP zoledronic acid results in increased expression of AP4B1 mRNA CTD PMID:24714768 NCBI chr 1:113,894,194...113,905,028
Ensembl chr 1:113,894,194...113,905,712 		JBrowse link
G APAF1 apoptotic peptidase activating factor 1 increases expression EXP
ISO 		zoledronic acid results in increased expression of APAF1 mRNA CTD PMID:28871336 NCBI chr12:98,645,290...98,735,433
Ensembl chr12:98,645,149...98,735,433 		JBrowse link
G APBA3 amyloid beta precursor protein binding family A member 3 decreases expression EXP zoledronic acid results in decreased expression of APBA3 mRNA CTD PMID:20977926 NCBI chr19:3,750,772...3,761,692
Ensembl chr19:3,750,772...3,761,692 		JBrowse link
G APH1A aph-1 homolog A, gamma-secretase subunit increases expression EXP zoledronic acid results in increased expression of APH1A mRNA CTD PMID:20977926 NCBI chr 1:150,265,404...150,269,016
Ensembl chr 1:150,265,399...150,269,580 		JBrowse link
G API5 apoptosis inhibitor 5 increases expression EXP zoledronic acid results in increased expression of API5 mRNA CTD PMID:20977926 NCBI chr11:43,311,996...43,344,529
Ensembl chr11:43,311,963...43,344,529 		JBrowse link
G ARAP1 ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 decreases expression EXP zoledronic acid results in decreased expression of ARAP1 mRNA CTD PMID:20977926 NCBI chr11:72,685,069...72,752,408
Ensembl chr11:72,685,069...72,793,599 		JBrowse link
G ARHGAP18 Rho GTPase activating protein 18 decreases expression EXP zoledronic acid results in decreased expression of ARHGAP18 mRNA CTD PMID:20977926 NCBI chr 6:129,576,132...129,710,177
Ensembl chr 6:129,576,132...129,710,177 		JBrowse link
G ARHGAP19 Rho GTPase activating protein 19 decreases expression EXP zoledronic acid results in decreased expression of ARHGAP19 mRNA CTD PMID:20977926 NCBI chr10:97,222,179...97,292,637
Ensembl chr10:97,222,173...97,292,673 		JBrowse link
G ARHGAP22 Rho GTPase activating protein 22 increases expression EXP zoledronic acid results in increased expression of ARHGAP22 mRNA CTD PMID:24714768 NCBI chr10:48,429,831...48,656,265
Ensembl chr10:48,446,036...48,656,265 		JBrowse link
G ARHGAP24 Rho GTPase activating protein 24 decreases expression EXP zoledronic acid results in decreased expression of ARHGAP24 mRNA CTD PMID:24714768 NCBI chr 4:85,475,150...86,002,666
Ensembl chr 4:85,475,150...86,002,668 		JBrowse link
G ARHGAP26 Rho GTPase activating protein 26 increases expression EXP zoledronic acid results in increased expression of ARHGAP26 mRNA CTD PMID:24714768 NCBI chr 5:142,770,377...143,229,011
Ensembl chr 5:142,770,377...143,229,011 		JBrowse link
G ARHGAP29 Rho GTPase activating protein 29 multiple interactions EXP [zoledronic acid co-treated with fluvastatin] results in increased expression of ARHGAP29 mRNA CTD PMID:16996129 NCBI chr 1:94,168,905...94,314,592
Ensembl chr 1:94,148,988...94,275,068 		JBrowse link
G ARHGDIA Rho GDP dissociation inhibitor alpha decreases expression EXP zoledronic acid results in decreased expression of ARHGDIA protein CTD PMID:28871336 NCBI chr17:81,867,721...81,871,337
Ensembl chr17:81,867,719...81,871,378 		JBrowse link
G ARHGEF12 Rho guanine nucleotide exchange factor 12 multiple interactions EXP [zoledronic acid co-treated with fluvastatin] results in increased expression of ARHGEF12 mRNA CTD PMID:16996129 NCBI chr11:120,336,413...120,489,937
Ensembl chr11:120,336,413...120,489,937 		JBrowse link
G ARHGEF3 Rho guanine nucleotide exchange factor 3 multiple interactions EXP [zoledronic acid co-treated with fluvastatin] results in increased expression of ARHGEF3 mRNA CTD PMID:16996129 NCBI chr 3:56,727,420...57,079,268
Ensembl chr 3:56,727,418...57,079,329 		JBrowse link
G ARHGEF35 Rho guanine nucleotide exchange factor 35 decreases expression EXP zoledronic acid results in decreased expression of ARHGEF35 protein CTD PMID:28871336 NCBI chr 7:144,186,083...144,195,879
Ensembl chr 7:144,186,083...144,195,879 		JBrowse link
G ARHGEF4 Rho guanine nucleotide exchange factor 4 decreases expression EXP zoledronic acid results in decreased expression of ARHGEF4 mRNA CTD PMID:24714768 NCBI chr 2:130,836,914...131,047,253
Ensembl chr 2:130,836,914...131,047,263 		JBrowse link
G ARID2 AT-rich interaction domain 2 decreases expression EXP zoledronic acid results in decreased expression of ARID2 mRNA CTD PMID:20977926 NCBI chr12:45,729,706...45,908,037
Ensembl chr12:45,729,706...45,908,040 		JBrowse link
G ARL14 ARF like GTPase 14 decreases expression EXP zoledronic acid results in decreased expression of ARL14 mRNA CTD PMID:24714768 NCBI chr 3:160,677,160...160,678,448
Ensembl chr 3:160,677,160...160,678,448 		JBrowse link
G ARL4C ARF like GTPase 4C decreases expression EXP zoledronic acid results in decreased expression of ARL4C mRNA CTD PMID:24714768 NCBI chr 2:234,493,041...234,497,081
Ensembl chr 2:234,493,041...234,497,081 		JBrowse link
G ARL5B ARF like GTPase 5B increases expression EXP zoledronic acid results in increased expression of ARL5B mRNA CTD PMID:20977926 NCBI chr10:18,659,431...18,681,639
Ensembl chr10:18,659,431...18,681,639 		JBrowse link
G ARNT2 aryl hydrocarbon receptor nuclear translocator 2 decreases expression EXP zoledronic acid results in decreased expression of ARNT2 mRNA CTD PMID:24714768 NCBI chr15:80,404,382...80,597,933
Ensembl chr15:80,404,350...80,597,933 		JBrowse link
G ARRDC3 arrestin domain containing 3 increases expression EXP zoledronic acid results in increased expression of ARRDC3 mRNA CTD PMID:24714768 NCBI chr 5:91,368,631...91,383,317
Ensembl chr 5:91,368,631...91,383,317 		JBrowse link
G ARRDC4 arrestin domain containing 4 increases expression EXP zoledronic acid results in increased expression of ARRDC4 mRNA CTD PMID:24714768 NCBI chr15:97,960,703...97,973,833
Ensembl chr15:97,960,703...97,973,833 		JBrowse link
G ASIC1 acid sensing ion channel subunit 1 multiple interactions
decreases expression 		ISO zoledronic acid inhibits the reaction [Freund's Adjuvant results in increased expression of ASIC1 mRNA]
zoledronic acid results in decreased expression of ASIC1 mRNA 		CTD PMID:16769263 PMID:17323179 NCBI chr12:50,057,596...50,083,622
Ensembl chr12:50,057,548...50,083,611 		JBrowse link
G ASNS asparagine synthetase (glutamine-hydrolyzing) decreases expression EXP zoledronic acid results in decreased expression of ASNS mRNA CTD PMID:24714768 PMID:25596134 NCBI chr 7:97,851,677...97,928,441
Ensembl chr 7:97,851,677...97,872,542 		JBrowse link
G ASPHD2 aspartate beta-hydroxylase domain containing 2 decreases expression EXP zoledronic acid results in decreased expression of ASPHD2 mRNA CTD PMID:24714768 NCBI chr22:26,429,260...26,445,015
Ensembl chr22:26,429,260...26,445,015 		JBrowse link
G ASPM assembly factor for spindle microtubules decreases expression EXP zoledronic acid results in decreased expression of ASPM mRNA CTD PMID:24714768 NCBI chr 1:197,084,127...197,146,669
Ensembl chr 1:197,084,121...197,146,694 		JBrowse link
G ATF4 activating transcription factor 4 decreases expression EXP zoledronic acid results in decreased expression of ATF4 mRNA CTD PMID:24714768 NCBI chr22:39,520,559...39,522,686
Ensembl chr22:39,519,695...39,522,686 		JBrowse link
G ATF5 activating transcription factor 5 increases expression EXP zoledronic acid results in increased expression of ATF5 mRNA CTD PMID:24714768 NCBI chr19:49,928,906...49,933,935
Ensembl chr19:49,928,702...49,933,935 		JBrowse link
G ATG2A autophagy related 2A increases expression EXP zoledronic acid results in increased expression of ATG2A protein CTD PMID:28871336 NCBI chr11:64,894,546...64,917,209
Ensembl chr11:64,894,546...64,917,209 		JBrowse link
G ATOH8 atonal bHLH transcription factor 8 increases expression EXP zoledronic acid results in increased expression of ATOH8 mRNA CTD PMID:24714768 NCBI chr 2:85,753,991...85,791,383
Ensembl chr 2:85,751,344...85,791,383 		JBrowse link
G ATOSA atos homolog A increases expression EXP Zoledronic Acid results in increased expression of ATOSA mRNA CTD PMID:25596134 NCBI chr15:52,581,321...52,709,815
Ensembl chr15:52,581,317...52,709,817 		JBrowse link
G ATP10B ATPase phospholipid transporting 10B (putative) increases expression EXP zoledronic acid results in increased expression of ATP10B mRNA CTD PMID:24714768 NCBI chr 5:160,563,120...160,929,360
Ensembl chr 5:160,563,120...160,852,214 		JBrowse link
G ATP1A1 ATPase Na+/K+ transporting subunit alpha 1 decreases expression EXP zoledronic acid results in decreased expression of ATP1A1 mRNA CTD PMID:24714768 NCBI chr 1:116,373,244...116,404,774
Ensembl chr 1:116,372,668...116,410,261 		JBrowse link
G ATP6V0A4 ATPase H+ transporting V0 subunit a4 decreases expression EXP zoledronic acid results in decreased expression of ATP6V0A4 mRNA CTD PMID:24714768 NCBI chr 7:138,706,294...138,798,196
Ensembl chr 7:138,706,294...138,799,560 		JBrowse link
G ATP6V1B1 ATPase H+ transporting V1 subunit B1 decreases expression EXP zoledronic acid results in decreased expression of ATP6V1B1 mRNA CTD PMID:24714768 NCBI chr 2:70,935,900...70,965,431
Ensembl chr 2:70,935,900...70,965,431 		JBrowse link
G ATP7B ATPase copper transporting beta decreases expression EXP zoledronic acid results in decreased expression of ATP7B mRNA CTD PMID:24714768 NCBI chr13:51,932,669...52,012,132
Ensembl chr13:51,930,436...52,012,125 		JBrowse link
G ATRX ATRX chromatin remodeler decreases expression EXP zoledronic acid results in decreased expression of ATRX mRNA CTD PMID:20977926 NCBI chr  X:77,504,880...77,786,216
Ensembl chr  X:77,504,880...77,786,233 		JBrowse link
G ATXN1 ataxin 1 increases expression EXP zoledronic acid results in increased expression of ATXN1 mRNA CTD PMID:24714768 PMID:25596134 NCBI chr 6:16,299,112...16,761,460
Ensembl chr 6:16,299,112...16,761,491 		JBrowse link
G AURKB aurora kinase B decreases expression EXP zoledronic acid results in decreased expression of AURKB mRNA CTD PMID:25596134 NCBI chr17:8,204,731...8,210,575
Ensembl chr17:8,204,733...8,210,600 		JBrowse link
G AVPI1 arginine vasopressin induced 1 decreases expression EXP zoledronic acid results in decreased expression of AVPI1 mRNA CTD PMID:24714768 NCBI chr10:97,677,424...97,687,241
Ensembl chr10:97,677,424...97,687,241 		JBrowse link
G AXL AXL receptor tyrosine kinase decreases expression EXP zoledronic acid results in decreased expression of AXL mRNA CTD PMID:24714768 PMID:25596134 NCBI chr19:41,219,223...41,261,766
Ensembl chr19:41,219,223...41,261,766 		JBrowse link
G B3GALT5 beta-1,3-galactosyltransferase 5 decreases expression EXP zoledronic acid results in decreased expression of B3GALT5 mRNA CTD PMID:24714768 NCBI chr21:39,612,940...39,673,137
Ensembl chr21:39,556,442...39,673,137 		JBrowse link
G BAAT bile acid-CoA:amino acid N-acyltransferase increases expression EXP zoledronic acid results in increased expression of BAAT mRNA CTD PMID:24714768 NCBI chr 9:101,360,417...101,385,006
Ensembl chr 9:101,354,182...101,385,400 		JBrowse link
G BAD BCL2 associated agonist of cell death multiple interactions
increases expression 		EXP [Tretinoin co-treated with zoledronic acid] results in increased expression of BAD protein
zoledronic acid results in increased expression of BAD mRNA 		CTD PMID:19036117 PMID:20349282 NCBI chr11:64,269,828...64,284,704
Ensembl chr11:64,269,830...64,284,704 		JBrowse link
G BAG1 BAG cochaperone 1 increases expression EXP zoledronic acid results in increased expression of BAG1 mRNA CTD PMID:19036117 NCBI chr 9:33,252,471...33,264,708
Ensembl chr 9:33,247,820...33,264,720 		JBrowse link
G BAG3 BAG cochaperone 3 increases expression EXP zoledronic acid results in increased expression of BAG3 mRNA CTD PMID:19036117 NCBI chr10:119,651,380...119,677,819
Ensembl chr10:119,651,380...119,677,819 		JBrowse link
G BASP1 brain abundant membrane attached signal protein 1 increases expression EXP zoledronic acid results in increased expression of BASP1 mRNA CTD PMID:24714768 NCBI chr 5:17,216,823...17,276,834
Ensembl chr 5:17,065,598...17,276,843 		JBrowse link
G BAX BCL2 associated X, apoptosis regulator decreases expression
increases expression
multiple interactions 		EXP
ISO 		zoledronic acid results in decreased expression of BAX mRNA
zoledronic acid results in increased expression of BAX mRNA
Zoledronic Acid results in increased expression of BAX mRNA
[zoledronic acid co-treated with Doxorubicin] results in increased expression of BAX protein
[Tretinoin co-treated with zoledronic acid] results in increased expression of BAX protein 		CTD PMID:19036117 PMID:19789217 PMID:20349282 PMID:28871336 PMID:35587103 NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798 		JBrowse link
G BBLN bublin coiled coil protein increases expression EXP Zoledronic Acid results in increased expression of BBLN mRNA CTD PMID:24714768 NCBI chr 9:128,160,265...128,163,924
Ensembl chr 9:128,160,265...128,163,924 		JBrowse link
G BBOX1 gamma-butyrobetaine hydroxylase 1 decreases expression EXP zoledronic acid results in decreased expression of BBOX1 mRNA CTD PMID:24714768 NCBI chr11:27,040,815...27,127,809
Ensembl chr11:27,040,725...27,127,809 		JBrowse link
G BBX BBX high mobility group box domain containing decreases expression EXP zoledronic acid results in decreased expression of BBX mRNA CTD PMID:20977926 NCBI chr 3:107,522,962...107,811,339
Ensembl chr 3:107,522,936...107,811,339 		JBrowse link
G BCAP29 B cell receptor associated protein 29 multiple interactions EXP [zoledronic acid co-treated with fluvastatin] results in increased expression of BCAP29 mRNA CTD PMID:16996129 NCBI chr 7:107,580,007...107,623,317
Ensembl chr 7:107,580,246...107,629,170 		JBrowse link
G BCAR3 BCAR3 adaptor protein, NSP family member decreases expression EXP Zoledronic Acid results in decreased expression of BCAR3 mRNA CTD PMID:25596134 NCBI chr 1:93,561,741...93,848,151
Ensembl chr 1:93,561,741...93,847,150 		JBrowse link
G BCHE butyrylcholinesterase decreases expression EXP zoledronic acid results in decreased expression of BCHE mRNA CTD PMID:24714768 NCBI chr 3:165,772,904...165,837,423
Ensembl chr 3:165,772,904...165,837,462 		JBrowse link
G BCL2 BCL2 apoptosis regulator decreases response to substance
decreases expression
multiple interactions
increases expression
affects expression 		EXP
ISO 		BCL2 protein results in decreased susceptibility to zoledronic acid
zoledronic acid results in decreased expression of BCL2 mRNA
[zoledronic acid co-treated with Doxorubicin] results in decreased expression of BCL2 protein
Zoledronic Acid results in increased expression of BCL2 mRNA
zoledronic acid affects the expression of BCL2 mRNA
[Tretinoin co-treated with Zoledronic Acid] results in decreased expression of BCL2 protein; [Zoledronic Acid co-treated with Docetaxel] results in decreased expression of BCL2 protein 		CTD PMID:11986784 PMID:18225567 PMID:19036117 PMID:19103299 PMID:19789217 More... NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128 		JBrowse link
G BCL2A1 BCL2 related protein A1 decreases expression EXP zoledronic acid results in decreased expression of BCL2A1 mRNA CTD PMID:19036117 NCBI chr15:79,960,892...79,971,196
Ensembl chr15:79,960,892...79,971,196 		JBrowse link
G BCL2L1 BCL2 like 1 increases expression EXP zoledronic acid results in increased expression of BCL2L1 mRNA CTD PMID:19036117 NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989 		JBrowse link
G BCL2L10 BCL2 like 10 affects expression EXP zoledronic acid affects the expression of BCL2L10 mRNA CTD PMID:19036117 NCBI chr15:52,109,263...52,112,775
Ensembl chr15:52,109,263...52,112,775 		JBrowse link
G BCL2L11 BCL2 like 11 multiple interactions EXP [zoledronic acid co-treated with fluvastatin] results in increased expression of BCL2L11 mRNA CTD PMID:16996129 NCBI chr 2:111,120,914...111,168,445
Ensembl chr 2:111,119,378...111,168,444 		JBrowse link
G BCL2L15 BCL2 like 15 increases expression EXP zoledronic acid results in increased expression of BCL2L15 mRNA CTD PMID:24714768 NCBI chr 1:113,876,816...113,887,581
Ensembl chr 1:113,876,816...113,887,581 		JBrowse link
G BCL2L2 BCL2 like 2 increases expression EXP zoledronic acid results in increased expression of BCL2L2 mRNA CTD PMID:19036117 NCBI chr14:23,306,833...23,311,751
Ensembl chr14:23,298,790...23,311,751 		JBrowse link
G BCRP5 BCR pseudogene 5 decreases expression EXP zoledronic acid results in decreased expression of BCRP5 mRNA CTD PMID:24714768 NCBI chr22:20,695,438...20,698,959
Ensembl chr22:20,697,962...20,698,934 		JBrowse link
G BCRP7 BCR pseudogene 7 decreases expression EXP zoledronic acid results in decreased expression of BCRP7 mRNA CTD PMID:24714768 NCBI chr22:18,852,284...18,858,643
Ensembl chr22:18,855,621...18,858,640 		JBrowse link
G BECN1 beclin 1 decreases expression EXP zoledronic acid results in decreased expression of BECN1 protein CTD PMID:28871336 NCBI chr17:42,810,132...42,824,282
Ensembl chr17:42,810,134...42,833,350 		JBrowse link
G BEND5 BEN domain containing 5 decreases expression EXP zoledronic acid results in decreased expression of BEND5 mRNA CTD PMID:24714768 PMID:25596134 NCBI chr 1:48,727,519...48,776,891
Ensembl chr 1:48,727,519...48,776,969 		JBrowse link
G BFSP1 beaded filament structural protein 1 decreases expression EXP zoledronic acid results in decreased expression of BFSP1 mRNA CTD PMID:24714768 NCBI chr20:17,493,905...17,569,220
Ensembl chr20:17,493,905...17,569,220 		JBrowse link
G BGLAP bone gamma-carboxyglutamate protein increases expression EXP zoledronic acid results in increased expression of BGLAP mRNA CTD PMID:14751568 NCBI chr 1:156,242,184...156,243,317
Ensembl chr 1:156,242,184...156,243,317 		JBrowse link
G BHLHE40 basic helix-loop-helix family member e40 multiple interactions EXP [zoledronic acid co-treated with fluvastatin] results in increased expression of BHLHE40 mRNA CTD PMID:16996129 NCBI chr 3:4,979,437...4,985,323
Ensembl chr 3:4,979,437...4,985,323 		JBrowse link
G BICDL1 BICD family like cargo adaptor 1 increases expression EXP zoledronic acid results in increased expression of BICDL1 mRNA CTD PMID:20977926 NCBI chr12:119,989,236...120,094,495
Ensembl chr12:119,989,236...120,094,494 		JBrowse link
G BID BH3 interacting domain death agonist increases expression EXP zoledronic acid results in increased expression of BID mRNA CTD PMID:19036117 NCBI chr22:17,734,138...17,774,665
Ensembl chr22:17,734,138...17,774,770 		JBrowse link
G BIRC2 baculoviral IAP repeat containing 2 multiple interactions
decreases expression 		EXP [Tretinoin co-treated with zoledronic acid] results in decreased expression of BIRC2 mRNA
zoledronic acid results in decreased expression of BIRC2 mRNA 		CTD PMID:19036117 PMID:20349282 NCBI chr11:102,347,214...102,378,670
Ensembl chr11:102,347,211...102,378,670 		JBrowse link
G BIRC3 baculoviral IAP repeat containing 3 increases expression EXP zoledronic acid results in increased expression of BIRC3 mRNA CTD PMID:24714768 NCBI chr11:102,317,484...102,339,403
Ensembl chr11:102,317,484...102,339,403 		JBrowse link
G BIRC5 baculoviral IAP repeat containing 5 multiple interactions
decreases expression 		EXP [Tretinoin co-treated with zoledronic acid] results in decreased expression of BIRC5 mRNA; [Tretinoin co-treated with zoledronic acid] results in decreased expression of BIRC5 protein
zoledronic acid results in decreased expression of BIRC5 mRNA; zoledronic acid results in decreased expression of BIRC5 protein 		CTD PMID:19036117 PMID:20349282 PMID:24714768 NCBI chr17:78,214,253...78,225,635
Ensembl chr17:78,214,186...78,225,636 		JBrowse link
G BIRC6 baculoviral IAP repeat containing 6 decreases expression EXP zoledronic acid results in decreased expression of BIRC6 mRNA CTD PMID:19036117 NCBI chr 2:32,357,023...32,618,878
Ensembl chr 2:32,357,023...32,619,571 		JBrowse link
G BIRC8 baculoviral IAP repeat containing 8 decreases expression EXP zoledronic acid results in decreased expression of BIRC8 mRNA CTD PMID:19036117 NCBI chr19:53,289,601...53,291,434
Ensembl chr19:53,289,664...53,291,131
Ensembl chr19:53,289,664...53,291,131 		JBrowse link
G BIVM basic, immunoglobulin-like variable motif containing decreases expression EXP zoledronic acid results in decreased expression of BIVM mRNA CTD PMID:24714768 NCBI chr13:102,799,119...102,841,533
Ensembl chr13:102,799,119...102,841,533 		JBrowse link
G BLOC1S5 biogenesis of lysosomal organelles complex 1 subunit 5 increases expression EXP zoledronic acid results in increased expression of BLOC1S5 mRNA CTD PMID:20977926 NCBI chr 6:8,013,567...8,064,414
Ensembl chr 6:8,013,567...8,064,396 		JBrowse link
G BMAL1 basic helix-loop-helix ARNT like 1 increases expression EXP Zoledronic Acid results in increased expression of BMAL1 mRNA CTD PMID:20977926 NCBI chr11:13,276,652...13,387,266
Ensembl chr11:13,276,652...13,387,266 		JBrowse link
G BMF Bcl2 modifying factor increases expression EXP zoledronic acid results in increased expression of BMF mRNA CTD PMID:24714768 PMID:25596134 NCBI chr15:40,087,890...40,108,879
Ensembl chr15:40,087,890...40,108,892 		JBrowse link
G BMP1 bone morphogenetic protein 1 increases expression EXP zoledronic acid results in increased expression of BMP1 mRNA CTD PMID:20977926 NCBI chr 8:22,165,372...22,212,326
Ensembl chr 8:22,165,140...22,212,326 		JBrowse link
G BMP2 bone morphogenetic protein 2 increases expression EXP zoledronic acid results in increased expression of BMP2 mRNA CTD PMID:14751568 PMID:24714768 NCBI chr20:6,767,686...6,780,246
Ensembl chr20:6,767,686...6,780,246 		JBrowse link
G BMPR1A bone morphogenetic protein receptor type 1A increases expression EXP zoledronic acid results in increased expression of BMPR1A mRNA CTD PMID:24714768 NCBI chr10:86,755,763...86,932,844
Ensembl chr10:86,755,786...86,932,825 		JBrowse link
G BMPR1AP1 bone morphogenetic protein receptor type 1A pseudogene 1 increases expression EXP zoledronic acid results in increased expression of BMPR1AP1 mRNA CTD PMID:24714768 NCBI chr 6:129,157,326...129,159,320
Ensembl chr 6:129,157,523...129,159,120 		JBrowse link
G BMPR2 bone morphogenetic protein receptor type 2 increases expression EXP zoledronic acid results in increased expression of BMPR2 mRNA CTD PMID:20977926 NCBI chr 2:202,376,327...202,567,749
Ensembl chr 2:202,376,327...202,567,751 		JBrowse link
G BNIP3 BCL2 interacting protein 3 decreases expression
increases expression 		EXP zoledronic acid results in decreased expression of BNIP3 mRNA
zoledronic acid results in increased expression of BNIP3 mRNA 		CTD PMID:19036117 PMID:25596134 NCBI chr10:131,967,684...131,981,923
Ensembl chr10:131,967,684...131,981,967 		JBrowse link
G BNIP5 BCL2 interacting protein 5 increases expression EXP Zoledronic Acid results in increased expression of BNIP5 mRNA CTD PMID:24714768 NCBI chr 6:36,315,761...36,336,888
Ensembl chr 6:36,315,761...36,336,888 		JBrowse link
G BOLA2 bolA family member 2 increases expression EXP zoledronic acid results in increased expression of BOLA2 mRNA CTD PMID:24714768 NCBI chr16:29,453,588...29,454,964
Ensembl chr16:30,192,932...30,194,306
Ensembl chr16:30,192,932...30,194,306 		JBrowse link
G BPGM bisphosphoglycerate mutase increases expression EXP zoledronic acid results in increased expression of BPGM mRNA CTD PMID:24714768 NCBI chr 7:134,646,853...134,679,816
Ensembl chr 7:134,646,811...134,679,816 		JBrowse link
G BRCA2 BRCA2 DNA repair associated increases expression EXP zoledronic acid results in increased expression of BRCA2 mRNA CTD PMID:20977926 NCBI chr13:32,315,077...32,400,268
Ensembl chr13:32,315,086...32,400,268 		JBrowse link
G BRIP1 BRCA1 interacting DNA helicase 1 increases expression EXP zoledronic acid results in increased expression of BRIP1 mRNA CTD PMID:20977926 NCBI chr17:61,679,139...61,863,528
Ensembl chr17:61,679,139...61,863,559 		JBrowse link
G BTG2 BTG anti-proliferation factor 2 decreases expression
increases expression 		EXP zoledronic acid results in decreased expression of BTG2 mRNA
zoledronic acid results in increased expression of BTG2 mRNA 		CTD PMID:20977926 PMID:25596134 NCBI chr 1:203,305,519...203,309,602
Ensembl chr 1:203,305,491...203,309,602 		JBrowse link
G BUB1 BUB1 mitotic checkpoint serine/threonine kinase multiple interactions EXP [zoledronic acid co-treated with fluvastatin] results in increased expression of BUB1 mRNA CTD PMID:16996129 NCBI chr 2:110,637,528...110,678,063
Ensembl chr 2:110,637,528...110,678,063 		JBrowse link
G C14orf132 chromosome 14 open reading frame 132 decreases expression EXP zoledronic acid results in decreased expression of C14ORF132 mRNA CTD PMID:24714768 NCBI chr14:96,039,362...96,093,971
Ensembl chr14:96,039,362...96,093,971 		JBrowse link
G C15orf48 chromosome 15 open reading frame 48 increases expression EXP zoledronic acid results in increased expression of C15ORF48 mRNA CTD PMID:24714768 NCBI chr15:45,430,610...45,433,340
Ensembl chr15:45,430,579...45,448,761 		JBrowse link
G C15orf62 chromosome 15 open reading frame 62 increases expression EXP zoledronic acid results in increased expression of C15ORF62 mRNA CTD PMID:24714768 NCBI chr15:40,769,980...40,772,449
Ensembl chr15:40,769,980...40,772,449 		JBrowse link
G C1orf53 chromosome 1 open reading frame 53 decreases expression EXP zoledronic acid results in decreased expression of C1ORF53 mRNA CTD PMID:24714768 NCBI chr 1:197,902,630...197,907,362
Ensembl chr 1:197,902,630...197,907,367 		JBrowse link
G C1QL4 complement C1q like 4 decreases expression EXP zoledronic acid results in decreased expression of C1QL4 mRNA CTD PMID:24714768 NCBI chr12:49,332,409...49,337,188
Ensembl chr12:49,332,409...49,337,188 		JBrowse link
G C1QTNF1 C1q and TNF related 1 increases expression EXP zoledronic acid results in increased expression of C1QTNF1 mRNA CTD PMID:24714768 NCBI chr17:79,022,934...79,049,788
Ensembl chr17:79,022,814...79,049,788 		JBrowse link
G C1QTNF6 C1q and TNF related 6 decreases expression EXP zoledronic acid results in decreased expression of C1QTNF6 mRNA CTD PMID:24714768 NCBI chr22:37,180,166...37,199,423
Ensembl chr22:37,180,166...37,199,385 		JBrowse link
G C1R complement C1r increases expression EXP zoledronic acid results in increased expression of C1R mRNA CTD PMID:24714768 NCBI chr12:7,080,219...7,092,445
Ensembl chr12:7,080,214...7,092,540 		JBrowse link
G C1S complement C1s increases expression EXP zoledronic acid results in increased expression of C1S mRNA CTD PMID:24714768 NCBI chr12:7,060,718...7,071,032
Ensembl chr12:6,988,259...7,071,032 		JBrowse link
G C2CD4A C2 calcium dependent domain containing 4A increases expression EXP zoledronic acid results in increased expression of C2CD4A mRNA CTD PMID:24714768 NCBI chr15:62,066,977...62,070,917
Ensembl chr15:62,066,977...62,070,917 		JBrowse link
G C2CD4B C2 calcium dependent domain containing 4B increases expression EXP zoledronic acid results in increased expression of NLF2 mRNA CTD PMID:24714768 NCBI chr15:62,163,535...62,165,285
Ensembl chr15:62,163,535...62,165,285 		JBrowse link
G C3 complement C3 increases expression EXP zoledronic acid results in increased expression of C3 mRNA CTD PMID:24714768 NCBI chr19:6,677,704...6,720,650
Ensembl chr19:6,677,704...6,730,562 		JBrowse link
G C3orf36 chromosome 3 putative open reading frame 36 increases expression EXP zoledronic acid results in increased expression of C3ORF36 mRNA CTD PMID:24714768 NCBI chr 3:133,928,145...133,929,812
Ensembl chr 3:133,928,145...133,929,812 		JBrowse link
G C4BPA complement component 4 binding protein alpha increases expression EXP zoledronic acid results in increased expression of C4BPA mRNA CTD PMID:24714768 NCBI chr 1:207,104,233...207,144,972
Ensembl chr 1:207,104,233...207,144,972 		JBrowse link
G C6orf58 chromosome 6 open reading frame 58 increases expression EXP zoledronic acid results in increased expression of C6ORF58 mRNA CTD PMID:24714768 NCBI chr 6:127,577,174...127,591,820
Ensembl chr 6:127,519,455...127,591,820 		JBrowse link
G C6orf89 chromosome 6 open reading frame 89 increases expression EXP zoledronic acid results in increased expression of C6ORF89 mRNA CTD PMID:20977926 NCBI chr 6:36,871,844...36,928,964
Ensembl chr 6:36,871,870...36,928,964 		JBrowse link
G C7orf57 chromosome 7 open reading frame 57 decreases expression EXP zoledronic acid results in decreased expression of C7ORF57 mRNA CTD PMID:24714768 NCBI chr 7:48,035,543...48,061,297
Ensembl chr 7:48,035,511...48,061,304 		JBrowse link
G CACNA2D3 calcium voltage-gated channel auxiliary subunit alpha2delta 3 increases expression EXP zoledronic acid results in increased expression of CACNA2D3 mRNA CTD PMID:24714768 NCBI chr 3:54,122,552...55,074,557
Ensembl chr 3:54,122,552...55,074,557 		JBrowse link
G CACTIN cactin, spliceosome C complex subunit decreases expression EXP zoledronic acid results in decreased expression of CACTIN protein CTD PMID:28871336 NCBI chr19:3,610,645...3,626,790
Ensembl chr19:3,610,645...3,626,815 		JBrowse link
G CALM1 calmodulin 1 decreases expression EXP zoledronic acid results in decreased expression of CALM1 protein CTD PMID:28871336 NCBI chr14:90,396,502...90,408,268
Ensembl chr14:90,396,502...90,408,268 		JBrowse link
G CALML4 calmodulin like 4 decreases expression EXP zoledronic acid results in decreased expression of CALML4 mRNA CTD PMID:20977926 NCBI chr15:68,190,705...68,206,110
Ensembl chr15:68,190,705...68,206,079 		JBrowse link
G CAMK1D calcium/calmodulin dependent protein kinase ID increases expression EXP zoledronic acid results in increased expression of CAMK1D mRNA CTD PMID:24714768 NCBI chr10:12,349,547...12,835,545
Ensembl chr10:12,349,547...12,835,545 		JBrowse link
G CAMK2D calcium/calmodulin dependent protein kinase II delta decreases expression EXP zoledronic acid results in decreased expression of CAMK2D mRNA CTD PMID:24714768 NCBI chr 4:113,451,032...113,761,738
Ensembl chr 4:113,418,054...113,761,927 		JBrowse link
G CAMK2N1 calcium/calmodulin dependent protein kinase II inhibitor 1 decreases expression EXP zoledronic acid results in decreased expression of CAMK2N1 mRNA CTD PMID:24714768 NCBI chr 1:20,482,391...20,486,210
Ensembl chr 1:20,482,391...20,486,210 		JBrowse link
G CAMK4 calcium/calmodulin dependent protein kinase IV decreases expression EXP zoledronic acid results in decreased expression of CAMK4 protein CTD PMID:28871336 NCBI chr 5:111,223,583...111,494,886
Ensembl chr 5:111,223,653...111,494,886 		JBrowse link
G CAMSAP1 calmodulin regulated spectrin associated protein 1 decreases expression EXP zoledronic acid results in decreased expression of CAMSAP1 protein CTD PMID:28871336 NCBI chr 9:135,808,487...135,907,546
Ensembl chr 9:135,808,487...135,907,546 		JBrowse link
G CANT1 calcium activated nucleotidase 1 increases expression EXP zoledronic acid results in increased expression of CANT1 mRNA CTD PMID:20977926 NCBI chr17:78,991,716...79,009,764
Ensembl chr17:78,991,716...79,009,867 		JBrowse link
G CAP2 cyclase associated actin cytoskeleton regulatory protein 2 decreases expression EXP zoledronic acid results in decreased expression of CAP2 mRNA CTD PMID:24714768 NCBI chr 6:17,393,595...17,557,780
Ensembl chr 6:17,393,595...17,557,780 		JBrowse link
G CAPN13 calpain 13 increases expression EXP zoledronic acid results in increased expression of CAPN13 mRNA CTD PMID:24714768 NCBI chr 2:30,722,771...30,807,446
Ensembl chr 2:30,722,771...30,820,542 		JBrowse link
G CAPN6 calpain 6 decreases expression EXP zoledronic acid results in decreased expression of CAPN6 mRNA CTD PMID:24714768 NCBI chr  X:111,245,099...111,270,483
Ensembl chr  X:111,245,099...111,270,483 		JBrowse link
G CAPRIN1 cell cycle associated protein 1 increases expression EXP zoledronic acid results in increased expression of CAPRIN1 mRNA CTD PMID:20977926 NCBI chr11:34,051,731...34,102,610
Ensembl chr11:34,051,731...34,102,610 		JBrowse link
G CARD10 caspase recruitment domain family member 10 decreases expression EXP zoledronic acid results in decreased expression of CARD10 mRNA CTD PMID:24714768 NCBI chr22:37,490,362...37,519,415
Ensembl chr22:37,490,362...37,519,542 		JBrowse link
G CARD8 caspase recruitment domain family member 8 increases expression EXP zoledronic acid results in increased expression of CARD8 mRNA CTD PMID:20977926 NCBI chr19:48,203,148...48,255,946
Ensembl chr19:48,180,770...48,255,946 		JBrowse link
G CARS1 cysteinyl-tRNA synthetase 1 increases expression EXP Zoledronic Acid results in increased expression of CARS1 mRNA CTD PMID:20977926 NCBI chr11:3,000,929...3,057,423
Ensembl chr11:3,000,922...3,057,613 		JBrowse link
G CASP1 caspase 1 affects expression
increases expression
multiple interactions 		EXP zoledronic acid affects the expression of CASP1 mRNA
zoledronic acid results in increased expression of CASP1 mRNA
[zoledronic acid co-treated with fluvastatin] results in increased expression of CASP1 mRNA 		CTD PMID:16996129 PMID:19036117 PMID:24714768 NCBI chr11:105,025,443...105,036,686
Ensembl chr11:105,025,397...105,035,250 		JBrowse link
G CASP14 caspase 14 decreases expression EXP zoledronic acid results in decreased expression of CASP14 mRNA CTD PMID:19036117 NCBI chr19:15,049,480...15,058,293
Ensembl chr19:15,049,480...15,058,293 		JBrowse link
G CASP2 caspase 2 affects expression EXP zoledronic acid affects the expression of CASP2 mRNA CTD PMID:19036117 NCBI chr 7:143,288,351...143,307,696
Ensembl chr 7:143,288,215...143,307,696 		JBrowse link
G CASP3 caspase 3 multiple interactions
increases expression
increases cleavage
increases activity
decreases expression 		EXP
ISO 		[Tretinoin co-treated with zoledronic acid] results in increased activity of CASP3 protein; [vorinostat co-treated with zoledronic acid] results in increased activity of CASP3 protein; [zoledronic acid co-treated with arsenic trioxide] results in increased cleavage of CASP3 protein; [zoledronic acid co-treated with docetaxel] results in decreased expression of CASP3 protein; [zoledronic acid co-treated with Doxorubicin] results in increased expression of CASP3 protein; [zoledronic acid co-treated with Gossypol] results in increased activity of CASP3 protein; vorinostat promotes the reaction [zoledronic acid results in increased activity of CASP3 protein]; zoledronic acid results in increased cleavage of and results in increased activity of CASP3 protein; zoledronic acid results in increased expression of and results in increased activity of CASP3 protein
Zoledronic Acid results in increased expression of CASP3 mRNA
zoledronic acid results in increased cleavage of CASP3 protein
[zoledronic acid co-treated with Doxorubicin] results in increased activity of CASP3 protein
zoledronic acid results in decreased expression of CASP3 protein 		CTD PMID:11986784 PMID:12796698 PMID:17070308 PMID:17562444 PMID:18025282 More... NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062 		JBrowse link
G CASP4 caspase 4 increases expression EXP Zoledronic Acid results in increased expression of CASP4 mRNA CTD PMID:35587103 NCBI chr11:104,942,866...104,968,574
Ensembl chr11:104,942,866...104,969,366 		JBrowse link
G CASP5 caspase 5 affects expression
increases expression 		EXP zoledronic acid affects the expression of CASP5 mRNA
zoledronic acid results in increased expression of CASP5 mRNA 		CTD PMID:19036117 PMID:24714768 NCBI chr11:104,994,243...105,023,168
Ensembl chr11:104,994,235...105,023,168 		JBrowse link
G CASP6 caspase 6 increases activity EXP zoledronic acid results in increased activity of CASP6 protein CTD PMID:17070308 NCBI chr 4:109,664,388...109,709,767
Ensembl chr 4:109,688,622...109,703,583 		JBrowse link
G CASP7 caspase 7 multiple interactions
increases activity 		EXP [Tretinoin co-treated with zoledronic acid] results in increased activity of CASP7 protein; [zoledronic acid co-treated with Gossypol] results in increased activity of CASP7 protein
zoledronic acid results in increased activity of CASP7 protein 		CTD PMID:19825521 PMID:20349282 NCBI chr10:113,679,194...113,730,909
Ensembl chr10:113,679,162...113,730,907 		JBrowse link
G CASP8 caspase 8 increases expression
multiple interactions 		EXP
ISO 		zoledronic acid results in increased expression of CASP8 mRNA
[zoledronic acid co-treated with Doxorubicin] results in increased activity of CASP8 protein 		CTD PMID:19036117 PMID:19789217 PMID:20977926 NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836 		JBrowse link
G CASP9 caspase 9 increases activity
affects expression
multiple interactions 		EXP
ISO 		zoledronic acid results in increased activity of CASP9 protein
Zoledronic Acid affects the expression of CASP9 mRNA
zoledronic acid results in increased cleavage of and results in increased activity of CASP9 protein
[zoledronic acid co-treated with Doxorubicin] results in increased activity of CASP9 protein 		CTD PMID:12799645 PMID:19036117 PMID:19789217 PMID:35587103 NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534 		JBrowse link
G CASR calcium sensing receptor decreases expression EXP zoledronic acid results in decreased expression of CASR mRNA CTD PMID:24714768 NCBI chr 3:122,183,668...122,291,629
Ensembl chr 3:122,183,668...122,291,629 		JBrowse link
G CASTOR1 cytosolic arginine sensor for mTORC1 subunit 1 increases expression EXP zoledronic acid results in increased expression of CASTOR1 mRNA CTD PMID:24714768 NCBI chr22:30,285,117...30,289,505
Ensembl chr22:30,285,117...30,289,622 		JBrowse link
G CAVIN2 caveolae associated protein 2 decreases expression EXP zoledronic acid results in decreased expression of CAVIN2 mRNA CTD PMID:24714768 NCBI chr 2:191,834,310...191,847,088
Ensembl chr 2:191,834,310...191,847,088 		JBrowse link
G CBR1 carbonyl reductase 1 decreases expression EXP zoledronic acid results in decreased expression of CBR1 mRNA CTD PMID:24714768 NCBI chr21:36,070,024...36,073,164
Ensembl chr21:36,069,941...36,073,166 		JBrowse link
G CBS cystathionine beta-synthase decreases expression EXP zoledronic acid results in decreased expression of CBS mRNA CTD PMID:24714768 NCBI chr21:43,053,191...43,076,873
Ensembl chr21:43,053,191...43,076,943 		JBrowse link
G CBX5 chromobox 5 increases expression EXP zoledronic acid results in increased expression of CBX5 mRNA CTD PMID:20977926 NCBI chr12:54,230,942...54,280,122
Ensembl chr12:54,230,942...54,280,133 		JBrowse link
G CC2D2A coiled-coil and C2 domain containing 2A decreases expression EXP zoledronic acid results in decreased expression of CC2D2A mRNA CTD PMID:24714768 NCBI chr 4:15,469,865...15,601,557
Ensembl chr 4:15,469,865...15,601,552 		JBrowse link
G CCDC138 coiled-coil domain containing 138 increases expression EXP zoledronic acid results in increased expression of CCDC138 mRNA CTD PMID:20977926 NCBI chr 2:108,786,750...108,885,485
Ensembl chr 2:108,786,757...108,885,477 		JBrowse link
G CCL2 C-C motif chemokine ligand 2 multiple interactions
increases expression 		EXP zoledronic acid promotes the reaction [Gossypol results in decreased expression of CCL2 mRNA]
zoledronic acid results in increased expression of CCL2 mRNA 		CTD PMID:19825521 PMID:24714768 NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208 		JBrowse link
G CCL20 C-C motif chemokine ligand 20 increases expression EXP zoledronic acid results in increased expression of CCL20 mRNA CTD PMID:20977926 PMID:24714768 NCBI chr 2:227,813,842...227,817,556
Ensembl chr 2:227,805,739...227,817,564 		JBrowse link
G CCL23 C-C motif chemokine ligand 23 increases expression EXP zoledronic acid results in increased expression of CCL23 mRNA CTD PMID:24714768 NCBI chr17:36,013,058...36,017,972
Ensembl chr17:36,013,056...36,017,972 		JBrowse link
G CCL28 C-C motif chemokine ligand 28 increases expression EXP zoledronic acid results in increased expression of CCL28 mRNA CTD PMID:24714768 NCBI chr 5:43,356,975...43,412,391
Ensembl chr 5:43,376,645...43,412,391 		JBrowse link
G CCL3L3 C-C motif chemokine ligand 3 like 3 increases expression EXP zoledronic acid results in increased expression of CCL3L3 mRNA CTD PMID:24714768 NCBI chr17:36,194,869...36,196,758
Ensembl chr17:36,194,869...36,196,758 		JBrowse link
G CCL8 C-C motif chemokine ligand 8 increases expression EXP zoledronic acid results in increased expression of CCL8 mRNA CTD PMID:24714768 NCBI chr17:34,319,435...34,321,402
Ensembl chr17:34,319,435...34,321,402 		JBrowse link
G CCN1 cellular communication network factor 1 multiple interactions
decreases expression 		EXP CCN1 protein affects the reaction [Zoledronic Acid results in decreased phosphorylation of and results in decreased activity of AKT1 protein]; CCN1 protein affects the reaction [Zoledronic Acid results in decreased phosphorylation of and results in decreased activity of MAPK1 protein]; CCN1 protein affects the reaction [Zoledronic Acid results in decreased phosphorylation of and results in decreased activity of MAPK3 protein]; CCN1 protein affects the reaction [Zoledronic Acid results in increased expression of CDKN1A protein]; geranylgeraniol inhibits the reaction [Zoledronic Acid results in decreased expression of CCN1 protein]; Zoledronic Acid promotes the reaction [CCN1 protein affects the expression of CDKN1B protein]
Zoledronic Acid results in decreased expression of CCN1 mRNA; Zoledronic Acid results in decreased expression of CCN1 protein 		CTD PMID:19530242 NCBI chr 1:85,580,761...85,583,950
Ensembl chr 1:85,580,761...85,584,589 		JBrowse link
G CCNA2 cyclin A2 decreases expression EXP zoledronic acid results in decreased expression of CCNA2 mRNA CTD PMID:24714768 NCBI chr 4:121,816,444...121,823,883
Ensembl chr 4:121,816,444...121,823,883 		JBrowse link
G CCNB1 cyclin B1 multiple interactions
decreases expression 		ISO
EXP 		[zoledronic acid co-treated with Doxorubicin] results in decreased expression of CCNB1 protein
zoledronic acid results in decreased expression of CCNB1 mRNA 		CTD PMID:19789217 PMID:20977926 NCBI chr 5:69,167,150...69,178,245
Ensembl chr 5:69,167,135...69,178,245 		JBrowse link
G CCNB2 cyclin B2 decreases expression EXP zoledronic acid results in decreased expression of CCNB2 mRNA CTD PMID:24714768 NCBI chr15:59,105,146...59,125,045
Ensembl chr15:59,105,126...59,125,045 		JBrowse link
G CCND1 cyclin D1 decreases expression
multiple interactions 		EXP
ISO 		zoledronic acid results in decreased expression of CCND1 mRNA
zoledronic acid results in decreased expression of CCND1 protein
[zoledronic acid co-treated with Doxorubicin] results in decreased expression of CCND1 protein 		CTD PMID:16621245 PMID:19789217 PMID:24714768 NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474 		JBrowse link
G CCND3 cyclin D3 multiple interactions
decreases expression 		ISO [zoledronic acid co-treated with Doxorubicin] results in decreased expression of CCND3 protein
zoledronic acid results in decreased expression of CCND3 protein 		CTD PMID:19789217 NCBI chr 6:41,934,933...42,050,035
Ensembl chr 6:41,934,934...42,050,357 		JBrowse link
G CCNE1 cyclin E1 multiple interactions ISO [zoledronic acid co-treated with Doxorubicin] results in decreased expression of CCNE1 protein CTD PMID:19789217 NCBI chr19:29,811,991...29,824,312
Ensembl chr19:29,811,991...29,824,312 		JBrowse link
G CCNE2 cyclin E2 decreases expression
increases expression 		EXP zoledronic acid results in decreased expression of CCNE2 mRNA
zoledronic acid results in increased expression of CCNE2 mRNA 		CTD PMID:20977926 PMID:25596134 NCBI chr 8:94,880,224...94,896,693
Ensembl chr 8:94,879,770...94,896,678 		JBrowse link
G CCT6P1 chaperonin containing TCP1 subunit 6 pseudogene 1 increases expression EXP zoledronic acid results in increased expression of CCT6P1 mRNA CTD PMID:20977926 NCBI chr 7:65,751,105...65,763,675
Ensembl chr 7:65,751,142...65,763,336 		JBrowse link
G CD14 CD14 molecule increases expression EXP zoledronic acid results in increased expression of CD14 mRNA; zoledronic acid results in increased expression of CD14 protein CTD PMID:24714768 PMID:28871336 NCBI chr 5:140,631,732...140,633,701
Ensembl chr 5:140,631,728...140,633,700 		JBrowse link
G CD27 CD27 molecule affects expression EXP zoledronic acid affects the expression of CD27 mRNA CTD PMID:19036117 NCBI chr12:6,443,892...6,451,713
Ensembl chr12:6,444,955...6,451,718 		JBrowse link
G CD34 CD34 molecule increases expression EXP zoledronic acid results in increased expression of CD34 mRNA CTD PMID:24714768 NCBI chr 1:207,880,972...207,911,125
Ensembl chr 1:207,880,972...207,911,402 		JBrowse link
G CD40 CD40 molecule increases expression EXP zoledronic acid results in increased expression of CD40 mRNA CTD PMID:24714768 NCBI chr20:46,118,314...46,129,858
Ensembl chr20:46,118,271...46,129,863 		JBrowse link
G CD40LG CD40 ligand decreases expression EXP zoledronic acid results in decreased expression of CD40LG mRNA CTD PMID:19036117 NCBI chr  X:136,648,158...136,660,390
Ensembl chr  X:136,648,158...136,660,390 		JBrowse link
G CD44 CD44 molecule (IN blood group) increases expression EXP zoledronic acid results in increased expression of CD44 mRNA CTD PMID:24714768 NCBI chr11:35,139,171...35,232,402
Ensembl chr11:35,138,882...35,232,402 		JBrowse link
G CD55 CD55 molecule (Cromer blood group) increases expression EXP zoledronic acid results in increased expression of CD55 mRNA; zoledronic acid results in increased expression of CD55 protein CTD PMID:20977926 PMID:24714768 PMID:28871336 NCBI chr 1:207,321,678...207,360,966
Ensembl chr 1:207,321,519...207,386,804 		JBrowse link
G CD59 CD59 molecule (CD59 blood group) increases expression EXP zoledronic acid results in increased expression of CD59 mRNA CTD PMID:24714768 NCBI chr11:33,703,010...33,736,479
Ensembl chr11:33,703,010...33,736,479 		JBrowse link
G CD68 CD68 molecule increases expression EXP zoledronic acid results in increased expression of CD68 mRNA CTD PMID:24714768 NCBI chr17:7,579,638...7,582,111
Ensembl chr17:7,579,491...7,582,111 		JBrowse link
G CD69 CD69 molecule increases expression EXP zoledronic acid results in increased expression of CD69 mRNA CTD PMID:24714768 NCBI chr12:9,752,486...9,760,901
Ensembl chr12:9,752,486...9,760,901 		JBrowse link
G CD74 CD74 molecule increases expression EXP zoledronic acid results in increased expression of CD74 mRNA CTD PMID:24714768 NCBI chr 5:150,401,639...150,412,910
Ensembl chr 5:150,401,637...150,412,969 		JBrowse link
G CD80 CD80 molecule increases expression EXP zoledronic acid results in increased expression of CD80 protein CTD PMID:19446661 NCBI chr 3:119,524,293...119,559,614
Ensembl chr 3:119,524,293...119,559,614 		JBrowse link
G CD83 CD83 molecule increases expression EXP zoledronic acid results in increased expression of CD83 mRNA CTD PMID:24714768 NCBI chr 6:14,117,256...14,136,918
Ensembl chr 6:14,117,256...14,140,682 		JBrowse link
G CD86 CD86 molecule increases expression EXP zoledronic acid results in increased expression of CD86 protein CTD PMID:19446661 NCBI chr 3:122,055,362...122,121,136
Ensembl chr 3:122,055,362...122,121,139 		JBrowse link
G CDC14A cell division cycle 14A increases expression EXP zoledronic acid results in increased expression of CDC14A mRNA CTD PMID:24714768 NCBI chr 1:100,345,001...100,520,277
Ensembl chr 1:100,325,629...100,520,277 		JBrowse link
G CDC20 cell division cycle 20 decreases expression EXP zoledronic acid results in decreased expression of CDC20 mRNA CTD PMID:20977926 PMID:24714768 NCBI chr 1:43,358,981...43,363,203
Ensembl chr 1:43,358,981...43,363,203 		JBrowse link
G CDC25C cell division cycle 25C increases expression EXP zoledronic acid results in increased expression of CDC25C mRNA CTD PMID:20977926 NCBI chr 5:138,285,265...138,338,355
Ensembl chr 5:138,285,269...138,338,355 		JBrowse link
G CDC26 cell division cycle 26 decreases expression EXP zoledronic acid results in decreased expression of CDC26 protein CTD PMID:28871336 NCBI chr 9:113,266,992...113,275,572
Ensembl chr 9:113,255,835...113,275,572 		JBrowse link
G CDC42 cell division cycle 42 multiple interactions ISO
EXP 		zoledronic acid results in increased abundance of [Guanosine Triphosphate binds to CDC42 protein]
zoledronic acid results in increased expression of [CDC42 protein binds to Guanosine Triphosphate]; zoledronic acid results in increased expression of and affects the localization of CDC42 protein 		CTD PMID:16734383 PMID:28871336 NCBI chr 1:22,052,709...22,101,360
Ensembl chr 1:22,052,627...22,101,360 		JBrowse link
G CDC42EP2 CDC42 effector protein 2 increases expression EXP zoledronic acid results in increased expression of CDC42EP2 mRNA CTD PMID:24714768 NCBI chr11:65,314,866...65,322,417
Ensembl chr11:65,314,866...65,322,417 		JBrowse link
G CDC42EP5 CDC42 effector protein 5 increases expression EXP zoledronic acid results in increased expression of CDC42EP5 mRNA CTD PMID:24714768 NCBI chr19:54,465,026...54,473,296
Ensembl chr19:54,465,026...54,473,296 		JBrowse link
G CDC45 cell division cycle 45 decreases expression EXP Zoledronic Acid results in decreased expression of CDC45 mRNA CTD PMID:24714768 NCBI chr22:19,479,466...19,520,612
Ensembl chr22:19,479,457...19,520,612 		JBrowse link
G CDCA5 cell division cycle associated 5 increases expression EXP zoledronic acid results in increased expression of CDCA5 protein CTD PMID:28871336 NCBI chr11:65,061,093...65,084,040
Ensembl chr11:65,066,300...65,084,164 		JBrowse link
G CDCA7 cell division cycle associated 7 decreases expression EXP zoledronic acid results in decreased expression of CDCA7 mRNA CTD PMID:24714768 NCBI chr 2:173,354,872...173,368,997
Ensembl chr 2:173,354,820...173,368,997 		JBrowse link
G CDCA8 cell division cycle associated 8 decreases expression EXP zoledronic acid results in decreased expression of CDCA8 mRNA CTD PMID:24714768 NCBI chr 1:37,692,516...37,709,719
Ensembl chr 1:37,692,481...37,709,719 		JBrowse link
G CDH4 cadherin 4 increases expression EXP zoledronic acid results in increased expression of CDH4 mRNA CTD PMID:24714768 NCBI chr20:61,252,261...61,940,617
Ensembl chr20:61,252,261...61,940,617 		JBrowse link
G CDK1 cyclin dependent kinase 1 decreases expression EXP zoledronic acid results in decreased expression of CDK1 mRNA CTD PMID:24714768 NCBI chr10:60,778,331...60,794,852
Ensembl chr10:60,778,331...60,794,852 		JBrowse link
G CDK2 cyclin dependent kinase 2 multiple interactions ISO [zoledronic acid co-treated with Doxorubicin] results in decreased expression of CDK2 protein CTD PMID:19789217 NCBI chr12:55,966,830...55,972,789
Ensembl chr12:55,966,781...55,972,789 		JBrowse link
G CDK2AP2 cyclin dependent kinase 2 associated protein 2 multiple interactions EXP [zoledronic acid co-treated with fluvastatin] results in increased expression of CDK2AP2 mRNA CTD PMID:16996129 NCBI chr11:67,506,497...67,508,162
Ensembl chr11:67,506,497...67,508,649 		JBrowse link
G CDK4 cyclin dependent kinase 4 multiple interactions ISO [zoledronic acid co-treated with Doxorubicin] results in decreased expression of CDK4 protein CTD PMID:19789217 NCBI chr12:57,747,727...57,752,310
Ensembl chr12:57,747,727...57,756,013 		JBrowse link
G CDKN1A cyclin dependent kinase inhibitor 1A multiple interactions
increases expression 		EXP CCN1 protein affects the reaction [Zoledronic Acid results in increased expression of CDKN1A protein]
zoledronic acid results in increased expression of CDKN1A protein 		CTD PMID:19530242 NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,397 		JBrowse link
G CDKN1B cyclin dependent kinase inhibitor 1B multiple interactions EXP [Zoledronic Acid co-treated with 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide] results in decreased expression of CDKN1B protein; Gefitinib promotes the reaction [[Zoledronic Acid co-treated with 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide] results in decreased expression of CDKN1B protein]; Zoledronic Acid promotes the reaction [CCN1 protein affects the expression of CDKN1B protein] CTD PMID:16322342 PMID:19530242 NCBI chr12:12,717,368...12,722,369
Ensembl chr12:12,685,498...12,722,369 		JBrowse link
G CDKN1C cyclin dependent kinase inhibitor 1C increases expression EXP zoledronic acid results in increased expression of CDKN1C mRNA CTD PMID:20977926 NCBI chr11:2,883,218...2,885,775
Ensembl chr11:2,883,213...2,885,775 		JBrowse link
G CDKN2AIP CDKN2A interacting protein decreases expression EXP zoledronic acid results in decreased expression of CDKN2AIP mRNA CTD PMID:24714768 NCBI chr 4:183,444,636...183,449,064
Ensembl chr 4:183,444,635...183,449,064 		JBrowse link
G CDKN2B cyclin dependent kinase inhibitor 2B increases expression EXP zoledronic acid results in increased expression of CDKN2B mRNA CTD PMID:24714768 NCBI chr 9:22,002,903...22,009,313
Ensembl chr 9:22,002,903...22,009,305 		JBrowse link
G CDKN2B-AS1 CDKN2B antisense RNA 1 increases expression EXP zoledronic acid results in increased expression of CDKN2B-AS1 mRNA CTD PMID:24714768 NCBI chr 9:21,994,791...22,128,142
Ensembl chr 9:21,994,139...22,212,895 		JBrowse link
G CDKN3 cyclin dependent kinase inhibitor 3 decreases expression EXP zoledronic acid results in decreased expression of CDKN3 mRNA CTD PMID:24714768 NCBI chr14:54,397,007...54,420,218
Ensembl chr14:54,396,849...54,420,218 		JBrowse link
G CDT1 chromatin licensing and DNA replication factor 1 decreases expression EXP zoledronic acid results in decreased expression of CDT1 mRNA CTD PMID:24714768 NCBI chr16:88,803,789...88,809,258
Ensembl chr16:88,803,789...88,809,258 		JBrowse link
G CDV3 CDV3 homolog increases expression EXP zoledronic acid results in increased expression of CDV3 mRNA CTD PMID:20977926 NCBI chr 3:133,573,686...133,590,274
Ensembl chr 3:133,573,686...133,590,261 		JBrowse link
G CEACAM5 CEA cell adhesion molecule 5 increases expression EXP zoledronic acid results in increased expression of CEACAM5 mRNA CTD PMID:24714768 NCBI chr19:41,708,626...41,730,433
Ensembl chr19:41,708,585...41,730,433 		JBrowse link
G CEACAM6 CEA cell adhesion molecule 6 increases expression EXP zoledronic acid results in increased expression of CEACAM6 mRNA CTD PMID:24714768 NCBI chr19:41,755,530...41,772,211
Ensembl chr19:41,750,977...41,772,211 		JBrowse link
G CEACAM7 CEA cell adhesion molecule 7 increases expression EXP zoledronic acid results in increased expression of CEACAM7 mRNA CTD PMID:24714768 NCBI chr19:41,673,303...41,688,270
Ensembl chr19:41,673,303...41,706,976 		JBrowse link
G CEBPA CCAAT enhancer binding protein alpha increases expression EXP zoledronic acid results in increased expression of CEBPA mRNA CTD PMID:20977926 NCBI chr19:33,299,934...33,302,534
Ensembl chr19:33,299,934...33,302,534 		JBrowse link
G CEBPB CCAAT enhancer binding protein beta increases expression EXP zoledronic acid results in increased expression of CEBPB mRNA CTD PMID:24714768 NCBI chr20:50,190,583...50,192,690
Ensembl chr20:50,190,734...50,192,690 		JBrowse link
G CEBPD CCAAT enhancer binding protein delta increases expression EXP zoledronic acid results in increased expression of CEBPD mRNA CTD PMID:24714768 NCBI chr 8:47,736,913...47,738,164
Ensembl chr 8:47,736,913...47,738,164 		JBrowse link
G CENPA centromere protein A decreases expression EXP zoledronic acid results in decreased expression of CENPA mRNA CTD PMID:24714768 NCBI chr 2:26,786,056...26,794,589
Ensembl chr 2:26,764,289...26,801,067 		JBrowse link
G CENPF centromere protein F decreases expression
decreases farnesylation 		EXP zoledronic acid results in decreased expression of CENPF mRNA
zoledronic acid results in decreased farnesylation of CENPF protein 		CTD PMID:20015195 PMID:24714768 NCBI chr 1:214,603,195...214,664,571
Ensembl chr 1:214,603,185...214,664,574 		JBrowse link
G CENPI centromere protein I increases expression EXP zoledronic acid results in increased expression of CENPI mRNA CTD PMID:20977926 NCBI chr  X:101,098,204...101,181,859
Ensembl chr  X:101,098,188...101,166,126 		JBrowse link
G CENPM centromere protein M decreases expression EXP zoledronic acid results in decreased expression of CENPM mRNA CTD PMID:24714768 NCBI chr22:41,927,196...41,947,152
Ensembl chr22:41,927,514...41,947,152 		JBrowse link
G CEP120 centrosomal protein 120 increases expression EXP zoledronic acid results in increased expression of CEP120 mRNA CTD PMID:20977926 NCBI chr 5:123,344,892...123,423,842
Ensembl chr 5:123,344,890...123,423,592 		JBrowse link
G CEP20 centrosomal protein 20 increases expression EXP Zoledronic Acid results in increased expression of CEP20 mRNA CTD PMID:20977926 NCBI chr16:15,865,719...15,888,603
Ensembl chr16:15,865,719...15,888,625 		JBrowse link
G CEP295 centrosomal protein 295 increases expression EXP zoledronic acid results in increased expression of CEP295 mRNA CTD PMID:20977926 NCBI chr11:93,661,682...93,730,358
Ensembl chr11:93,661,682...93,730,358 		JBrowse link
G CEP55 centrosomal protein 55 decreases expression EXP zoledronic acid results in decreased expression of CEP55 mRNA CTD PMID:24714768 NCBI chr10:93,496,612...93,529,092
Ensembl chr10:93,496,612...93,529,092 		JBrowse link
G CEP57 centrosomal protein 57 increases expression EXP zoledronic acid results in increased expression of CEP57 mRNA CTD PMID:20977926 NCBI chr11:95,790,498...95,832,693
Ensembl chr11:95,789,965...95,832,693 		JBrowse link
G CEPT1 choline/ethanolamine phosphotransferase 1 increases expression EXP zoledronic acid results in increased expression of CEPT1 mRNA CTD PMID:24714768 NCBI chr 1:111,139,499...111,185,104
Ensembl chr 1:111,139,479...111,185,104 		JBrowse link
G CFB complement factor B increases expression EXP zoledronic acid results in increased expression of CFB mRNA CTD PMID:24714768 NCBI chr 6:31,946,095...31,952,084
Ensembl chr 6:31,945,650...31,952,086 		JBrowse link
G CFL1 cofilin 1 increases expression EXP zoledronic acid results in increased expression of CFL1 protein CTD PMID:28871336 NCBI chr11:65,854,673...65,858,180
Ensembl chr11:65,823,022...65,862,026 		JBrowse link
G CFLAR CASP8 and FADD like apoptosis regulator increases expression EXP zoledronic acid results in increased expression of CFLAR mRNA CTD PMID:24714768 NCBI chr 2:201,116,164...201,176,687
Ensembl chr 2:201,116,154...201,176,687 		JBrowse link
G CGN cingulin decreases expression EXP zoledronic acid results in decreased expression of CGN mRNA CTD PMID:24714768 NCBI chr 1:151,510,170...151,538,692
Ensembl chr 1:151,510,510...151,538,692 		JBrowse link
G CGNL1 cingulin like 1 decreases expression EXP zoledronic acid results in decreased expression of CGNL1 mRNA CTD PMID:24714768 NCBI chr15:57,376,505...57,550,717
Ensembl chr15:57,375,967...57,550,717 		JBrowse link
G CHAC1 ChaC glutathione specific gamma-glutamylcyclotransferase 1 increases expression EXP zoledronic acid results in increased expression of CHAC1 mRNA CTD PMID:20977926 NCBI chr15:40,953,471...40,956,512
Ensembl chr15:40,952,962...40,956,512 		JBrowse link
G CHI3L2 chitinase 3 like 2 increases expression EXP zoledronic acid results in increased expression of CHI3L2 mRNA CTD PMID:24714768 NCBI chr 1:111,227,659...111,243,440
Ensembl chr 1:111,200,771...111,243,440 		JBrowse link
G CHMP4B charged multivesicular body protein 4B increases expression EXP zoledronic acid results in increased expression of CHMP4B mRNA CTD PMID:20977926 NCBI chr20:33,811,348...33,854,366
Ensembl chr20:33,811,348...33,854,366 		JBrowse link
G CHMP6 charged multivesicular body protein 6 increases expression EXP zoledronic acid results in increased expression of CHMP6 protein CTD PMID:28871336 NCBI chr17:80,991,841...81,000,133
Ensembl chr17:80,991,598...81,009,517 		JBrowse link
G CHST4 carbohydrate sulfotransferase 4 increases expression EXP zoledronic acid results in increased expression of CHST4 mRNA CTD PMID:24714768 NCBI chr16:71,526,120...71,538,748
Ensembl chr16:71,525,233...71,538,748 		JBrowse link
G CIITA class II major histocompatibility complex transactivator increases expression EXP zoledronic acid results in increased expression of CIITA mRNA CTD PMID:24714768 NCBI chr16:10,866,206...10,943,021
Ensembl chr16:10,866,222...10,943,021 		JBrowse link
G CIMIP2C ciliary microtubule inner protein 2C decreases expression EXP Zoledronic Acid results in decreased expression of CIMIP2C mRNA CTD PMID:24714768 NCBI chr 2:26,562,587...26,579,524
Ensembl chr 2:26,562,585...26,579,532 		JBrowse link
G CKS2 CDC28 protein kinase regulatory subunit 2 multiple interactions EXP [zoledronic acid co-treated with fluvastatin] results in increased expression of CKS2 mRNA CTD PMID:16996129 NCBI chr 9:89,311,195...89,316,703
Ensembl chr 9:89,311,195...89,316,703 		JBrowse link
G CLCA3P chloride channel accessory 3, pseudogene decreases expression EXP zoledronic acid results in decreased expression of CLCA3 mRNA CTD PMID:24714768 NCBI chr 1:86,634,276...86,655,376
Ensembl chr 1:86,634,276...86,654,745
Ensembl chr 1:86,634,276...86,654,745 		JBrowse link
G CLCN5 chloride voltage-gated channel 5 decreases expression EXP zoledronic acid results in decreased expression of CLCN5 mRNA CTD PMID:24714768 NCBI chr  X:49,922,596...50,099,230
Ensembl chr  X:49,922,596...50,099,235 		JBrowse link
G CLCNKA chloride voltage-gated channel Ka decreases expression EXP zoledronic acid results in decreased expression of CLCNKA mRNA CTD PMID:24714768 NCBI chr 1:16,022,036...16,034,050
Ensembl chr 1:16,018,875...16,034,050 		JBrowse link
G CLCNKB chloride voltage-gated channel Kb decreases expression EXP zoledronic acid results in decreased expression of CLCNKB mRNA CTD PMID:24714768 NCBI chr 1:16,043,782...16,057,326
Ensembl chr 1:16,040,252...16,057,311 		JBrowse link
G CLDN14 claudin 14 increases expression EXP zoledronic acid results in increased expression of CLDN14 mRNA CTD PMID:24714768 NCBI chr21:36,460,621...36,576,569
Ensembl chr21:36,460,621...36,576,569 		JBrowse link
G CLDN16 claudin 16 decreases expression EXP zoledronic acid results in decreased expression of CLDN16 mRNA CTD PMID:24714768 NCBI chr 3:190,290,361...190,412,138
Ensembl chr 3:190,322,541...190,412,138 		JBrowse link
G CLDN2 claudin 2 decreases expression EXP zoledronic acid results in decreased expression of CLDN2 mRNA CTD PMID:24714768 NCBI chr  X:106,900,164...106,930,861
Ensembl chr  X:106,900,164...106,930,861 		JBrowse link
G CLDN3 claudin 3 increases expression EXP zoledronic acid results in increased expression of CLDN3 mRNA CTD PMID:20977926 NCBI chr 7:73,768,997...73,770,270
Ensembl chr 7:73,768,997...73,770,270 		JBrowse link
G CLEC4E C-type lectin domain family 4 member E increases expression EXP zoledronic acid results in increased expression of CLEC4E mRNA CTD PMID:24714768 NCBI chr12:8,533,275...8,540,905
Ensembl chr12:8,533,305...8,540,905 		JBrowse link
G CLN3 CLN3 lysosomal/endosomal transmembrane protein, battenin increases expression EXP zoledronic acid results in increased expression of CLN3 mRNA CTD PMID:24714768 NCBI chr16:28,466,653...28,492,082
Ensembl chr16:28,474,111...28,495,575 		JBrowse link
G CNGB1 cyclic nucleotide gated channel subunit beta 1 increases expression EXP zoledronic acid results in increased expression of CNGB1 mRNA CTD PMID:24714768 NCBI chr16:57,882,340...57,971,128
Ensembl chr16:57,882,340...57,971,128 		JBrowse link
G CNTNAP1 contactin associated protein 1 increases expression EXP zoledronic acid results in increased expression of CNTNAP1 mRNA CTD PMID:24714768 NCBI chr17:42,682,531...42,699,993
Ensembl chr17:42,682,531...42,699,993 		JBrowse link
G COL16A1 collagen type XVI alpha 1 chain increases expression EXP zoledronic acid results in increased expression of COL16A1 mRNA CTD PMID:24714768 NCBI chr 1:31,652,263...31,704,017
Ensembl chr 1:31,652,263...31,704,319 		JBrowse link
G COL18A1 collagen type XVIII alpha 1 chain decreases expression EXP zoledronic acid results in decreased expression of COL18A1 mRNA CTD PMID:24714768 NCBI chr21:45,405,165...45,513,720
Ensembl chr21:45,405,165...45,513,720 		JBrowse link
G COL1A1 collagen type I alpha 1 chain decreases expression
multiple interactions
increases expression 		EXP
ISO 		zoledronic acid results in decreased expression of COL1A1 mRNA; zoledronic acid results in decreased expression of COL1A1 protein
Fenofibrate inhibits the reaction [zoledronic acid results in increased expression of COL1A1 mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in increased expression of COL1A1 mRNA] 		CTD PMID:19597852 PMID:28871336 NCBI chr17:50,184,101...50,201,631
Ensembl chr17:50,184,101...50,201,632 		JBrowse link
G COL3A1 collagen type III alpha 1 chain multiple interactions
increases expression 		ISO Fenofibrate inhibits the reaction [zoledronic acid results in increased expression of COL3A1 mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in increased expression of COL3A1 mRNA] CTD PMID:28871336 NCBI chr 2:188,974,373...189,012,746
Ensembl chr 2:188,974,373...189,012,746 		JBrowse link
G COL4A1 collagen type IV alpha 1 chain multiple interactions
increases expression 		ISO Fenofibrate inhibits the reaction [zoledronic acid results in increased expression of COL4A1 mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in increased expression of COL4A1 mRNA] CTD PMID:28871336 NCBI chr13:110,148,963...110,307,157
Ensembl chr13:110,148,963...110,307,202 		JBrowse link
G COL4A3 collagen type IV alpha 3 chain decreases expression EXP zoledronic acid results in decreased expression of COL4A3 mRNA CTD PMID:24714768 NCBI chr 2:227,164,624...227,314,792
Ensembl chr 2:227,164,624...227,314,792 		JBrowse link
G COL4A5 collagen type IV alpha 5 chain decreases expression EXP zoledronic acid results in decreased expression of COL4A5 mRNA CTD PMID:24714768 NCBI chr  X:108,439,838...108,697,545
Ensembl chr  X:108,439,838...108,697,545 		JBrowse link
G COL5A1 collagen type V alpha 1 chain increases expression EXP zoledronic acid results in increased expression of COL5A1 protein CTD PMID:28871336 NCBI chr 9:134,641,803...134,844,843
Ensembl chr 9:134,641,803...134,844,843 		JBrowse link
G COL9A2 collagen type IX alpha 2 chain increases expression EXP zoledronic acid results in increased expression of COL9A2 mRNA CTD PMID:24714768 NCBI chr 1:40,300,489...40,317,286
Ensembl chr 1:40,300,489...40,317,813 		JBrowse link
G COMP cartilage oligomeric matrix protein increases expression EXP zoledronic acid results in increased expression of COMP protein CTD PMID:28871336 NCBI chr19:18,782,773...18,791,305
Ensembl chr19:18,782,773...18,791,305 		JBrowse link
G COQ3 coenzyme Q3, methyltransferase decreases expression EXP zoledronic acid results in decreased expression of COQ3 mRNA CTD PMID:24714768 NCBI chr 6:99,369,401...99,394,195
Ensembl chr 6:99,369,401...99,394,195 		JBrowse link
G COQ4 coenzyme Q4 decreases expression EXP zoledronic acid results in decreased expression of COQ4 mRNA CTD PMID:20977926 NCBI chr 9:128,322,839...128,334,072
Ensembl chr 9:128,322,544...128,334,072 		JBrowse link
G COX17 cytochrome c oxidase copper chaperone COX17 decreases expression EXP zoledronic acid results in decreased expression of COX17 mRNA CTD PMID:20977926 NCBI chr 3:119,663,975...119,677,406
Ensembl chr 3:119,654,513...119,677,454 		JBrowse link
G CP ceruloplasmin increases expression EXP zoledronic acid results in increased expression of CP mRNA CTD PMID:24714768 PMID:25596134 NCBI chr 3:149,162,414...149,221,829
Ensembl chr 3:149,162,410...149,221,829 		JBrowse link
G CPA4 carboxypeptidase A4 decreases expression EXP zoledronic acid results in decreased expression of CPA4 mRNA CTD PMID:24714768 NCBI chr 7:130,293,161...130,324,180
Ensembl chr 7:130,293,134...130,324,180 		JBrowse link
G CPD carboxypeptidase D increases expression EXP zoledronic acid results in increased expression of CPD mRNA CTD PMID:20977926 NCBI chr17:30,378,927...30,469,989
Ensembl chr17:30,378,927...30,469,989 		JBrowse link
G CPEB2 cytoplasmic polyadenylation element binding protein 2 decreases expression EXP zoledronic acid results in decreased expression of CPEB2 mRNA CTD PMID:24714768 NCBI chr 4:15,002,481...15,070,151
Ensembl chr 4:15,002,481...15,070,153 		JBrowse link
G CPNE3 copine 3 increases expression EXP zoledronic acid results in increased expression of CPNE3 mRNA CTD PMID:20977926 NCBI chr 8:86,514,435...86,561,498
Ensembl chr 8:86,514,435...86,561,498 		JBrowse link
G CPNE8 copine 8 decreases expression EXP zoledronic acid results in decreased expression of CPNE8 mRNA CTD PMID:24714768 NCBI chr12:38,652,203...38,906,835
Ensembl chr12:38,646,822...38,907,430 		JBrowse link
G CPQ carboxypeptidase Q decreases expression EXP zoledronic acid results in decreased expression of PGCP mRNA CTD PMID:24714768 NCBI chr 8:96,645,242...97,143,501
Ensembl chr 8:96,645,242...97,149,654 		JBrowse link
G CPT1A carnitine palmitoyltransferase 1A decreases expression
multiple interactions 		EXP
ISO 		Zoledronic Acid results in decreased expression of CPT1A mRNA; Zoledronic Acid results in decreased expression of CPT1A protein
Fenofibrate inhibits the reaction [zoledronic acid results in decreased expression of CPT1A mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in decreased expression of CPT1A mRNA] 		CTD PMID:28871336 NCBI chr11:68,754,620...68,844,277
Ensembl chr11:68,754,620...68,844,410 		JBrowse link
G CPT2 carnitine palmitoyltransferase 2 decreases expression
multiple interactions 		ISO zoledronic acid results in decreased expression of CPT2 mRNA
Fenofibrate inhibits the reaction [zoledronic acid results in decreased expression of CPT2 mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in decreased expression of CPT2 mRNA] 		CTD PMID:28871336 NCBI chr 1:53,196,824...53,214,197
Ensembl chr 1:53,196,792...53,214,197 		JBrowse link
G CPVL carboxypeptidase vitellogenic like decreases expression EXP zoledronic acid results in decreased expression of CPVL mRNA CTD PMID:24714768 NCBI chr 7:28,994,636...29,195,451
Ensembl chr 7:28,995,235...29,195,451 		JBrowse link
G CRAT carnitine O-acetyltransferase decreases expression ISO zoledronic acid results in decreased expression of CRAT mRNA CTD PMID:28871336 NCBI chr 9:129,094,794...129,110,793
Ensembl chr 9:129,094,142...129,111,189 		JBrowse link
G CREB5 cAMP responsive element binding protein 5 decreases expression EXP zoledronic acid results in decreased expression of CREB5 mRNA CTD PMID:24714768 NCBI chr 7:28,299,321...28,825,894
Ensembl chr 7:28,299,321...28,825,894 		JBrowse link
G CRLS1 cardiolipin synthase 1 decreases expression EXP zoledronic acid results in decreased expression of CRLS1 mRNA CTD PMID:20977926 NCBI chr20:6,005,938...6,040,053
Ensembl chr20:6,006,093...6,040,053 		JBrowse link
G CRYAB crystallin alpha B increases expression EXP zoledronic acid results in increased expression of CRYAB mRNA CTD PMID:24714768 NCBI chr11:111,908,564...111,923,740
Ensembl chr11:111,908,564...111,923,722 		JBrowse link
G CSF1 colony stimulating factor 1 increases expression
decreases expression 		EXP zoledronic acid results in increased expression of CSF1 mRNA
zoledronic acid results in decreased expression of CSF1 mRNA 		CTD PMID:20977926 PMID:24714768 NCBI chr 1:109,910,506...109,930,992
Ensembl chr 1:109,910,242...109,930,992 		JBrowse link
G CSF2 colony stimulating factor 2 increases expression EXP zoledronic acid results in increased expression of CSF2 mRNA CTD PMID:24714768 NCBI chr 5:132,073,789...132,076,170
Ensembl chr 5:132,073,789...132,076,170 		JBrowse link
G CSRP2 cysteine and glycine rich protein 2 decreases expression EXP zoledronic acid results in decreased expression of CSRP2 mRNA CTD PMID:24714768 NCBI chr12:76,858,709...76,879,019
Ensembl chr12:76,858,709...76,879,023 		JBrowse link
G CST2 cystatin SA increases expression EXP zoledronic acid results in increased expression of CST2 mRNA CTD PMID:24714768 NCBI chr20:23,823,769...23,826,729
Ensembl chr20:23,823,769...23,826,729 		JBrowse link
G CST3 cystatin C increases expression EXP zoledronic acid results in increased expression of CST3 protein CTD PMID:28871336 NCBI chr20:23,626,706...23,637,955
Ensembl chr20:23,626,706...23,638,473 		JBrowse link
G CTBS chitobiase increases expression EXP zoledronic acid results in increased expression of CTBS mRNA CTD PMID:20977926 NCBI chr 1:84,549,611...84,574,440
Ensembl chr 1:84,549,611...84,574,480 		JBrowse link
G CTH cystathionine gamma-lyase decreases expression EXP zoledronic acid results in decreased expression of CTH mRNA CTD PMID:24714768 PMID:25596134 NCBI chr 1:70,411,268...70,439,851
Ensembl chr 1:70,411,218...70,439,851 		JBrowse link
G CTSB cathepsin B decreases expression EXP zoledronic acid results in decreased expression of CTSB protein CTD PMID:16475674 NCBI chr 8:11,842,524...11,868,087
Ensembl chr 8:11,842,524...11,869,533 		JBrowse link
G CTSC cathepsin C increases expression EXP zoledronic acid results in increased expression of CTSC mRNA CTD PMID:25596134 NCBI chr11:88,293,592...88,337,736
Ensembl chr11:88,265,069...88,359,684 		JBrowse link
G CTSE cathepsin E increases expression EXP zoledronic acid results in increased expression of CTSE mRNA CTD PMID:24714768 NCBI chr 1:206,009,264...206,023,895
Ensembl chr 1:206,008,535...206,023,909 		JBrowse link
G CTSS cathepsin S increases expression EXP zoledronic acid results in increased expression of CTSS mRNA CTD PMID:24714768 NCBI chr 1:150,730,188...150,765,778
Ensembl chr 1:150,730,079...150,765,957 		JBrowse link
G CTTN cortactin decreases expression EXP zoledronic acid results in decreased expression of CTTN mRNA CTD PMID:25596134 NCBI chr11:70,398,529...70,436,575
Ensembl chr11:70,398,404...70,436,584 		JBrowse link
G CTU2 cytosolic thiouridylase subunit 2 decreases expression EXP zoledronic acid results in decreased expression of CTU2 mRNA CTD PMID:20977926 NCBI chr16:88,706,503...88,715,396
Ensembl chr16:88,706,483...88,715,396 		JBrowse link
G CUBN cubilin increases expression EXP zoledronic acid results in increased expression of CUBN mRNA CTD PMID:24714768 NCBI chr10:16,823,966...17,129,811
Ensembl chr10:16,823,966...17,129,811 		JBrowse link
G CUL4A cullin 4A increases expression EXP zoledronic acid results in increased expression of CUL4A mRNA CTD PMID:24714768 NCBI chr13:113,208,193...113,267,108
Ensembl chr13:113,208,193...113,267,108 		JBrowse link
G CX3CL1 C-X3-C motif chemokine ligand 1 increases expression EXP zoledronic acid results in increased expression of CX3CL1 mRNA CTD PMID:24714768 NCBI chr16:57,372,490...57,385,044
Ensembl chr16:57,372,477...57,385,044 		JBrowse link
G CXCL1 C-X-C motif chemokine ligand 1 multiple interactions
increases expression 		EXP [zoledronic acid co-treated with Gossypol] results in decreased expression of CXCL1 mRNA
zoledronic acid results in increased expression of CXCL1 mRNA 		CTD PMID:19825521 PMID:24714768 NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308 		JBrowse link
G CXCL10 C-X-C motif chemokine ligand 10 increases expression EXP zoledronic acid results in increased expression of CXCL10 mRNA CTD PMID:24714768 NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497 		JBrowse link
G CXCL12 C-X-C motif chemokine ligand 12 decreases expression EXP zoledronic acid results in decreased expression of CXCL12 mRNA CTD PMID:24714768 NCBI chr10:44,370,165...44,385,097
Ensembl chr10:44,370,165...44,386,493 		JBrowse link
G CXCL14 C-X-C motif chemokine ligand 14 decreases expression EXP zoledronic acid results in decreased expression of CXCL14 mRNA CTD PMID:24714768 NCBI chr 5:135,570,679...135,578,991
Ensembl chr 5:135,570,679...135,579,279 		JBrowse link
G CXCL16 C-X-C motif chemokine ligand 16 increases expression EXP zoledronic acid results in increased expression of CXCL16 mRNA CTD PMID:24714768 NCBI chr17:4,733,533...4,739,928
Ensembl chr17:4,733,533...4,739,928 		JBrowse link
G CXCL2 C-X-C motif chemokine ligand 2 increases expression EXP zoledronic acid results in increased expression of CXCL2 mRNA CTD PMID:24714768 NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196 		JBrowse link
G CXCL5 C-X-C motif chemokine ligand 5 increases expression EXP zoledronic acid results in increased expression of CXCL5 mRNA CTD PMID:24714768 NCBI chr 4:73,995,642...73,998,677
Ensembl chr 4:73,995,642...73,998,677 		JBrowse link
G CXCL8 C-X-C motif chemokine ligand 8 increases expression EXP zoledronic acid results in increased expression of CXCL8 mRNA CTD PMID:24714768 NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716 		JBrowse link
G CXCR4 C-X-C motif chemokine receptor 4 increases expression EXP zoledronic acid results in increased expression of CXCR4 mRNA CTD PMID:24714768 NCBI chr 2:136,114,349...136,118,149
Ensembl chr 2:136,114,349...136,119,177 		JBrowse link
G CYB5R3 cytochrome b5 reductase 3 increases expression EXP zoledronic acid results in increased expression of CYB5R3 mRNA CTD PMID:20977926 NCBI chr22:42,617,840...42,649,392
Ensembl chr22:42,615,730...42,720,870 		JBrowse link
G CYCS cytochrome c, somatic increases expression EXP Zoledronic Acid results in increased expression of CYCS mRNA CTD PMID:35587103 NCBI chr 7:25,118,656...25,125,260
Ensembl chr 7:25,118,656...25,125,260 		JBrowse link
G CYFIP2 cytoplasmic FMR1 interacting protein 2 decreases expression EXP zoledronic acid results in decreased expression of CYFIP2 mRNA CTD PMID:24714768 NCBI chr 5:157,266,123...157,395,594
Ensembl chr 5:157,266,079...157,395,595 		JBrowse link
G CYP1A1 cytochrome P450 family 1 subfamily A member 1 increases expression EXP zoledronic acid results in increased expression of CYP1A1 mRNA CTD PMID:24714768 PMID:25596134 NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536 		JBrowse link
G CYP1A2 cytochrome P450 family 1 subfamily A member 2 increases expression EXP zoledronic acid results in increased expression of CYP1A2 mRNA CTD PMID:24714768 PMID:25596134 NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607 		JBrowse link
G CYP1B1 cytochrome P450 family 1 subfamily B member 1 increases expression EXP zoledronic acid results in increased expression of CYP1B1 mRNA CTD PMID:24714768 PMID:25596134 NCBI chr 2:38,067,509...38,076,151
Ensembl chr 2:38,066,973...38,109,902 		JBrowse link
G CYP2C9 cytochrome P450 family 2 subfamily C member 9 increases expression EXP zoledronic acid results in increased expression of CYP2C9 mRNA CTD PMID:24714768 NCBI chr10:94,938,658...94,990,091
Ensembl chr10:94,938,658...94,990,091 		JBrowse link
G CYP3A5 cytochrome P450 family 3 subfamily A member 5 increases expression EXP zoledronic acid results in increased expression of CYP3A5 mRNA CTD PMID:24714768 NCBI chr 7:99,648,194...99,679,996
Ensembl chr 7:99,648,194...99,679,996 		JBrowse link
G CYP3A7 cytochrome P450 family 3 subfamily A member 7 increases expression EXP zoledronic acid results in increased expression of CYP3A7 mRNA CTD PMID:24714768 NCBI chr 7:99,705,036...99,735,196
Ensembl chr 7:99,705,036...99,735,196 		JBrowse link
G CYP4B1 cytochrome P450 family 4 subfamily B member 1 increases expression EXP zoledronic acid results in increased expression of CYP4B1 mRNA CTD PMID:24714768 NCBI chr 1:46,799,046...46,819,413
Ensembl chr 1:46,757,838...46,819,413 		JBrowse link
G CYP51A1 cytochrome P450 family 51 subfamily A member 1 increases expression EXP zoledronic acid results in increased expression of CYP51A1 mRNA CTD PMID:24714768 NCBI chr 7:92,112,153...92,134,803
Ensembl chr 7:92,084,987...92,134,803 		JBrowse link
G CYS1 cystin 1 decreases expression EXP zoledronic acid results in decreased expression of CYS1 mRNA CTD PMID:24714768 NCBI chr 2:10,056,473...10,080,411
Ensembl chr 2:10,056,473...10,080,944 		JBrowse link
G CYTIP cytohesin 1 interacting protein increases expression EXP zoledronic acid results in increased expression of CYTIP mRNA CTD PMID:24714768 NCBI chr 2:157,414,619...157,444,089
Ensembl chr 2:157,409,360...157,491,093 		JBrowse link
G CYTOR cytoskeleton regulator RNA decreases expression EXP zoledronic acid results in decreased expression of CYTOR mRNA CTD PMID:24714768 NCBI chr 2:87,455,427...87,521,518
Ensembl chr 2:87,454,781...87,636,740 		JBrowse link
G DAPK1 death associated protein kinase 1 decreases expression EXP zoledronic acid results in decreased expression of DAPK1 mRNA CTD PMID:19036117 NCBI chr 9:87,497,228...87,708,634
Ensembl chr 9:87,497,228...87,708,634 		JBrowse link
G DAPP1 dual adaptor of phosphotyrosine and 3-phosphoinositides 1 increases expression EXP zoledronic acid results in increased expression of DAPP1 mRNA CTD PMID:20977926 PMID:24714768 NCBI chr 4:99,816,827...99,872,333
Ensembl chr 4:99,816,827...99,870,190 		JBrowse link
G DCAF15 DDB1 and CUL4 associated factor 15 increases expression EXP zoledronic acid results in increased expression of DCAF15 mRNA CTD PMID:20977926 NCBI chr19:13,952,509...13,961,449
Ensembl chr19:13,952,509...13,961,449 		JBrowse link
G DCDC2 doublecortin domain containing 2 decreases expression EXP zoledronic acid results in decreased expression of DCDC2 mRNA CTD PMID:24714768 NCBI chr 6:24,171,755...24,383,292
Ensembl chr 6:24,171,755...24,358,059 		JBrowse link
G DCUN1D4 defective in cullin neddylation 1 domain containing 4 increases expression EXP zoledronic acid results in increased expression of DCUN1D4 mRNA CTD PMID:20977926 NCBI chr 4:51,833,884...51,916,837
Ensembl chr 4:51,843,000...51,916,837 		JBrowse link
G DDAH1 dimethylarginine dimethylaminohydrolase 1 decreases expression EXP zoledronic acid results in decreased expression of DDAH1 mRNA CTD PMID:24714768 NCBI chr 1:85,318,485...85,578,200
Ensembl chr 1:85,318,481...85,578,363 		JBrowse link
G DDIT3 DNA damage inducible transcript 3 increases expression EXP Zoledronic Acid results in increased expression of DDIT3 mRNA CTD PMID:35587103 NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737 		JBrowse link
G DDIT4 DNA damage inducible transcript 4 decreases expression EXP zoledronic acid results in decreased expression of DDIT4 mRNA CTD PMID:25596134 NCBI chr10:72,273,924...72,276,036
Ensembl chr10:72,273,919...72,276,036 		JBrowse link
G DDIT4L DNA damage inducible transcript 4 like increases expression EXP zoledronic acid results in increased expression of DDIT4L mRNA CTD PMID:24714768 NCBI chr 4:100,185,870...100,190,468
Ensembl chr 4:100,185,870...100,190,782 		JBrowse link
G DDR1 discoidin domain receptor tyrosine kinase 1 increases expression
decreases expression 		EXP zoledronic acid results in increased expression of DDR1 mRNA
zoledronic acid monohydrate decreases expression of DDR1 mRNA and protein in human PC3 cancer cell line 		CTD
RGD		 PMID:24714768 PMID:26366216 RGD:151347692 NCBI chr 6:30,880,970...30,900,156
Ensembl chr 6:30,876,421...30,900,156 		JBrowse link
G DDX10 DEAD-box helicase 10 decreases expression EXP zoledronic acid results in decreased expression of DDX10 mRNA CTD PMID:24714768 NCBI chr11:108,665,069...108,940,927
Ensembl chr11:108,665,058...108,940,999 		JBrowse link
G DDX12P DEAD/H-box helicase 12, pseudogene decreases expression EXP zoledronic acid results in decreased expression of DDX12P mRNA CTD PMID:24714768 NCBI chr12:9,417,691...9,448,172
Ensembl chr12:9,418,673...9,448,229 		JBrowse link
G DDX42 DEAD-box helicase 42 increases expression EXP zoledronic acid results in increased expression of DDX42 mRNA CTD PMID:20977926 NCBI chr17:63,773,800...63,819,317
Ensembl chr17:63,773,603...63,819,317 		JBrowse link
G DEFB1 defensin beta 1 increases expression EXP zoledronic acid results in increased expression of DEFB1 mRNA CTD PMID:24714768 NCBI chr 8:6,870,592...6,877,936
Ensembl chr 8:6,870,592...6,877,936 		JBrowse link
G DEFB4A defensin beta 4A increases expression EXP Zoledronic Acid results in increased expression of DEFB4 mRNA CTD PMID:24714768 NCBI chr 8:7,894,677...7,896,716
Ensembl chr 8:7,894,677...7,896,716
Ensembl chr 8:7,894,677...7,896,716 		JBrowse link
G DENND2A DENN domain containing 2A decreases expression EXP zoledronic acid results in decreased expression of DENND2A mRNA CTD PMID:24714768 NCBI chr 7:140,518,419...140,641,460
Ensembl chr 7:140,518,420...140,673,993 		JBrowse link
G DENND2B DENN domain containing 2B increases expression EXP Zoledronic Acid results in increased expression of DENND2B mRNA CTD PMID:24714768 NCBI chr11:8,693,352...8,910,951
Ensembl chr11:8,693,351...8,910,951 		JBrowse link
G DENND2D DENN domain containing 2D increases expression EXP zoledronic acid results in increased expression of DENND2D mRNA CTD PMID:24714768 NCBI chr 1:111,185,969...111,204,578
Ensembl chr 1:111,185,969...111,204,535 		JBrowse link
G DEPDC1 DEP domain containing 1 decreases expression EXP zoledronic acid results in decreased expression of DEPDC1 mRNA CTD PMID:24714768 NCBI chr 1:68,474,152...68,497,082
Ensembl chr 1:68,474,152...68,497,221 		JBrowse link
G DEPP1 DEPP autophagy regulator 1 increases expression EXP zoledronic acid results in increased expression of DEPP1 mRNA CTD PMID:24714768 NCBI chr10:44,976,128...44,978,809
Ensembl chr10:44,970,981...44,978,809 		JBrowse link
G DEPTOR DEP domain containing MTOR interacting protein decreases expression EXP Zoledronic Acid results in decreased expression of DEPTOR mRNA CTD PMID:24714768 NCBI chr 8:119,873,722...120,050,918
Ensembl chr 8:119,873,717...120,050,918 		JBrowse link
G DFFA DNA fragmentation factor subunit alpha decreases expression EXP zoledronic acid results in decreased expression of DFFA mRNA CTD PMID:20977926 NCBI chr 1:10,456,522...10,472,529
Ensembl chr 1:10,456,522...10,472,529 		JBrowse link
G DHCR7 7-dehydrocholesterol reductase increases expression EXP zoledronic acid results in increased expression of DHCR7 mRNA CTD PMID:24714768 NCBI chr11:71,427,287...71,449,043
Ensembl chr11:71,428,193...71,452,868 		JBrowse link
G DHRS11 dehydrogenase/reductase 11 decreases expression EXP zoledronic acid results in decreased expression of DHRS11 mRNA CTD PMID:24714768 NCBI chr17:36,591,879...36,600,804
Ensembl chr17:36,591,879...36,600,804 		JBrowse link
G DHRS3 dehydrogenase/reductase 3 decreases expression EXP zoledronic acid results in decreased expression of DHRS3 mRNA CTD PMID:24714768 NCBI chr 1:12,567,910...12,618,210
Ensembl chr 1:12,567,909...12,620,133 		JBrowse link
G DHX35 DEAH-box helicase 35 increases expression EXP zoledronic acid results in increased expression of DHX35 mRNA CTD PMID:20977926 NCBI chr20:38,962,344...39,039,721
Ensembl chr20:38,962,299...39,039,723 		JBrowse link
G DIABLO diablo IAP-binding mitochondrial protein multiple interactions EXP [Tretinoin co-treated with zoledronic acid] results in decreased expression of DIABLO protein CTD PMID:20349282 NCBI chr12:122,207,662...122,227,456
Ensembl chr12:122,207,668...122,226,062 		JBrowse link
G DIAPH3 diaphanous related formin 3 decreases expression EXP zoledronic acid results in decreased expression of DIAPH3 mRNA CTD PMID:24714768 NCBI chr13:59,665,583...60,163,928
Ensembl chr13:59,665,583...60,163,928 		JBrowse link
G DIO2 iodothyronine deiodinase 2 decreases expression EXP zoledronic acid results in decreased expression of DIO2 mRNA CTD PMID:24714768 NCBI chr14:80,197,526...80,231,057
Ensembl chr14:80,197,526...80,387,757 		JBrowse link
G DKK1 dickkopf WNT signaling pathway inhibitor 1 decreases expression EXP zoledronic acid results in decreased expression of DKK1 mRNA CTD PMID:24714768 NCBI chr10:52,314,281...52,317,657
Ensembl chr10:52,314,281...52,318,042 		JBrowse link
G DLC1 DLC1 Rho GTPase activating protein decreases expression EXP zoledronic acid results in decreased expression of DLC1 mRNA CTD PMID:24714768 NCBI chr 8:13,083,361...13,604,620
Ensembl chr 8:13,083,361...13,604,610 		JBrowse link
G DLG1 discs large MAGUK scaffold protein 1 increases expression EXP zoledronic acid results in increased expression of DLG1 mRNA CTD PMID:20977926 NCBI chr 3:197,042,560...197,299,321
Ensembl chr 3:197,042,560...197,299,330 		JBrowse link
G DLGAP4 DLG associated protein 4 decreases expression EXP zoledronic acid results in decreased expression of DLGAP4 mRNA CTD PMID:20977926 NCBI chr20:36,306,339...36,528,633
Ensembl chr20:36,306,336...36,528,637 		JBrowse link
G DLGAP5 DLG associated protein 5 decreases expression EXP zoledronic acid results in decreased expression of DLGAP5 mRNA CTD PMID:24714768 PMID:25596134 NCBI chr14:55,148,135...55,191,585
Ensembl chr14:55,148,112...55,191,608 		JBrowse link
G DLX1 distal-less homeobox 1 decreases expression EXP zoledronic acid results in decreased expression of DLX1 mRNA CTD PMID:25596134 NCBI chr 2:172,085,507...172,089,674
Ensembl chr 2:172,084,740...172,089,677 		JBrowse link
G DNAJB9 DnaJ heat shock protein family (Hsp40) member B9 increases expression EXP zoledronic acid results in increased expression of DNAJB9 mRNA CTD PMID:20977926 NCBI chr 7:108,569,874...108,574,850
Ensembl chr 7:108,569,867...108,574,850 		JBrowse link
G DNASE1L1 deoxyribonuclease 1 like 1 increases expression EXP zoledronic acid results in increased expression of DNASE1L1 mRNA CTD PMID:20977926 NCBI chr  X:154,401,236...154,412,101
Ensembl chr  X:154,401,236...154,412,112 		JBrowse link
G DNER delta/notch like EGF repeat containing increases expression EXP zoledronic acid results in increased expression of DNER mRNA CTD PMID:24714768 NCBI chr 2:229,357,629...229,714,555
Ensembl chr 2:229,357,629...229,714,555 		JBrowse link
G DOCK10 dedicator of cytokinesis 10 increases expression EXP zoledronic acid results in increased expression of DOCK10 mRNA CTD PMID:24714768 NCBI chr 2:224,765,090...225,042,468
Ensembl chr 2:224,765,090...225,042,468 		JBrowse link
G DPP9 dipeptidyl peptidase 9 increases expression EXP zoledronic acid results in increased expression of DPP9 mRNA CTD PMID:20977926 NCBI chr19:4,675,227...4,723,842
Ensembl chr19:4,674,341...4,724,673 		JBrowse link
G DSE dermatan sulfate epimerase increases expression EXP zoledronic acid results in increased expression of DSE mRNA CTD PMID:24714768 NCBI chr 6:116,254,171...116,444,861
Ensembl chr 6:116,254,173...116,444,861 		JBrowse link
G DSEL dermatan sulfate epimerase like decreases expression EXP zoledronic acid results in decreased expression of DSEL mRNA CTD PMID:24714768 NCBI chr18:67,506,587...67,516,720
Ensembl chr18:67,506,587...67,516,720 		JBrowse link
G DTWD2 DTW domain containing 2 decreases expression EXP zoledronic acid results in decreased expression of DTWD2 mRNA CTD PMID:20977926 NCBI chr 5:118,836,074...118,988,547
Ensembl chr 5:118,836,074...118,988,547 		JBrowse link
G DTX3 deltex E3 ubiquitin ligase 3 increases expression EXP zoledronic acid results in increased expression of DTX3 mRNA CTD PMID:20977926 NCBI chr12:57,604,824...57,609,802
Ensembl chr12:57,604,622...57,609,804 		JBrowse link
G DUSP18 dual specificity phosphatase 18 increases expression EXP zoledronic acid results in increased expression of DUSP18 mRNA CTD PMID:20977926 NCBI chr22:30,652,051...30,667,875
Ensembl chr22:30,652,051...30,667,887 		JBrowse link
G DUSP4 dual specificity phosphatase 4 decreases expression EXP zoledronic acid results in decreased expression of DUSP4 mRNA CTD PMID:24714768 NCBI chr 8:29,333,064...29,350,684
Ensembl chr 8:29,333,064...29,350,684 		JBrowse link
G DUSP5 dual specificity phosphatase 5 decreases expression EXP zoledronic acid results in decreased expression of DUSP5 mRNA CTD PMID:24714768 PMID:25596134 NCBI chr10:110,497,907...110,511,533
Ensembl chr10:110,497,907...110,511,533 		JBrowse link
G DUSP6 dual specificity phosphatase 6 decreases expression EXP zoledronic acid results in decreased expression of DUSP6 mRNA CTD PMID:24714768 NCBI chr12:89,347,235...89,352,501
Ensembl chr12:89,347,235...89,352,501 		JBrowse link
G DYNC2LI1 dynein cytoplasmic 2 light intermediate chain 1 decreases expression EXP zoledronic acid results in decreased expression of DYNC2LI1 mRNA CTD PMID:24714768 NCBI chr 2:43,774,039...43,828,347
Ensembl chr 2:43,774,039...43,810,010 		JBrowse link
G E2F2 E2F transcription factor 2 increases expression EXP zoledronic acid results in increased expression of E2F2 mRNA CTD PMID:20977926 NCBI chr 1:23,505,212...23,531,233
Ensembl chr 1:23,506,438...23,531,233 		JBrowse link
G EBI3 Epstein-Barr virus induced 3 increases expression EXP zoledronic acid results in increased expression of EBI3 mRNA CTD PMID:24714768 NCBI chr19:4,229,523...4,237,528
Ensembl chr19:4,229,523...4,237,528 		JBrowse link
G EBP EBP cholestenol delta-isomerase increases expression EXP zoledronic acid results in increased expression of EBP mRNA CTD PMID:24714768 NCBI chr  X:48,521,808...48,528,716
Ensembl chr  X:48,521,799...48,528,716 		JBrowse link
G ECE1 endothelin converting enzyme 1 increases expression EXP zoledronic acid results in increased expression of ECE1 mRNA CTD PMID:24714768 NCBI chr 1:21,217,250...21,345,504
Ensembl chr 1:21,217,247...21,345,572 		JBrowse link
G ECH1 enoyl-CoA hydratase 1 decreases expression ISO zoledronic acid results in decreased expression of ECH1 mRNA CTD PMID:28871336 NCBI chr19:38,815,422...38,831,794
Ensembl chr19:38,815,422...38,831,841 		JBrowse link
G ECM1 extracellular matrix protein 1 increases expression EXP zoledronic acid results in increased expression of ECM1 mRNA CTD PMID:24714768 NCBI chr 1:150,508,109...150,513,789
Ensembl chr 1:150,508,062...150,513,789 		JBrowse link
G EDN1 endothelin 1 increases expression EXP zoledronic acid results in increased expression of EDN1 mRNA CTD PMID:24714768 NCBI chr 6:12,230,516...12,297,194
Ensembl chr 6:12,290,361...12,297,194 		JBrowse link
G EFHD1 EF-hand domain family member D1 decreases expression EXP zoledronic acid results in decreased expression of EFHD1 mRNA CTD PMID:24714768 NCBI chr 2:232,606,057...232,682,776
Ensembl chr 2:232,606,057...232,682,776 		JBrowse link
G EFNA1 ephrin A1 increases expression EXP zoledronic acid results in increased expression of EFNA1 mRNA CTD PMID:24714768 PMID:25596134 NCBI chr 1:155,127,876...155,134,899
Ensembl chr 1:155,127,876...155,134,899 		JBrowse link
G EFNB2 ephrin B2 decreases expression EXP zoledronic acid results in decreased expression of EFNB2 mRNA CTD PMID:24714768 NCBI chr13:106,489,745...106,535,662
Ensembl chr13:106,489,745...106,535,662 		JBrowse link
G EGFL6 EGF like domain multiple 6 decreases expression EXP zoledronic acid results in decreased expression of EGFL6 mRNA CTD PMID:24714768 NCBI chr  X:13,569,601...13,633,575
Ensembl chr  X:13,569,601...13,633,575 		JBrowse link
G EGLN2 egl-9 family hypoxia inducible factor 2 increases expression EXP zoledronic acid results in increased expression of EGLN2 mRNA CTD PMID:20977926 NCBI chr19:40,799,191...40,808,434
Ensembl chr19:40,798,996...40,808,434 		JBrowse link
G EGR1 early growth response 1 increases expression
decreases expression 		EXP zoledronic acid results in increased expression of EGR1 mRNA
zoledronic acid results in decreased expression of EGR1 mRNA 		CTD PMID:20977926 PMID:24714768 NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303 		JBrowse link
G EGR2 early growth response 2 increases expression EXP zoledronic acid results in increased expression of EGR2 mRNA CTD PMID:20977926 NCBI chr10:62,811,996...62,819,167
Ensembl chr10:62,811,996...62,819,167 		JBrowse link
G EGR4 early growth response 4 increases expression EXP zoledronic acid results in increased expression of EGR4 mRNA CTD PMID:20977926 NCBI chr 2:73,290,929...73,293,548
Ensembl chr 2:73,290,929...73,293,701 		JBrowse link
G EHHADH enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase decreases expression ISO zoledronic acid results in decreased expression of EHHADH mRNA CTD PMID:28871336 NCBI chr 3:185,190,624...185,254,049
Ensembl chr 3:185,190,624...185,281,990 		JBrowse link
G ELK1 ETS transcription factor ELK1 increases expression EXP zoledronic acid results in increased expression of ELK1 mRNA CTD PMID:20977926 NCBI chr  X:47,635,520...47,650,604
Ensembl chr  X:47,635,520...47,650,604 		JBrowse link
G ELL2 elongation factor for RNA polymerase II 2 increases expression EXP zoledronic acid results in increased expression of ELL2 mRNA CTD PMID:20977926 NCBI chr 5:95,885,098...95,961,851
Ensembl chr 5:95,885,098...95,961,851 		JBrowse link
G ELOB elongin B decreases expression EXP zoledronic acid results in decreased expression of ELOB mRNA CTD PMID:24714768 NCBI chr16:2,771,414...2,777,280
Ensembl chr16:2,771,414...2,777,289 		JBrowse link
G ELOVL6 ELOVL fatty acid elongase 6 increases expression EXP zoledronic acid results in increased expression of ELOVL6 mRNA CTD PMID:24714768 NCBI chr 4:110,045,846...110,199,202
Ensembl chr 4:110,045,846...110,199,199 		JBrowse link
G EML4 EMAP like 4 increases expression EXP zoledronic acid results in increased expression of EML4 mRNA CTD PMID:20977926 NCBI chr 2:42,169,353...42,332,548
Ensembl chr 2:42,169,353...42,332,548 		JBrowse link
G EMP3 epithelial membrane protein 3 (MAM blood group) multiple interactions
increases expression 		EXP [zoledronic acid co-treated with fluvastatin] results in increased expression of EMP3 mRNA
zoledronic acid results in increased expression of EMP3 mRNA 		CTD PMID:16996129 PMID:20977926 NCBI chr19:48,325,552...48,330,553
Ensembl chr19:48,321,310...48,330,559 		JBrowse link
G ENPP6 ectonucleotide pyrophosphatase/phosphodiesterase 6 increases expression EXP zoledronic acid results in increased expression of ENPP6 mRNA CTD PMID:24714768 NCBI chr 4:184,088,706...184,217,873
Ensembl chr 4:184,088,706...184,221,230 		JBrowse link
G EP400 E1A binding protein p400 decreases expression EXP zoledronic acid results in decreased expression of EP400 mRNA CTD PMID:25596134 NCBI chr12:131,949,942...132,080,460
Ensembl chr12:131,949,942...132,080,460 		JBrowse link
G EPHA4 EPH receptor A4 increases expression EXP zoledronic acid results in increased expression of EPHA4 mRNA CTD PMID:24714768 NCBI chr 2:221,418,027...221,574,202
Ensembl chr 2:221,418,027...221,574,202 		JBrowse link
G EPHB3 EPH receptor B3 decreases expression EXP zoledronic acid results in decreased expression of EPHB3 mRNA CTD PMID:24714768 NCBI chr 3:184,561,785...184,582,408
Ensembl chr 3:184,561,785...184,582,408 		JBrowse link
G EPHB4 EPH receptor B4 multiple interactions EXP [zoledronic acid co-treated with Gossypol] results in decreased expression of EPHB4 mRNA CTD PMID:19825521 NCBI chr 7:100,802,565...100,827,523
Ensembl chr 7:100,802,565...100,827,523 		JBrowse link
G EPHX2 epoxide hydrolase 2 decreases expression
increases expression 		EXP zoledronic acid results in decreased expression of EPHX2 mRNA
zoledronic acid results in increased expression of EPHX2 protein 		CTD PMID:24714768 PMID:28871336 NCBI chr 8:27,491,143...27,548,626
Ensembl chr 8:27,490,781...27,545,564 		JBrowse link
G EPRS1 glutamyl-prolyl-tRNA synthetase 1 decreases expression EXP Zoledronic Acid results in decreased expression of EPRS1 mRNA CTD PMID:25596134 NCBI chr 1:219,968,600...220,046,505
Ensembl chr 1:219,968,600...220,046,530 		JBrowse link
G EPSTI1 epithelial stromal interaction 1 increases expression EXP zoledronic acid results in increased expression of EPSTI1 mRNA CTD PMID:24714768 NCBI chr13:42,886,388...42,992,241
Ensembl chr13:42,886,388...42,992,271 		JBrowse link
G ERCC5 ERCC excision repair 5, endonuclease multiple interactions EXP [zoledronic acid co-treated with fluvastatin] results in increased expression of ERCC5 mRNA CTD PMID:16996129 NCBI chr13:102,846,032...102,875,995
Ensembl chr13:102,845,831...102,875,995 		JBrowse link
G ERG ETS transcription factor ERG multiple interactions EXP [zoledronic acid co-treated with fluvastatin] results in increased expression of ERG mRNA CTD PMID:16996129 NCBI chr21:38,367,261...38,661,783
Ensembl chr21:38,380,027...38,661,780 		JBrowse link
G ERGIC2 ERGIC and golgi 2 decreases expression EXP zoledronic acid results in decreased expression of ERGIC2 mRNA CTD PMID:20977926 NCBI chr12:29,337,352...29,381,172
Ensembl chr12:29,337,352...29,381,189 		JBrowse link
G ERLIN1 ER lipid raft associated 1 increases expression EXP zoledronic acid results in increased expression of ERLIN1 mRNA CTD PMID:20977926 NCBI chr10:100,150,094...100,186,029
Ensembl chr10:100,150,094...100,186,033 		JBrowse link
G ERN1 endoplasmic reticulum to nucleus signaling 1 increases expression EXP Zoledronic Acid results in increased expression of ERN1 mRNA; Zoledronic Acid results in increased expression of ERN1 protein CTD PMID:35587103 NCBI chr17:64,039,142...64,130,144
Ensembl chr17:64,039,080...64,130,819 		JBrowse link
G ERO1A endoplasmic reticulum oxidoreductase 1 alpha increases expression EXP Zoledronic Acid results in increased expression of ERO1A mRNA CTD PMID:24714768 PMID:25596134 NCBI chr14:52,639,915...52,695,558
Ensembl chr14:52,639,915...52,695,900 		JBrowse link
G ERP27 endoplasmic reticulum protein 27 increases expression EXP zoledronic acid results in increased expression of ERP27 mRNA CTD PMID:24714768 NCBI chr12:14,914,039...14,938,537
Ensembl chr12:14,914,039...14,938,537 		JBrowse link
G ESCO2 establishment of sister chromatid cohesion N-acetyltransferase 2 increases expression EXP zoledronic acid results in increased expression of ESCO2 mRNA CTD PMID:20977926 NCBI chr 8:27,771,974...27,819,660
Ensembl chr 8:27,771,949...27,812,640 		JBrowse link
G ESRRG estrogen related receptor gamma decreases expression EXP zoledronic acid results in decreased expression of ESRRG mRNA CTD PMID:24714768 NCBI chr 1:216,503,246...217,137,702
Ensembl chr 1:216,503,246...217,137,755 		JBrowse link
G ETS1 ETS proto-oncogene 1, transcription factor increases expression EXP zoledronic acid results in increased expression of ETS1 mRNA CTD PMID:24714768 NCBI chr11:128,458,765...128,587,558
Ensembl chr11:128,458,761...128,587,558 		JBrowse link
G ETS2 ETS proto-oncogene 2, transcription factor decreases expression EXP zoledronic acid results in decreased expression of ETS2 mRNA CTD PMID:24714768 NCBI chr21:38,805,183...38,824,955
Ensembl chr21:38,805,183...38,824,955 		JBrowse link
G ETV4 ETS variant transcription factor 4 decreases expression EXP zoledronic acid results in decreased expression of ETV4 mRNA CTD PMID:24714768 NCBI chr17:43,527,846...43,546,340
Ensembl chr17:43,527,844...43,579,620 		JBrowse link
G EVA1A eva-1 homolog A, regulator of programmed cell death decreases expression EXP zoledronic acid results in decreased expression of EVA1A mRNA CTD PMID:24714768 NCBI chr 2:75,492,318...75,569,719
Ensembl chr 2:75,469,302...75,569,722 		JBrowse link
G EXOC5 exocyst complex component 5 increases expression EXP zoledronic acid results in increased expression of EXOC5 mRNA CTD PMID:20977926 NCBI chr14:57,200,507...57,268,905
Ensembl chr14:57,200,507...57,268,905 		JBrowse link
G EZR ezrin increases expression EXP zoledronic acid results in increased expression of EZR mRNA CTD PMID:20977926 NCBI chr 6:158,765,748...158,819,368
Ensembl chr 6:158,765,741...158,819,368 		JBrowse link
G F3 coagulation factor III, tissue factor decreases expression EXP zoledronic acid results in decreased expression of F3 mRNA CTD PMID:24714768 NCBI chr 1:94,529,173...94,541,759
Ensembl chr 1:94,529,173...94,541,759 		JBrowse link
G FABP1 fatty acid binding protein 1 increases expression EXP Zoledronic Acid results in increased expression of FABP1 mRNA CTD PMID:35587103 NCBI chr 2:88,122,982...88,128,062
Ensembl chr 2:88,122,982...88,128,062 		JBrowse link
G FABP5P2 fatty acid binding protein 5 pseudogene 2 decreases expression EXP Zoledronic Acid results in decreased expression of FABP5L2 mRNA CTD PMID:24714768 NCBI chr13:51,966,682...51,967,340
Ensembl chr13:51,966,742...51,967,149 		JBrowse link
G FADD Fas associated via death domain multiple interactions EXP [Tretinoin co-treated with zoledronic acid] results in increased expression of FADD protein CTD PMID:20349282 NCBI chr11:70,203,296...70,207,390
Ensembl chr11:70,203,296...70,207,390 		JBrowse link
G FADS2 fatty acid desaturase 2 increases expression EXP zoledronic acid results in increased expression of FADS2 mRNA CTD PMID:24714768 NCBI chr11:61,816,203...61,867,354
Ensembl chr11:61,792,980...61,867,354 		JBrowse link
G FADS3 fatty acid desaturase 3 increases expression EXP zoledronic acid results in increased expression of FADS3 mRNA CTD PMID:20977926 NCBI chr11:61,873,526...61,892,224
Ensembl chr11:61,873,519...61,892,051 		JBrowse link
G FAM107A family with sequence similarity 107 member A increases expression EXP zoledronic acid results in increased expression of FAM107A mRNA CTD PMID:24714768 NCBI chr 3:58,564,117...58,627,610
Ensembl chr 3:58,564,117...58,627,610 		JBrowse link
G FAM167A family with sequence similarity 167 member A decreases expression EXP zoledronic acid results in decreased expression of FAM167A mRNA CTD PMID:25596134 NCBI chr 8:11,421,476...11,475,908
Ensembl chr 8:11,421,476...11,475,908 		JBrowse link
G FAM171B family with sequence similarity 171 member B decreases expression EXP zoledronic acid results in decreased expression of FAM171B mRNA CTD PMID:24714768 NCBI chr 2:186,694,060...186,765,959
Ensembl chr 2:186,694,060...186,765,959 		JBrowse link
G FAM20A FAM20A golgi associated secretory pathway pseudokinase increases expression EXP zoledronic acid results in increased expression of FAM20A mRNA CTD PMID:24714768 NCBI chr17:68,535,116...68,601,367
Ensembl chr17:68,535,113...68,601,367 		JBrowse link
G FAM222B family with sequence similarity 222 member B decreases expression EXP zoledronic acid results in decreased expression of FAM222B mRNA CTD PMID:20977926 NCBI chr17:28,755,980...28,855,004
Ensembl chr17:28,755,980...28,855,232 		JBrowse link
G FAM43A family with sequence similarity 43 member A decreases expression EXP zoledronic acid results in decreased expression of FAM43A mRNA CTD PMID:24714768 NCBI chr 3:194,685,883...194,689,037
Ensembl chr 3:194,685,883...194,689,037 		JBrowse link
G FAM72B family with sequence similarity 72 member B increases expression EXP zoledronic acid results in increased expression of FAM72B mRNA CTD PMID:24714768 NCBI chr 1:121,167,646...121,184,340
Ensembl chr 1:121,167,646...121,185,539 		JBrowse link
G FAS Fas cell surface death receptor increases expression
multiple interactions 		EXP zoledronic acid results in increased expression of FAS mRNA
[Tretinoin co-treated with zoledronic acid] results in increased expression of FAS protein 		CTD PMID:19036117 PMID:20349282 PMID:25596134 NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605 		JBrowse link
G FASLG Fas ligand affects expression EXP zoledronic acid affects the expression of FASLG mRNA CTD PMID:19036117 NCBI chr 1:172,659,103...172,666,876
Ensembl chr 1:172,659,103...172,666,876 		JBrowse link
G FBLIM1 filamin binding LIM protein 1 decreases expression EXP zoledronic acid results in decreased expression of FBLIM1 protein CTD PMID:28871336 NCBI chr 1:15,756,638...15,786,589
Ensembl chr 1:15,756,607...15,786,594 		JBrowse link
G FBLN1 fibulin 1 increases expression EXP zoledronic acid results in increased expression of FBLN1 mRNA; zoledronic acid results in increased expression of FBLN1 protein CTD PMID:24714768 PMID:28871336 NCBI chr22:45,502,883...45,601,135
Ensembl chr22:45,502,238...45,601,135 		JBrowse link
G FBLN5 fibulin 5 increases expression EXP zoledronic acid results in increased expression of FBLN5 mRNA CTD PMID:24714768 NCBI chr14:91,869,411...91,947,694
Ensembl chr14:91,869,411...91,947,987 		JBrowse link
G FBN1 fibrillin 1 increases expression EXP zoledronic acid results in increased expression of FBN1 mRNA CTD PMID:20977926 PMID:24714768 NCBI chr15:48,408,313...48,645,709
Ensembl chr15:48,408,313...48,645,721 		JBrowse link
G FCGBP Fc gamma binding protein increases expression EXP zoledronic acid results in increased expression of FCGBP mRNA CTD PMID:24714768 NCBI chr19:39,863,323...39,934,634
Ensembl chr19:39,863,323...39,934,626 		JBrowse link
G FCGRT Fc gamma receptor and transporter decreases expression EXP zoledronic acid results in decreased expression of FCGRT mRNA CTD PMID:24714768 NCBI chr19:49,512,661...49,526,428
Ensembl chr19:49,506,816...49,526,428 		JBrowse link
G FCMR Fc mu receptor increases expression EXP zoledronic acid results in increased expression of FCMR mRNA CTD PMID:24714768 NCBI chr 1:206,903,317...206,923,196
Ensembl chr 1:206,903,317...206,923,247 		JBrowse link
G FCRL2 Fc receptor like 2 increases expression EXP zoledronic acid results in increased expression of FCRL2 mRNA CTD PMID:24714768 NCBI chr 1:157,745,733...157,777,132
Ensembl chr 1:157,745,733...157,777,132 		JBrowse link
G FCRL3 Fc receptor like 3 increases expression EXP zoledronic acid results in increased expression of FCRL3 mRNA CTD PMID:24714768 NCBI chr 1:157,676,481...157,700,956
Ensembl chr 1:157,674,321...157,700,769 		JBrowse link
G FCRLA Fc receptor like A increases expression EXP zoledronic acid results in increased expression of FCRLA mRNA CTD PMID:24714768 NCBI chr 1:161,707,229...161,714,352
Ensembl chr 1:161,706,972...161,714,352 		JBrowse link
G FDFT1 farnesyl-diphosphate farnesyltransferase 1 multiple interactions
increases expression 		EXP
ISO 		[zoledronic acid co-treated with fluvastatin] results in increased expression of FDFT1 mRNA
zoledronic acid results in increased expression of FDFT1 mRNA 		CTD PMID:16996129 PMID:18325729 NCBI chr 8:11,795,582...11,839,298
Ensembl chr 8:11,795,573...11,839,395 		JBrowse link
G FDPS farnesyl diphosphate synthase affects binding
increases expression
decreases activity
increases activity
multiple interactions 		EXP
ISO 		zoledronic acid binds to FDPS protein
zoledronic acid results in increased expression of FDPS mRNA
zoledronic acid results in decreased activity of FDPS protein
zoledronic acid results in increased activity of FDPS protein
[zoledronic acid results in decreased activity of FDPS protein] which results in increased abundance of isopentenyl pyrophosphate 		CTD PMID:11160603 PMID:12846887 PMID:16684881 PMID:17208200 PMID:18325729 More... NCBI chr 1:155,308,866...155,320,665
Ensembl chr 1:155,308,748...155,320,666 		JBrowse link
G FECH ferrochelatase decreases expression EXP zoledronic acid results in decreased expression of FECH mRNA CTD PMID:24714768 NCBI chr18:57,544,377...57,586,702
Ensembl chr18:57,544,377...57,586,732 		JBrowse link
G FEM1B fem-1 homolog B increases expression EXP zoledronic acid results in increased expression of FEM1B mRNA CTD PMID:20977926 NCBI chr15:68,277,745...68,295,862
Ensembl chr15:68,277,745...68,295,862 		JBrowse link
G FEZ1 fasciculation and elongation protein zeta 1 increases expression EXP zoledronic acid results in increased expression of FEZ1 mRNA CTD PMID:24714768 NCBI chr11:125,442,881...125,496,265
Ensembl chr11:125,442,881...125,592,568 		JBrowse link
G FGF18 fibroblast growth factor 18 increases expression EXP zoledronic acid results in increased expression of FGF18 mRNA CTD PMID:24714768 NCBI chr 5:171,419,647...171,457,626
Ensembl chr 5:171,419,647...171,457,626 		JBrowse link
G FGF2 fibroblast growth factor 2 decreases expression
multiple interactions 		EXP zoledronic acid results in decreased expression of FGF2 mRNA
zoledronic acid promotes the reaction [Gossypol results in decreased expression of FGF2 mRNA] 		CTD PMID:19825521 PMID:24714768 NCBI chr 4:122,826,682...122,898,236
Ensembl chr 4:122,826,682...122,898,236 		JBrowse link
G FGF9 fibroblast growth factor 9 decreases expression EXP zoledronic acid results in decreased expression of FGF9 mRNA CTD PMID:24714768 NCBI chr13:21,671,073...21,704,498
Ensembl chr13:21,671,073...21,704,498 		JBrowse link
G FGFBP1 fibroblast growth factor binding protein 1 increases expression EXP zoledronic acid results in increased expression of FGFBP1 mRNA CTD PMID:24714768 NCBI chr 4:15,935,577...15,938,740
Ensembl chr 4:15,935,577...15,938,740 		JBrowse link
G FGFR3 fibroblast growth factor receptor 3 multiple interactions
decreases expression 		EXP zoledronic acid promotes the reaction [Gossypol results in decreased expression of FGFR3 mRNA]
zoledronic acid results in decreased expression of FGFR3 mRNA 		CTD PMID:19825521 PMID:24714768 NCBI chr 4:1,793,293...1,808,867
Ensembl chr 4:1,793,293...1,808,872 		JBrowse link
G FGFR4 fibroblast growth factor receptor 4 decreases expression EXP zoledronic acid results in decreased expression of FGFR4 mRNA CTD PMID:24714768 NCBI chr 5:177,086,915...177,098,144
Ensembl chr 5:177,086,905...177,098,144 		JBrowse link
G FGL2 fibrinogen like 2 decreases expression EXP zoledronic acid results in decreased expression of FGL2 mRNA CTD PMID:24714768 NCBI chr 7:77,193,369...77,199,819
Ensembl chr 7:77,193,369...77,199,848 		JBrowse link
G FHL1 four and a half LIM domains 1 increases expression EXP zoledronic acid results in increased expression of FHL1 mRNA CTD PMID:20977926 NCBI chr  X:136,146,702...136,211,359
Ensembl chr  X:136,146,702...136,211,359 		JBrowse link
G FHL2 four and a half LIM domains 2 decreases expression EXP zoledronic acid results in decreased expression of FHL2 mRNA CTD PMID:24714768 NCBI chr 2:105,357,712...105,438,529
Ensembl chr 2:105,357,712...105,438,513 		JBrowse link
G FIGNL1 fidgetin like 1 increases expression EXP zoledronic acid results in increased expression of FIGNL1 mRNA CTD PMID:20977926 NCBI chr 7:50,444,133...50,450,350
Ensembl chr 7:50,444,128...50,450,390 		JBrowse link
G FILIP1L filamin A interacting protein 1 like decreases expression EXP zoledronic acid results in decreased expression of FILIP1L mRNA CTD PMID:24714768 NCBI chr 3:99,828,811...100,114,501
Ensembl chr 3:99,828,811...100,114,513 		JBrowse link
G FJX1 four-jointed box kinase 1 decreases expression EXP zoledronic acid results in decreased expression of FJX1 mRNA CTD PMID:24714768 NCBI chr11:35,618,460...35,620,865
Ensembl chr11:35,618,460...35,620,865 		JBrowse link
G FKBP1A FKBP prolyl isomerase 1A increases expression EXP zoledronic acid results in increased expression of FKBP1A mRNA CTD PMID:24714768 NCBI chr20:1,368,978...1,393,054
Ensembl chr20:1,368,977...1,393,164 		JBrowse link
G FMNL3 formin like 3 increases expression EXP zoledronic acid results in increased expression of FMNL3 mRNA CTD PMID:24714768 NCBI chr12:49,636,499...49,707,405
Ensembl chr12:49,636,499...49,708,165 		JBrowse link
G FN1 fibronectin 1 multiple interactions
increases expression 		ISO
EXP 		Fenofibrate inhibits the reaction [zoledronic acid results in increased expression of FN1 protein]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in increased expression of FN1 mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in increased expression of FN1 protein]
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [zoledronic acid results in increased expression of FN1 protein]
zoledronic acid results in increased expression of FN1 mRNA; zoledronic acid results in increased expression of FN1 protein 		CTD PMID:28871336 NCBI chr 2:215,360,865...215,436,068
Ensembl chr 2:215,360,440...215,436,073 		JBrowse link
G FNBP1 formin binding protein 1 increases expression EXP zoledronic acid results in increased expression of FNBP1 mRNA CTD PMID:24714768 NCBI chr 9:129,887,187...130,053,879
Ensembl chr 9:129,887,187...130,043,189 		JBrowse link
G FNTA farnesyltransferase, CAAX box, subunit alpha multiple interactions EXP [zoledronic acid co-treated with fluvastatin] results in increased expression of FNTA mRNA CTD PMID:16996129 NCBI chr 8:43,056,323...43,085,785
Ensembl chr 8:43,034,194...43,085,788 		JBrowse link
G FOLR1 folate receptor alpha decreases expression EXP zoledronic acid results in decreased expression of FOLR1 mRNA CTD PMID:24714768 NCBI chr11:72,189,709...72,196,323
Ensembl chr11:72,189,558...72,196,323 		JBrowse link
G FOS Fos proto-oncogene, AP-1 transcription factor subunit decreases expression
multiple interactions 		EXP
ISO 		zoledronic acid results in decreased expression of FOS mRNA
zoledronic acid inhibits the reaction [Freund's Adjuvant results in increased expression of FOS protein]
zoledronic acid results in decreased expression of FOS protein 		CTD PMID:16769263 PMID:17323179 PMID:24714768 NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,283,190 		JBrowse link
G FOXJ1 forkhead box J1 decreases expression EXP zoledronic acid results in decreased expression of FOXJ1 mRNA CTD PMID:24714768 NCBI chr17:76,136,333...76,141,245
Ensembl chr17:76,136,333...76,141,245 		JBrowse link
G FOXO1 forkhead box O1 decreases expression EXP zoledronic acid results in decreased expression of FOXO1 mRNA CTD PMID:24714768 NCBI chr13:40,555,667...40,666,641
Ensembl chr13:40,555,667...40,666,641 		JBrowse link
G FREM2 FRAS1 related extracellular matrix 2 decreases expression EXP zoledronic acid results in decreased expression of FREM2 mRNA CTD PMID:25596134 NCBI chr13:38,687,077...38,887,131
Ensembl chr13:38,687,077...38,887,131 		JBrowse link
G FRK fyn related Src family tyrosine kinase increases expression EXP zoledronic acid results in increased expression of FRK mRNA CTD PMID:24714768 NCBI chr 6:115,931,149...116,100,725
Ensembl chr 6:115,931,149...116,060,891 		JBrowse link
G FSCN1 fascin actin-bundling protein 1 increases expression EXP zoledronic acid results in increased expression of FSCN1 mRNA CTD PMID:20977926 NCBI chr 7:5,592,816...5,606,655
Ensembl chr 7:5,592,816...5,606,655 		JBrowse link
G FSD1L fibronectin type III and SPRY domain containing 1 like increases expression EXP zoledronic acid results in increased expression of FSD1L mRNA CTD PMID:24714768 NCBI chr 9:105,442,177...105,552,433
Ensembl chr 9:105,447,796...105,552,433 		JBrowse link
G FSTL1 follistatin like 1 increases expression EXP zoledronic acid results in increased expression of FSTL1 mRNA CTD PMID:24714768 NCBI chr 3:120,392,293...120,450,992
Ensembl chr 3:120,392,293...120,451,016 		JBrowse link
G FSTL3 follistatin like 3 decreases expression EXP zoledronic acid results in decreased expression of FSTL3 mRNA CTD PMID:24714768 NCBI chr19:676,392...683,385
Ensembl chr19:676,392...683,392 		JBrowse link
G FTH1 ferritin heavy chain 1 increases expression EXP zoledronic acid results in increased expression of FTH1 mRNA CTD PMID:25596134 NCBI chr11:61,964,285...61,967,634
Ensembl chr11:61,959,718...61,967,634 		JBrowse link
G FTH1P11 ferritin heavy chain 1 pseudogene 11 increases expression EXP zoledronic acid results in increased expression of FTH1P11 mRNA CTD PMID:24714768 NCBI chr 8:81,521,520...81,522,427
Ensembl chr 8:81,521,682...81,522,232 		JBrowse link
G FTH1P16 ferritin heavy chain 1 pseudogene 16 increases expression EXP zoledronic acid results in increased expression of FTH1P16 mRNA CTD PMID:24714768 NCBI chr11:77,734,315...77,735,232
Ensembl chr11:77,734,475...77,735,026 		JBrowse link
G FTH1P2 ferritin heavy chain 1 pseudogene 2 increases expression EXP zoledronic acid results in increased expression of FTH1P2 mRNA CTD PMID:24714768 NCBI chr 1:228,687,417...228,687,879
Ensembl chr 1:228,687,415...228,687,826 		JBrowse link
G FTH1P3 ferritin heavy chain 1 pseudogene 3 increases expression EXP zoledronic acid results in increased expression of FTH1P3 mRNA CTD PMID:24714768 NCBI chr 2:27,392,623...27,393,576
Ensembl chr 2:27,392,784...27,393,367 		JBrowse link
G FUCA1 alpha-L-fucosidase 1 increases expression EXP zoledronic acid results in increased expression of FUCA1 mRNA CTD PMID:24714768 NCBI chr 1:23,845,077...23,868,290
Ensembl chr 1:23,845,077...23,868,290 		JBrowse link
G FUT8 fucosyltransferase 8 increases expression EXP zoledronic acid results in increased expression of FUT8 mRNA CTD PMID:24714768 NCBI chr14:65,356,842...65,744,121
Ensembl chr14:65,410,592...65,744,121 		JBrowse link
G FUT8-AS1 FUT8 antisense RNA 1 increases expression EXP zoledronic acid results in increased expression of FUT8-AS1 mRNA CTD PMID:24714768 NCBI chr14:65,410,592...65,412,617
Ensembl chr14:65,410,768...65,412,690 		JBrowse link
G FXYD2 FXYD domain containing ion transport regulator 2 decreases expression EXP zoledronic acid results in decreased expression of FXYD2 mRNA CTD PMID:24714768 NCBI chr11:117,820,057...117,828,089
Ensembl chr11:117,800,844...117,828,698 		JBrowse link
G FYB1 FYN binding protein 1 decreases expression EXP zoledronic acid results in decreased expression of FYB1 mRNA CTD PMID:24714768 NCBI chr 5:39,105,252...39,274,528
Ensembl chr 5:39,105,252...39,274,528 		JBrowse link
G FZD5 frizzled class receptor 5 increases expression EXP zoledronic acid results in increased expression of FZD5 mRNA CTD PMID:24714768 NCBI chr 2:207,762,598...207,769,906
Ensembl chr 2:207,762,598...207,769,906 		JBrowse link
G GABARAPL1 GABA type A receptor associated protein like 1 decreases expression EXP zoledronic acid results in decreased expression of GABARAPL1 mRNA CTD PMID:24714768 PMID:25596134 NCBI chr12:10,212,877...10,223,128
Ensembl chr12:10,212,458...10,223,128 		JBrowse link
G GABRP gamma-aminobutyric acid type A receptor subunit pi decreases expression EXP zoledronic acid results in decreased expression of GABRP mRNA CTD PMID:24714768 NCBI chr 5:170,782,720...170,814,047
Ensembl chr 5:170,763,350...170,814,047 		JBrowse link
G GADD45A growth arrest and DNA damage inducible alpha decreases expression EXP zoledronic acid results in decreased expression of GADD45A mRNA CTD PMID:24714768 PMID:25596134 NCBI chr 1:67,685,201...67,688,334
Ensembl chr 1:67,685,201...67,688,334 		JBrowse link
G GADD45B growth arrest and DNA damage inducible beta multiple interactions
increases expression 		EXP [zoledronic acid co-treated with fluvastatin] results in increased expression of GADD45B mRNA
zoledronic acid results in increased expression of GADD45B mRNA 		CTD PMID:16996129 PMID:20977926 NCBI chr19:2,476,127...2,478,257
Ensembl chr19:2,476,122...2,478,805 		JBrowse link
G GADD45G growth arrest and DNA damage inducible gamma increases expression EXP zoledronic acid results in increased expression of GADD45G mRNA CTD PMID:24714768 NCBI chr 9:89,605,012...89,606,555
Ensembl chr 9:89,605,012...89,606,555 		JBrowse link
G GAGE4 G antigen 4 decreases expression EXP zoledronic acid results in decreased expression of GAGE4 mRNA CTD PMID:24714768
G GALNT10 polypeptide N-acetylgalactosaminyltransferase 10 decreases expression EXP zoledronic acid results in decreased expression of GALNT10 mRNA CTD PMID:24714768 NCBI chr 5:154,190,733...154,420,984
Ensembl chr 5:154,190,730...154,420,984 		JBrowse link
G GALNT11 polypeptide N-acetylgalactosaminyltransferase 11 decreases expression EXP zoledronic acid results in decreased expression of GALNT11 mRNA CTD PMID:24714768 NCBI chr 7:152,025,674...152,122,340
Ensembl chr 7:152,025,674...152,122,340 		JBrowse link
G GALNT16 polypeptide N-acetylgalactosaminyltransferase 16 decreases expression EXP zoledronic acid results in decreased expression of GALNT16 mRNA CTD PMID:24714768 PMID:25596134 NCBI chr14:69,259,631...69,386,337
Ensembl chr14:69,259,277...69,357,033 		JBrowse link
G GALNT18 polypeptide N-acetylgalactosaminyltransferase 18 increases expression EXP Zoledronic Acid results in increased expression of GALNT18 mRNA CTD PMID:24714768 NCBI chr11:11,270,877...11,622,005
Ensembl chr11:11,270,877...11,622,005 		JBrowse link
G GBP2 guanylate binding protein 2 increases expression EXP zoledronic acid results in increased expression of GBP2 mRNA CTD PMID:24714768 NCBI chr 1:89,106,132...89,126,114
Ensembl chr 1:89,106,132...89,150,456 		JBrowse link
G GBP4 guanylate binding protein 4 increases expression EXP zoledronic acid results in increased expression of GBP4 mRNA CTD PMID:24714768 NCBI chr 1:89,181,144...89,198,942
Ensembl chr 1:89,181,144...89,198,942 		JBrowse link
G GBP5 guanylate binding protein 5 increases expression EXP zoledronic acid results in increased expression of GBP5 mRNA CTD PMID:24714768 NCBI chr 1:89,256,189...89,272,860
Ensembl chr 1:89,256,189...89,272,860 		JBrowse link
G GC GC vitamin D binding protein increases expression EXP zoledronic acid results in increased expression of GC protein CTD PMID:28871336 NCBI chr 4:71,741,693...71,805,520
Ensembl chr 4:71,741,696...71,804,041 		JBrowse link
G GCNT1 glucosaminyl (N-acetyl) transferase 1 decreases expression EXP zoledronic acid results in decreased expression of GCNT1 mRNA CTD PMID:24714768 NCBI chr 9:76,393,869...76,507,416
Ensembl chr 9:76,419,850...76,651,203 		JBrowse link
G GCNT3 glucosaminyl (N-acetyl) transferase 3, mucin type increases expression EXP zoledronic acid results in increased expression of GCNT3 mRNA CTD PMID:24714768 PMID:25596134 NCBI chr15:59,611,783...59,622,723
Ensembl chr15:59,594,875...59,640,239 		JBrowse link
G GDF15 growth differentiation factor 15 decreases expression EXP zoledronic acid results in decreased expression of GDF15 mRNA CTD PMID:24714768 PMID:25596134 NCBI chr19:18,386,158...18,389,176
Ensembl chr19:18,374,731...18,389,176 		JBrowse link
G GDI2 GDP dissociation inhibitor 2 increases expression EXP zoledronic acid results in increased expression of GDI2 protein CTD PMID:28871336 NCBI chr10:5,765,223...5,813,434
Ensembl chr10:5,765,222...5,842,132 		JBrowse link
G GEM GTP binding protein overexpressed in skeletal muscle decreases expression EXP zoledronic acid results in decreased expression of GEM mRNA CTD PMID:24714768 NCBI chr 8:94,249,253...94,262,319
Ensembl chr 8:94,249,253...94,262,350 		JBrowse link
G GGPS1 geranylgeranyl diphosphate synthase 1 decreases activity EXP zoledronic acid results in decreased activity of GGPS1 protein CTD PMID:17208200 NCBI chr 1:235,327,216...235,344,532
Ensembl chr 1:235,327,350...235,344,532 		JBrowse link
G GGT1 gamma-glutamyltransferase 1 decreases expression EXP zoledronic acid results in decreased expression of GGT1 mRNA CTD PMID:24714768 NCBI chr22:24,583,750...24,628,996
Ensembl chr22:24,594,811...24,629,005 		JBrowse link
G GGT2P gamma-glutamyltransferase 2, pseudogene decreases expression EXP Zoledronic Acid results in decreased expression of GGT2P mRNA CTD PMID:24714768 NCBI chr22:21,207,976...21,259,684
Ensembl chr22:21,207,973...21,225,554 		JBrowse link
G GGTLC2 gamma-glutamyltransferase light chain 2 decreases expression EXP zoledronic acid results in decreased expression of GGTLC2 mRNA CTD PMID:24714768 NCBI chr22:22,644,614...22,647,898
Ensembl chr22:22,644,614...22,647,898 		JBrowse link
G GGTLC3 gamma-glutamyltransferase light chain family member 3 decreases expression EXP zoledronic acid results in decreased expression of GGTLC3 mRNA CTD PMID:24714768 NCBI chr22:18,516,338...18,518,166
Ensembl chr22:18,516,344...18,518,161 		JBrowse link
G GINS2 GINS complex subunit 2 decreases expression EXP zoledronic acid results in decreased expression of GINS2 mRNA CTD PMID:24714768 NCBI chr16:85,676,198...85,688,954
Ensembl chr16:85,676,198...85,690,073 		JBrowse link
G GJB1 gap junction protein beta 1 decreases expression EXP zoledronic acid results in decreased expression of GJB1 mRNA CTD PMID:24714768 NCBI chr  X:71,215,239...71,225,516
Ensembl chr  X:71,212,811...71,225,516 		JBrowse link
G GJB2 gap junction protein beta 2 increases expression EXP zoledronic acid results in increased expression of GJB2 mRNA CTD PMID:24714768 NCBI chr13:20,187,470...20,192,938
Ensembl chr13:20,187,463...20,192,938 		JBrowse link
G GK glycerol kinase increases expression EXP zoledronic acid results in increased expression of GK mRNA CTD PMID:20977926 NCBI chr  X:30,653,423...30,731,462
Ensembl chr  X:30,653,359...30,731,462 		JBrowse link
G GLA galactosidase alpha decreases expression EXP zoledronic acid results in decreased expression of GLA protein CTD PMID:28871336 NCBI chr  X:101,397,803...101,407,925
Ensembl chr  X:101,393,273...101,408,012 		JBrowse link
G GLCE glucuronic acid epimerase increases expression EXP zoledronic acid results in increased expression of GLCE mRNA CTD PMID:24714768 NCBI chr15:69,160,635...69,272,207
Ensembl chr15:69,160,584...69,272,217 		JBrowse link
G GLG1 golgi glycoprotein 1 decreases expression EXP zoledronic acid results in decreased expression of GLG1 mRNA CTD PMID:20977926 NCBI chr16:74,447,440...74,607,114
Ensembl chr16:74,447,427...74,607,144 		JBrowse link
G GLIPR1 GLI pathogenesis related 1 decreases expression EXP zoledronic acid results in decreased expression of GLIPR1 mRNA CTD PMID:20977926 NCBI chr12:75,480,755...75,503,863
Ensembl chr12:75,480,753...75,503,863 		JBrowse link
G GLRX3 glutaredoxin 3 decreases expression EXP zoledronic acid results in decreased expression of GLRX3 mRNA CTD PMID:20977926 NCBI chr10:130,136,391...130,180,377
Ensembl chr10:130,136,391...130,184,521 		JBrowse link
G GNB2 G protein subunit beta 2 increases expression EXP zoledronic acid results in increased expression of GNB2 protein CTD PMID:28871336 NCBI chr 7:100,673,740...100,679,169
Ensembl chr 7:100,673,567...100,679,174 		JBrowse link
G GNB4 G protein subunit beta 4 increases expression EXP zoledronic acid results in increased expression of GNB4 mRNA CTD PMID:20977926 NCBI chr 3:179,396,088...179,527,798
Ensembl chr 3:179,396,088...179,451,476 		JBrowse link
G GNG10 G protein subunit gamma 10 increases expression EXP zoledronic acid results in increased expression of GNG10 protein CTD PMID:28871336 NCBI chr 9:111,661,605...111,670,226
Ensembl chr 9:111,661,605...111,670,226 		JBrowse link
G GNG7 G protein subunit gamma 7 decreases expression EXP zoledronic acid results in decreased expression of GNG7 mRNA CTD PMID:24714768 NCBI chr19:2,511,219...2,702,694
Ensembl chr19:2,511,219...2,702,694 		JBrowse link
G GOLGA8S golgin A8 family member S increases expression EXP zoledronic acid results in increased expression of GOLGA8S mRNA CTD PMID:24714768 NCBI chr15:23,354,748...23,368,489
Ensembl chr15:23,354,748...23,368,341 		JBrowse link
G GOLT1A golgi transport 1A decreases expression EXP zoledronic acid results in decreased expression of GOLT1A mRNA CTD PMID:24714768 NCBI chr 1:204,198,163...204,213,988
Ensembl chr 1:204,198,163...204,213,988 		JBrowse link
G GOT1 glutamic-oxaloacetic transaminase 1 increases expression EXP zoledronic acid results in increased expression of GOT1 mRNA CTD PMID:25596134 NCBI chr10:99,396,870...99,430,624
Ensembl chr10:99,396,870...99,430,624 		JBrowse link
G GPC3 glypican 3 decreases expression EXP zoledronic acid results in decreased expression of GPC3 mRNA CTD PMID:24714768 NCBI chr  X:133,535,745...133,985,594
Ensembl chr  X:133,535,745...133,987,100 		JBrowse link
G GPC4 glypican 4 decreases expression EXP zoledronic acid results in decreased expression of GPC4 mRNA CTD PMID:24714768 NCBI chr  X:133,300,103...133,415,489
Ensembl chr  X:133,300,103...133,415,489 		JBrowse link
G GPNMB glycoprotein nmb decreases expression EXP zoledronic acid results in decreased expression of GPNMB mRNA CTD PMID:24714768 NCBI chr 7:23,246,775...23,275,108
Ensembl chr 7:23,235,967...23,275,108 		JBrowse link
G GPR141 G protein-coupled receptor 141 increases expression EXP zoledronic acid results in increased expression of GPR141 mRNA CTD PMID:24714768 NCBI chr 7:37,683,766...37,743,835
Ensembl chr 7:37,683,766...37,833,788 		JBrowse link
G GPR37L1 G protein-coupled receptor 37 like 1 increases expression EXP zoledronic acid results in increased expression of GPR37L1 mRNA CTD PMID:24714768 NCBI chr 1:202,122,917...202,133,592
Ensembl chr 1:202,122,886...202,133,592 		JBrowse link
G GPRC5A G protein-coupled receptor class C group 5 member A decreases expression EXP zoledronic acid results in decreased expression of GPRC5A mRNA CTD PMID:24714768 NCBI chr12:12,891,562...12,917,937
Ensembl chr12:12,890,782...12,917,937 		JBrowse link
G GRB14 growth factor receptor bound protein 14 decreases expression EXP zoledronic acid results in decreased expression of GRB14 mRNA CTD PMID:24714768 NCBI chr 2:164,492,417...164,621,482
Ensembl chr 2:164,492,417...164,621,482 		JBrowse link
G GRIP2 glutamate receptor interacting protein 2 increases expression EXP zoledronic acid results in increased expression of GRIP2 mRNA CTD PMID:24714768 NCBI chr 3:14,489,107...14,603,017
Ensembl chr 3:14,489,107...14,556,075 		JBrowse link
G GRK5 G protein-coupled receptor kinase 5 increases expression EXP zoledronic acid results in increased expression of GRK5 mRNA CTD PMID:24714768 NCBI chr10:119,207,571...119,459,745
Ensembl chr10:119,207,571...119,459,745 		JBrowse link
G GRM8 glutamate metabotropic receptor 8 decreases expression EXP zoledronic acid results in decreased expression of GRM8 mRNA CTD PMID:24714768 NCBI chr 7:126,438,598...127,252,941
Ensembl chr 7:126,438,598...127,253,093 		JBrowse link
G GTF2I general transcription factor IIi increases expression EXP zoledronic acid results in increased expression of GTF2I mRNA CTD PMID:20977926 NCBI chr 7:74,657,718...74,760,692
Ensembl chr 7:74,650,231...74,760,692 		JBrowse link
G GTF2IRD1 GTF2I repeat domain containing 1 decreases expression EXP zoledronic acid results in decreased expression of GTF2IRD1 mRNA CTD PMID:24714768 NCBI chr 7:74,453,906...74,602,605
Ensembl chr 7:74,453,790...74,602,605 		JBrowse link
G GTF3C4 general transcription factor IIIC subunit 4 increases expression EXP zoledronic acid results in increased expression of GTF3C4 mRNA CTD PMID:20977926 NCBI chr 9:132,670,035...132,694,955
Ensembl chr 9:132,670,035...132,694,953 		JBrowse link
G GTPBP2 GTP binding protein 2 increases expression EXP zoledronic acid results in increased expression of GTPBP2 mRNA CTD PMID:20977926 NCBI chr 6:43,620,494...43,631,333
Ensembl chr 6:43,605,316...43,629,264 		JBrowse link
G GUCA1C guanylate cyclase activator 1C decreases expression EXP zoledronic acid results in decreased expression of GUCA1C mRNA CTD PMID:24714768 NCBI chr 3:108,907,792...108,955,195
Ensembl chr 3:108,907,792...108,953,879 		JBrowse link
G GZMB granzyme B affects expression
multiple interactions 		EXP zoledronic acid affects the expression of GZMB mRNA
IL2 protein affects the reaction [zoledronic acid affects the expression of GZMB mRNA] 		CTD PMID:19446661 NCBI chr14:24,630,954...24,634,190
Ensembl chr14:24,630,954...24,634,267 		JBrowse link
G H1-2 H1.2 linker histone, cluster member increases expression EXP Zoledronic Acid results in increased expression of H1-2 mRNA CTD PMID:24714768 PMID:25596134 NCBI chr 6:26,055,740...26,056,470
Ensembl chr 6:26,054,760...26,056,470 		JBrowse link
G H2AC18 H2A clustered histone 18 increases expression EXP Zoledronic Acid results in increased expression of H2AC18 mRNA CTD PMID:24714768 NCBI chr 1:149,842,218...149,842,750
Ensembl chr 1:149,842,218...149,842,750 		JBrowse link
G H2AC19 H2A clustered histone 19 increases expression EXP Zoledronic Acid results in increased expression of H2AC19 mRNA CTD PMID:24714768 NCBI chr 1:149,851,061...149,851,594
Ensembl chr 1:149,851,061...149,851,594 		JBrowse link
G H2AC20 H2A clustered histone 20 increases expression EXP Zoledronic Acid results in increased expression of H2AC20 mRNA CTD PMID:24714768 NCBI chr 1:149,886,918...149,887,411
Ensembl chr 1:149,886,918...149,887,411 		JBrowse link
G H2AC6 H2A clustered histone 6 increases expression EXP Zoledronic Acid results in increased expression of H2AC6 mRNA CTD PMID:24714768 NCBI chr 6:26,124,172...26,124,690
Ensembl chr 6:26,124,145...26,139,116 		JBrowse link
G H2AX H2A.X variant histone increases expression EXP Zoledronic Acid results in increased expression of H2AX mRNA CTD PMID:20977926 NCBI chr11:119,093,874...119,095,465
Ensembl chr11:119,093,874...119,095,465 		JBrowse link
G H2BC12 H2B clustered histone 12 increases expression EXP Zoledronic Acid results in increased expression of H2BC12 mRNA CTD PMID:24714768 NCBI chr 6:27,138,293...27,146,858
Ensembl chr 6:27,137,298...27,146,855 		JBrowse link
G H2BC21 H2B clustered histone 21 increases expression EXP Zoledronic Acid results in increased expression of H2BC21 mRNA CTD PMID:24714768 NCBI chr 1:149,884,459...149,886,682
Ensembl chr 1:149,884,459...149,886,682 		JBrowse link
G H2BC5 H2B clustered histone 5 increases expression EXP Zoledronic Acid results in increased expression of H2BC5 mRNA CTD PMID:24714768 NCBI chr 6:26,158,121...26,171,349
Ensembl chr 6:26,158,122...26,171,349 		JBrowse link
G H4C3 H4 clustered histone 3 decreases expression EXP Zoledronic Acid results in decreased expression of H4C3 mRNA CTD PMID:20977926 NCBI chr 6:26,103,933...26,104,337
Ensembl chr 6:26,103,933...26,104,337 		JBrowse link
G H4C8 H4 clustered histone 8 increases expression EXP Zoledronic Acid results in increased expression of H4C8 mRNA CTD PMID:24714768 NCBI chr 6:26,285,126...26,285,534
Ensembl chr 6:26,277,609...26,285,638 		JBrowse link
G HADHA hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha decreases expression ISO zoledronic acid results in decreased expression of HADHA mRNA CTD PMID:28871336 NCBI chr 2:26,190,635...26,244,632
Ensembl chr 2:26,190,635...26,244,672 		JBrowse link
G HAPLN3 hyaluronan and proteoglycan link protein 3 increases expression EXP zoledronic acid results in increased expression of HAPLN3 mRNA CTD PMID:24714768 NCBI chr15:88,877,294...88,895,544
Ensembl chr15:88,877,294...88,895,597 		JBrowse link
G HAVCR1 hepatitis A virus cellular receptor 1 increases expression ISO
EXP 		zoledronic acid results in increased expression of HAVCR1 mRNA CTD PMID:28871336 NCBI chr 5:157,029,413...157,069,407
Ensembl chr 5:157,026,742...157,069,396 		JBrowse link
G HDAC9 histone deacetylase 9 increases expression EXP zoledronic acid results in increased expression of HDAC9 mRNA CTD PMID:24714768 NCBI chr 7:18,086,825...19,002,416
Ensembl chr 7:18,086,949...19,002,416 		JBrowse link
G HDGF heparin binding growth factor increases expression EXP zoledronic acid results in increased expression of HDGF mRNA CTD PMID:24714768 NCBI chr 1:156,742,107...156,767,366
Ensembl chr 1:156,742,109...156,766,925 		JBrowse link
G HEG1 heart development protein with EGF like domains 1 increases expression EXP zoledronic acid results in increased expression of HEG1 mRNA CTD PMID:24714768 NCBI chr 3:124,965,710...125,055,997
Ensembl chr 3:124,965,710...125,055,997 		JBrowse link
G HERC4 HECT and RLD domain containing E3 ubiquitin protein ligase 4 decreases expression EXP zoledronic acid results in decreased expression of HERC4 mRNA CTD PMID:20977926 NCBI chr10:67,921,905...68,075,283
Ensembl chr10:67,921,899...68,075,301 		JBrowse link
G HES1 hes family bHLH transcription factor 1 decreases expression EXP zoledronic acid results in decreased expression of HES1 mRNA CTD PMID:24714768 NCBI chr 3:194,136,148...194,138,732
Ensembl chr 3:194,136,148...194,138,732 		JBrowse link
G HES2 hes family bHLH transcription factor 2 decreases expression EXP zoledronic acid results in decreased expression of HES2 mRNA CTD PMID:24714768 NCBI chr 1:6,415,232...6,419,919
Ensembl chr 1:6,412,418...6,424,670 		JBrowse link
G HES4 hes family bHLH transcription factor 4 decreases expression EXP zoledronic acid results in decreased expression of HES4 mRNA CTD PMID:24714768 NCBI chr 1:998,964...1,000,097
Ensembl chr 1:998,962...1,000,172 		JBrowse link
G HGD homogentisate 1,2-dioxygenase decreases expression EXP zoledronic acid results in decreased expression of HGD mRNA CTD PMID:24714768 NCBI chr 3:120,628,172...120,682,239
Ensembl chr 3:120,628,172...120,682,269 		JBrowse link
G HHLA2 HHLA2 member of B7 family increases expression EXP zoledronic acid results in increased expression of HHLA2 mRNA CTD PMID:24714768 NCBI chr 3:108,296,548...108,378,285
Ensembl chr 3:108,296,529...108,378,285 		JBrowse link
G HIF1A hypoxia inducible factor 1 subunit alpha multiple interactions ISO zoledronic acid inhibits the reaction [Dopamine results in decreased expression of HIF1A protein] CTD PMID:25818600 NCBI chr14:61,695,513...61,748,258
Ensembl chr14:61,695,513...61,748,259 		JBrowse link
G HINT2 histidine triad nucleotide binding protein 2 increases expression EXP zoledronic acid results in increased expression of HINT2 protein CTD PMID:28871336 NCBI chr 9:35,812,960...35,815,479
Ensembl chr 9:35,812,960...35,815,354 		JBrowse link
G HLA-A major histocompatibility complex, class I, A increases expression EXP zoledronic acid results in increased expression of HLA-A mRNA CTD PMID:24714768 NCBI chr 6:29,942,532...29,945,870
Ensembl chr 6:29,941,260...29,949,572 		JBrowse link
G HLA-DMA major histocompatibility complex, class II, DM alpha increases expression EXP zoledronic acid results in increased expression of HLA-DMA mRNA CTD PMID:24714768 NCBI chr 6:32,948,618...32,953,097
Ensembl chr 6:32,948,613...32,969,094 		JBrowse link
G HLA-DMB major histocompatibility complex, class II, DM beta increases expression EXP zoledronic acid results in increased expression of HLA-DMB mRNA CTD PMID:24714768 NCBI chr 6:32,934,636...32,941,028
Ensembl chr 6:32,934,629...32,941,028 		JBrowse link
G HLA-DRA major histocompatibility complex, class II, DR alpha increases expression EXP zoledronic acid results in increased expression of HLA-DRA mRNA CTD PMID:24714768 NCBI chr 6:32,439,887...32,445,046
Ensembl chr 6:32,439,878...32,445,046 		JBrowse link
G HLA-DRB1 major histocompatibility complex, class II, DR beta 1 increases expression EXP zoledronic acid results in increased expression of HLA-DRB1 mRNA CTD PMID:24714768 NCBI chr 6:32,578,775...32,589,848
Ensembl chr 6:32,577,902...32,589,848 		JBrowse link
G HLA-DRB4 major histocompatibility complex, class II, DR beta 4 increases expression EXP zoledronic acid results in increased expression of HLA-DRB4 mRNA CTD PMID:24714768
G HLA-DRB5 major histocompatibility complex, class II, DR beta 5 increases expression EXP zoledronic acid results in increased expression of HLA-DRB5 mRNA CTD PMID:24714768 NCBI chr 6:32,517,353...32,530,287
Ensembl chr 6:32,517,353...32,530,287 		JBrowse link
G HLA-DRB6 major histocompatibility complex, class II, DR beta 6 (pseudogene) increases expression EXP zoledronic acid results in increased expression of HLA-DRB6 mRNA CTD PMID:24714768 NCBI chr 6:32,552,713...32,560,002
Ensembl chr 6:32,553,046...32,558,186
Ensembl chr 6:32,553,046...32,558,186 		JBrowse link
G HLA-E major histocompatibility complex, class I, E increases expression EXP zoledronic acid results in increased expression of HLA-E mRNA CTD PMID:24714768 NCBI chr 6:30,489,509...30,494,194
Ensembl chr 6:30,489,509...30,494,194 		JBrowse link
G HLA-F major histocompatibility complex, class I, F increases expression EXP zoledronic acid results in increased expression of HLA-F mRNA CTD PMID:24714768 NCBI chr 6:29,723,434...29,738,532
Ensembl chr 6:29,722,775...29,738,528 		JBrowse link
G HLF HLF transcription factor, PAR bZIP family member decreases expression EXP zoledronic acid results in decreased expression of HLF mRNA CTD PMID:24714768 NCBI chr17:55,264,960...55,325,187
Ensembl chr17:55,264,960...55,325,187 		JBrowse link
G HMCN1 hemicentin 1 decreases expression EXP zoledronic acid results in decreased expression of HMCN1 mRNA CTD PMID:24714768 NCBI chr 1:185,734,391...186,190,949
Ensembl chr 1:185,734,391...186,190,949 		JBrowse link
G HMGB3 high mobility group box 3 increases expression EXP zoledronic acid results in increased expression of HMGB3 mRNA CTD PMID:24714768 NCBI chr  X:150,980,507...150,990,771
Ensembl chr  X:150,980,509...150,990,771 		JBrowse link
G HMGCS1 3-hydroxy-3-methylglutaryl-CoA synthase 1 increases expression EXP zoledronic acid results in increased expression of HMGCS1 mRNA CTD PMID:24714768 NCBI chr 5:43,287,470...43,313,412
Ensembl chr 5:43,287,470...43,313,512 		JBrowse link
G HMMR hyaluronan mediated motility receptor decreases expression EXP zoledronic acid results in decreased expression of HMMR mRNA CTD PMID:24714768 NCBI chr 5:163,460,632...163,491,941
Ensembl chr 5:163,460,203...163,491,941 		JBrowse link
G HMOX1 heme oxygenase 1 decreases expression
increases expression 		EXP zoledronic acid results in decreased expression of HMOX1 mRNA
Zoledronic Acid results in increased expression of HMOX1 mRNA 		CTD PMID:24714768 PMID:25596134 PMID:35587103 NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214 		JBrowse link
G HMOX2 heme oxygenase 2 multiple interactions EXP [Tretinoin co-treated with zoledronic acid] results in increased expression of HMOX2 protein CTD PMID:20349282 NCBI chr16:4,474,736...4,510,347
Ensembl chr16:4,474,690...4,510,347 		JBrowse link
G HOXA-AS2 HOXA cluster antisense RNA 2 decreases expression EXP zoledronic acid results in decreased expression of HOXA-AS2 mRNA CTD PMID:24714768 NCBI chr 7:27,121,919...27,128,760
Ensembl chr 7:27,107,777...27,134,302 		JBrowse link
G HOXB-AS3 HOXB cluster antisense RNA 3 decreases expression EXP zoledronic acid results in decreased expression of HOXB-AS3 mRNA CTD PMID:24714768 NCBI chr17:48,590,420...48,606,414
Ensembl chr17:48,549,630...48,606,414 		JBrowse link
G HP1BP3 heterochromatin protein 1 binding protein 3 increases expression EXP zoledronic acid results in increased expression of HP1BP3 mRNA CTD PMID:20977926 NCBI chr 1:20,740,266...20,787,307
Ensembl chr 1:20,740,266...20,787,323 		JBrowse link
G HPCAL4 hippocalcin like 4 decreases expression EXP zoledronic acid results in decreased expression of HPCAL4 mRNA CTD PMID:24714768 NCBI chr 1:39,678,648...39,691,433
Ensembl chr 1:39,678,648...39,691,485 		JBrowse link
G HPGD 15-hydroxyprostaglandin dehydrogenase decreases expression EXP zoledronic acid results in decreased expression of HPGD mRNA CTD PMID:24714768 NCBI chr 4:174,490,175...174,522,893
Ensembl chr 4:174,490,175...174,523,154 		JBrowse link
G HRAS HRas proto-oncogene, GTPase decreases localization
increases expression 		EXP zoledronic acid results in decreased localization of HRAS protein
zoledronic acid results in increased expression of HRAS protein 		CTD PMID:11986784 PMID:28871336 NCBI chr11:532,242...535,576
Ensembl chr11:532,242...537,321 		JBrowse link
G HS3ST1 heparan sulfate-glucosamine 3-sulfotransferase 1 increases expression EXP zoledronic acid results in increased expression of HS3ST1 mRNA CTD PMID:24714768 NCBI chr 4:11,393,150...11,434,327
Ensembl chr 4:11,393,150...11,429,564 		JBrowse link
G HS3ST3A1 heparan sulfate-glucosamine 3-sulfotransferase 3A1 increases expression EXP zoledronic acid results in increased expression of HS3ST3A1 mRNA CTD PMID:24714768 NCBI chr17:13,494,032...13,601,929
Ensembl chr17:13,494,032...13,601,929 		JBrowse link
G HS3ST3B1 heparan sulfate-glucosamine 3-sulfotransferase 3B1 decreases expression EXP zoledronic acid results in decreased expression of HS3ST3B1 mRNA CTD PMID:20977926 NCBI chr17:14,301,081...14,349,404
Ensembl chr17:14,301,081...14,349,404 		JBrowse link
G HSD11B1 hydroxysteroid 11-beta dehydrogenase 1 increases expression EXP zoledronic acid results in increased expression of HSD11B1 mRNA CTD PMID:24714768 NCBI chr 1:209,686,179...209,734,929
Ensembl chr 1:209,686,178...209,734,949 		JBrowse link
G HSD11B2 hydroxysteroid 11-beta dehydrogenase 2 decreases expression EXP zoledronic acid results in decreased expression of HSD11B2 mRNA CTD PMID:24714768 NCBI chr16:67,429,801...67,437,553
Ensembl chr16:67,430,652...67,437,553 		JBrowse link
G HSD17B2 hydroxysteroid 17-beta dehydrogenase 2 increases expression EXP zoledronic acid results in increased expression of HSD17B2 mRNA CTD PMID:24714768 NCBI chr16:82,035,253...82,098,534
Ensembl chr16:82,035,004...82,098,534 		JBrowse link
G HSD17B4 hydroxysteroid 17-beta dehydrogenase 4 decreases expression ISO zoledronic acid results in decreased expression of HSD17B4 mRNA CTD PMID:28871336 NCBI chr 5:119,452,497...119,542,332
Ensembl chr 5:119,452,465...119,637,199 		JBrowse link
G HSD17B7P2 hydroxysteroid 17-beta dehydrogenase 7 pseudogene 2 increases expression EXP zoledronic acid results in increased expression of HSD17B7P2 mRNA CTD PMID:24714768 NCBI chr10:38,356,380...38,378,505
Ensembl chr10:38,356,455...38,378,107
Ensembl chr10:38,356,455...38,378,107 		JBrowse link
G HSPA12A heat shock protein family A (Hsp70) member 12A decreases expression EXP zoledronic acid results in decreased expression of HSPA12A mRNA CTD PMID:24714768 NCBI chr10:116,671,192...116,850,747
Ensembl chr10:116,671,192...116,850,251 		JBrowse link
G HSPA2 heat shock protein family A (Hsp70) member 2 increases expression EXP zoledronic acid results in increased expression of HSPA2 protein CTD PMID:28871336 NCBI chr14:64,535,905...64,543,237
Ensembl chr14:64,535,905...64,546,173 		JBrowse link
G HSPA5 heat shock protein family A (Hsp70) member 5 increases expression
decreases expression 		EXP zoledronic acid results in increased expression of HSPA5 mRNA
Zoledronic Acid results in decreased expression of HSPA5 mRNA; Zoledronic Acid results in decreased expression of HSPA5 protein 		CTD PMID:25596134 PMID:35587103 NCBI chr 9:125,234,853...125,241,343
Ensembl chr 9:125,234,853...125,241,382 		JBrowse link
G HSPA6 heat shock protein family A (Hsp70) member 6 increases expression EXP zoledronic acid results in increased expression of HSPA6 protein CTD PMID:28871336 NCBI chr 1:161,524,540...161,526,894
Ensembl chr 1:161,524,540...161,526,894 		JBrowse link
G HSPB8 heat shock protein family B (small) member 8 increases expression EXP zoledronic acid results in increased expression of HSPB8 mRNA CTD PMID:24714768 NCBI chr12:119,178,931...119,194,746
Ensembl chr12:119,171,555...119,224,855 		JBrowse link
G HTR4 5-hydroxytryptamine receptor 4 increases expression EXP zoledronic acid results in increased expression of HTR4 mRNA CTD PMID:20977926 NCBI chr 5:148,451,032...148,654,527
Ensembl chr 5:148,446,042...148,677,235 		JBrowse link
G HTRA1 HtrA serine peptidase 1 decreases expression EXP zoledronic acid results in decreased expression of HTRA1 mRNA CTD PMID:24714768 NCBI chr10:122,461,553...122,514,907
Ensembl chr10:122,458,551...122,514,907 		JBrowse link
G IBSP integrin binding sialoprotein multiple interactions
increases expression 		EXP [zoledronic acid results in decreased geranoylation of RHOA protein] which results in increased expression of IBSP mRNA; geranylgeraniol inhibits the reaction [zoledronic acid results in increased expression of IBSP mRNA]; zoledronic acid inhibits the reaction [RHOA protein results in decreased expression of IBSP mRNA]; zoledronic acid results in increased expression of and results in decreased degradation of IBSP mRNA
zoledronic acid results in increased expression of IBSP protein 		CTD PMID:15324309 NCBI chr 4:87,799,554...87,812,435
Ensembl chr 4:87,799,554...87,812,435 		JBrowse link
G ICAM1 intercellular adhesion molecule 1 increases expression EXP zoledronic acid results in increased expression of ICAM1 protein CTD PMID:19446661 NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615 		JBrowse link
G ICOSLG inducible T cell costimulator ligand increases expression EXP zoledronic acid results in increased expression of ICOSLG mRNA CTD PMID:24714768 NCBI chr21:44,216,981...44,240,943
Ensembl chr21:44,215,382...44,241,446 		JBrowse link
G ID1 inhibitor of DNA binding 1 multiple interactions EXP zoledronic acid promotes the reaction [Gossypol results in decreased expression of ID1 mRNA] CTD PMID:19825521 NCBI chr20:31,605,289...31,606,510
Ensembl chr20:31,573,014...31,606,515 		JBrowse link
G ID3 inhibitor of DNA binding 3 increases expression EXP zoledronic acid results in increased expression of ID3 mRNA CTD PMID:24714768 NCBI chr 1:23,557,926...23,559,501
Ensembl chr 1:23,557,926...23,559,501 		JBrowse link
G ID4 inhibitor of DNA binding 4 increases expression EXP zoledronic acid results in increased expression of ID4 mRNA CTD PMID:24714768 NCBI chr 6:19,837,370...19,842,197
Ensembl chr 6:19,837,370...19,842,197 		JBrowse link
G IDH2 isocitrate dehydrogenase (NADP(+)) 2 decreases expression
increases expression 		EXP zoledronic acid results in decreased expression of IDH2 mRNA
zoledronic acid results in increased expression of IDH2 protein 		CTD PMID:24714768 PMID:28871336 NCBI chr15:90,083,045...90,102,468
Ensembl chr15:90,083,045...90,102,477 		JBrowse link
G IDI1 isopentenyl-diphosphate delta isomerase 1 increases expression EXP
ISO 		zoledronic acid results in increased expression of IDI1 mRNA CTD PMID:18325729 PMID:24714768 NCBI chr10:1,039,152...1,056,704
Ensembl chr10:1,039,152...1,049,119 		JBrowse link
G IDO1 indoleamine 2,3-dioxygenase 1 increases expression EXP zoledronic acid results in increased expression of IDO1 mRNA; zoledronic acid results in increased expression of INDO mRNA CTD PMID:24714768 NCBI chr 8:39,913,891...39,928,790
Ensembl chr 8:39,902,275...39,928,790 		JBrowse link
G IER5 immediate early response 5 increases expression EXP zoledronic acid results in increased expression of IER5 mRNA CTD PMID:24714768 NCBI chr 1:181,088,700...181,092,900
Ensembl chr 1:181,088,700...181,092,900 		JBrowse link
G IFFO2 intermediate filament family orphan 2 increases expression EXP zoledronic acid results in increased expression of IFFO2 mRNA CTD PMID:24714768 NCBI chr 1:18,904,280...18,956,676
Ensembl chr 1:18,904,280...18,956,676 		JBrowse link
G IFI27 interferon alpha inducible protein 27 increases expression EXP zoledronic acid results in increased expression of IFI27 mRNA CTD PMID:24714768 NCBI chr14:94,105,894...94,116,690
Ensembl chr14:94,104,836...94,116,695 		JBrowse link
G IFI6 interferon alpha inducible protein 6 increases expression EXP zoledronic acid results in increased expression of IFI6 mRNA CTD PMID:24714768 NCBI chr 1:27,666,064...27,672,192
Ensembl chr 1:27,666,064...27,672,212 		JBrowse link
G IFNG interferon gamma multiple interactions
increases expression 		EXP
ISO 		zoledronic acid promotes the reaction [IL2 protein affects the expression of IFNG protein]
zoledronic acid results in increased expression of IFNG protein 		CTD PMID:19400555 PMID:19818098 NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740 		JBrowse link
G IFNGR1 interferon gamma receptor 1 increases expression EXP zoledronic acid results in increased expression of IFNGR1 mRNA CTD PMID:24714768 NCBI chr 6:137,197,484...137,219,385
Ensembl chr 6:137,197,483...137,219,449 		JBrowse link
G IFT81 intraflagellar transport 81 decreases expression EXP zoledronic acid results in decreased expression of IFT81 mRNA CTD PMID:20977926 NCBI chr12:110,124,357...110,218,793
Ensembl chr12:110,124,335...110,218,793 		JBrowse link
G IGF1 insulin like growth factor 1 multiple interactions EXP [zoledronic acid co-treated with fluvastatin] results in increased expression of IGF1 mRNA CTD PMID:16996129 NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744 		JBrowse link
G IGFBP5 insulin like growth factor binding protein 5 multiple interactions EXP [zoledronic acid co-treated with fluvastatin] results in increased expression of IGFBP5 mRNA CTD PMID:16996129 NCBI chr 2:216,672,105...216,695,549
Ensembl chr 2:216,672,105...216,695,549 		JBrowse link
G IKBKE inhibitor of nuclear factor kappa B kinase subunit epsilon increases expression EXP zoledronic acid results in increased expression of IKBKE mRNA CTD PMID:24714768 NCBI chr 1:206,470,476...206,496,889
Ensembl chr 1:206,470,476...206,496,889 		JBrowse link
G IKZF5 IKAROS family zinc finger 5 decreases expression EXP zoledronic acid results in decreased expression of IKZF5 mRNA CTD PMID:20977926 NCBI chr10:122,990,806...123,008,795
Ensembl chr10:122,990,807...123,008,812 		JBrowse link
G IL10 interleukin 10 decreases expression ISO zoledronic acid results in decreased expression of IL10 protein CTD PMID:19818098 NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541 		JBrowse link
G IL10RA interleukin 10 receptor subunit alpha multiple interactions EXP [zoledronic acid co-treated with fluvastatin] results in increased expression of IL10RA mRNA CTD PMID:16996129 NCBI chr11:117,986,394...118,003,037
Ensembl chr11:117,986,370...118,003,037 		JBrowse link
G IL13RA2 interleukin 13 receptor subunit alpha 2 increases expression EXP zoledronic acid results in increased expression of IL13RA2 mRNA CTD PMID:24714768 NCBI chr  X:115,003,982...115,017,616
Ensembl chr  X:115,003,975...115,019,977 		JBrowse link
G IL17RB interleukin 17 receptor B decreases expression EXP zoledronic acid results in decreased expression of IL17RB mRNA CTD PMID:24714768 PMID:25596134 NCBI chr 3:53,846,568...53,865,794
Ensembl chr 3:53,846,568...53,865,794 		JBrowse link
G IL18R1 interleukin 18 receptor 1 increases expression EXP zoledronic acid results in increased expression of IL18R1 mRNA CTD PMID:24714768 NCBI chr 2:102,355,796...102,398,776
Ensembl chr 2:102,311,529...102,398,777 		JBrowse link
G IL19 interleukin 19 increases expression
increases secretion 		EXP zoledronic acid results in increased expression of IL19 mRNA
zoledronic acid results in increased secretion of IL19 protein 		CTD PMID:24714768 NCBI chr 1:206,770,773...206,842,981
Ensembl chr 1:206,770,764...206,842,981 		JBrowse link
G IL1B interleukin 1 beta increases expression EXP
ISO 		zoledronic acid results in increased expression of IL1B mRNA CTD PMID:24714768 PMID:28871336 NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816 		JBrowse link
G IL1R1 interleukin 1 receptor type 1 increases expression EXP zoledronic acid results in increased expression of IL1R1 mRNA CTD PMID:24714768 NCBI chr 2:102,070,390...102,179,874
Ensembl chr 2:102,064,544...102,179,874 		JBrowse link
G IL1R2 interleukin 1 receptor type 2 decreases expression EXP zoledronic acid results in decreased expression of IL1R2 mRNA CTD PMID:24714768 NCBI chr 2:101,991,960...102,028,544
Ensembl chr 2:101,991,960...102,028,544 		JBrowse link
G IL2 interleukin 2 multiple interactions EXP IL2 protein affects the reaction [zoledronic acid affects the expression of GZMB mRNA]; zoledronic acid promotes the reaction [IL2 protein affects the expression of IFNG protein] CTD PMID:19400555 PMID:19446661 NCBI chr 4:122,451,470...122,456,725
Ensembl chr 4:122,451,470...122,456,725 		JBrowse link
G IL23A interleukin 23 subunit alpha increases expression EXP zoledronic acid results in increased expression of IL23A mRNA CTD PMID:20977926 NCBI chr12:56,338,884...56,340,410
Ensembl chr12:56,334,174...56,340,410 		JBrowse link
G IL2RG interleukin 2 receptor subunit gamma multiple interactions EXP [zoledronic acid co-treated with fluvastatin] results in increased expression of IL2RG mRNA CTD PMID:16996129 NCBI chr  X:71,107,404...71,111,577
Ensembl chr  X:71,107,404...71,112,108 		JBrowse link
G IL32 interleukin 32 increases expression EXP zoledronic acid results in increased expression of IL32 mRNA CTD PMID:24714768 NCBI chr16:3,065,403...3,069,530
Ensembl chr16:3,065,297...3,082,192 		JBrowse link
G IL36G interleukin 36 gamma increases expression EXP Zoledronic Acid results in increased expression of IL36G mRNA CTD PMID:24714768 NCBI chr 2:112,978,006...112,985,658
Ensembl chr 2:112,973,203...112,985,658 		JBrowse link
G IL4I1 interleukin 4 induced 1 increases expression EXP zoledronic acid results in increased expression of IL4I1 mRNA CTD PMID:24714768 NCBI chr19:49,889,654...49,929,504
Ensembl chr19:49,889,654...49,929,539 		JBrowse link
G IL6 interleukin 6 decreases expression
increases expression
multiple interactions 		EXP
ISO 		Zoledronic Acid results in decreased expression of IL6 mRNA; Zoledronic Acid results in decreased expression of IL6 protein
zoledronic acid results in increased expression of IL6 mRNA
SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in increased expression of IL6 mRNA]
Zoledronic Acid results in increased expression of IL6 mRNA; Zoledronic Acid results in increased expression of IL6 protein 		CTD PMID:9351880 PMID:18601766 PMID:28871336 NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002 		JBrowse link
G IL7 interleukin 7 decreases expression EXP zoledronic acid results in decreased expression of IL7 mRNA CTD PMID:24714768 NCBI chr 8:78,675,044...78,805,463
Ensembl chr 8:78,675,743...78,805,523 		JBrowse link
G INHBE inhibin subunit beta E increases expression EXP zoledronic acid results in increased expression of INHBE mRNA CTD PMID:20977926 NCBI chr12:57,455,307...57,458,025
Ensembl chr12:57,452,323...57,459,280 		JBrowse link
G INSIG1 insulin induced gene 1 increases expression EXP zoledronic acid results in increased expression of INSIG1 mRNA CTD PMID:24714768 PMID:25596134 NCBI chr 7:155,297,878...155,310,235
Ensembl chr 7:155,297,776...155,310,235 		JBrowse link
G IQCD IQ motif containing D increases expression EXP zoledronic acid results in increased expression of IQCD mRNA CTD PMID:24714768 NCBI chr12:113,195,446...113,221,094
Ensembl chr12:113,195,441...113,221,094 		JBrowse link
G IRAK2 interleukin 1 receptor associated kinase 2 increases expression EXP zoledronic acid results in increased expression of IRAK2 mRNA CTD PMID:24714768 NCBI chr 3:10,164,919...10,243,745
Ensembl chr 3:10,164,919...10,243,745 		JBrowse link
G IREB2 iron responsive element binding protein 2 increases expression EXP zoledronic acid results in increased expression of IREB2 mRNA CTD PMID:20977926 NCBI chr15:78,437,431...78,501,453
Ensembl chr15:78,437,431...78,501,453 		JBrowse link
G IRF2 interferon regulatory factor 2 increases expression EXP zoledronic acid results in increased expression of IRF2 mRNA CTD PMID:24714768 NCBI chr 4:184,387,729...184,474,550
Ensembl chr 4:184,385,702...184,474,558 		JBrowse link
G IRF2BP1 interferon regulatory factor 2 binding protein 1 decreases expression EXP zoledronic acid results in decreased expression of IRF2BP1 mRNA CTD PMID:20977926 NCBI chr19:45,883,608...45,886,141
Ensembl chr19:45,883,608...45,886,141 		JBrowse link
G IRF2BPL interferon regulatory factor 2 binding protein like decreases expression EXP zoledronic acid results in decreased expression of IRF2BPL mRNA CTD PMID:24714768 NCBI chr14:77,024,543...77,028,708
Ensembl chr14:77,024,543...77,028,708 		JBrowse link
G IRF8 interferon regulatory factor 8 decreases expression EXP zoledronic acid results in decreased expression of IRF8 mRNA CTD PMID:24714768 NCBI chr16:85,899,162...85,922,609
Ensembl chr16:85,899,116...85,922,606 		JBrowse link
G IRX3 iroquois homeobox 3 decreases expression EXP zoledronic acid results in decreased expression of IRX3 mRNA CTD PMID:24714768 NCBI chr16:54,283,304...54,286,787
Ensembl chr16:54,283,304...54,286,787 		JBrowse link
G ISM1 isthmin 1 increases expression EXP zoledronic acid results in increased expression of ISM1 mRNA CTD PMID:24714768 NCBI chr20:13,221,274...13,326,723
Ensembl chr20:13,221,274...13,300,651 		JBrowse link
G ISM2 isthmin 2 decreases expression EXP zoledronic acid results in decreased expression of ISM2 mRNA CTD PMID:24714768 NCBI chr14:77,474,394...77,498,816
Ensembl chr14:77,474,394...77,498,816 		JBrowse link
G ITFG2 integrin alpha FG-GAP repeat containing 2 decreases expression EXP zoledronic acid results in decreased expression of ITFG2 mRNA CTD PMID:25596134 NCBI chr12:2,812,668...2,859,791
Ensembl chr12:2,812,622...2,859,791 		JBrowse link
G ITGA1 integrin subunit alpha 1 increases expression EXP zoledronic acid results in increased expression of ITGA1 mRNA CTD PMID:24714768 NCBI chr 5:52,787,916...52,959,209
Ensembl chr 5:52,787,916...52,959,209 		JBrowse link
G ITGB2 integrin subunit beta 2 increases expression EXP zoledronic acid results in increased expression of ITGB2 mRNA CTD PMID:24714768 NCBI chr21:44,885,953...44,928,815
Ensembl chr21:44,885,953...44,931,989 		JBrowse link
G ITGB5 integrin subunit beta 5 decreases expression EXP zoledronic acid results in decreased expression of ITGB5 mRNA CTD PMID:24714768 NCBI chr 3:124,761,948...124,901,418
Ensembl chr 3:124,761,948...124,901,418 		JBrowse link
G ITIH3 inter-alpha-trypsin inhibitor heavy chain 3 increases expression EXP zoledronic acid results in increased expression of ITIH3 protein CTD PMID:28871336 NCBI chr 3:52,794,796...52,808,797
Ensembl chr 3:52,794,768...52,808,799 		JBrowse link
G ITPRID2 ITPR interacting domain containing 2 decreases expression EXP zoledronic acid results in decreased expression of ITPRID2 mRNA CTD PMID:24714768 NCBI chr 2:181,891,730...181,930,738
Ensembl chr 2:181,891,730...181,930,738 		JBrowse link
G IVNS1ABP influenza virus NS1A binding protein decreases expression EXP zoledronic acid results in decreased expression of IVNS1ABP mRNA CTD PMID:24714768 NCBI chr 1:185,296,388...185,317,243
Ensembl chr 1:185,292,931...185,317,273 		JBrowse link
G IYD iodotyrosine deiodinase decreases expression EXP zoledronic acid results in decreased expression of IYD mRNA CTD PMID:24714768 NCBI chr 6:150,369,012...150,405,969
Ensembl chr 6:150,368,892...150,405,969 		JBrowse link
G IZUMO4 IZUMO family member 4 increases expression EXP zoledronic acid results in increased expression of IZUMO4 mRNA CTD PMID:24714768 NCBI chr19:2,096,915...2,099,590
Ensembl chr19:2,096,429...2,099,593 		JBrowse link
G JAK1 Janus kinase 1 increases expression EXP zoledronic acid results in increased expression of JAK1 mRNA CTD PMID:24714768 NCBI chr 1:64,833,229...65,067,746
Ensembl chr 1:64,833,223...65,067,754 		JBrowse link
G JAK2 Janus kinase 2 increases expression EXP zoledronic acid results in increased expression of JAK2 mRNA CTD PMID:24714768 NCBI chr 9:4,984,390...5,129,948
Ensembl chr 9:4,984,390...5,129,948 		JBrowse link
G JAK3 Janus kinase 3 increases expression EXP zoledronic acid results in increased expression of JAK3 mRNA CTD PMID:20977926 NCBI chr19:17,824,782...17,847,982
Ensembl chr19:17,824,780...17,848,071 		JBrowse link
G JOSD1 Josephin domain containing 1 increases expression EXP zoledronic acid results in increased expression of JOSD1 mRNA CTD PMID:20977926 NCBI chr22:38,685,543...38,701,403
Ensembl chr22:38,685,543...38,701,556 		JBrowse link
G KAT2B lysine acetyltransferase 2B multiple interactions EXP [zoledronic acid co-treated with fluvastatin] results in increased expression of KAT2B mRNA CTD PMID:16996129 NCBI chr 3:20,040,446...20,154,404
Ensembl chr 3:20,040,446...20,154,404 		JBrowse link
G KBTBD2 kelch repeat and BTB domain containing 2 increases expression EXP zoledronic acid results in increased expression of KBTBD2 mRNA CTD PMID:20977926 NCBI chr 7:32,868,172...32,892,166
Ensembl chr 7:32,868,172...32,894,131 		JBrowse link
G KCNH1 potassium voltage-gated channel subfamily H member 1 decreases expression EXP zoledronic acid results in decreased expression of KCNH1 mRNA CTD PMID:24714768 NCBI chr 1:210,678,314...211,134,148
Ensembl chr 1:210,676,823...211,134,165 		JBrowse link
G KCNH3 potassium voltage-gated channel subfamily H member 3 decreases expression EXP zoledronic acid results in decreased expression of KCNH3 mRNA CTD PMID:24714768 NCBI chr12:49,539,030...49,558,337
Ensembl chr12:49,539,030...49,558,337 		JBrowse link
G KCNIP3 potassium voltage-gated channel interacting protein 3 increases expression EXP zoledronic acid results in increased expression of KCNIP3 mRNA CTD PMID:24714768 NCBI chr 2:95,297,347...95,386,077
Ensembl chr 2:95,297,327...95,386,077 		JBrowse link
G KCNIP4 potassium voltage-gated channel interacting protein 4 decreases expression EXP zoledronic acid results in decreased expression of KCNIP4 mRNA CTD PMID:24714768 NCBI chr 4:20,728,606...21,948,772
Ensembl chr 4:20,728,606...21,948,772 		JBrowse link
G KCNJ1 potassium inwardly rectifying channel subfamily J member 1 decreases expression EXP zoledronic acid results in decreased expression of KCNJ1 mRNA CTD PMID:24714768 NCBI chr11:128,838,020...128,867,296
Ensembl chr11:128,836,315...128,867,373 		JBrowse link
G KCNS3 potassium voltage-gated channel modifier subfamily S member 3 increases expression EXP zoledronic acid results in increased expression of KCNS3 mRNA CTD PMID:24714768 NCBI chr 2:17,877,847...17,932,958
Ensembl chr 2:17,877,847...18,361,616 		JBrowse link
G KCTD5 potassium channel tetramerization domain containing 5 increases expression EXP zoledronic acid results in increased expression of KCTD5 mRNA CTD PMID:20977926 NCBI chr16:2,682,523...2,709,030
Ensembl chr16:2,682,523...2,709,030 		JBrowse link
G KDM3A lysine demethylase 3A increases expression EXP zoledronic acid results in increased expression of KDM3A mRNA CTD PMID:25596134 NCBI chr 2:86,437,044...86,492,716
Ensembl chr 2:86,440,647...86,492,716 		JBrowse link
G KIAA0930 KIAA0930 decreases expression EXP zoledronic acid results in decreased expression of KIAA0930 mRNA CTD PMID:24714768 NCBI chr22:45,192,244...45,240,894
Ensembl chr22:45,192,244...45,240,894 		JBrowse link
G KIF13A kinesin family member 13A decreases expression EXP zoledronic acid results in decreased expression of KIF13A protein CTD PMID:28871336 NCBI chr 6:17,759,126...17,987,635
Ensembl chr 6:17,759,183...17,987,635 		JBrowse link
G KIF20A kinesin family member 20A decreases expression EXP zoledronic acid results in decreased expression of KIF20A mRNA CTD PMID:20977926 PMID:24714768 NCBI chr 5:138,179,112...138,187,723
Ensembl chr 5:138,178,719...138,187,723 		JBrowse link
G KIF4A kinesin family member 4A decreases expression EXP zoledronic acid results in decreased expression of KIF4A mRNA CTD PMID:24714768 NCBI chr  X:70,290,104...70,420,886
Ensembl chr  X:70,290,104...70,420,886 		JBrowse link
G KIFC1 kinesin family member C1 decreases expression EXP zoledronic acid results in decreased expression of KIFC1 mRNA CTD PMID:24714768 NCBI chr 6:33,391,461...33,409,896
Ensembl chr 6:33,391,823...33,409,896 		JBrowse link
G KIR2DL1 killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 1 increases expression EXP zoledronic acid results in increased expression of KIR2DL1 mRNA CTD PMID:20977926 NCBI chr19:54,769,793...54,784,322
Ensembl chr19:54,769,793...54,784,322 		JBrowse link
G KIT KIT proto-oncogene, receptor tyrosine kinase increases expression EXP zoledronic acid results in increased expression of KIT mRNA CTD PMID:24714768 NCBI chr 4:54,657,957...54,740,715
Ensembl chr 4:54,657,267...54,740,783 		JBrowse link
G KITLG KIT ligand decreases expression EXP zoledronic acid results in decreased expression of KITLG mRNA CTD PMID:24714768 NCBI chr12:88,492,793...88,580,471
Ensembl chr12:88,492,793...88,580,851 		JBrowse link
G KLF11 KLF transcription factor 11 increases expression EXP zoledronic acid results in increased expression of KLF11 mRNA CTD PMID:20977926 PMID:24714768 NCBI chr 2:10,043,550...10,054,836
Ensembl chr 2:10,042,849...10,054,836 		JBrowse link
G KLF7 KLF transcription factor 7 increases expression EXP zoledronic acid results in increased expression of KLF7 mRNA CTD PMID:20977926 NCBI chr 2:207,074,137...207,173,851
Ensembl chr 2:207,074,137...207,173,856 		JBrowse link
G KLHL13 kelch like family member 13 decreases expression EXP zoledronic acid results in decreased expression of KLHL13 mRNA CTD PMID:24714768 NCBI chr  X:117,897,813...118,117,340
Ensembl chr  X:117,897,813...118,117,340 		JBrowse link
G KLHL23 kelch like family member 23 increases expression EXP Zoledronic Acid results in increased expression of KLHL23 mRNA CTD PMID:20977926 NCBI chr 2:169,733,832...169,751,878
Ensembl chr 2:169,694,488...169,776,989 		JBrowse link
G KLK10 kallikrein related peptidase 10 increases expression EXP zoledronic acid results in increased expression of KLK10 mRNA CTD PMID:24714768 NCBI chr19:51,012,739...51,020,097
Ensembl chr19:51,012,739...51,020,175 		JBrowse link
G KLK6 kallikrein related peptidase 6 decreases expression EXP zoledronic acid results in decreased expression of KLK6 mRNA CTD PMID:24714768 NCBI chr19:50,958,631...50,969,591
Ensembl chr19:50,958,631...50,969,673 		JBrowse link
G KLRG2 killer cell lectin like receptor G2 increases expression EXP zoledronic acid results in increased expression of KLRG2 mRNA CTD PMID:24714768 NCBI chr 7:139,427,098...139,483,673
Ensembl chr 7:139,452,690...139,483,673 		JBrowse link
G KRAS KRAS proto-oncogene, GTPase increases expression EXP zoledronic acid results in increased expression of KRAS protein CTD PMID:28871336 NCBI chr12:25,205,246...25,250,929
Ensembl chr12:25,205,246...25,250,936 		JBrowse link
G KRCC1 lysine rich coiled-coil 1 increases expression EXP zoledronic acid results in increased expression of KRCC1 mRNA CTD PMID:20977926 NCBI chr 2:88,027,205...88,055,783
Ensembl chr 2:88,027,205...88,064,252 		JBrowse link
G KRT10-AS1 KRT10 antisense RNA 1 increases expression EXP Zoledronic Acid results in increased expression of KRT10-AS1 mRNA CTD PMID:20977926 NCBI chr17:40,819,145...40,836,274
Ensembl chr17:40,819,071...40,836,273 		JBrowse link
G KRT15 keratin 15 increases expression EXP zoledronic acid results in increased expression of KRT15 mRNA CTD PMID:25596134 NCBI chr17:41,513,745...41,518,890
Ensembl chr17:41,513,745...41,522,529 		JBrowse link
G KRT8 keratin 8 decreases expression EXP zoledronic acid results in decreased expression of KRT8 mRNA CTD PMID:24714768 NCBI chr12:52,897,191...52,949,860
Ensembl chr12:52,897,187...52,949,954 		JBrowse link
G KRT80 keratin 80 decreases expression EXP zoledronic acid results in decreased expression of KRT80 mRNA CTD PMID:24714768 NCBI chr12:52,168,996...52,192,014
Ensembl chr12:52,168,996...52,192,014 		JBrowse link
G KRT81 keratin 81 decreases expression EXP zoledronic acid results in decreased expression of KRT81 mRNA CTD PMID:24714768 NCBI chr12:52,285,913...52,291,534
Ensembl chr12:52,285,913...52,291,534 		JBrowse link
G KRT8P47 keratin 8 pseudogene 47 decreases expression EXP zoledronic acid results in decreased expression of KRT8P47 mRNA CTD PMID:24714768 NCBI chr 1:44,103,063...44,104,705
Ensembl chr 1:44,103,306...44,104,703 		JBrowse link
G KYNU kynureninase increases expression EXP zoledronic acid results in increased expression of KYNU mRNA CTD PMID:24714768 NCBI chr 2:142,877,664...143,055,833
Ensembl chr 2:142,877,657...143,055,833 		JBrowse link
G L3MBTL3 L3MBTL histone methyl-lysine binding protein 3 decreases expression EXP zoledronic acid results in decreased expression of L3MBTL3 mRNA CTD PMID:24714768 NCBI chr 6:130,018,581...130,141,438
Ensembl chr 6:130,013,699...130,141,449 		JBrowse link
G LAMA1 laminin subunit alpha 1 decreases expression EXP zoledronic acid results in decreased expression of LAMA1 mRNA CTD PMID:24714768 PMID:25596134 NCBI chr18:6,941,742...7,117,797
Ensembl chr18:6,941,742...7,117,797 		JBrowse link
G LAMA3 laminin subunit alpha 3 increases expression EXP zoledronic acid results in increased expression of LAMA3 mRNA CTD PMID:20977926 PMID:24714768 PMID:25596134 NCBI chr18:23,689,453...23,955,066
Ensembl chr18:23,689,453...23,956,222 		JBrowse link
G LAMA4 laminin subunit alpha 4 decreases expression EXP zoledronic acid results in decreased expression of LAMA4 mRNA CTD PMID:24714768 NCBI chr 6:112,107,931...112,254,985
Ensembl chr 6:112,107,931...112,254,939 		JBrowse link
G LAMA5 laminin subunit alpha 5 multiple interactions EXP [zoledronic acid co-treated with Gossypol] results in decreased expression of LAMA5 mRNA CTD PMID:19825521 NCBI chr20:62,309,065...62,367,312
Ensembl chr20:62,307,955...62,367,312 		JBrowse link
G LAMB1 laminin subunit beta 1 decreases expression EXP zoledronic acid results in decreased expression of LAMB1 mRNA CTD PMID:24714768 NCBI chr 7:107,923,799...108,003,161
Ensembl chr 7:107,923,799...108,003,213 		JBrowse link
G LAMB3 laminin subunit beta 3 increases expression EXP zoledronic acid results in increased expression of LAMB3 mRNA CTD PMID:24714768 NCBI chr 1:209,614,870...209,652,425
Ensembl chr 1:209,614,870...209,652,425 		JBrowse link
G LAMC2 laminin subunit gamma 2 increases expression EXP zoledronic acid results in increased expression of LAMC2 mRNA CTD PMID:24714768 NCBI chr 1:183,186,264...183,258,968
Ensembl chr 1:183,186,238...183,245,127 		JBrowse link
G LAMP1 lysosomal associated membrane protein 1 decreases expression EXP zoledronic acid results in decreased expression of LAMP1 protein CTD PMID:28871336 NCBI chr13:113,297,239...113,323,672
Ensembl chr13:113,297,239...113,323,672 		JBrowse link
G LBH LBH regulator of WNT signaling pathway increases expression EXP zoledronic acid results in increased expression of LBH mRNA CTD PMID:24714768 NCBI chr 2:30,231,534...30,260,028
Ensembl chr 2:30,231,534...30,323,730 		JBrowse link
G LCN2 lipocalin 2 increases expression
increases secretion 		EXP zoledronic acid results in increased expression of LCN2 mRNA
zoledronic acid results in increased secretion of LCN2 protein 		CTD PMID:24714768 NCBI chr 9:128,149,453...128,153,453
Ensembl chr 9:128,149,071...128,153,453 		JBrowse link
G LCP1 lymphocyte cytosolic protein 1 increases expression EXP zoledronic acid results in increased expression of LCP1 mRNA CTD PMID:24714768 NCBI chr13:46,125,923...46,182,177
Ensembl chr13:46,125,920...46,211,871 		JBrowse link
G LDAF1 lipid droplet assembly factor 1 increases expression EXP Zoledronic Acid results in increased expression of LDAF1 mRNA CTD PMID:24714768 NCBI chr16:21,158,674...21,180,616
Ensembl chr16:21,158,377...21,180,616 		JBrowse link
G LDB2 LIM domain binding 2 increases expression EXP zoledronic acid results in increased expression of LDB2 mRNA CTD PMID:24714768 NCBI chr 4:16,501,541...16,898,645
Ensembl chr 4:16,501,541...16,898,678 		JBrowse link
G LDLR low density lipoprotein receptor increases expression EXP zoledronic acid results in increased expression of LDLR mRNA CTD PMID:20977926 NCBI chr19:11,089,463...11,133,820
Ensembl chr19:11,089,418...11,133,820 		JBrowse link
G LDOC1 LDOC1 regulator of NFKB signaling decreases expression EXP zoledronic acid results in decreased expression of LDOC1 mRNA CTD PMID:24714768 NCBI chr  X:141,173,235...141,177,129
Ensembl chr  X:141,111,605...141,177,129 		JBrowse link
G LGI2 leucine rich repeat LGI family member 2 decreases expression EXP zoledronic acid results in decreased expression of LGI2 mRNA CTD PMID:24714768 NCBI chr 4:24,992,081...25,030,946
Ensembl chr 4:24,998,847...25,030,946 		JBrowse link
G LHFPL6 LHFPL tetraspan subfamily member 6 increases expression EXP zoledronic acid results in increased expression of LHFPL6 mRNA CTD PMID:24714768 NCBI chr13:39,342,892...39,603,193
Ensembl chr13:39,209,116...39,603,528 		JBrowse link
G LHX3 LIM homeobox 3 increases expression EXP zoledronic acid results in increased expression of LHX3 mRNA CTD PMID:20977926 NCBI chr 9:136,196,250...136,205,128
Ensembl chr 9:136,196,250...136,205,128 		JBrowse link
G LIMCH1 LIM and calponin homology domains 1 increases expression EXP zoledronic acid results in increased expression of LIMCH1 mRNA CTD PMID:24714768 NCBI chr 4:41,359,607...41,700,044
Ensembl chr 4:41,359,607...41,700,044 		JBrowse link
G LIN52 lin-52 DREAM MuvB core complex component increases expression EXP zoledronic acid results in increased expression of LIN52 mRNA CTD PMID:20977926 NCBI chr14:74,084,956...74,201,493
Ensembl chr14:74,084,956...74,201,493 		JBrowse link
G LINC01559 long intergenic non-protein coding RNA 1559 increases expression EXP zoledronic acid results in increased expression of LINC01559 mRNA CTD PMID:24714768 NCBI chr12:13,370,671...13,376,745
Ensembl chr12:13,371,089...13,387,167 		JBrowse link
G LINC03040 long intergenic non-protein coding RNA 3040 increases expression EXP Zoledronic Acid results in increased expression of LINC03040 mRNA CTD PMID:24714768 NCBI chr 6:44,000,585...44,007,612
Ensembl chr 6:44,000,580...44,007,612 		JBrowse link
G LINS1 lines homolog 1 increases expression EXP zoledronic acid results in increased expression of LINS1 mRNA CTD PMID:20977926 NCBI chr15:100,566,924...100,602,184
Ensembl chr15:100,559,369...100,603,230 		JBrowse link
G LIPG lipase G, endothelial type increases expression EXP zoledronic acid results in increased expression of LIPG mRNA CTD PMID:24714768 NCBI chr18:49,561,479...49,599,185
Ensembl chr18:49,560,699...49,599,185 		JBrowse link
G LITAF lipopolysaccharide induced TNF factor increases expression EXP zoledronic acid results in increased expression of LITAF mRNA CTD PMID:24714768 NCBI chr16:11,547,722...11,640,317
Ensembl chr16:11,546,875...11,636,381 		JBrowse link
G LIX1 limb and CNS expressed 1 decreases expression EXP zoledronic acid results in decreased expression of LIX1 mRNA CTD PMID:24714768 NCBI chr 5:97,091,867...97,142,611
Ensembl chr 5:97,091,867...97,142,753 		JBrowse link
G LLGL2 LLGL scribble cell polarity complex component 2 increases expression EXP zoledronic acid results in increased expression of LLGL2 mRNA CTD PMID:24714768 NCBI chr17:75,525,002...75,575,209
Ensembl chr17:75,525,080...75,575,209 		JBrowse link
G LMNA lamin A/C decreases expression
decreases farnesylation 		EXP zoledronic acid results in decreased expression of LMNA mRNA
zoledronic acid results in decreased farnesylation of LMNA protein 		CTD PMID:16996129 PMID:24714768 NCBI chr 1:156,082,573...156,140,081
Ensembl chr 1:156,082,572...156,140,081 		JBrowse link
G LMNB1 lamin B1 decreases expression
increases expression 		EXP zoledronic acid results in decreased expression of LMNB1 mRNA
zoledronic acid results in increased expression of LMNB1 protein 		CTD PMID:24714768 PMID:28871336 NCBI chr 5:126,776,623...126,837,020
Ensembl chr 5:126,776,623...126,837,020 		JBrowse link
G LNPEP leucyl and cystinyl aminopeptidase increases expression EXP zoledronic acid results in increased expression of LNPEP mRNA CTD PMID:20977926 NCBI chr 5:96,936,080...97,037,513
Ensembl chr 5:96,935,394...97,037,513 		JBrowse link
G LPAR6 lysophosphatidic acid receptor 6 increases expression EXP Zoledronic Acid results in increased expression of LPAR6 mRNA CTD PMID:24714768 NCBI chr13:48,389,571...48,444,669
Ensembl chr13:48,389,567...48,444,704 		JBrowse link
G LPIN1 lipin 1 increases expression EXP zoledronic acid results in increased expression of LPIN1 mRNA CTD PMID:20977926 NCBI chr 2:11,677,544...11,827,409
Ensembl chr 2:11,677,595...11,827,409 		JBrowse link
G LRATD2 LRAT domain containing 2 decreases expression EXP Zoledronic Acid results in decreased expression of LRATD2 mRNA CTD PMID:24714768 PMID:25596134 NCBI chr 8:126,552,443...126,558,478
Ensembl chr 8:126,552,443...126,558,478 		JBrowse link
G LRG1 leucine rich alpha-2-glycoprotein 1 increases expression EXP zoledronic acid results in increased expression of LRG1 mRNA CTD PMID:24714768 NCBI chr19:4,536,402...4,540,036
Ensembl chr19:4,536,402...4,540,036 		JBrowse link
G LRP3 LDL receptor related protein 3 decreases expression EXP zoledronic acid results in decreased expression of LRP3 mRNA CTD PMID:24714768 NCBI chr19:33,194,330...33,208,864
Ensembl chr19:33,177,603...33,208,864 		JBrowse link
G LRRC14 leucine rich repeat containing 14 increases expression EXP zoledronic acid results in increased expression of LRRC14 mRNA CTD PMID:20977926 NCBI chr 8:144,517,992...144,525,178
Ensembl chr 8:144,517,992...144,525,172 		JBrowse link
G LRRC19 leucine rich repeat containing 19 decreases expression EXP zoledronic acid results in decreased expression of LRRC19 mRNA CTD PMID:24714768 NCBI chr 9:26,993,136...27,005,672
Ensembl chr 9:26,993,136...27,005,672 		JBrowse link
G LRRC26 leucine rich repeat containing 26 decreases expression EXP zoledronic acid results in decreased expression of LRRC26 mRNA CTD PMID:24714768 NCBI chr 9:137,168,758...137,170,051
Ensembl chr 9:137,168,758...137,170,051 		JBrowse link
G LRRC75B leucine rich repeat containing 75B decreases expression EXP zoledronic acid results in decreased expression of LRRC75B mRNA CTD PMID:24714768 NCBI chr22:24,585,635...24,593,073
Ensembl chr22:24,585,620...24,593,208 		JBrowse link
G LRRK2 leucine rich repeat kinase 2 decreases expression EXP zoledronic acid results in decreased expression of LRRK2 mRNA CTD PMID:24714768 NCBI chr12:40,224,997...40,369,285
Ensembl chr12:40,196,744...40,369,285 		JBrowse link
G LSS lanosterol synthase increases expression EXP
ISO 		zoledronic acid results in increased expression of LSS mRNA CTD PMID:18325729 PMID:24714768 NCBI chr21:46,188,446...46,228,774
Ensembl chr21:46,188,141...46,228,824 		JBrowse link
G LTB lymphotoxin beta increases expression EXP zoledronic acid results in increased expression of LTB mRNA CTD PMID:24714768 NCBI chr 6:31,580,558...31,582,425
Ensembl chr 6:31,580,525...31,582,522 		JBrowse link
G LTBR lymphotoxin beta receptor multiple interactions
increases expression 		EXP [Tretinoin co-treated with zoledronic acid] results in decreased expression of LTBR mRNA
zoledronic acid results in increased expression of LTBR mRNA 		CTD PMID:19036117 PMID:20349282 NCBI chr12:6,375,160...6,391,566
Ensembl chr12:6,375,045...6,391,571 		JBrowse link
G LTF lactotransferrin increases expression EXP zoledronic acid results in increased expression of LTF protein CTD PMID:28871336 NCBI chr 3:46,435,645...46,485,234
Ensembl chr 3:46,435,645...46,485,234 		JBrowse link
G LURAP1L leucine rich adaptor protein 1 like decreases expression EXP zoledronic acid results in decreased expression of LURAP1L mRNA CTD PMID:24714768 NCBI chr 9:12,775,020...12,823,060
Ensembl chr 9:12,775,020...12,823,060 		JBrowse link
G LYN LYN proto-oncogene, Src family tyrosine kinase increases expression EXP zoledronic acid results in increased expression of LYN mRNA CTD PMID:24714768 NCBI chr 8:55,879,835...56,014,169
Ensembl chr 8:55,879,835...56,014,169 		JBrowse link
G LYPD1 LY6/PLAUR domain containing 1 increases expression EXP zoledronic acid results in increased expression of LYPD1 mRNA CTD PMID:24714768 NCBI chr 2:132,643,286...132,671,526
Ensembl chr 2:132,643,286...132,671,579 		JBrowse link
G LYPD6B LY6/PLAUR domain containing 6B increases expression EXP zoledronic acid results in increased expression of LYPD6B mRNA CTD PMID:24714768 NCBI chr 2:149,038,699...149,215,262
Ensembl chr 2:149,038,107...149,215,262 		JBrowse link
G LZTS1 leucine zipper tumor suppressor 1 multiple interactions
decreases expression 		EXP [zoledronic acid co-treated with fluvastatin] results in increased expression of LZTS1 mRNA
zoledronic acid results in decreased expression of LZTS1 mRNA 		CTD PMID:16996129 PMID:24714768 NCBI chr 8:20,246,165...20,303,963
Ensembl chr 8:20,246,165...20,303,963 		JBrowse link
G M6PR mannose-6-phosphate receptor, cation dependent decreases expression EXP zoledronic acid results in decreased expression of M6PR protein CTD PMID:28871336 NCBI chr12:8,940,361...8,949,645
Ensembl chr12:8,940,361...8,949,761 		JBrowse link
G MAFB MAF bZIP transcription factor B increases expression EXP zoledronic acid results in increased expression of MAFB mRNA CTD PMID:24714768 NCBI chr20:40,685,848...40,689,236
Ensembl chr20:40,685,848...40,689,236 		JBrowse link
G MAFF MAF bZIP transcription factor F increases expression EXP zoledronic acid results in increased expression of MAFF mRNA CTD PMID:24714768 NCBI chr22:38,201,994...38,216,511
Ensembl chr22:38,200,767...38,216,507 		JBrowse link
G MALT1 MALT1 paracaspase increases expression EXP zoledronic acid results in increased expression of MALT1 mRNA CTD PMID:24714768 NCBI chr18:58,671,465...58,754,477
Ensembl chr18:58,671,465...58,754,477 		JBrowse link
G MAN1C1 mannosidase alpha class 1C member 1 decreases expression EXP zoledronic acid results in decreased expression of MAN1C1 mRNA CTD PMID:24714768 NCBI chr 1:25,616,791...25,784,450
Ensembl chr 1:25,616,791...25,784,450 		JBrowse link
G MAP2 microtubule associated protein 2 decreases expression EXP zoledronic acid results in decreased expression of MAP2 mRNA CTD PMID:24714768 NCBI chr 2:209,424,047...209,734,112
Ensembl chr 2:209,424,047...209,734,147 		JBrowse link
G MAP3K2 mitogen-activated protein kinase kinase kinase 2 decreases expression EXP zoledronic acid results in decreased expression of MAP3K2 mRNA CTD PMID:20977926 NCBI chr 2:127,298,668...127,388,465
Ensembl chr 2:127,298,668...127,388,465 		JBrowse link
G MAP3K8 mitogen-activated protein kinase kinase kinase 8 increases expression EXP zoledronic acid results in increased expression of MAP3K8 mRNA CTD PMID:24714768 PMID:25596134 NCBI chr10:30,434,021...30,461,833
Ensembl chr10:30,434,021...30,461,833 		JBrowse link
G MAP7D3 MAP7 domain containing 3 increases expression EXP zoledronic acid results in increased expression of MAP7D3 mRNA CTD PMID:20977926 NCBI chr  X:136,213,220...136,256,482
Ensembl chr  X:136,213,220...136,256,482 		JBrowse link
G MAPK1 mitogen-activated protein kinase 1 decreases phosphorylation
increases phosphorylation
multiple interactions 		EXP zoledronic acid results in decreased phosphorylation of MAPK1 protein
zoledronic acid results in increased phosphorylation of MAPK1 protein
[Zoledronic Acid co-treated with 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide] results in decreased phosphorylation of MAPK1 protein; CCN1 protein affects the reaction [Zoledronic Acid results in decreased phosphorylation of and results in decreased activity of MAPK1 protein]; Gefitinib promotes the reaction [[Zoledronic Acid co-treated with 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide] results in decreased phosphorylation of MAPK1 protein]; Zoledronic Acid results in decreased phosphorylation of and results in decreased activity of MAPK1 protein 		CTD PMID:12799645 PMID:16322342 PMID:16996129 PMID:17059425 PMID:19530242 NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680 		JBrowse link
G MAPK10 mitogen-activated protein kinase 10 decreases expression EXP zoledronic acid results in decreased expression of MAPK10 mRNA CTD PMID:24714768 NCBI chr 4:86,010,405...86,594,074
Ensembl chr 4:85,990,007...86,594,625 		JBrowse link
G MAPK3 mitogen-activated protein kinase 3 multiple interactions
increases phosphorylation
decreases phosphorylation 		EXP [Zoledronic Acid co-treated with 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide] results in decreased phosphorylation of MAPK3 protein; CCN1 protein affects the reaction [Zoledronic Acid results in decreased phosphorylation of and results in decreased activity of MAPK3 protein]; Gefitinib promotes the reaction [[Zoledronic Acid co-treated with 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide] results in decreased phosphorylation of MAPK3 protein]; Zoledronic Acid results in decreased phosphorylation of and results in decreased activity of MAPK3 protein
zoledronic acid results in increased phosphorylation of MAPK3 protein
zoledronic acid results in decreased phosphorylation of MAPK3 protein 		CTD PMID:12799645 PMID:16322342 PMID:16996129 PMID:17059425 PMID:19530242 NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506 		JBrowse link
G MAPK8 mitogen-activated protein kinase 8 multiple interactions EXP zoledronic acid promotes the reaction [TNF protein results in increased phosphorylation of MAPK8 protein] CTD PMID:17059425 NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360 		JBrowse link
G MAPKAPK3 MAPK activated protein kinase 3 decreases expression EXP zoledronic acid results in decreased expression of MAPKAPK3 mRNA CTD PMID:24714768 NCBI chr 3:50,611,520...50,649,291
Ensembl chr 3:50,611,520...50,649,291 		JBrowse link
G MARCHF3 membrane associated ring-CH-type finger 3 increases expression EXP Zoledronic Acid results in increased expression of MARCHF3 mRNA CTD PMID:24714768 NCBI chr 5:126,867,714...127,030,558
Ensembl chr 5:126,867,714...127,030,558 		JBrowse link
G MARCKS myristoylated alanine rich protein kinase C substrate increases expression EXP zoledronic acid results in increased expression of MARCKS mRNA CTD PMID:24714768 NCBI chr 6:113,857,345...113,863,475
Ensembl chr 6:113,857,345...113,863,475 		JBrowse link
G MAST4 microtubule associated serine/threonine kinase family member 4 increases expression EXP zoledronic acid results in increased expression of MAST4 mRNA CTD PMID:24714768 NCBI chr 5:66,596,393...67,169,593
Ensembl chr 5:66,596,380...67,169,593 		JBrowse link
G MATN3 matrilin 3 decreases expression EXP zoledronic acid results in decreased expression of MATN3 mRNA CTD PMID:24714768 NCBI chr 2:19,992,052...20,012,668
Ensembl chr 2:19,992,052...20,012,668 		JBrowse link
G MAX MYC associated factor X increases expression EXP zoledronic acid results in increased expression of MAX mRNA CTD PMID:20977926 NCBI chr14:65,006,101...65,102,695
Ensembl chr14:65,006,174...65,102,695 		JBrowse link
G MB21D2 Mab-21 domain containing 2 increases expression EXP zoledronic acid results in increased expression of MB21D2 mRNA CTD PMID:24714768 NCBI chr 3:192,796,815...192,917,856
Ensembl chr 3:192,796,815...192,917,856 		JBrowse link
G MBIP MAP3K12 binding inhibitory protein 1 increases expression EXP zoledronic acid results in increased expression of MBIP mRNA CTD PMID:24714768 NCBI chr14:36,298,564...36,320,637
Ensembl chr14:36,298,564...36,320,637 		JBrowse link
G MBTPS2 membrane bound transcription factor peptidase, site 2 increases expression EXP zoledronic acid results in increased expression of MBTPS2 mRNA CTD PMID:20977926 NCBI chr  X:21,839,617...21,885,423
Ensembl chr  X:21,839,617...21,885,423 		JBrowse link
G MCL1 MCL1 apoptosis regulator, BCL2 family member multiple interactions EXP [Tretinoin co-treated with zoledronic acid] results in decreased expression of MCL1 mRNA CTD PMID:20349282 NCBI chr 1:150,574,558...150,579,610
Ensembl chr 1:150,560,895...150,579,738 		JBrowse link
G MCM10 minichromosome maintenance 10 replication initiation factor decreases expression EXP zoledronic acid results in decreased expression of MCM10 mRNA CTD PMID:24714768 NCBI chr10:13,161,558...13,211,110
Ensembl chr10:13,161,558...13,211,110 		JBrowse link
G MCM2 minichromosome maintenance complex component 2 multiple interactions
decreases expression 		EXP [zoledronic acid co-treated with docetaxel] results in decreased expression of MCM2 protein
zoledronic acid results in decreased expression of MCM2 protein 		CTD PMID:17562444 PMID:28871336 NCBI chr 3:127,598,411...127,622,436
Ensembl chr 3:127,598,223...127,622,436 		JBrowse link
G MCM4 minichromosome maintenance complex component 4 increases expression EXP zoledronic acid results in increased expression of MCM4 mRNA CTD PMID:20977926 NCBI chr 8:47,960,941...47,978,160
Ensembl chr 8:47,960,185...47,978,160 		JBrowse link
G MCM6 minichromosome maintenance complex component 6 decreases expression EXP zoledronic acid results in decreased expression of MCM6 mRNA CTD PMID:24714768 NCBI chr 2:135,839,626...135,876,443
Ensembl chr 2:135,839,626...135,876,443 		JBrowse link
G MCUR1 mitochondrial calcium uniporter regulator 1 increases expression EXP zoledronic acid results in increased expression of MCUR1 mRNA CTD PMID:24714768 NCBI chr 6:13,786,557...13,814,557
Ensembl chr 6:13,786,557...13,814,568 		JBrowse link
G MDK midkine multiple interactions EXP zoledronic acid promotes the reaction [Gossypol results in decreased expression of MDK mRNA] CTD PMID:19825521 NCBI chr11:46,380,784...46,383,837
Ensembl chr11:46,380,756...46,383,837 		JBrowse link
G MDM4 MDM4 regulator of p53 increases expression EXP zoledronic acid results in increased expression of MDM4 mRNA CTD PMID:20977926 NCBI chr 1:204,516,406...204,558,120
Ensembl chr 1:204,516,379...204,558,120 		JBrowse link
G ME1 malic enzyme 1 increases expression EXP zoledronic acid results in increased expression of ME1 mRNA CTD PMID:24714768 PMID:25596134 NCBI chr 6:83,210,402...83,431,051
Ensembl chr 6:83,210,402...83,431,051 		JBrowse link
G MECOM MDS1 and EVI1 complex locus decreases expression EXP Zoledronic Acid results in decreased expression of MECOM mRNA CTD PMID:24714768 NCBI chr 3:169,083,507...169,663,712
Ensembl chr 3:169,083,499...169,663,775 		JBrowse link
G MED13L mediator complex subunit 13L decreases expression EXP zoledronic acid results in decreased expression of MED13L mRNA CTD PMID:20977926 NCBI chr12:115,958,576...116,277,693
Ensembl chr12:115,957,905...116,277,693 		JBrowse link
G MED20 mediator complex subunit 20 increases expression EXP zoledronic acid results in increased expression of MED20 mRNA CTD PMID:20977926 NCBI chr 6:41,905,354...41,921,139
Ensembl chr 6:41,905,354...41,921,139 		JBrowse link
G MED23 mediator complex subunit 23 multiple interactions EXP [zoledronic acid co-treated with fluvastatin] results in increased expression of MED23 mRNA CTD PMID:16996129 NCBI chr 6:131,573,966...131,628,313
Ensembl chr 6:131,573,966...131,628,242 		JBrowse link
G MEGF11 multiple EGF like domains 11 increases expression EXP zoledronic acid results in increased expression of MEGF11 mRNA CTD PMID:24714768 NCBI chr15:65,895,299...66,253,750
Ensembl chr15:65,895,079...66,253,756 		JBrowse link
G MELK maternal embryonic leucine zipper kinase decreases expression EXP zoledronic acid results in decreased expression of MELK mRNA CTD PMID:24714768 NCBI chr 9:36,572,895...36,677,682
Ensembl chr 9:36,572,862...36,677,683 		JBrowse link
G METRNL meteorin like, glial cell differentiation regulator decreases expression EXP zoledronic acid results in decreased expression of METRNL mRNA CTD PMID:24714768 NCBI chr17:83,079,609...83,095,122
Ensembl chr17:83,079,609...83,095,122 		JBrowse link
G MEX3C mex-3 RNA binding family member C increases expression EXP zoledronic acid results in increased expression of MEX3C mRNA CTD PMID:20977926 NCBI chr18:51,174,550...51,197,681
Ensembl chr18:51,174,550...51,218,333 		JBrowse link
G MFSD4A major facilitator superfamily domain containing 4A decreases expression EXP zoledronic acid results in decreased expression of MFSD4A mRNA CTD PMID:24714768 NCBI chr 1:205,569,014...205,602,918
Ensembl chr 1:205,568,885...205,602,918 		JBrowse link
G MGAT3 beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase increases expression EXP zoledronic acid results in increased expression of MGAT3 mRNA CTD PMID:24714768 NCBI chr22:39,457,012...39,492,194
Ensembl chr22:39,457,012...39,492,194 		JBrowse link
G MGST1 microsomal glutathione S-transferase 1 decreases expression EXP zoledronic acid results in decreased expression of MGST1 mRNA CTD PMID:24714768 NCBI chr12:16,347,115...16,593,331
Ensembl chr12:16,347,142...16,609,259 		JBrowse link
G MID1 midline 1 increases expression EXP zoledronic acid results in increased expression of MID1 mRNA CTD PMID:24714768 NCBI chr  X:10,445,310...10,833,683
Ensembl chr  X:10,445,310...10,833,654 		JBrowse link
G MINK1 misshapen like kinase 1 decreases expression EXP zoledronic acid results in decreased expression of MINK1 mRNA CTD PMID:20977926 NCBI chr17:4,833,340...4,898,061
Ensembl chr17:4,833,340...4,898,061 		JBrowse link
G MIR22HG MIR22 host gene decreases expression EXP zoledronic acid results in decreased expression of MIR22HG mRNA CTD PMID:24714768 NCBI chr17:1,711,504...1,716,210
Ensembl chr17:1,711,447...1,717,174 		JBrowse link
G MIR302C microRNA 302c increases expression EXP zoledronic acid results in increased expression of MIR302C mRNA CTD PMID:24714768 NCBI chr 4:112,648,363...112,648,430
Ensembl chr 4:112,648,363...112,648,430 		JBrowse link
G MIR503HG MIR503 host gene decreases expression EXP zoledronic acid results in decreased expression of MIR503HG mRNA CTD PMID:24714768 NCBI chr  X:134,543,377...134,546,630
Ensembl chr  X:134,543,118...134,549,644 		JBrowse link
G MIR586 microRNA 586 decreases expression EXP zoledronic acid results in decreased expression of MIR586 mRNA CTD PMID:24714768 NCBI chr 6:45,197,674...45,197,770
Ensembl chr 6:45,197,674...45,197,770 		JBrowse link
G MKI67 marker of proliferation Ki-67 multiple interactions EXP [zoledronic acid co-treated with Doxorubicin] results in decreased expression of MKI67 protein CTD PMID:18695136 NCBI chr10:128,096,659...128,126,423
Ensembl chr10:128,096,659...128,126,423 		JBrowse link
G MLLT11 MLLT11 transcription factor 7 cofactor decreases expression EXP zoledronic acid results in decreased expression of MLLT11 mRNA CTD PMID:24714768 NCBI chr 1:151,060,397...151,069,544
Ensembl chr 1:151,060,397...151,069,544 		JBrowse link
G MMEL1 membrane metalloendopeptidase like 1 increases expression EXP zoledronic acid results in increased expression of MMEL1 mRNA CTD PMID:20977926 NCBI chr 1:2,590,639...2,633,016
Ensembl chr 1:2,590,639...2,633,016 		JBrowse link
G MMP10 matrix metallopeptidase 10 increases expression EXP zoledronic acid results in increased expression of MMP10 mRNA CTD PMID:24714768 NCBI chr11:102,770,502...102,780,628
Ensembl chr11:102,770,502...102,780,628 		JBrowse link
G MMP2 matrix metallopeptidase 2 decreases expression EXP zoledronic acid results in decreased expression of MMP2 protein CTD PMID:16475674 NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691 		JBrowse link
G MMP23B matrix metallopeptidase 23B increases expression EXP zoledronic acid results in increased expression of MMP23B mRNA CTD PMID:24714768 NCBI chr 1:1,632,173...1,634,654
Ensembl chr 1:1,632,163...1,635,263 		JBrowse link
G MMP9 matrix metallopeptidase 9 multiple interactions ISO zoledronic acid results in decreased expression of and results in decreased activity of MMP9 protein CTD PMID:15343380 NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561 		JBrowse link
G MOCS1 molybdenum cofactor synthesis 1 increases expression EXP zoledronic acid results in increased expression of MOCS1 mRNA CTD PMID:24714768 NCBI chr 6:39,904,170...39,934,462
Ensembl chr 6:39,899,578...39,934,551 		JBrowse link
G MON2 MON2 homolog, regulator of endosome-to-Golgi trafficking increases expression EXP zoledronic acid results in increased expression of MON2 protein CTD PMID:28871336 NCBI chr12:62,466,826...62,600,476
Ensembl chr12:62,466,817...62,600,476 		JBrowse link
G MOXD1 monooxygenase DBH like 1 increases expression EXP zoledronic acid results in increased expression of MOXD1 mRNA CTD PMID:24714768 NCBI chr 6:132,296,055...132,401,475
Ensembl chr 6:132,296,055...132,401,475 		JBrowse link
G MPC2 mitochondrial pyruvate carrier 2 decreases expression EXP zoledronic acid results in decreased expression of MPC2 mRNA CTD PMID:24714768 NCBI chr 1:167,916,675...167,937,072
Ensembl chr 1:167,916,675...167,937,072 		JBrowse link
G MPDU1 mannose-P-dolichol utilization defect 1 increases expression EXP zoledronic acid results in increased expression of MPDU1 mRNA CTD PMID:20977926 NCBI chr17:7,583,647...7,588,212
Ensembl chr17:7,583,529...7,592,789 		JBrowse link
G MPHOSPH8 M-phase phosphoprotein 8 multiple interactions EXP [zoledronic acid co-treated with fluvastatin] results in increased expression of MPHOSPH8 mRNA CTD PMID:16996129 NCBI chr13:19,633,659...19,673,441
Ensembl chr13:19,633,659...19,673,441 		JBrowse link
G MPZL2 myelin protein zero like 2 increases expression EXP zoledronic acid results in increased expression of MPZL2 mRNA CTD PMID:24714768 NCBI chr11:118,253,416...118,264,297
Ensembl chr11:118,253,416...118,264,536 		JBrowse link
G MREG melanoregulin increases expression EXP zoledronic acid results in increased expression of MREG mRNA CTD PMID:20977926 NCBI chr 2:215,939,308...216,034,096
Ensembl chr 2:215,942,584...216,034,096 		JBrowse link
G MRTFA myocardin related transcription factor A increases expression EXP zoledronic acid results in increased expression of MRTFA mRNA CTD PMID:24714768 NCBI chr22:40,410,289...40,636,719
Ensembl chr22:40,410,281...40,636,719 		JBrowse link
G MSH2 mutS homolog 2 decreases expression
affects localization 		EXP zoledronic acid results in decreased expression of MSH2 protein
zoledronic acid affects the localization of MSH2 protein 		CTD PMID:17070308 NCBI chr 2:47,403,067...47,709,830
Ensembl chr 2:47,403,067...47,663,146 		JBrowse link
G MSH3 mutS homolog 3 increases expression EXP zoledronic acid results in increased expression of MSH3 mRNA CTD PMID:20977926 NCBI chr 5:80,654,652...80,876,815
Ensembl chr 5:80,654,652...80,876,815 		JBrowse link
G MSMO1 methylsterol monooxygenase 1 increases expression EXP zoledronic acid results in increased expression of MSMO1 mRNA CTD PMID:24714768 NCBI chr 4:165,327,669...165,343,164
Ensembl chr 4:165,327,667...165,343,164 		JBrowse link
G MT1A metallothionein 1A increases expression EXP zoledronic acid results in increased expression of MT1A protein CTD PMID:28871336 NCBI chr16:56,638,666...56,640,087
Ensembl chr16:56,638,666...56,640,087 		JBrowse link
G MT1G metallothionein 1G increases expression EXP zoledronic acid results in increased expression of MT1G mRNA CTD PMID:24714768 NCBI chr16:56,666,730...56,668,065
Ensembl chr16:56,666,730...56,668,065 		JBrowse link
G MT2A metallothionein 2A increases expression EXP zoledronic acid results in increased expression of MT2A mRNA CTD PMID:24714768 PMID:25596134 NCBI chr16:56,608,584...56,609,497
Ensembl chr16:56,608,584...56,609,497 		JBrowse link
G MTA1 metastasis associated 1 decreases expression EXP zoledronic acid results in decreased expression of MTA1 protein CTD PMID:28871336 NCBI chr14:105,419,827...105,470,729
Ensembl chr14:105,419,820...105,470,729 		JBrowse link
G MTERF4 mitochondrial transcription termination factor 4 increases expression EXP zoledronic acid results in increased expression of MTERF4 mRNA CTD PMID:20977926 NCBI chr 2:241,042,586...241,102,287
Ensembl chr 2:241,072,169...241,102,332 		JBrowse link
G MTPAP mitochondrial poly(A) polymerase increases expression EXP zoledronic acid results in increased expression of MTPAP mRNA CTD PMID:20977926 NCBI chr10:30,309,801...30,349,278
Ensembl chr10:30,309,801...30,374,448 		JBrowse link
G MTURN maturin, neural progenitor differentiation regulator homolog decreases expression EXP zoledronic acid results in decreased expression of MTURN mRNA CTD PMID:24714768 NCBI chr 7:30,134,986...30,162,762
Ensembl chr 7:30,134,986...30,162,765 		JBrowse link
G MUSK muscle associated receptor tyrosine kinase decreases expression EXP zoledronic acid results in decreased expression of MUSK mRNA CTD PMID:24714768 NCBI chr 9:110,668,791...110,806,558
Ensembl chr 9:110,668,779...110,806,558 		JBrowse link
G MVD mevalonate diphosphate decarboxylase increases expression EXP zoledronic acid results in increased expression of MVD mRNA CTD PMID:24714768 NCBI chr16:88,651,940...88,663,091
Ensembl chr16:88,651,935...88,663,161 		JBrowse link
G MVK mevalonate kinase increases expression EXP zoledronic acid results in increased expression of MVK mRNA CTD PMID:20977926 NCBI chr12:109,573,272...109,598,125
Ensembl chr12:109,573,255...109,598,125 		JBrowse link
G MVP major vault protein decreases expression
increases expression 		EXP zoledronic acid results in decreased expression of MVP mRNA
zoledronic acid results in increased expression of MVP mRNA 		CTD PMID:18225567 PMID:20977926 NCBI chr16:29,820,394...29,848,039
Ensembl chr16:29,820,394...29,848,039 		JBrowse link
G MXRA7 matrix remodeling associated 7 increases expression EXP zoledronic acid results in increased expression of MXRA7 mRNA CTD PMID:24714768 NCBI chr17:76,672,551...76,710,965
Ensembl chr17:76,672,551...76,711,004 		JBrowse link
G MYL3 myosin light chain 3 decreases expression EXP zoledronic acid results in decreased expression of MYL3 mRNA CTD PMID:24714768 NCBI chr 3:46,857,872...46,882,182
Ensembl chr 3:46,835,110...46,882,178 		JBrowse link
G N4BP2L1 NEDD4 binding protein 2 like 1 increases expression EXP zoledronic acid results in increased expression of N4BP2L1 mRNA CTD PMID:20977926 NCBI chr13:32,400,723...32,429,615
Ensembl chr13:32,400,723...32,428,311 		JBrowse link
G NAB1 NGFI-A binding protein 1 increases expression EXP zoledronic acid results in increased expression of NAB1 mRNA CTD PMID:24714768 NCBI chr 2:190,648,895...190,692,766
Ensembl chr 2:190,646,746...190,692,766 		JBrowse link
G NACA4P NACA family member 4, pseudogene decreases expression EXP zoledronic acid results in decreased expression of NACA4P mRNA CTD PMID:20977926 NCBI chr 8:101,368,893...101,369,595
Ensembl chr 8:101,368,910...101,369,550 		JBrowse link
G NAIP NLR family apoptosis inhibitory protein affects expression EXP zoledronic acid affects the expression of NAIP mRNA CTD PMID:19036117 NCBI chr 5:70,968,166...71,025,339
Ensembl chr 5:70,968,166...71,025,339 		JBrowse link
G NAMPT nicotinamide phosphoribosyltransferase increases expression EXP zoledronic acid results in increased expression of NAMPT mRNA CTD PMID:24714768 PMID:25596134 NCBI chr 7:106,248,298...106,285,888
Ensembl chr 7:106,248,298...106,285,966 		JBrowse link
G NANOS1 nanos C2HC-type zinc finger 1 increases expression EXP zoledronic acid results in increased expression of NANOS1 mRNA CTD PMID:20977926 NCBI chr10:119,029,714...119,033,730
Ensembl chr10:119,029,714...119,033,730 		JBrowse link
G NAPEPLD N-acyl phosphatidylethanolamine phospholipase D increases expression EXP zoledronic acid results in increased expression of NAPEPLD mRNA CTD PMID:24714768 NCBI chr 7:103,099,776...103,150,001
Ensembl chr 7:103,099,776...103,149,560 		JBrowse link
G NAPSB napsin B aspartic peptidase (pseudogene) increases expression EXP zoledronic acid results in increased expression of NAPSB mRNA CTD PMID:24714768 NCBI chr19:50,333,800...50,344,767
Ensembl chr19:50,333,877...50,344,761
Ensembl chr19:50,333,877...50,344,761 		JBrowse link
G NARS1 asparaginyl-tRNA synthetase 1 decreases expression EXP Zoledronic Acid results in decreased expression of NARS1 mRNA CTD PMID:25596134 NCBI chr18:57,600,656...57,621,836
Ensembl chr18:57,600,656...57,622,213 		JBrowse link
G NAT8 N-acetyltransferase 8 (putative) decreases expression EXP zoledronic acid results in decreased expression of NAT8 mRNA CTD PMID:24714768 NCBI chr 2:73,640,723...73,642,422
Ensembl chr 2:73,640,723...73,642,422 		JBrowse link
G NAT8B N-acetyltransferase 8B (putative, gene/pseudogene) decreases expression EXP zoledronic acid results in decreased expression of NAT8B mRNA CTD PMID:24714768 NCBI chr 2:73,700,509...73,702,125
Ensembl chr 2:73,700,576...73,701,340 		JBrowse link
G NAV1 neuron navigator 1 decreases expression EXP zoledronic acid results in decreased expression of NAV1 mRNA CTD PMID:24714768 NCBI chr 1:201,539,127...201,826,969
Ensembl chr 1:201,539,127...201,826,969 		JBrowse link
G NAV2 neuron navigator 2 decreases expression EXP zoledronic acid results in decreased expression of NAV2 mRNA CTD PMID:24714768 NCBI chr11:19,345,236...20,121,601
Ensembl chr11:19,350,724...20,121,601 		JBrowse link
G NBR1 NBR1 autophagy cargo receptor increases expression EXP zoledronic acid results in increased expression of NBR1 mRNA CTD PMID:20977926 NCBI chr17:43,170,409...43,211,688
Ensembl chr17:43,170,481...43,211,689 		JBrowse link
G NCAPG non-SMC condensin I complex subunit G decreases expression EXP zoledronic acid results in decreased expression of NCAPG mRNA CTD PMID:24714768 NCBI chr 4:17,810,979...17,844,865
Ensembl chr 4:17,810,979...17,844,865 		JBrowse link
G NCK1 NCK adaptor protein 1 increases expression EXP zoledronic acid results in increased expression of NCK1 mRNA CTD PMID:24714768 NCBI chr 3:136,862,208...136,951,606
Ensembl chr 3:136,862,208...136,951,606 		JBrowse link
G NCKAP5 NCK associated protein 5 increases expression EXP zoledronic acid results in increased expression of NCKAP5 mRNA CTD PMID:24714768 NCBI chr 2:132,671,788...133,674,836
Ensembl chr 2:132,671,788...133,568,463 		JBrowse link
G NCOA7 nuclear receptor coactivator 7 increases expression EXP zoledronic acid results in increased expression of NCOA7 mRNA CTD PMID:24714768 NCBI chr 6:125,781,115...125,932,034
Ensembl chr 6:125,781,161...125,932,034 		JBrowse link
G NDC80 NDC80 kinetochore complex component multiple interactions EXP [zoledronic acid co-treated with fluvastatin] results in increased expression of NDC80 mRNA CTD PMID:16996129 NCBI chr18:2,571,557...2,616,635
Ensembl chr18:2,571,557...2,616,635 		JBrowse link
G NDE1 nudE neurodevelopment protein 1 increases expression EXP zoledronic acid results in increased expression of NDE1 mRNA CTD PMID:20977926 NCBI chr16:15,643,382...15,726,353
Ensembl chr16:15,643,267...15,734,691 		JBrowse link
G NDRG4 NDRG family member 4 increases expression EXP zoledronic acid results in increased expression of NDRG4 mRNA CTD PMID:24714768 NCBI chr16:58,463,715...58,515,387
Ensembl chr16:58,462,846...58,513,628 		JBrowse link
G NEFL neurofilament light chain decreases expression EXP zoledronic acid results in decreased expression of NEFL mRNA CTD PMID:24714768 NCBI chr 8:24,950,955...24,956,612
Ensembl chr 8:24,950,955...24,956,721 		JBrowse link
G NEFM neurofilament medium chain decreases expression EXP zoledronic acid results in decreased expression of NEFM mRNA CTD PMID:24714768 NCBI chr 8:24,913,761...24,919,093
Ensembl chr 8:24,913,758...24,919,098 		JBrowse link
G NEK2 NIMA related kinase 2 decreases expression EXP zoledronic acid results in decreased expression of NEK2 mRNA CTD PMID:24714768 NCBI chr 1:211,658,256...211,675,621
Ensembl chr 1:211,658,657...211,675,630 		JBrowse link
G NEMP1 nuclear envelope integral membrane protein 1 increases expression EXP zoledronic acid results in increased expression of NEMP1 mRNA CTD PMID:20977926 NCBI chr12:57,055,643...57,088,627
Ensembl chr12:57,055,643...57,088,063 		JBrowse link
G NEURL3 neuralized E3 ubiquitin protein ligase 3 increases expression EXP zoledronic acid results in increased expression of LINCR mRNA CTD PMID:24714768 NCBI chr 2:96,497,646...96,508,109
Ensembl chr 2:96,497,646...96,508,109 		JBrowse link
G NFE2L2 NFE2 like bZIP transcription factor 2 increases expression EXP Zoledronic Acid results in increased expression of NFE2L2 mRNA CTD PMID:20977926 PMID:35587103 NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756 		JBrowse link
G NFE2L3 NFE2 like bZIP transcription factor 3 decreases expression EXP zoledronic acid results in decreased expression of NFE2L3 mRNA CTD PMID:20977926 NCBI chr 7:26,152,198...26,187,137
Ensembl chr 7:26,152,198...26,187,137 		JBrowse link
G NFKB2 nuclear factor kappa B subunit 2 increases expression EXP zoledronic acid results in increased expression of NFKB2 mRNA CTD PMID:24714768 NCBI chr10:102,394,110...102,402,529
Ensembl chr10:102,394,110...102,402,524 		JBrowse link
G NFKBIA NFKB inhibitor alpha increases expression EXP zoledronic acid results in increased expression of NFKBIA mRNA CTD PMID:24714768 NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749 		JBrowse link
G NFKBIZ NFKB inhibitor zeta increases expression EXP zoledronic acid results in increased expression of NFKBIZ mRNA CTD PMID:24714768 NCBI chr 3:101,827,990...101,861,022
Ensembl chr 3:101,827,991...101,861,022 		JBrowse link
G NHS NHS actin remodeling regulator decreases expression EXP zoledronic acid results in decreased expression of NHS mRNA CTD PMID:24714768 NCBI chr  X:17,375,200...17,735,994
Ensembl chr  X:17,375,200...17,735,994 		JBrowse link
G NIBAN1 niban apoptosis regulator 1 increases expression EXP Zoledronic Acid results in increased expression of NIBAN1 mRNA CTD PMID:24714768 NCBI chr 1:184,791,032...184,974,508
Ensembl chr 1:184,790,724...184,974,508 		JBrowse link
G NICOL1 NELL2 interacting cell ontogeny regulator 1 decreases expression EXP Zoledronic Acid results in decreased expression of NICOL1 mRNA CTD PMID:20977926 NCBI chr 4:2,036,554...2,043,964
Ensembl chr 4:2,041,995...2,043,964 		JBrowse link
G NID2 nidogen 2 increases expression EXP zoledronic acid results in increased expression of NID2 mRNA CTD PMID:24714768 NCBI chr14:52,004,809...52,069,059
Ensembl chr14:52,004,809...52,069,059 		JBrowse link
G NINJ1 ninjurin 1 decreases expression EXP zoledronic acid results in decreased expression of NINJ1 mRNA CTD PMID:25596134 NCBI chr 9:93,121,496...93,134,251
Ensembl chr 9:93,121,496...93,134,251 		JBrowse link
G NINJ2 ninjurin 2 decreases expression EXP zoledronic acid results in decreased expression of NINJ2 mRNA CTD PMID:24714768 NCBI chr12:564,296...663,445
Ensembl chr12:564,296...663,589 		JBrowse link
G NKRF NFKB repressing factor decreases expression EXP zoledronic acid results in decreased expression of NKRF mRNA CTD PMID:20977926 NCBI chr  X:119,588,337...119,606,424
Ensembl chr  X:119,588,337...119,606,443 		JBrowse link
G NLGN4X neuroligin 4 X-linked increases expression EXP zoledronic acid results in increased expression of NLGN4X mRNA CTD PMID:24714768 NCBI chr  X:5,890,042...6,228,867
Ensembl chr  X:5,840,637...6,228,867 		JBrowse link
G NOS2 nitric oxide synthase 2 multiple interactions
increases expression 		ISO
EXP 		[zoledronic acid results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide
Zoledronic Acid results in increased expression of NOS2 mRNA; Zoledronic Acid results in increased expression of NOS2A mRNA 		CTD PMID:19818098 PMID:24714768 NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529 		JBrowse link
G NOSTRIN nitric oxide synthase trafficking decreases expression EXP zoledronic acid results in decreased expression of NOSTRIN mRNA CTD PMID:24714768 NCBI chr 2:168,786,539...168,865,514
Ensembl chr 2:168,786,539...168,865,514 		JBrowse link
G NOTCH3 notch receptor 3 decreases expression EXP zoledronic acid results in decreased expression of NOTCH3 mRNA CTD PMID:24714768 NCBI chr19:15,159,038...15,200,995
Ensembl chr19:15,159,038...15,200,995 		JBrowse link
G NOX4 NADPH oxidase 4 increases expression EXP zoledronic acid results in increased expression of NOX4 protein CTD PMID:28871336 NCBI chr11:89,324,353...89,589,557
Ensembl chr11:89,324,353...89,498,187 		JBrowse link
G NPAT nuclear protein, coactivator of histone transcription increases expression EXP zoledronic acid results in increased expression of NPAT mRNA CTD PMID:20977926 NCBI chr11:108,157,215...108,222,638
Ensembl chr11:108,155,280...108,222,638 		JBrowse link
G NPC1L1 NPC1 like intracellular cholesterol transporter 1 increases expression EXP zoledronic acid results in increased expression of NPC1L1 mRNA CTD PMID:24714768 NCBI chr 7:44,512,535...44,541,330
Ensembl chr 7:44,512,535...44,541,330 		JBrowse link
G NPFFR2 neuropeptide FF receptor 2 increases expression EXP zoledronic acid results in increased expression of NPFFR2 mRNA CTD PMID:24714768 NCBI chr 4:72,032,000...72,148,305
Ensembl chr 4:72,031,902...72,148,305 		JBrowse link
G NPR3 natriuretic peptide receptor 3 decreases expression EXP zoledronic acid results in decreased expression of NPR3 mRNA CTD PMID:24714768 NCBI chr 5:32,690,872...32,791,720
Ensembl chr 5:32,689,070...32,791,724 		JBrowse link
G NPSR1-AS1 NPSR1 antisense RNA 1 decreases expression EXP zoledronic acid results in decreased expression of AAA1 mRNA CTD PMID:24714768 NCBI chr 7:34,346,512...34,834,331
Ensembl chr 7:34,287,269...34,871,582 		JBrowse link
G NQO1 NAD(P)H quinone dehydrogenase 1 decreases expression EXP zoledronic acid results in decreased expression of NQO1 mRNA CTD PMID:24714768 PMID:25596134 NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668 		JBrowse link
G NR1H4 nuclear receptor subfamily 1 group H member 4 decreases expression EXP zoledronic acid results in decreased expression of NR1H4 mRNA CTD PMID:24714768 NCBI chr12:100,473,866...100,564,414
Ensembl chr12:100,473,708...100,564,414 		JBrowse link
G NRAD1 non-coding RNA in the aldehyde dehydrogenase 1A pathway increases expression EXP Zoledronic Acid results in increased expression of NRAD1 mRNA CTD PMID:24714768 NCBI chr13:44,022,335...44,030,463
Ensembl chr13:43,908,669...44,042,929 		JBrowse link
G NRCAM neuronal cell adhesion molecule increases expression EXP zoledronic acid results in increased expression of NRCAM mRNA CTD PMID:24714768 NCBI chr 7:108,147,649...108,456,720
Ensembl chr 7:108,147,623...108,456,717 		JBrowse link
G NREP neuronal regeneration related protein increases expression EXP zoledronic acid results in increased expression of NREP mRNA CTD PMID:20977926 PMID:25596134 NCBI chr 5:111,728,802...111,976,932
Ensembl chr 5:111,662,621...111,997,464 		JBrowse link
G NRG1 neuregulin 1 decreases expression EXP zoledronic acid results in decreased expression of NRG1 mRNA CTD PMID:24714768 NCBI chr 8:31,639,245...32,774,046
Ensembl chr 8:31,639,222...32,855,666 		JBrowse link
G NRIP3 nuclear receptor interacting protein 3 increases expression EXP zoledronic acid results in increased expression of NRIP3 mRNA CTD PMID:24714768 NCBI chr11:8,980,576...9,004,505
Ensembl chr11:8,965,682...9,005,288 		JBrowse link
G NSDHL NAD(P) dependent 3-beta-hydroxysteroid dehydrogenase NSDHL increases expression EXP zoledronic acid results in increased expression of NSDHL mRNA CTD PMID:24714768 NCBI chr  X:152,831,063...152,869,729
Ensembl chr  X:152,830,967...152,869,729 		JBrowse link
G NTN1 netrin 1 increases expression EXP zoledronic acid results in increased expression of NTN1 mRNA CTD PMID:24714768 NCBI chr17:9,003,087...9,244,000
Ensembl chr17:9,021,510...9,244,000 		JBrowse link
G NTNG1 netrin G1 decreases expression EXP zoledronic acid results in decreased expression of NTNG1 mRNA CTD PMID:24714768 NCBI chr 1:107,140,088...107,484,923
Ensembl chr 1:107,140,007...107,484,923 		JBrowse link
G NTPCR nucleoside-triphosphatase, cancer-related increases expression EXP zoledronic acid results in increased expression of NTPCR mRNA CTD PMID:25596134 NCBI chr 1:232,950,611...232,983,882
Ensembl chr 1:232,950,605...232,983,882 		JBrowse link
G NTRK2 neurotrophic receptor tyrosine kinase 2 increases expression EXP zoledronic acid results in increased expression of NTRK2 mRNA CTD PMID:24714768 NCBI chr 9:84,668,522...85,027,054
Ensembl chr 9:84,668,375...85,095,751 		JBrowse link
G NUP93 nucleoporin 93 increases expression EXP zoledronic acid results in increased expression of NUP93 mRNA CTD PMID:24714768 NCBI chr16:56,730,129...56,850,286
Ensembl chr16:56,730,118...56,850,286 		JBrowse link
G NUP98 nucleoporin 98 and 96 precursor decreases expression EXP zoledronic acid results in decreased expression of NUP98 mRNA CTD PMID:24714768 NCBI chr11:3,675,010...3,797,554
Ensembl chr11:3,671,083...3,797,792 		JBrowse link
G NXNL2 nucleoredoxin like 2 decreases expression EXP zoledronic acid results in decreased expression of NXNL2 mRNA CTD PMID:24714768 NCBI chr 9:88,535,178...88,584,510
Ensembl chr 9:88,534,033...88,584,274 		JBrowse link
G NXT2 nuclear transport factor 2 like export factor 2 increases expression EXP zoledronic acid results in increased expression of NXT2 mRNA CTD PMID:20977926 NCBI chr  X:109,535,824...109,544,698
Ensembl chr  X:109,535,781...109,544,698 		JBrowse link
G OGDHL oxoglutarate dehydrogenase L decreases expression EXP zoledronic acid results in decreased expression of OGDHL mRNA CTD PMID:24714768 NCBI chr10:49,734,641...49,762,379
Ensembl chr10:49,734,641...49,762,379 		JBrowse link
G OIP5 Opa interacting protein 5 decreases expression EXP zoledronic acid results in decreased expression of OIP5 mRNA CTD PMID:24714768 NCBI chr15:41,309,273...41,332,591
Ensembl chr15:41,309,273...41,332,591 		JBrowse link
G OLFM4 olfactomedin 4 increases expression EXP zoledronic acid results in increased expression of OLFM4 mRNA CTD PMID:24714768 NCBI chr13:53,028,813...53,052,057
Ensembl chr13:53,028,813...53,052,057 		JBrowse link
G OLR1 oxidized low density lipoprotein receptor 1 increases expression EXP zoledronic acid results in increased expression of OLR1 protein CTD PMID:28871336 NCBI chr12:10,158,301...10,176,266
Ensembl chr12:10,158,301...10,172,138 		JBrowse link
G OPTN optineurin multiple interactions EXP [zoledronic acid co-treated with fluvastatin] results in increased expression of OPTN mRNA CTD PMID:16996129 NCBI chr10:13,100,082...13,138,308
Ensembl chr10:13,099,449...13,138,308 		JBrowse link
G OR12D2 olfactory receptor family 12 subfamily D member 2 increases expression EXP zoledronic acid results in increased expression of OR12D2 mRNA CTD PMID:24714768 NCBI chr 6:29,395,631...29,398,008
Ensembl chr 6:29,395,631...29,398,008 		JBrowse link
G OR2H1 olfactory receptor family 2 subfamily H member 1 increases expression EXP zoledronic acid results in increased expression of OR2H1 mRNA CTD PMID:24714768 NCBI chr 6:29,457,155...29,464,328
Ensembl chr 6:29,457,155...29,464,328 		JBrowse link
G OR4K15 olfactory receptor family 4 subfamily K member 15 increases expression EXP zoledronic acid results in increased expression of OR4K15 mRNA CTD PMID:24714768 NCBI chr14:19,975,591...19,976,565
Ensembl chr14:19,975,591...19,976,565 		JBrowse link
G OR51B2 olfactory receptor family 51 subfamily B member 2 increases expression EXP zoledronic acid results in increased expression of OR51B2 mRNA CTD PMID:20977926 NCBI chr11:5,323,359...5,324,297
Ensembl chr11:5,323,359...5,324,297 		JBrowse link
G OR8H1 olfactory receptor family 8 subfamily H member 1 increases expression EXP zoledronic acid results in increased expression of OR8H1 mRNA CTD PMID:24714768 NCBI chr11:56,288,462...56,292,254
Ensembl chr11:56,288,462...56,292,254 		JBrowse link
G ORC2 origin recognition complex subunit 2 decreases expression EXP zoledronic acid results in decreased expression of ORC2 protein CTD PMID:28871336 NCBI chr 2:200,908,977...200,963,660
Ensembl chr 2:200,908,977...200,963,680 		JBrowse link
G OSGEPL1 O-sialoglycoprotein endopeptidase like 1 decreases expression EXP zoledronic acid results in decreased expression of OSGEPL1 mRNA CTD PMID:20977926 NCBI chr 2:189,746,660...189,763,198
Ensembl chr 2:189,746,660...189,763,227 		JBrowse link
G OSGIN1 oxidative stress induced growth inhibitor 1 decreases expression EXP zoledronic acid results in decreased expression of OSGIN1 mRNA CTD PMID:25596134 NCBI chr16:83,953,240...83,966,332
Ensembl chr16:83,931,311...83,966,332 		JBrowse link
G OVGP1 oviductal glycoprotein 1 increases expression EXP zoledronic acid results in increased expression of OVGP1 mRNA CTD PMID:24714768 NCBI chr 1:111,414,319...111,427,735
Ensembl chr 1:111,414,319...111,427,735 		JBrowse link
G P2RX4 purinergic receptor P2X 4 increases expression EXP zoledronic acid results in increased expression of P2RX4 mRNA CTD PMID:24714768 NCBI chr12:121,210,129...121,234,106
Ensembl chr12:121,210,065...121,234,106 		JBrowse link
G P3H2 prolyl 3-hydroxylase 2 decreases expression EXP zoledronic acid results in decreased expression of P3H2 mRNA CTD PMID:24714768 NCBI chr 3:189,956,728...190,122,278
Ensembl chr 3:189,956,728...190,122,437 		JBrowse link
G P4HA1 prolyl 4-hydroxylase subunit alpha 1 increases expression EXP zoledronic acid results in increased expression of P4HA1 mRNA CTD PMID:25596134 NCBI chr10:73,007,217...73,096,866
Ensembl chr10:73,007,217...73,096,974 		JBrowse link
G P4HA2 prolyl 4-hydroxylase subunit alpha 2 increases expression EXP zoledronic acid results in increased expression of P4HA2 mRNA CTD PMID:24714768 NCBI chr 5:132,190,147...132,227,853
Ensembl chr 5:132,190,147...132,295,315 		JBrowse link
G P4HB prolyl 4-hydroxylase subunit beta increases expression EXP zoledronic acid results in increased expression of P4HB mRNA CTD PMID:20977926 NCBI chr17:81,843,166...81,860,535
Ensembl chr17:81,843,159...81,860,856 		JBrowse link
G PALM paralemmin decreases expression EXP zoledronic acid results in decreased expression of PALM mRNA CTD PMID:24714768 NCBI chr19:708,935...748,329
Ensembl chr19:708,935...748,329 		JBrowse link
G PALS1 protein associated with LIN7 1, MAGUK p55 family member multiple interactions EXP [Zoledronic Acid co-treated with Fluvastatin] results in increased expression of PALS1 mRNA CTD PMID:16996129 NCBI chr14:67,241,435...67,336,061
Ensembl chr14:67,240,713...67,336,061 		JBrowse link
G PANK1 pantothenate kinase 1 decreases expression EXP zoledronic acid results in decreased expression of PANK1 mRNA CTD PMID:24714768 PMID:25596134 NCBI chr10:89,579,495...89,645,242
Ensembl chr10:89,579,497...89,645,242 		JBrowse link
G PAPPA pappalysin 1 decreases expression EXP zoledronic acid results in decreased expression of PAPPA mRNA CTD PMID:24714768 NCBI chr 9:116,153,791...116,402,321
Ensembl chr 9:116,153,791...116,402,321 		JBrowse link
G PAPPA2 pappalysin 2 multiple interactions
decreases expression 		EXP [zoledronic acid co-treated with fluvastatin] results in increased expression of PAPPA2 mRNA
zoledronic acid results in decreased expression of PAPPA2 mRNA 		CTD PMID:16996129 PMID:24714768 NCBI chr 1:176,463,175...176,845,601
Ensembl chr 1:176,463,171...176,845,601 		JBrowse link
G PAQR5 progestin and adipoQ receptor family member 5 decreases expression EXP zoledronic acid results in decreased expression of PAQR5 mRNA CTD PMID:24714768 NCBI chr15:69,298,912...69,407,780
Ensembl chr15:69,298,912...69,407,780 		JBrowse link
G PAQR8 progestin and adipoQ receptor family member 8 increases expression EXP zoledronic acid results in increased expression of PAQR8 mRNA CTD PMID:24714768 NCBI chr 6:52,362,151...52,407,777
Ensembl chr 6:52,361,421...52,407,777 		JBrowse link
G PARD6A par-6 family cell polarity regulator alpha decreases expression EXP zoledronic acid results in decreased expression of PARD6A mRNA CTD PMID:24714768 NCBI chr16:67,660,960...67,662,774
Ensembl chr16:67,660,946...67,662,774 		JBrowse link
G PARM1 prostate androgen-regulated mucin-like protein 1 increases expression EXP zoledronic acid results in increased expression of PARM1 mRNA CTD PMID:24714768 NCBI chr 4:74,933,116...75,050,113
Ensembl chr 4:74,933,095...75,050,115 		JBrowse link
G PARP1 poly(ADP-ribose) polymerase 1 increases expression
multiple interactions
increases cleavage 		EXP zoledronic acid results in increased expression of PARP1 mRNA
arsenic trioxide promotes the reaction [zoledronic acid results in increased cleavage of PARP1 protein] 		CTD PMID:10780527 PMID:20977926 PMID:24714768 NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154 		JBrowse link
G PBK PDZ binding kinase decreases expression EXP zoledronic acid results in decreased expression of PBK mRNA CTD PMID:24714768 NCBI chr 8:27,809,624...27,837,817
Ensembl chr 8:27,809,624...27,838,082 		JBrowse link
G PBLD phenazine biosynthesis like protein domain containing decreases expression EXP zoledronic acid results in decreased expression of PBLD mRNA CTD PMID:24714768 NCBI chr10:68,282,660...68,332,928
Ensembl chr10:68,282,660...68,333,049 		JBrowse link
G PCDH17 protocadherin 17 increases expression EXP zoledronic acid results in increased expression of PCDH17 mRNA CTD PMID:24714768 NCBI chr13:57,630,108...57,729,311
Ensembl chr13:57,631,744...57,729,311 		JBrowse link
G PCDH20 protocadherin 20 decreases expression EXP zoledronic acid results in decreased expression of PCDH20 mRNA CTD PMID:24714768 NCBI chr13:61,409,685...61,415,849
Ensembl chr13:61,409,685...61,415,849 		JBrowse link
G PCED1B PC-esterase domain containing 1B increases expression EXP zoledronic acid results in increased expression of PCED1B mRNA CTD PMID:24714768 NCBI chr12:47,079,621...47,236,660
Ensembl chr12:47,079,603...47,236,662 		JBrowse link
G PCGF5 polycomb group ring finger 5 increases expression EXP zoledronic acid results in increased expression of PCGF5 mRNA CTD PMID:20977926 NCBI chr10:91,156,219...91,284,337
Ensembl chr10:91,163,012...91,284,337 		JBrowse link
G PCLAF PCNA clamp associated factor decreases expression EXP zoledronic acid results in decreased expression of PCLAF mRNA CTD PMID:24714768 NCBI chr15:64,364,304...64,387,687
Ensembl chr15:64,364,304...64,387,687 		JBrowse link
G PCOLCE2 procollagen C-endopeptidase enhancer 2 decreases expression EXP zoledronic acid results in decreased expression of PCOLCE2 mRNA CTD PMID:24714768 NCBI chr 3:142,817,874...142,889,083
Ensembl chr 3:142,815,922...142,889,206 		JBrowse link
G PCSK9 proprotein convertase subtilisin/kexin type 9 increases expression EXP zoledronic acid results in increased expression of PCSK9 mRNA CTD PMID:24714768 NCBI chr 1:55,039,548...55,064,852
Ensembl chr 1:55,039,445...55,064,852 		JBrowse link
G PCYOX1 prenylcysteine oxidase 1 increases expression EXP zoledronic acid results in increased expression of PCYOX1 mRNA CTD PMID:20977926 NCBI chr 2:70,257,915...70,281,185
Ensembl chr 2:70,257,386...70,281,185 		JBrowse link
G PDE1A phosphodiesterase 1A decreases expression EXP zoledronic acid results in decreased expression of PDE1A mRNA CTD PMID:24714768 NCBI chr 2:182,140,041...182,716,797
Ensembl chr 2:182,139,968...182,523,359 		JBrowse link
G PDE4B phosphodiesterase 4B decreases expression EXP zoledronic acid results in decreased expression of PDE4B mRNA CTD PMID:24714768 NCBI chr 1:65,792,510...66,374,579
Ensembl chr 1:65,792,514...66,374,579 		JBrowse link
G PDE5A phosphodiesterase 5A decreases expression EXP zoledronic acid results in decreased expression of PDE5A mRNA CTD PMID:24714768 NCBI chr 4:119,494,403...119,628,804
Ensembl chr 4:119,494,397...119,628,804 		JBrowse link
G PDE7B phosphodiesterase 7B decreases expression EXP zoledronic acid results in decreased expression of PDE7B mRNA CTD PMID:24714768 NCBI chr 6:135,851,701...136,195,574
Ensembl chr 6:135,851,701...136,195,574 		JBrowse link
G PDE8A phosphodiesterase 8A increases expression EXP zoledronic acid results in increased expression of PDE8A mRNA CTD PMID:25596134 NCBI chr15:84,980,467...85,139,142
Ensembl chr15:84,980,440...85,139,145 		JBrowse link
G PDGFA platelet derived growth factor subunit A multiple interactions EXP [zoledronic acid co-treated with Gossypol] results in decreased expression of PDGFA mRNA CTD PMID:19825521 NCBI chr 7:497,258...520,700
Ensembl chr 7:497,258...520,296 		JBrowse link
G PDGFC platelet derived growth factor C decreases expression EXP zoledronic acid results in decreased expression of PDGFC mRNA CTD PMID:24714768 NCBI chr 4:156,760,454...156,971,799
Ensembl chr 4:156,760,454...156,971,799 		JBrowse link
G PDGFRA platelet derived growth factor receptor alpha increases expression EXP zoledronic acid results in increased expression of PDGFRA mRNA CTD PMID:24714768 NCBI chr 4:54,229,293...54,298,245
Ensembl chr 4:54,229,280...54,298,245 		JBrowse link
G PDGFRL platelet derived growth factor receptor like increases expression EXP zoledronic acid results in increased expression of PDGFRL mRNA CTD PMID:24714768 NCBI chr 8:17,576,433...17,643,144
Ensembl chr 8:17,576,433...17,644,071 		JBrowse link
G PDHB pyruvate dehydrogenase E1 subunit beta increases expression EXP zoledronic acid results in increased expression of PDHB protein CTD PMID:28871336 NCBI chr 3:58,427,630...58,433,832
Ensembl chr 3:58,427,630...58,433,857 		JBrowse link
G PDK4 pyruvate dehydrogenase kinase 4 decreases expression EXP zoledronic acid results in decreased expression of PDK4 mRNA CTD PMID:24714768 PMID:25596134 NCBI chr 7:95,583,499...95,596,516
Ensembl chr 7:95,583,499...95,596,516 		JBrowse link
G PDLIM7 PDZ and LIM domain 7 increases expression EXP zoledronic acid results in increased expression of PDLIM7 mRNA CTD PMID:20977926 NCBI chr 5:177,483,394...177,497,604
Ensembl chr 5:177,483,394...177,497,606 		JBrowse link
G PDZK1 PDZ domain containing 1 decreases expression EXP zoledronic acid results in decreased expression of PDZK1 mRNA CTD PMID:24714768 NCBI chr 1:145,670,852...145,707,400
Ensembl chr 1:145,670,852...145,708,148 		JBrowse link
G PDZK1IP1 PDZK1 interacting protein 1 increases expression EXP zoledronic acid results in increased expression of PDZK1IP1 mRNA CTD PMID:24714768 NCBI chr 1:47,183,582...47,190,036
Ensembl chr 1:47,183,582...47,191,044 		JBrowse link
G PDZK1P1 PDZ domain containing 1 pseudogene 1 decreases expression EXP zoledronic acid results in decreased expression of PDZK1P1 mRNA CTD PMID:24714768 NCBI chr 1:147,993,862...148,014,956
Ensembl chr 1:147,994,301...148,009,592 		JBrowse link
G PEA15 proliferation and apoptosis adaptor protein 15 increases expression EXP zoledronic acid results in increased expression of PEA15 mRNA CTD PMID:24714768 NCBI chr 1:160,205,384...160,215,372
Ensembl chr 1:160,205,380...160,215,376 		JBrowse link
G PECAM1 platelet and endothelial cell adhesion molecule 1 multiple interactions ISO zoledronic acid promotes the reaction [[Imatinib Mesylate co-treated with Paclitaxel] results in decreased expression of PECAM1 protein] CTD PMID:15867366 NCBI chr17:64,319,415...64,390,860
Ensembl chr17:64,319,415...64,413,776 		JBrowse link
G PELI1 pellino E3 ubiquitin protein ligase 1 increases expression EXP zoledronic acid results in increased expression of PELI1 mRNA CTD PMID:24714768 NCBI chr 2:64,092,652...64,144,420
Ensembl chr 2:64,092,652...64,144,420 		JBrowse link
G PFKFB4 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 increases expression EXP zoledronic acid results in increased expression of PFKFB4 mRNA CTD PMID:24714768 PMID:25596134 NCBI chr 3:48,517,684...48,563,136
Ensembl chr 3:48,517,684...48,562,015 		JBrowse link
G PGCKA1 PDCD10 and GCKIII kinases associated 1 increases expression EXP Zoledronic Acid results in increased expression of PGCKA1 mRNA CTD PMID:24714768 NCBI chr 4:37,453,255...37,593,510
Ensembl chr 4:37,453,925...37,623,495 		JBrowse link
G PGLYRP4 peptidoglycan recognition protein 4 increases expression EXP zoledronic acid results in increased expression of PGLYRP4 mRNA CTD PMID:20977926 NCBI chr 1:153,330,120...153,348,841
Ensembl chr 1:153,330,120...153,348,841 		JBrowse link
G PGM5 phosphoglucomutase 5 decreases expression EXP zoledronic acid results in decreased expression of PGM5 mRNA CTD PMID:24714768 NCBI chr 9:68,356,611...68,531,061
Ensembl chr 9:68,328,308...68,531,061 		JBrowse link
G PHACTR1 phosphatase and actin regulator 1 increases expression EXP zoledronic acid results in increased expression of PHACTR1 mRNA CTD PMID:24714768 NCBI chr 6:12,716,767...13,287,837
Ensembl chr 6:12,716,312...13,290,446 		JBrowse link
G PHGDH phosphoglycerate dehydrogenase decreases expression EXP zoledronic acid results in decreased expression of PHGDH mRNA CTD PMID:24714768 PMID:25596134 NCBI chr 1:119,711,934...119,744,215
Ensembl chr 1:119,648,411...119,744,218 		JBrowse link
G PHLDA3 pleckstrin homology like domain family A member 3 decreases expression EXP zoledronic acid results in decreased expression of PHLDA3 mRNA CTD PMID:25596134 NCBI chr 1:201,464,278...201,469,188
Ensembl chr 1:201,464,278...201,469,237 		JBrowse link
G PHLDB1 pleckstrin homology like domain family B member 1 decreases expression EXP zoledronic acid results in decreased expression of PHLDB1 mRNA CTD PMID:24714768 NCBI chr11:118,606,436...118,658,028
Ensembl chr11:118,606,440...118,658,031 		JBrowse link
G PHPT1 phosphohistidine phosphatase 1 increases expression EXP zoledronic acid results in increased expression of PHPT1 mRNA CTD PMID:20977926 NCBI chr 9:136,849,409...136,851,024
Ensembl chr 9:136,848,724...136,851,027 		JBrowse link
G PI3 peptidase inhibitor 3 increases expression EXP zoledronic acid results in increased expression of PI3 mRNA CTD PMID:24714768 NCBI chr20:45,174,902...45,176,544
Ensembl chr20:45,174,902...45,176,544 		JBrowse link
G PIGR polymeric immunoglobulin receptor increases expression EXP zoledronic acid results in increased expression of PIGR mRNA CTD PMID:24714768 NCBI chr 1:206,928,522...206,946,466
Ensembl chr 1:206,928,522...206,946,466 		JBrowse link
G PIK3AP1 phosphoinositide-3-kinase adaptor protein 1 increases expression EXP zoledronic acid results in increased expression of PIK3AP1 mRNA CTD PMID:24714768 NCBI chr10:96,593,315...96,720,514
Ensembl chr10:96,593,315...96,720,514 		JBrowse link
G PIK3C2A phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha increases expression EXP zoledronic acid results in increased expression of PIK3C2A mRNA CTD PMID:20977926 NCBI chr11:17,086,575...17,207,986
Ensembl chr11:17,077,730...17,207,986 		JBrowse link
G PIK3R1 phosphoinositide-3-kinase regulatory subunit 1 increases expression EXP zoledronic acid results in increased expression of PIK3R1 mRNA CTD PMID:24714768 NCBI chr 5:68,215,756...68,301,821
Ensembl chr 5:68,215,740...68,301,821 		JBrowse link
G PILRA paired immunoglobin like type 2 receptor alpha increases expression EXP zoledronic acid results in increased expression of PILRA mRNA CTD PMID:24714768 NCBI chr 7:100,371,291...100,400,096
Ensembl chr 7:100,367,530...100,400,096 		JBrowse link
G PILRB paired immunoglobin like type 2 receptor beta increases expression EXP zoledronic acid results in increased expression of PILRB mRNA CTD PMID:20977926 NCBI chr 7:100,358,117...100,367,831
Ensembl chr 7:100,352,176...100,367,831 		JBrowse link
G PIM2 Pim-2 proto-oncogene, serine/threonine kinase increases expression EXP zoledronic acid results in increased expression of PIM2 mRNA CTD PMID:24714768 NCBI chr  X:48,913,182...48,919,024
Ensembl chr  X:48,913,182...48,919,024 		JBrowse link
G PIP4P2 phosphatidylinositol-4,5-bisphosphate 4-phosphatase 2 decreases expression EXP zoledronic acid results in decreased expression of PIP4P2 mRNA CTD PMID:24714768 NCBI chr 8:90,993,802...91,040,859
Ensembl chr 8:90,993,802...91,040,872 		JBrowse link
G PIR pirin increases expression EXP zoledronic acid results in increased expression of PIR mRNA CTD PMID:25596134 NCBI chr  X:15,384,799...15,493,333
Ensembl chr  X:15,384,799...15,493,564 		JBrowse link
G PISD phosphatidylserine decarboxylase increases expression EXP zoledronic acid results in increased expression of PISD mRNA CTD PMID:24714768 NCBI chr22:31,618,491...31,662,564
Ensembl chr22:31,618,491...31,662,221 		JBrowse link
G PKHD1 PKHD1 ciliary IPT domain containing fibrocystin/polyductin decreases expression EXP zoledronic acid results in decreased expression of PKHD1 mRNA CTD PMID:24714768 NCBI chr 6:51,615,299...52,087,615
Ensembl chr 6:51,615,299...52,087,613 		JBrowse link
G PKIA cAMP-dependent protein kinase inhibitor alpha decreases expression EXP zoledronic acid results in decreased expression of PKIA mRNA CTD PMID:24714768 NCBI chr 8:78,516,340...78,605,267
Ensembl chr 8:78,516,340...78,605,267 		JBrowse link
G PKIB cAMP-dependent protein kinase inhibitor beta decreases expression EXP zoledronic acid results in decreased expression of PKIB mRNA CTD PMID:24714768 NCBI chr 6:122,471,921...122,726,373
Ensembl chr 6:122,471,917...122,726,373 		JBrowse link
G PKP4 plakophilin 4 decreases expression EXP zoledronic acid results in decreased expression of PKP4 mRNA CTD PMID:24714768 NCBI chr 2:158,456,952...158,681,429
Ensembl chr 2:158,456,952...158,682,879 		JBrowse link
G PLA1A phospholipase A1 member A increases expression EXP zoledronic acid results in increased expression of PLA1A mRNA CTD PMID:24714768 NCBI chr 3:119,597,885...119,629,811
Ensembl chr 3:119,597,875...119,629,811 		JBrowse link
G PLA2G4C phospholipase A2 group IVC increases expression EXP zoledronic acid results in increased expression of PLA2G4C mRNA CTD PMID:24714768 NCBI chr19:48,047,846...48,110,817
Ensembl chr19:48,047,843...48,110,817 		JBrowse link
G PLA2G4F phospholipase A2 group IVF decreases expression EXP zoledronic acid results in decreased expression of PLA2G4F mRNA CTD PMID:24714768 NCBI chr15:42,139,034...42,156,636
Ensembl chr15:42,139,034...42,156,636 		JBrowse link
G PLAT plasminogen activator, tissue type increases expression EXP zoledronic acid results in increased expression of PLAT mRNA CTD PMID:24714768 NCBI chr 8:42,174,718...42,207,565
Ensembl chr 8:42,174,718...42,207,709 		JBrowse link
G PLAU plasminogen activator, urokinase increases expression EXP zoledronic acid results in increased expression of PLAU mRNA CTD PMID:20977926 NCBI chr10:73,909,164...73,917,494
Ensembl chr10:73,909,177...73,917,496 		JBrowse link
G PLCB1 phospholipase C beta 1 decreases expression EXP zoledronic acid results in decreased expression of PLCB1 mRNA CTD PMID:24714768 NCBI chr20:8,132,266...8,884,900
Ensembl chr20:8,077,251...8,968,360 		JBrowse link
G PLCD4 phospholipase C delta 4 decreases expression EXP zoledronic acid results in decreased expression of PLCD4 mRNA CTD PMID:24714768 NCBI chr 2:218,607,899...218,637,175
Ensembl chr 2:218,607,855...218,637,184 		JBrowse link
G PLCL2 phospholipase C like 2 increases expression EXP zoledronic acid results in increased expression of PLCL2 mRNA CTD PMID:24714768 NCBI chr 3:16,884,955...17,090,606
Ensembl chr 3:16,802,651...17,090,604 		JBrowse link
G PLD5 phospholipase D family member 5 increases expression EXP zoledronic acid results in increased expression of PLD5 mRNA CTD PMID:24714768 NCBI chr 1:242,082,986...242,530,546
Ensembl chr 1:242,082,986...242,524,697 		JBrowse link
G PLEC plectin decreases expression EXP zoledronic acid results in decreased expression of PLEC mRNA; zoledronic acid results in decreased expression of PLEC protein CTD PMID:25596134 PMID:28871336 NCBI chr 8:143,915,153...143,976,745
Ensembl chr 8:143,915,153...143,976,734 		JBrowse link
G PLEK pleckstrin increases expression EXP zoledronic acid results in increased expression of PLEK mRNA CTD PMID:20977926 NCBI chr 2:68,365,282...68,397,453
Ensembl chr 2:68,365,282...68,397,453 		JBrowse link
G PLEKHG7 pleckstrin homology and RhoGEF domain containing G7 increases expression EXP zoledronic acid results in increased expression of PLEKHG7 mRNA CTD PMID:24714768 NCBI chr12:92,702,989...92,772,455
Ensembl chr12:92,702,843...92,772,455 		JBrowse link
G PLEKHH2 pleckstrin homology, MyTH4 and FERM domain containing H2 decreases expression EXP zoledronic acid results in decreased expression of PLEKHH2 mRNA CTD PMID:24714768 NCBI chr 2:43,637,260...43,767,987
Ensembl chr 2:43,637,260...43,767,987 		JBrowse link
G PLK1 polo like kinase 1 decreases expression EXP zoledronic acid results in decreased expression of PLK1 mRNA CTD PMID:20977926 NCBI chr16:23,678,889...23,690,367
Ensembl chr16:23,677,656...23,690,367 		JBrowse link
G PLOD2 procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 increases expression EXP zoledronic acid results in increased expression of PLOD2 mRNA CTD PMID:24714768 NCBI chr 3:146,069,440...146,161,184
Ensembl chr 3:146,035,139...146,163,725 		JBrowse link
G PLPP3 phospholipid phosphatase 3 increases expression EXP zoledronic acid results in increased expression of PLPP3 mRNA CTD PMID:24714768 NCBI chr 1:56,494,761...56,579,563
Ensembl chr 1:56,494,761...56,645,301 		JBrowse link
G PLSCR1 phospholipid scramblase 1 increases expression EXP zoledronic acid results in increased expression of PLSCR1 mRNA CTD PMID:24714768 NCBI chr 3:146,515,180...146,544,607
Ensembl chr 3:146,515,180...146,544,856 		JBrowse link
G PMS2P2 PMS1 homolog 2, mismatch repair system component pseudogene 2 increases expression EXP zoledronic acid results in increased expression of PMS2P2 mRNA CTD PMID:20977926 NCBI chr 7:75,343,937...75,358,997
Ensembl chr 7:75,344,015...75,359,550 		JBrowse link
G PNKD PNKD metallo-beta-lactamase domain containing increases expression EXP zoledronic acid results in increased expression of PNKD mRNA CTD PMID:24714768 NCBI chr 2:218,270,519...218,346,793
Ensembl chr 2:218,269,651...218,346,793 		JBrowse link
G PNRC2 proline rich nuclear receptor coactivator 2 increases expression EXP zoledronic acid results in increased expression of PNRC2 mRNA CTD PMID:20977926 NCBI chr 1:23,959,164...23,963,462
Ensembl chr 1:23,956,839...23,963,462 		JBrowse link
G POGLUT2 protein O-glucosyltransferase 2 decreases expression EXP Zoledronic Acid results in decreased expression of POGLUT2 mRNA CTD PMID:24714768 NCBI chr13:102,784,281...102,798,976
Ensembl chr13:102,784,281...102,799,040 		JBrowse link
G POLR2A RNA polymerase II subunit A decreases expression EXP zoledronic acid results in decreased expression of POLR2A mRNA CTD PMID:20977926 NCBI chr17:7,484,366...7,514,616
Ensembl chr17:7,484,366...7,514,616 		JBrowse link
G POLR2D RNA polymerase II subunit D increases expression EXP zoledronic acid results in increased expression of POLR2D mRNA CTD PMID:20977926 NCBI chr 2:127,843,553...127,858,155
Ensembl chr 2:127,843,553...127,858,155 		JBrowse link
G POMGNT1 protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-) increases expression EXP zoledronic acid results in increased expression of POMGNT1 mRNA CTD PMID:20977926 NCBI chr 1:46,188,683...46,220,305
Ensembl chr 1:46,188,683...46,220,305 		JBrowse link
G PON1 paraoxonase 1 increases activity
multiple interactions 		ISO zoledronic acid results in increased activity of PON1 protein
[zoledronic acid results in increased activity of PON1 protein] which results in increased metabolism of phenyl acetate 		CTD PMID:27387541 NCBI chr 7:95,297,676...95,324,532
Ensembl chr 7:95,297,676...95,324,532 		JBrowse link
G PON2 paraoxonase 2 multiple interactions EXP [Tretinoin co-treated with zoledronic acid] results in increased expression of PON2 protein CTD PMID:20349282 NCBI chr 7:95,404,862...95,435,028
Ensembl chr 7:95,404,862...95,435,329 		JBrowse link
G PPARA peroxisome proliferator activated receptor alpha decreases expression
multiple interactions 		ISO
EXP 		zoledronic acid results in decreased expression of PPARA mRNA
zoledronic acid results in decreased expression of PPARA mRNA; zoledronic acid results in decreased expression of PPARA protein
Fenofibrate inhibits the reaction [zoledronic acid results in decreased expression of PPARA mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in decreased expression of PPARA mRNA] 		CTD PMID:28871336 NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,150,521...46,243,755 		JBrowse link
G PPARD peroxisome proliferator activated receptor delta increases expression EXP zoledronic acid results in increased expression of PPARD mRNA CTD PMID:24714768 NCBI chr 6:35,342,558...35,428,178
Ensembl chr 6:35,342,558...35,428,191 		JBrowse link
G PPARG peroxisome proliferator activated receptor gamma affects activity EXP zoledronic acid affects the activity of PPARG protein CTD PMID:25596134 NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356 		JBrowse link
G PPARGC1A PPARG coactivator 1 alpha decreases expression
multiple interactions 		EXP
ISO 		Zoledronic Acid results in decreased expression of PPARGC1A mRNA; Zoledronic Acid results in decreased expression of PPARGC1A protein
zoledronic acid results in decreased expression of PPARGC1A mRNA
Fenofibrate inhibits the reaction [zoledronic acid results in decreased expression of PPARGC1A mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in decreased expression of PPARGC1A mRNA] 		CTD PMID:24714768 PMID:28871336 NCBI chr 4:23,792,021...24,472,905
Ensembl chr 4:23,755,041...23,904,089 		JBrowse link
G PPBP pro-platelet basic protein increases expression EXP zoledronic acid results in increased expression of PPBP mRNA CTD PMID:24714768 NCBI chr 4:73,986,439...73,988,190
Ensembl chr 4:73,985,966...73,988,276 		JBrowse link
G PPL periplakin decreases expression EXP zoledronic acid results in decreased expression of PPL mRNA CTD PMID:24714768 NCBI chr16:4,882,507...4,937,148
Ensembl chr16:4,882,507...4,960,741 		JBrowse link
G PPM1H protein phosphatase, Mg2+/Mn2+ dependent 1H increases expression EXP zoledronic acid results in increased expression of PPM1H mRNA CTD PMID:24714768 NCBI chr12:62,643,994...62,935,150
Ensembl chr12:62,643,994...62,935,150 		JBrowse link
G PPP1R15A protein phosphatase 1 regulatory subunit 15A multiple interactions
increases expression 		EXP [zoledronic acid co-treated with fluvastatin] results in increased expression of PPP1R15A mRNA
zoledronic acid results in increased expression of PPP1R15A mRNA 		CTD PMID:16996129 PMID:20977926 NCBI chr19:48,872,421...48,876,058
Ensembl chr19:48,872,212...48,876,059 		JBrowse link
G PPP1R1A protein phosphatase 1 regulatory inhibitor subunit 1A decreases expression EXP zoledronic acid results in decreased expression of PPP1R1A mRNA CTD PMID:24714768 NCBI chr12:54,579,246...54,588,659
Ensembl chr12:54,575,387...54,588,659 		JBrowse link
G PPP1R1B protein phosphatase 1 regulatory inhibitor subunit 1B decreases expression EXP zoledronic acid results in decreased expression of PPP1R1B mRNA CTD PMID:24714768 NCBI chr17:39,626,707...39,636,624
Ensembl chr17:39,626,740...39,636,626 		JBrowse link
G PPP2R2B protein phosphatase 2 regulatory subunit Bbeta affects expression EXP zoledronic acid affects the expression of PPP2R2B mRNA CTD PMID:24714768 NCBI chr 5:146,580,742...147,081,520
Ensembl chr 5:146,580,742...147,084,784 		JBrowse link
G PPP3CA protein phosphatase 3 catalytic subunit alpha increases expression EXP zoledronic acid results in increased expression of PPP3CA mRNA CTD PMID:24714768 NCBI chr 4:101,023,418...101,347,526
Ensembl chr 4:101,023,409...101,348,278 		JBrowse link
G PRC1 protein regulator of cytokinesis 1 decreases expression EXP zoledronic acid results in decreased expression of PRC1 mRNA CTD PMID:24714768 PMID:25596134 NCBI chr15:90,966,040...90,994,535
Ensembl chr15:90,966,040...90,995,629 		JBrowse link
G PRDM1 PR/SET domain 1 increases expression EXP zoledronic acid results in increased expression of PRDM1 mRNA CTD PMID:24714768 PMID:25596134 NCBI chr 6:105,992,690...106,109,938
Ensembl chr 6:105,993,463...106,109,939 		JBrowse link
G PRDX3 peroxiredoxin 3 multiple interactions EXP [zoledronic acid co-treated with fluvastatin] results in increased expression of PRDX3 mRNA CTD PMID:16996129 NCBI chr10:119,167,720...119,178,812
Ensembl chr10:119,167,720...119,178,812 		JBrowse link
G PREX2 phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 2 increases expression EXP zoledronic acid results in increased expression of PREX2 mRNA CTD PMID:24714768 NCBI chr 8:67,952,046...68,237,032
Ensembl chr 8:67,952,046...68,237,032 		JBrowse link
G PRKAB2 protein kinase AMP-activated non-catalytic subunit beta 2 decreases expression EXP zoledronic acid results in decreased expression of PRKAB2 mRNA CTD PMID:25596134 NCBI chr 1:147,155,106...147,172,470
Ensembl chr 1:147,155,106...147,172,550 		JBrowse link
G PRKACB protein kinase cAMP-activated catalytic subunit beta increases expression EXP zoledronic acid results in increased expression of PRKACB mRNA CTD PMID:20977926 NCBI chr 1:84,078,079...84,238,498
Ensembl chr 1:84,078,062...84,238,498 		JBrowse link
G PROM1 prominin 1 increases expression EXP zoledronic acid results in increased expression of PROM1 mRNA CTD PMID:24714768 NCBI chr 4:15,968,228...16,084,023
Ensembl chr 4:15,963,076...16,084,378 		JBrowse link
G PROSER2 proline and serine rich 2 increases expression EXP zoledronic acid results in increased expression of PROSER2 mRNA CTD PMID:24714768 NCBI chr10:11,823,356...11,872,277
Ensembl chr10:11,823,339...11,872,277 		JBrowse link
G PROSER3 proline and serine rich 3 increases expression EXP zoledronic acid results in increased expression of PROSER3 mRNA CTD PMID:20977926 NCBI chr19:35,758,176...35,771,166
Ensembl chr19:35,758,143...35,771,166 		JBrowse link
G PRR14 proline rich 14 increases expression EXP zoledronic acid results in increased expression of PRR14 mRNA CTD PMID:20977926 NCBI chr16:30,650,778...30,656,413
Ensembl chr16:30,650,717...30,656,413 		JBrowse link
G PRR15L proline rich 15 like decreases expression EXP zoledronic acid results in decreased expression of PRR15L mRNA CTD PMID:24714768 NCBI chr17:47,951,967...47,957,883
Ensembl chr17:47,951,967...47,957,883 		JBrowse link
G PRRG4 proline rich and Gla domain 4 increases expression EXP zoledronic acid results in increased expression of PRRG4 mRNA CTD PMID:20977926 NCBI chr11:32,829,789...32,858,120
Ensembl chr11:32,829,927...32,858,120 		JBrowse link
G PRRX2 paired related homeobox 2 increases expression EXP zoledronic acid results in increased expression of PRRX2 mRNA CTD PMID:24714768 NCBI chr 9:129,665,647...129,722,674
Ensembl chr 9:129,665,647...129,722,674 		JBrowse link
G PRSS23 serine protease 23 decreases expression EXP zoledronic acid results in decreased expression of PRSS23 mRNA CTD PMID:24714768 NCBI chr11:86,791,071...86,952,910
Ensembl chr11:86,791,059...86,952,910 		JBrowse link
G PRSS3 serine protease 3 increases expression EXP zoledronic acid results in increased expression of PRSS3 mRNA CTD PMID:20977926 NCBI chr 9:33,750,679...33,799,231
Ensembl chr 9:33,750,679...33,799,231 		JBrowse link
G PRSS35 serine protease 35 increases expression EXP zoledronic acid results in increased expression of PRSS35 mRNA CTD PMID:24714768 NCBI chr 6:83,512,534...83,525,704
Ensembl chr 6:83,512,534...83,525,704 		JBrowse link
G PRTFDC1 phosphoribosyl transferase domain containing 1 decreases expression EXP zoledronic acid results in decreased expression of PRTFDC1 mRNA CTD PMID:24714768 NCBI chr10:24,848,614...24,952,606
Ensembl chr10:24,848,614...24,952,606 		JBrowse link
G PRUNE2 prune homolog 2 with BCH domain increases expression EXP zoledronic acid results in increased expression of PRUNE2 mRNA CTD PMID:24714768 NCBI chr 9:76,611,376...76,906,114
Ensembl chr 9:76,611,376...76,906,114 		JBrowse link
G PRXL2B peroxiredoxin like 2B increases expression EXP zoledronic acid results in increased expression of PRXL2B mRNA CTD PMID:24714768 NCBI chr 1:2,586,523...2,591,468
Ensembl chr 1:2,586,491...2,591,469 		JBrowse link
G PSAT1 phosphoserine aminotransferase 1 decreases expression EXP zoledronic acid results in decreased expression of PSAT1 mRNA CTD PMID:24714768 PMID:25596134 NCBI chr 9:78,297,125...78,330,093
Ensembl chr 9:78,297,125...78,330,093 		JBrowse link
G PSAT1P3 phosphoserine aminotransferase 1 pseudogene 3 decreases expression EXP zoledronic acid results in decreased expression of PSAT1P3 mRNA CTD PMID:24714768 NCBI chr 1:79,054,749...79,056,122
Ensembl chr 1:79,054,945...79,056,055 		JBrowse link
G PSG4 pregnancy specific beta-1-glycoprotein 4 decreases expression EXP zoledronic acid results in decreased expression of PSG4 mRNA CTD PMID:24714768 NCBI chr19:43,192,702...43,205,638
Ensembl chr19:43,192,702...43,207,299 		JBrowse link
G PSRC1 proline and serine rich coiled-coil 1 decreases expression EXP zoledronic acid results in decreased expression of PSRC1 mRNA CTD PMID:20977926 PMID:24714768 NCBI chr 1:109,279,556...109,283,145
Ensembl chr 1:109,279,556...109,283,186 		JBrowse link
G PTGER4 prostaglandin E receptor 4 increases expression EXP zoledronic acid results in increased expression of PTGER4 mRNA CTD PMID:24714768 NCBI chr 5:40,679,915...40,746,800
Ensembl chr 5:40,679,915...40,693,735 		JBrowse link
G PTGS2 prostaglandin-endoperoxide synthase 2 decreases expression
increases expression
multiple interactions 		EXP zoledronic acid results in decreased expression of PTGS2 mRNA
zoledronic acid results in increased expression of PTGS2 mRNA
[Zoledronic Acid co-treated with 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide] results in decreased expression of PTGS2 protein; Gefitinib promotes the reaction [[Zoledronic Acid co-treated with 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide] results in decreased expression of PTGS2 protein] 		CTD PMID:16322342 PMID:20977926 PMID:24714768 NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922 		JBrowse link
G PTH1R parathyroid hormone 1 receptor decreases expression EXP zoledronic acid results in decreased expression of PTH1R mRNA CTD PMID:24714768 NCBI chr 3:46,877,721...46,903,799
Ensembl chr 3:46,877,721...46,903,799 		JBrowse link
G PTHLH parathyroid hormone like hormone affects response to substance
decreases expression 		EXP PTHLH protein affects the susceptibility to zoledronic acid
zoledronic acid results in decreased expression of PTHLH mRNA 		CTD PMID:16278781 PMID:16475708 PMID:24714768 NCBI chr12:27,958,084...27,972,733
Ensembl chr12:27,958,084...27,972,733 		JBrowse link
G PTK2 protein tyrosine kinase 2 decreases phosphorylation
increases expression 		EXP zoledronic acid results in decreased phosphorylation of PTK2 protein
zoledronic acid results in increased expression of PTK2 mRNA 		CTD PMID:12933798 PMID:20977926 NCBI chr 8:140,657,900...141,002,079
Ensembl chr 8:140,657,900...141,002,216 		JBrowse link
G PTPN13 protein tyrosine phosphatase non-receptor type 13 decreases expression EXP zoledronic acid results in decreased expression of PTPN13 mRNA CTD PMID:24714768 NCBI chr 4:86,594,315...86,815,161
Ensembl chr 4:86,594,315...86,815,171 		JBrowse link
G PTPN20 protein tyrosine phosphatase non-receptor type 20 increases expression EXP zoledronic acid results in increased expression of PTPN20 mRNA CTD PMID:24714768 NCBI chr10:46,911,428...47,003,653
Ensembl chr10:46,911,396...47,002,488 		JBrowse link
G PTPRG protein tyrosine phosphatase receptor type G increases expression EXP zoledronic acid results in increased expression of PTPRG mRNA CTD PMID:24714768 NCBI chr 3:61,561,571...62,297,609
Ensembl chr 3:61,561,569...62,297,609 		JBrowse link
G PYGL glycogen phosphorylase L decreases expression EXP zoledronic acid results in decreased expression of PYGL mRNA CTD PMID:25596134 NCBI chr14:50,905,217...50,944,483
Ensembl chr14:50,857,891...50,944,483 		JBrowse link
G QPCT glutaminyl-peptide cyclotransferase increases expression EXP zoledronic acid results in increased expression of QPCT mRNA CTD PMID:24714768 NCBI chr 2:37,344,630...37,373,322
Ensembl chr 2:37,342,827...37,373,322 		JBrowse link
G RAB10 RAB10, member RAS oncogene family increases expression EXP zoledronic acid results in increased expression of RAB10 protein CTD PMID:28871336 NCBI chr 2:26,033,285...26,137,454
Ensembl chr 2:26,034,084...26,137,454 		JBrowse link
G RAB11FIP5 RAB11 family interacting protein 5 increases expression EXP zoledronic acid results in increased expression of RAB11FIP5 protein CTD PMID:28871336 NCBI chr 2:73,073,382...73,112,948
Ensembl chr 2:73,073,382...73,156,721 		JBrowse link
G RAB23 RAB23, member RAS oncogene family increases expression EXP zoledronic acid results in increased expression of RAB23 mRNA CTD PMID:20977926 NCBI chr 6:57,186,992...57,222,307
Ensembl chr 6:57,186,992...57,222,307 		JBrowse link
G RAB26 RAB26, member RAS oncogene family increases expression EXP zoledronic acid results in increased expression of RAB26 mRNA CTD PMID:25596134 NCBI chr16:2,148,144...2,154,165
Ensembl chr16:2,140,803...2,154,165 		JBrowse link
G RAB27B RAB27B, member RAS oncogene family multiple interactions EXP [zoledronic acid co-treated with fluvastatin] results in increased expression of RAB27B mRNA CTD PMID:16996129 NCBI chr18:54,717,857...54,895,516
Ensembl chr18:54,717,860...54,895,516 		JBrowse link
G RAB2B RAB2B, member RAS oncogene family increases expression EXP zoledronic acid results in increased expression of RAB2B protein CTD PMID:28871336 NCBI chr14:21,459,020...21,476,959
Ensembl chr14:21,459,020...21,476,960 		JBrowse link
G RAB31 RAB31, member RAS oncogene family increases expression EXP zoledronic acid results in increased expression of RAB31 mRNA CTD PMID:24714768 PMID:25596134 NCBI chr18:9,708,301...9,862,551
Ensembl chr18:9,708,275...9,862,551 		JBrowse link
G RAB32 RAB32, member RAS oncogene family multiple interactions EXP [zoledronic acid co-treated with fluvastatin] results in increased expression of RAB32 mRNA CTD PMID:16996129 NCBI chr 6:146,543,833...146,554,953
Ensembl chr 6:146,543,833...146,554,953 		JBrowse link
G RAB35 RAB35, member RAS oncogene family increases expression EXP zoledronic acid results in increased expression of RAB35 protein CTD PMID:28871336 NCBI chr12:120,095,099...120,116,753
Ensembl chr12:120,095,099...120,117,502 		JBrowse link
G RAB5B RAB5B, member RAS oncogene family multiple interactions EXP [zoledronic acid co-treated with fluvastatin] results in increased expression of RAB5B mRNA CTD PMID:16996129 NCBI chr12:55,973,949...55,996,683
Ensembl chr12:55,973,913...55,996,683 		JBrowse link
G RAB6A RAB6A, member RAS oncogene family increases expression EXP zoledronic acid results in increased expression of RAB6A mRNA CTD PMID:20977926 NCBI chr11:73,675,638...73,761,074
Ensembl chr11:73,675,638...73,761,137 		JBrowse link
G RAB7A RAB7A, member RAS oncogene family increases expression EXP zoledronic acid results in increased expression of RAB7A protein CTD PMID:28871336 NCBI chr 3:128,726,183...128,814,798
Ensembl chr 3:128,693,669...128,825,942 		JBrowse link
G RAB9A RAB9A, member RAS oncogene family increases expression EXP zoledronic acid results in increased expression of RAB9A protein CTD PMID:28871336 NCBI chr  X:13,689,128...13,710,504
Ensembl chr  X:13,689,128...13,710,504 		JBrowse link
G RABEP2 rabaptin, RAB GTPase binding effector protein 2 decreases expression EXP zoledronic acid results in decreased expression of RABEP2 protein CTD PMID:28871336 NCBI chr16:28,904,421...28,925,238
Ensembl chr16:28,904,421...28,936,526 		JBrowse link
G RABGAP1L RAB GTPase activating protein 1 like multiple interactions
decreases expression 		EXP [zoledronic acid co-treated with fluvastatin] results in increased expression of RABGAP1L mRNA
zoledronic acid results in decreased expression of RABGAP1L protein 		CTD PMID:16996129 PMID:28871336 NCBI chr 1:174,159,520...174,995,308
Ensembl chr 1:174,159,410...174,995,308 		JBrowse link
G RABL2B RAB, member of RAS oncogene family like 2B increases expression EXP zoledronic acid results in increased expression of RABL2B protein CTD PMID:28871336 NCBI chr22:50,767,506...50,783,636
Ensembl chr22:50,767,501...50,783,667 		JBrowse link
G RAC1 Rac family small GTPase 1 multiple interactions
increases expression 		ISO
EXP 		zoledronic acid results in increased abundance of [Guanosine Triphosphate binds to RAC1 protein]
zoledronic acid results in increased expression of RAC1 protein
zoledronic acid results in increased expression of [RAC1 protein binds to Guanosine Triphosphate] 		CTD PMID:16734383 PMID:28871336 NCBI chr 7:6,374,527...6,403,967
Ensembl chr 7:6,374,527...6,403,967 		JBrowse link
G RACK1 receptor for activated C kinase 1 increases expression EXP zoledronic acid results in increased expression of RACK1 protein CTD PMID:28871336 NCBI chr 5:181,236,897...181,243,906
Ensembl chr 5:181,236,897...181,248,096 		JBrowse link
G RAD17 RAD17 checkpoint clamp loader component multiple interactions EXP [Tretinoin co-treated with zoledronic acid] results in increased expression of RAD17 protein CTD PMID:20349282 NCBI chr 5:69,369,293...69,414,801
Ensembl chr 5:69,369,293...69,414,801 		JBrowse link
G RAD51D RAD51 paralog D increases expression EXP zoledronic acid results in increased expression of RAD51D mRNA CTD PMID:20977926 NCBI chr17:35,092,221...35,119,860
Ensembl chr17:35,092,221...35,121,522 		JBrowse link
G RADX RPA1 related single stranded DNA binding protein, X-linked decreases expression EXP zoledronic acid results in decreased expression of RADX mRNA CTD PMID:24714768 NCBI chr  X:106,611,978...106,679,439
Ensembl chr  X:106,611,930...106,679,439 		JBrowse link
G RAF1 Raf-1 proto-oncogene, serine/threonine kinase decreases expression EXP zoledronic acid results in decreased expression of RAF1 protein CTD PMID:12799645 NCBI chr 3:12,583,601...12,664,117
Ensembl chr 3:12,582,101...12,664,201 		JBrowse link
G RAI14 retinoic acid induced 14 decreases expression EXP zoledronic acid results in decreased expression of RAI14 mRNA CTD PMID:24714768 NCBI chr 5:34,656,328...34,832,612
Ensembl chr 5:34,656,328...34,832,612 		JBrowse link
G RAI2 retinoic acid induced 2 increases expression EXP zoledronic acid results in increased expression of RAI2 mRNA CTD PMID:24714768 NCBI chr  X:17,800,049...17,861,298
Ensembl chr  X:17,800,049...17,861,337 		JBrowse link
G RALA RAS like proto-oncogene A increases expression EXP zoledronic acid results in increased expression of RALA protein CTD PMID:28871336 NCBI chr 7:39,623,572...39,708,120
Ensembl chr 7:39,623,565...39,708,120 		JBrowse link
G RANBP3L RAN binding protein 3 like decreases expression EXP zoledronic acid results in decreased expression of RANBP3L mRNA CTD PMID:24714768 NCBI chr 5:36,246,913...36,301,902
Ensembl chr 5:36,246,913...36,302,114 		JBrowse link
G RAP1A RAP1A, member of RAS oncogene family multiple interactions
decreases expression
increases expression
decreases prenylation
decreases geranoylation 		EXP
ISO 		geranylgeraniol inhibits the reaction [zoledronic acid results in decreased geranoylation of RAP1A protein]
Zoledronic Acid results in decreased expression of RAP1A protein modified form
zoledronic acid results in increased expression of RAP1A protein
[zoledronic acid co-treated with Doxorubicin] results in decreased expression of RAP1A protein modified form
zoledronic acid results in decreased prenylation of RAP1A protein 		CTD PMID:12406088 PMID:16539721 PMID:16602111 PMID:16675582 PMID:16996129 More... NCBI chr 1:111,542,009...111,716,691
Ensembl chr 1:111,542,218...111,716,691 		JBrowse link
G RAP1B RAP1B, member of RAS oncogene family increases expression EXP zoledronic acid results in increased expression of RAP1B mRNA CTD PMID:24714768 NCBI chr12:68,610,899...68,671,901
Ensembl chr12:68,610,855...68,671,901 		JBrowse link
G RAP1BL RAP1B like (pseudogene) increases expression EXP Zoledronic Acid results in increased expression of RAP1BL mRNA CTD PMID:24714768 NCBI chr 5:76,173,091...76,174,354 JBrowse link
G RAP1GAP RAP1 GTPase activating protein decreases expression EXP zoledronic acid results in decreased expression of RAP1GAP mRNA CTD PMID:24714768 NCBI chr 1:21,596,221...21,669,357
Ensembl chr 1:21,596,221...21,669,357 		JBrowse link
G RARA retinoic acid receptor alpha decreases expression EXP zoledronic acid results in decreased expression of RARA mRNA CTD PMID:24714768 PMID:25596134 NCBI chr17:40,309,180...40,357,643
Ensembl chr17:40,309,180...40,357,643 		JBrowse link
G RASAL1 RAS protein activator like 1 decreases expression EXP zoledronic acid results in decreased expression of RASAL1 mRNA CTD PMID:24714768 NCBI chr12:113,099,278...113,136,756
Ensembl chr12:113,098,819...113,136,239 		JBrowse link
G RASGRP1 RAS guanyl releasing protein 1 increases expression EXP zoledronic acid results in increased expression of RASGRP1 mRNA CTD PMID:24714768 NCBI chr15:38,488,103...38,564,814
Ensembl chr15:38,488,103...38,565,575 		JBrowse link
G RASL11B RAS like family 11 member B decreases expression EXP zoledronic acid results in decreased expression of RASL11B mRNA CTD PMID:24714768 NCBI chr 4:52,862,317...52,866,835
Ensembl chr 4:52,862,317...52,866,835 		JBrowse link
G RASSF5 Ras association domain family member 5 increases expression EXP zoledronic acid results in increased expression of RASSF5 mRNA CTD PMID:20977926 NCBI chr 1:206,507,531...206,589,448
Ensembl chr 1:206,507,531...206,589,448 		JBrowse link
G RASSF7 Ras association domain family member 7 decreases expression EXP zoledronic acid results in decreased expression of RASSF7 protein CTD PMID:28871336 NCBI chr11:560,970...564,025
Ensembl chr11:560,404...564,025 		JBrowse link
G RBBP9 RB binding protein 9, serine hydrolase increases expression EXP zoledronic acid results in increased expression of RBBP9 mRNA CTD PMID:20977926 NCBI chr20:18,486,540...18,497,225
Ensembl chr20:18,486,540...18,497,225 		JBrowse link
G RBM14 RNA binding motif protein 14 increases expression EXP zoledronic acid results in increased expression of RBM14 mRNA CTD PMID:20977926 NCBI chr11:66,616,630...66,629,934
Ensembl chr11:66,616,626...66,629,934 		JBrowse link
G RBM8A RNA binding motif protein 8A increases expression EXP zoledronic acid results in increased expression of RBM8A mRNA CTD PMID:20977926 NCBI chr 1:145,921,556...145,927,484
Ensembl chr 1:145,921,556...145,927,678 		JBrowse link
G RBPMS2 RNA binding protein, mRNA processing factor 2 decreases expression EXP zoledronic acid results in decreased expression of RBPMS2 mRNA CTD PMID:24714768 NCBI chr15:64,739,891...64,775,589
Ensembl chr15:64,739,891...64,775,589 		JBrowse link
G RBX1 ring-box 1 decreases expression EXP zoledronic acid results in decreased expression of RBX1 protein CTD PMID:28871336 NCBI chr22:40,951,378...40,973,309
Ensembl chr22:40,951,347...40,973,309 		JBrowse link
G RCBTB2 RCC1 and BTB domain containing protein 2 increases expression EXP zoledronic acid results in increased expression of RCBTB2 mRNA CTD PMID:24714768 NCBI chr13:48,488,963...48,535,895
Ensembl chr13:48,488,963...48,533,256 		JBrowse link
G RCN1 reticulocalbin 1 decreases expression EXP zoledronic acid results in decreased expression of RCN1 protein CTD PMID:28871336 NCBI chr11:32,091,074...32,105,722
Ensembl chr11:32,091,074...32,105,722 		JBrowse link
G RCN2 reticulocalbin 2 decreases expression EXP zoledronic acid results in decreased expression of RCN2 protein CTD PMID:28871336 NCBI chr15:76,931,749...76,954,393
Ensembl chr15:76,931,738...76,954,393 		JBrowse link
G RDH10 retinol dehydrogenase 10 increases expression EXP zoledronic acid results in increased expression of RDH10 mRNA CTD PMID:24714768 NCBI chr 8:73,294,602...73,325,281
Ensembl chr 8:73,294,602...73,325,281 		JBrowse link
G REG3A regenerating family member 3 alpha increases expression EXP zoledronic acid results in increased expression of REG3A mRNA CTD PMID:24714768 NCBI chr 2:79,157,006...79,159,753
Ensembl chr 2:79,157,003...79,159,753 		JBrowse link
G RELB RELB proto-oncogene, NF-kB subunit increases expression EXP zoledronic acid results in increased expression of RELB mRNA CTD PMID:24714768 NCBI chr19:45,001,464...45,038,192
Ensembl chr19:45,001,461...45,038,192 		JBrowse link
G REPS2 RALBP1 associated Eps domain containing 2 increases expression EXP zoledronic acid results in increased expression of REPS2 mRNA CTD PMID:24714768 NCBI chr  X:16,946,658...17,196,655
Ensembl chr  X:16,946,658...17,153,272 		JBrowse link
G RERG RAS like estrogen regulated growth inhibitor decreases expression EXP zoledronic acid results in decreased expression of RERG mRNA CTD PMID:24714768 NCBI chr12:15,107,783...15,221,417
Ensembl chr12:15,107,783...15,348,675 		JBrowse link
G RETREG1 reticulophagy regulator 1 increases expression EXP zoledronic acid results in increased expression of RETREG1 mRNA CTD PMID:24714768 NCBI chr 5:16,473,053...16,616,997
Ensembl chr 5:16,473,038...16,617,101 		JBrowse link
G RGL1 ral guanine nucleotide dissociation stimulator like 1 increases expression EXP zoledronic acid results in increased expression of RGL1 mRNA CTD PMID:24714768 NCBI chr 1:183,636,109...183,928,532
Ensembl chr 1:183,636,085...183,928,532 		JBrowse link
G RGS11 regulator of G protein signaling 11 multiple interactions EXP [zoledronic acid co-treated with fluvastatin] results in increased expression of RGS11 mRNA CTD PMID:16996129 NCBI chr16:268,307...275,944
Ensembl chr16:268,301...275,980 		JBrowse link
G RGS14 regulator of G protein signaling 14 increases expression EXP zoledronic acid results in increased expression of RGS14 mRNA CTD PMID:20977926 NCBI chr 5:177,357,924...177,372,596
Ensembl chr 5:177,357,924...177,372,596 		JBrowse link
G RHBDD2 rhomboid domain containing 2 increases expression EXP zoledronic acid results in increased expression of RHBDD2 mRNA CTD PMID:20977926 NCBI chr 7:75,879,034...75,888,926
Ensembl chr 7:75,842,602...75,888,926 		JBrowse link
G RHBDF2 rhomboid 5 homolog 2 increases expression EXP zoledronic acid results in increased expression of RHBDF2 mRNA CTD PMID:24714768 NCBI chr17:76,470,893...76,501,427
Ensembl chr17:76,470,891...76,501,790 		JBrowse link
G RHEX regulator of hemoglobinization and erythroid cell expansion increases expression EXP zoledronic acid results in increased expression of RHEX mRNA CTD PMID:24714768 NCBI chr 1:206,053,173...206,102,449
Ensembl chr 1:206,053,173...206,102,449 		JBrowse link
G RHOA ras homolog family member A multiple interactions
decreases geranoylation 		EXP
ISO 		[zoledronic acid results in decreased geranoylation of RHOA protein] which results in increased expression of IBSP mRNA; geranylgeraniol inhibits the reaction [zoledronic acid results in decreased expression of and affects the localization of RHOA protein]; zoledronic acid inhibits the reaction [RHOA protein results in decreased expression of IBSP mRNA]; zoledronic acid results in decreased expression of and affects the localization of RHOA protein; zoledronic acid results in increased expression of [RHOA protein binds to Guanosine Triphosphate]; zoledronic acid results in increased expression of and affects the localization of RHOA protein
zoledronic acid results in increased abundance of [Guanosine Triphosphate binds to RHOA protein] 		CTD PMID:15324309 PMID:16734383 PMID:28871336 NCBI chr 3:49,359,145...49,411,976
Ensembl chr 3:49,359,139...49,412,998 		JBrowse link
G RHOB ras homolog family member B increases expression
multiple interactions 		EXP zoledronic acid results in increased expression of RHOB mRNA
[zoledronic acid co-treated with fluvastatin] results in increased expression of RHOB mRNA; zoledronic acid results in increased expression of and affects the localization of RHOB protein 		CTD PMID:16996129 PMID:20977926 PMID:28871336 NCBI chr 2:20,447,074...20,449,440
Ensembl chr 2:20,447,074...20,449,440 		JBrowse link
G RHOBTB1 Rho related BTB domain containing 1 decreases expression EXP zoledronic acid results in decreased expression of RHOBTB1 mRNA CTD PMID:24714768 NCBI chr10:60,860,860...61,001,967
Ensembl chr10:60,869,438...61,001,440 		JBrowse link
G RHOBTB3 Rho related BTB domain containing 3 decreases expression EXP zoledronic acid results in decreased expression of RHOBTB3 mRNA CTD PMID:24714768 NCBI chr 5:95,717,624...95,796,361
Ensembl chr 5:95,713,522...95,824,383 		JBrowse link
G RHOC ras homolog family member C affects localization EXP zoledronic acid affects the localization of RHOC protein CTD PMID:28871336 NCBI chr 1:112,701,131...112,707,408
Ensembl chr 1:112,701,127...112,707,434 		JBrowse link
G RHOG ras homolog family member G increases expression EXP zoledronic acid results in increased expression of RHOG protein CTD PMID:28871336 NCBI chr11:3,826,978...3,840,959
Ensembl chr11:3,826,978...3,840,959 		JBrowse link
G RHOV ras homolog family member V increases expression EXP zoledronic acid results in increased expression of RHOV mRNA CTD PMID:24714768 NCBI chr15:40,872,214...40,874,234
Ensembl chr15:40,872,214...40,874,234 		JBrowse link
G RIMS2 regulating synaptic membrane exocytosis 2 multiple interactions EXP [zoledronic acid co-treated with fluvastatin] results in increased expression of RIMS2 mRNA CTD PMID:16996129 NCBI chr 8:103,500,610...104,256,094
Ensembl chr 8:103,500,610...104,254,430 		JBrowse link
G RIMS3 regulating synaptic membrane exocytosis 3 decreases expression EXP zoledronic acid results in decreased expression of RIMS3 mRNA CTD PMID:24714768 NCBI chr 1:40,620,680...40,692,066
Ensembl chr 1:40,620,680...40,665,682 		JBrowse link
G RIN2 Ras and Rab interactor 2 multiple interactions EXP [zoledronic acid co-treated with fluvastatin] results in increased expression of RIN2 mRNA CTD PMID:16996129 NCBI chr20:19,757,599...20,002,456
Ensembl chr20:19,757,606...20,002,457 		JBrowse link
G RIPK2 receptor interacting serine/threonine kinase 2 increases expression EXP zoledronic acid results in increased expression of RIPK2 mRNA CTD PMID:24714768 NCBI chr 8:89,757,816...89,791,064
Ensembl chr 8:89,757,806...89,791,064 		JBrowse link
G RIPOR3 RIPOR family member 3 decreases expression EXP zoledronic acid results in decreased expression of RIPOR3 mRNA CTD PMID:24714768 NCBI chr20:50,586,108...50,691,542
Ensembl chr20:50,586,108...50,691,542 		JBrowse link
G RIPPLY3 ripply transcriptional repressor 3 decreases expression EXP zoledronic acid results in decreased expression of RIPPLY3 mRNA CTD PMID:24714768 NCBI chr21:37,006,150...37,019,662
Ensembl chr21:37,006,150...37,019,662 		JBrowse link
G RND1 Rho family GTPase 1 increases expression EXP zoledronic acid results in increased expression of RND1 mRNA CTD PMID:24714768 PMID:25596134 NCBI chr12:48,857,145...48,865,870
Ensembl chr12:48,857,145...48,865,870 		JBrowse link
G RNF114 ring finger protein 114 increases expression EXP zoledronic acid results in increased expression of RNF114 mRNA CTD PMID:20977926 NCBI chr20:49,936,397...49,953,885
Ensembl chr20:49,936,336...49,953,885 		JBrowse link
G RNF141 ring finger protein 141 decreases expression EXP zoledronic acid results in decreased expression of RNF141 mRNA CTD PMID:20977926 NCBI chr11:10,511,673...10,541,187
Ensembl chr11:10,511,673...10,541,230 		JBrowse link
G RNF144B ring finger protein 144B increases expression EXP zoledronic acid results in increased expression of RNF144B mRNA CTD PMID:24714768 NCBI chr 6:18,387,350...18,468,870
Ensembl chr 6:18,387,350...18,468,870 		JBrowse link
G RNF167 ring finger protein 167 increases expression EXP zoledronic acid results in increased expression of RNF167 mRNA CTD PMID:20977926 NCBI chr17:4,940,092...4,945,222
Ensembl chr17:4,940,008...4,945,222 		JBrowse link
G RNFT2 ring finger protein, transmembrane 2 decreases expression EXP zoledronic acid results in decreased expression of RNFT2 mRNA CTD PMID:24714768 NCBI chr12:116,738,315...116,853,631
Ensembl chr12:116,738,178...116,853,631 		JBrowse link
G RPL7 ribosomal protein L7 increases expression EXP zoledronic acid results in increased expression of RPL7 mRNA CTD PMID:20977926 NCBI chr 8:73,290,242...73,294,466
Ensembl chr 8:73,290,242...73,295,789 		JBrowse link
G RPS9 ribosomal protein S9 decreases expression EXP zoledronic acid results in decreased expression of RPS9 mRNA CTD PMID:20977926 NCBI chr19:54,200,858...54,207,647
Ensembl chr19:54,200,809...54,249,003 		JBrowse link
G RPTOR regulatory associated protein of MTOR complex 1 decreases expression EXP zoledronic acid results in decreased expression of RPTOR mRNA; zoledronic acid results in decreased expression of RPTOR protein CTD PMID:20977926 PMID:28871336 NCBI chr17:80,544,838...80,966,368
Ensembl chr17:80,544,819...80,966,371 		JBrowse link
G RRAS2 RAS related 2 increases expression EXP zoledronic acid results in increased expression of RRAS2 protein CTD PMID:28871336 NCBI chr11:14,277,920...14,364,506
Ensembl chr11:14,277,922...14,364,506 		JBrowse link
G RRM2 ribonucleotide reductase regulatory subunit M2 decreases expression EXP zoledronic acid results in decreased expression of RRM2 mRNA CTD PMID:24714768 NCBI chr 2:10,122,568...10,211,010
Ensembl chr 2:10,120,698...10,211,725 		JBrowse link
G RSPH1 radial spoke head component 1 increases expression EXP zoledronic acid results in increased expression of RSPH1 mRNA CTD PMID:24714768 NCBI chr21:42,472,486...42,496,224
Ensembl chr21:42,472,486...42,496,246 		JBrowse link
G RSRC1 arginine and serine rich coiled-coil 1 decreases expression EXP zoledronic acid results in decreased expression of RSRC1 mRNA CTD PMID:20977926 NCBI chr 3:158,110,089...158,545,730
Ensembl chr 3:158,105,855...158,545,730 		JBrowse link
G RUNX2 RUNX family transcription factor 2 increases expression EXP zoledronic acid results in increased expression of RUNX2 mRNA CTD PMID:25596134 NCBI chr 6:45,328,330...45,551,082
Ensembl chr 6:45,328,157...45,664,349 		JBrowse link
G RXFP1 relaxin family peptide receptor 1 increases expression EXP zoledronic acid results in increased expression of RXFP1 mRNA CTD PMID:24714768 NCBI chr 4:158,521,714...158,653,372
Ensembl chr 4:158,315,311...158,653,372 		JBrowse link
G S100A14 S100 calcium binding protein A14 decreases expression EXP zoledronic acid results in decreased expression of S100A14 mRNA CTD PMID:24714768 NCBI chr 1:153,614,255...153,616,325
Ensembl chr 1:153,614,255...153,616,986 		JBrowse link
G S100A2 S100 calcium binding protein A2 decreases expression EXP zoledronic acid results in decreased expression of S100A2 mRNA CTD PMID:24714768 NCBI chr 1:153,561,108...153,565,844
Ensembl chr 1:153,561,108...153,567,890 		JBrowse link
G S100A3 S100 calcium binding protein A3 increases expression EXP zoledronic acid results in increased expression of S100A3 mRNA CTD PMID:24714768 NCBI chr 1:153,547,329...153,549,258
Ensembl chr 1:153,547,329...153,549,258 		JBrowse link
G S100A6 S100 calcium binding protein A6 decreases expression EXP zoledronic acid results in decreased expression of S100A6 protein CTD PMID:28871336 NCBI chr 1:153,534,599...153,535,991
Ensembl chr 1:153,534,599...153,536,244 		JBrowse link
G S100A9 S100 calcium binding protein A9 increases expression EXP zoledronic acid results in increased expression of S100A9 mRNA CTD PMID:24714768 NCBI chr 1:153,357,854...153,361,023
Ensembl chr 1:153,357,854...153,361,023 		JBrowse link
G S100P S100 calcium binding protein P decreases expression EXP zoledronic acid results in decreased expression of S100P protein CTD PMID:28871336 NCBI chr 4:6,693,878...6,697,170
Ensembl chr 4:6,693,878...6,697,170 		JBrowse link
G SAA1 serum amyloid A1 increases expression EXP zoledronic acid results in increased expression of SAA1 mRNA CTD PMID:24714768 NCBI chr11:18,266,264...18,269,967
Ensembl chr11:18,266,260...18,269,977 		JBrowse link
G SAA2 serum amyloid A2 increases expression EXP zoledronic acid results in increased expression of SAA2 mRNA CTD PMID:24714768 NCBI chr11:18,238,236...18,248,668
Ensembl chr11:18,239,223...18,248,668 		JBrowse link
G SAA4 serum amyloid A4, constitutive increases expression EXP zoledronic acid results in increased expression of SAA4 mRNA CTD PMID:24714768 NCBI chr11:18,231,355...18,236,802
Ensembl chr11:18,231,355...18,236,802 		JBrowse link
G SALL2 spalt like transcription factor 2 decreases expression EXP zoledronic acid results in decreased expression of SALL2 mRNA CTD PMID:24714768 NCBI chr14:21,521,080...21,537,121
Ensembl chr14:21,521,080...21,537,216 		JBrowse link
G SAMD11 sterile alpha motif domain containing 11 decreases expression EXP zoledronic acid results in decreased expression of SAMD11 mRNA CTD PMID:24714768 NCBI chr 1:923,923...944,574
Ensembl chr 1:923,923...944,575 		JBrowse link
G SAPCD2 suppressor APC domain containing 2 decreases expression EXP zoledronic acid results in decreased expression of SAPCD2 mRNA CTD PMID:24714768 NCBI chr 9:137,062,127...137,070,557
Ensembl chr 9:137,062,127...137,070,557 		JBrowse link
G SASH1 SAM and SH3 domain containing 1 decreases expression EXP zoledronic acid results in decreased expression of SASH1 mRNA CTD PMID:24714768 NCBI chr 6:148,193,468...148,552,044
Ensembl chr 6:148,272,304...148,552,044 		JBrowse link
G SAV1 salvador family WW domain containing protein 1 increases expression EXP zoledronic acid results in increased expression of SAV1 mRNA CTD PMID:24714768 NCBI chr14:50,633,580...50,668,306
Ensembl chr14:50,632,058...50,668,306 		JBrowse link
G SBNO2 strawberry notch homolog 2 increases expression EXP zoledronic acid results in increased expression of SBNO2 protein CTD PMID:28871336 NCBI chr19:1,107,638...1,174,268
Ensembl chr19:1,107,637...1,174,268 		JBrowse link
G SC5D sterol-C5-desaturase increases expression EXP zoledronic acid results in increased expression of SC5D mRNA CTD PMID:24714768 NCBI chr11:121,292,771...121,313,410
Ensembl chr11:121,292,681...121,313,410 		JBrowse link
G SCARB2 scavenger receptor class B member 2 decreases expression EXP zoledronic acid results in decreased expression of SCARB2 protein CTD PMID:28871336 NCBI chr 4:76,158,737...76,234,532
Ensembl chr 4:76,158,737...76,234,536 		JBrowse link
G SCD5 stearoyl-CoA desaturase 5 decreases expression EXP zoledronic acid results in decreased expression of SCD5 mRNA CTD PMID:24714768 NCBI chr 4:82,629,539...82,798,796
Ensembl chr 4:82,629,539...82,798,796 		JBrowse link
G SCDP1 stearoyl-CoA desaturase pseudogene 1 increases expression EXP zoledronic acid results in increased expression of SCDP1 mRNA CTD PMID:24714768 NCBI chr17:20,784,374...20,789,614
Ensembl chr17:20,784,645...20,785,725 		JBrowse link
G SCEL sciellin decreases expression EXP zoledronic acid results in decreased expression of SCEL mRNA CTD PMID:24714768 NCBI chr13:77,535,706...77,645,263
Ensembl chr13:77,535,674...77,645,263 		JBrowse link
G SCG5 secretogranin V increases expression EXP zoledronic acid results in increased expression of SCG5 mRNA CTD PMID:24714768 NCBI chr15:32,641,710...32,697,092
Ensembl chr15:32,641,676...32,697,098 		JBrowse link
G SCGB1D2 secretoglobin family 1D member 2 increases expression EXP zoledronic acid results in increased expression of SCGB1D2 mRNA CTD PMID:24714768 NCBI chr11:62,242,239...62,244,812
Ensembl chr11:62,242,239...62,244,812 		JBrowse link
G SCGB2A1 secretoglobin family 2A member 1 increases expression EXP zoledronic acid results in increased expression of SCGB2A1 mRNA CTD PMID:24714768 NCBI chr11:62,208,673...62,213,943
Ensembl chr11:62,208,673...62,213,943 		JBrowse link
G SCGB2A2 secretoglobin family 2A member 2 increases expression EXP zoledronic acid results in increased expression of SCGB2A2 mRNA CTD PMID:24714768 NCBI chr11:62,270,158...62,273,160
Ensembl chr11:62,270,158...62,273,160 		JBrowse link
G SCNN1G sodium channel epithelial 1 subunit gamma increases expression EXP zoledronic acid results in increased expression of SCNN1G mRNA CTD PMID:24714768 NCBI chr16:23,182,745...23,216,883
Ensembl chr16:23,182,745...23,216,883 		JBrowse link
G SCOC short coiled-coil protein increases expression EXP zoledronic acid results in increased expression of SCOC mRNA CTD PMID:20977926 NCBI chr 4:140,257,308...140,385,728
Ensembl chr 4:140,257,286...140,385,728 		JBrowse link
G SCTR secretin receptor decreases expression EXP zoledronic acid results in decreased expression of SCTR mRNA CTD PMID:24714768 NCBI chr 2:119,439,843...119,524,483
Ensembl chr 2:119,439,843...119,525,301 		JBrowse link
G SDC1 syndecan 1 decreases expression EXP zoledronic acid results in decreased expression of SDC1 mRNA CTD PMID:24714768 NCBI chr 2:20,200,797...20,225,475
Ensembl chr 2:20,200,797...20,225,433 		JBrowse link
G SDC2 syndecan 2 decreases expression EXP zoledronic acid results in decreased expression of SDC2 mRNA CTD PMID:24714768 NCBI chr 8:96,493,813...96,611,790
Ensembl chr 8:96,493,813...96,611,790 		JBrowse link
G SDC4 syndecan 4 increases expression EXP zoledronic acid results in increased expression of SDC4 mRNA; zoledronic acid results in increased expression of SDC4 protein CTD PMID:24714768 PMID:28871336 NCBI chr20:45,325,288...45,348,424
Ensembl chr20:45,325,288...45,348,424 		JBrowse link
G SDCBP2 syndecan binding protein 2 increases expression EXP zoledronic acid results in increased expression of SDCBP2 mRNA CTD PMID:24714768 NCBI chr20:1,309,909...1,329,139
Ensembl chr20:1,309,909...1,329,139 		JBrowse link
G SECISBP2L SECIS binding protein 2 like increases expression EXP zoledronic acid results in increased expression of SECISBP2L mRNA CTD PMID:20977926 NCBI chr15:48,988,638...49,046,446
Ensembl chr15:48,988,476...49,046,447 		JBrowse link
G SELL selectin L increases expression EXP zoledronic acid results in increased expression of SELL mRNA CTD PMID:24714768 NCBI chr 1:169,690,667...169,711,620
Ensembl chr 1:169,690,665...169,711,702 		JBrowse link
G SEMA5B semaphorin 5B decreases expression EXP zoledronic acid results in decreased expression of SEMA5B mRNA CTD PMID:24714768 NCBI chr 3:122,909,082...123,028,605
Ensembl chr 3:122,909,082...123,028,605 		JBrowse link
G SERPINA1 serpin family A member 1 increases expression EXP zoledronic acid results in increased expression of SERPINA1 mRNA CTD PMID:24714768 NCBI chr14:94,376,747...94,390,635
Ensembl chr14:94,376,747...94,390,693 		JBrowse link
G SERPINA3 serpin family A member 3 increases secretion
increases expression 		EXP zoledronic acid results in increased secretion of SERPINA3 protein
zoledronic acid results in increased expression of SERPINA3 mRNA 		CTD PMID:24714768 NCBI chr14:94,612,391...94,624,053
Ensembl chr14:94,612,384...94,624,055 		JBrowse link
G SERPINB3 serpin family B member 3 increases expression EXP zoledronic acid results in increased expression of SERPINB3 mRNA CTD PMID:24714768 NCBI chr18:63,655,197...63,661,893
Ensembl chr18:63,655,197...63,661,893 		JBrowse link
G SERPINB7 serpin family B member 7 increases expression EXP zoledronic acid results in increased expression of SERPINB7 mRNA CTD PMID:24714768 NCBI chr18:63,753,057...63,805,370
Ensembl chr18:63,752,935...63,805,376 		JBrowse link
G SERPINF2 serpin family F member 2 decreases expression EXP zoledronic acid results in decreased expression of SERPINF2 mRNA CTD PMID:24714768 NCBI chr17:1,742,871...1,755,265
Ensembl chr17:1,742,836...1,755,265 		JBrowse link
G SERPINH1 serpin family H member 1 increases expression EXP zoledronic acid results in increased expression of SERPINH1 mRNA CTD PMID:20977926 PMID:24714768 NCBI chr11:75,562,253...75,572,783
Ensembl chr11:75,562,056...75,572,783 		JBrowse link
G SERTAD1 SERTA domain containing 1 decreases expression EXP zoledronic acid results in decreased expression of SERTAD1 mRNA CTD PMID:25596134 NCBI chr19:40,421,589...40,425,992
Ensembl chr19:40,421,589...40,425,992 		JBrowse link
G SERTAD4 SERTA domain containing 4 decreases expression EXP zoledronic acid results in decreased expression of SERTAD4 mRNA CTD PMID:24714768 NCBI chr 1:210,232,796...210,246,631
Ensembl chr 1:210,232,796...210,246,631 		JBrowse link
G SESN1 sestrin 1 decreases expression EXP zoledronic acid results in decreased expression of SESN1 mRNA CTD PMID:25596134 NCBI chr 6:108,984,309...109,094,846
Ensembl chr 6:108,984,309...109,094,846 		JBrowse link
G SETBP1 SET binding protein 1 decreases expression EXP zoledronic acid results in decreased expression of SETBP1 mRNA CTD PMID:24714768 NCBI chr18:44,680,073...45,068,510
Ensembl chr18:44,680,173...45,068,510 		JBrowse link
G SETD1A SET domain containing 1A, histone lysine methyltransferase decreases expression EXP zoledronic acid results in decreased expression of SETD1A mRNA CTD PMID:20977926 NCBI chr16:30,957,754...30,984,664
Ensembl chr16:30,957,294...30,984,664 		JBrowse link
G SFXN3 sideroflexin 3 decreases expression EXP zoledronic acid results in decreased expression of SFXN3 mRNA CTD PMID:20977926 NCBI chr10:101,031,234...101,041,241
Ensembl chr10:101,031,234...101,041,241 		JBrowse link
G SGMS1 sphingomyelin synthase 1 increases expression EXP zoledronic acid results in increased expression of SGMS1 mRNA CTD PMID:24714768 NCBI chr10:50,305,600...50,625,184
Ensembl chr10:50,305,586...50,625,163 		JBrowse link
G SGPP2 sphingosine-1-phosphate phosphatase 2 increases expression EXP zoledronic acid results in increased expression of SGPP2 mRNA CTD PMID:24714768 NCBI chr 2:222,423,988...222,562,621
Ensembl chr 2:222,424,543...222,562,621 		JBrowse link
G SH2D1B SH2 domain containing 1B increases expression EXP zoledronic acid results in increased expression of SH2D1B mRNA CTD PMID:24714768 NCBI chr 1:162,395,268...162,412,136
Ensembl chr 1:162,395,268...162,412,138 		JBrowse link
G SH2D4A SH2 domain containing 4A increases expression EXP zoledronic acid results in increased expression of SH2D4A mRNA CTD PMID:24714768 NCBI chr 8:19,313,693...19,396,218
Ensembl chr 8:19,313,693...19,396,218 		JBrowse link
G SHC4 SHC adaptor protein 4 decreases expression EXP zoledronic acid results in decreased expression of SHC4 mRNA CTD PMID:24714768 NCBI chr15:48,823,741...48,963,919
Ensembl chr15:48,823,741...48,963,919 		JBrowse link
G SHISA3 shisa family member 3 decreases expression EXP zoledronic acid results in decreased expression of SHISA3 mRNA CTD PMID:24714768 NCBI chr 4:42,397,488...42,402,487
Ensembl chr 4:42,397,488...42,402,487 		JBrowse link
G SHROOM1 shroom family member 1 increases expression EXP zoledronic acid results in increased expression of SHROOM1 mRNA CTD PMID:20977926 NCBI chr 5:132,822,141...132,830,647
Ensembl chr 5:132,822,141...132,830,659 		JBrowse link
G SIRPB1 signal regulatory protein beta 1 increases expression EXP zoledronic acid results in increased expression of SIRPB1 mRNA CTD PMID:24714768 NCBI chr20:1,561,385...1,620,009
Ensembl chr20:1,561,385...1,620,061 		JBrowse link
G SKP1 S-phase kinase associated protein 1 decreases expression EXP zoledronic acid results in decreased expression of SKP1 protein CTD PMID:28871336 NCBI chr 5:134,148,935...134,176,950
Ensembl chr 5:134,148,935...134,176,964 		JBrowse link
G SLC11A2 solute carrier family 11 member 2 increases expression EXP zoledronic acid results in increased expression of SLC11A2 mRNA CTD PMID:24714768 NCBI chr12:50,952,263...51,028,886
Ensembl chr12:50,979,401...51,028,566 		JBrowse link
G SLC12A1 solute carrier family 12 member 1 decreases expression EXP zoledronic acid results in decreased expression of SLC12A1 mRNA CTD PMID:24714768 NCBI chr15:48,206,302...48,304,078
Ensembl chr15:48,178,438...48,304,078 		JBrowse link
G SLC14A1 solute carrier family 14 member 1 (Kidd blood group) decreases expression EXP zoledronic acid results in decreased expression of SLC14A1 mRNA CTD PMID:24714768 NCBI chr18:45,724,181...45,752,520
Ensembl chr18:45,687,025...45,752,520 		JBrowse link
G SLC15A1 solute carrier family 15 member 1 increases expression EXP zoledronic acid results in increased expression of SLC15A1 mRNA CTD PMID:24714768 NCBI chr13:98,683,801...98,752,672
Ensembl chr13:98,683,801...98,752,672 		JBrowse link
G SLC15A2 solute carrier family 15 member 2 decreases expression EXP zoledronic acid results in decreased expression of SLC15A2 mRNA CTD PMID:24714768 NCBI chr 3:121,894,401...121,944,188
Ensembl chr 3:121,894,401...121,944,188 		JBrowse link
G SLC16A1 solute carrier family 16 member 1 increases expression EXP zoledronic acid results in increased expression of SLC16A1 mRNA CTD PMID:20977926 NCBI chr 1:112,911,847...112,956,196
Ensembl chr 1:112,911,847...112,957,593 		JBrowse link
G SLC16A10 solute carrier family 16 member 10 increases expression EXP zoledronic acid results in increased expression of SLC16A10 mRNA CTD PMID:24714768 NCBI chr 6:111,087,503...111,231,194
Ensembl chr 6:111,087,503...111,231,194 		JBrowse link
G SLC16A14 solute carrier family 16 member 14 decreases expression EXP zoledronic acid results in decreased expression of SLC16A14 mRNA CTD PMID:24714768 NCBI chr 2:230,034,982...230,068,924
Ensembl chr 2:230,034,982...230,068,993 		JBrowse link
G SLC16A4 solute carrier family 16 member 4 decreases expression EXP zoledronic acid results in decreased expression of SLC16A4 mRNA CTD PMID:24714768 NCBI chr 1:110,362,857...110,391,026
Ensembl chr 1:110,362,851...110,391,082 		JBrowse link
G SLC1A3 solute carrier family 1 member 3 increases expression EXP zoledronic acid results in increased expression of SLC1A3 mRNA CTD PMID:24714768 NCBI chr 5:36,606,606...36,688,334
Ensembl chr 5:36,596,588...36,688,334 		JBrowse link
G SLC1A5 solute carrier family 1 member 5 decreases expression EXP zoledronic acid results in decreased expression of SLC1A5 mRNA CTD PMID:25596134 NCBI chr19:46,774,883...46,788,594
Ensembl chr19:46,774,883...46,788,594 		JBrowse link
G SLC22A23 solute carrier family 22 member 23 increases expression EXP zoledronic acid results in increased expression of SLC22A23 mRNA CTD PMID:24714768 NCBI chr 6:3,268,973...3,457,050
Ensembl chr 6:3,268,962...3,457,050 		JBrowse link
G SLC22A4 solute carrier family 22 member 4 increases expression EXP zoledronic acid results in increased expression of SLC22A4 mRNA CTD PMID:24714768 NCBI chr 5:132,294,394...132,344,190
Ensembl chr 5:132,294,394...132,344,190 		JBrowse link
G SLC23A2 solute carrier family 23 member 2 increases expression EXP zoledronic acid results in increased expression of SLC23A2 mRNA CTD PMID:20977926 NCBI chr20:4,852,358...5,010,313
Ensembl chr20:4,852,356...5,010,293 		JBrowse link
G SLC25A20 solute carrier family 25 member 20 decreases expression ISO zoledronic acid results in decreased expression of SLC25A20 mRNA CTD PMID:28871336 NCBI chr 3:48,856,926...48,898,882
Ensembl chr 3:48,856,926...48,898,904 		JBrowse link
G SLC25A24 solute carrier family 25 member 24 increases expression EXP zoledronic acid results in increased expression of SLC25A24 mRNA CTD PMID:24714768 NCBI chr 1:108,134,043...108,200,343
Ensembl chr 1:108,134,043...108,200,849 		JBrowse link
G SLC25A40 solute carrier family 25 member 40 increases expression EXP zoledronic acid results in increased expression of SLC25A40 mRNA CTD PMID:20977926 NCBI chr 7:87,833,568...87,876,360
Ensembl chr 7:87,833,568...87,876,360 		JBrowse link
G SLC27A1 solute carrier family 27 member 1 increases expression EXP zoledronic acid results in increased expression of SLC27A1 mRNA CTD PMID:20977926 NCBI chr19:17,468,767...17,506,168
Ensembl chr19:17,468,769...17,506,168 		JBrowse link
G SLC27A2 solute carrier family 27 member 2 decreases expression
increases expression
multiple interactions 		EXP
ISO 		zoledronic acid results in decreased expression of SLC27A2 mRNA
zoledronic acid results in increased expression of SLC27A2 mRNA; zoledronic acid results in increased expression of SLC27A2 protein
Zoledronic Acid results in increased expression of SLC27A2 mRNA; Zoledronic Acid results in increased expression of SLC27A2 protein
SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in decreased expression of ACOX1 mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in decreased expression of ACOX2 mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in decreased expression of CPT1A mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in decreased expression of CPT2 mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in decreased expression of PPARA mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in decreased expression of PPARGC1A mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in increased expression of ACTA2 protein]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in increased expression of COL1A1 mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in increased expression of COL3A1 mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in increased expression of COL4A1 mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in increased expression of FN1 mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in increased expression of FN1 protein]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in increased expression of IL6 mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in increased expression of TIMP1 mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in increased expression of TIMP2 mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in increased expression of TNF mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in increased expression of VIM mRNA] 		CTD PMID:24714768 PMID:25596134 PMID:28871336 NCBI chr15:50,182,196...50,236,385
Ensembl chr15:50,182,196...50,236,385 		JBrowse link
G SLC28A3 solute carrier family 28 member 3 increases expression EXP zoledronic acid results in increased expression of SLC28A3 mRNA CTD PMID:24714768 NCBI chr 9:84,275,457...84,368,727
Ensembl chr 9:84,275,457...84,340,758 		JBrowse link
G SLC29A4 solute carrier family 29 member 4 decreases expression EXP zoledronic acid results in decreased expression of SLC29A4 mRNA CTD PMID:24714768 NCBI chr 7:5,282,943...5,306,912
Ensembl chr 7:5,274,369...5,306,912 		JBrowse link
G SLC29A4P1 solute carrier family 29 member 4 pseudogene 1 decreases expression EXP zoledronic acid results in decreased expression of SLC29A4P1 mRNA CTD PMID:24714768 NCBI chr 7:57,014,085...57,020,273
Ensembl chr 7:57,014,285...57,020,273 		JBrowse link
G SLC2A11 solute carrier family 2 member 11 decreases expression EXP zoledronic acid results in decreased expression of SLC2A11 mRNA CTD PMID:25596134 NCBI chr22:23,856,934...23,886,312
Ensembl chr22:23,856,703...23,886,312 		JBrowse link
G SLC34A2 solute carrier family 34 member 2 increases expression EXP zoledronic acid results in increased expression of SLC34A2 mRNA CTD PMID:24714768 NCBI chr 4:25,655,851...25,678,748
Ensembl chr 4:25,648,011...25,678,748 		JBrowse link
G SLC35B3 solute carrier family 35 member B3 increases expression EXP zoledronic acid results in increased expression of SLC35B3 mRNA CTD PMID:24714768 NCBI chr 6:8,411,435...8,435,567
Ensembl chr 6:8,411,435...8,435,561 		JBrowse link
G SLC37A1 solute carrier family 37 member 1 increases expression EXP zoledronic acid results in increased expression of SLC37A1 mRNA CTD PMID:24714768 NCBI chr21:42,499,622...42,581,426
Ensembl chr21:42,496,008...42,581,440 		JBrowse link
G SLC37A4 solute carrier family 37 member 4 increases expression EXP zoledronic acid results in increased expression of SLC37A4 mRNA CTD PMID:24714768 NCBI chr11:119,024,112...119,030,877
Ensembl chr11:119,023,751...119,030,906 		JBrowse link
G SLC39A10 solute carrier family 39 member 10 decreases expression EXP zoledronic acid results in decreased expression of SLC39A10 mRNA CTD PMID:24714768 NCBI chr 2:195,613,029...195,737,700
Ensembl chr 2:195,575,977...195,737,702 		JBrowse link
G SLC39A8 solute carrier family 39 member 8 increases expression EXP zoledronic acid results in increased expression of SLC39A8 mRNA CTD PMID:24714768 NCBI chr 4:102,251,041...102,345,482
Ensembl chr 4:102,251,080...102,431,258 		JBrowse link
G SLC3A1 solute carrier family 3 member 1 decreases expression EXP zoledronic acid results in decreased expression of SLC3A1 mRNA CTD PMID:24714768 NCBI chr 2:44,275,480...44,322,437
Ensembl chr 2:44,275,458...44,321,494 		JBrowse link
G SLC3A2 solute carrier family 3 member 2 decreases expression EXP zoledronic acid results in decreased expression of SLC3A2 mRNA CTD PMID:24714768 PMID:25596134 NCBI chr11:62,856,109...62,888,860
Ensembl chr11:62,856,004...62,888,880 		JBrowse link
G SLC40A1 solute carrier family 40 member 1 increases expression EXP zoledronic acid results in increased expression of SLC40A1 mRNA CTD PMID:24714768 NCBI chr 2:189,560,590...189,580,786
Ensembl chr 2:189,560,590...189,583,758 		JBrowse link
G SLC44A2 solute carrier family 44 member 2 (CTL2 blood group) decreases expression EXP zoledronic acid results in decreased expression of SLC44A2 mRNA CTD PMID:24714768 NCBI chr19:10,602,455...10,644,557
Ensembl chr19:10,602,457...10,644,557 		JBrowse link
G SLC45A3 solute carrier family 45 member 3 decreases expression EXP zoledronic acid results in decreased expression of SLC45A3 mRNA CTD PMID:24714768 NCBI chr 1:205,657,851...205,680,509
Ensembl chr 1:205,657,851...205,680,509 		JBrowse link
G SLC46A3 solute carrier family 46 member 3 increases expression EXP zoledronic acid results in increased expression of SLC46A3 mRNA CTD PMID:24714768 NCBI chr13:28,700,080...28,718,970
Ensembl chr13:28,700,064...28,718,970 		JBrowse link
G SLC47A1 solute carrier family 47 member 1 decreases expression EXP zoledronic acid results in decreased expression of SLC47A1 mRNA CTD PMID:24714768 NCBI chr17:19,533,854...19,579,034
Ensembl chr17:19,495,385...19,579,034 		JBrowse link
G SLC4A4 solute carrier family 4 member 4 decreases expression EXP zoledronic acid results in decreased expression of SLC4A4 mRNA CTD PMID:24714768 NCBI chr 4:71,062,660...71,572,083
Ensembl chr 4:71,062,667...71,572,087 		JBrowse link
G SLC5A3 solute carrier family 5 member 3 decreases expression EXP zoledronic acid results in decreased expression of SLC5A3 mRNA CTD PMID:24714768 NCBI chr21:34,073,578...34,106,260
Ensembl chr21:34,073,578...34,106,260 		JBrowse link
G SLC6A10P solute carrier family 6 member 10, pseudogene decreases expression EXP zoledronic acid results in decreased expression of SLC6A10P mRNA CTD PMID:24714768 NCBI chr16:32,877,473...32,885,142
Ensembl chr16:32,877,469...32,885,142
Ensembl chr16:32,877,469...32,885,142 		JBrowse link
G SLC6A20 solute carrier family 6 member 20 increases expression EXP zoledronic acid results in increased expression of SLC6A20 mRNA CTD PMID:24714768 NCBI chr 3:45,755,449...45,796,536
Ensembl chr 3:45,755,449...45,796,574 		JBrowse link
G SLC6A8 solute carrier family 6 member 8 decreases expression EXP zoledronic acid results in decreased expression of SLC6A8 mRNA CTD PMID:24714768 NCBI chr  X:153,687,926...153,696,593
Ensembl chr  X:153,687,926...153,696,588 		JBrowse link
G SLC7A2 solute carrier family 7 member 2 decreases expression EXP zoledronic acid results in decreased expression of SLC7A2 mRNA CTD PMID:24714768 NCBI chr 8:17,494,069...17,570,566
Ensembl chr 8:17,497,088...17,570,573 		JBrowse link
G SLC7A5 solute carrier family 7 member 5 decreases expression EXP zoledronic acid results in decreased expression of SLC7A5 mRNA CTD PMID:24714768 PMID:25596134 NCBI chr16:87,830,023...87,869,507
Ensembl chr16:87,830,016...87,869,507 		JBrowse link
G SLCO2A1 solute carrier organic anion transporter family member 2A1 increases expression EXP zoledronic acid results in increased expression of SLCO2A1 mRNA CTD PMID:24714768 NCBI chr 3:133,932,701...134,029,925
Ensembl chr 3:133,932,701...134,052,184 		JBrowse link
G SLCO2B1 solute carrier organic anion transporter family member 2B1 increases expression EXP zoledronic acid results in increased expression of SLCO2B1 mRNA CTD PMID:24714768 PMID:25596134 NCBI chr11:75,151,107...75,206,549
Ensembl chr11:75,100,563...75,206,549 		JBrowse link
G SLCO3A1 solute carrier organic anion transporter family member 3A1 decreases expression
increases expression 		EXP zoledronic acid results in decreased expression of SLCO3A1 mRNA
zoledronic acid results in increased expression of SLCO3A1 mRNA 		CTD PMID:20977926 PMID:24714768 NCBI chr15:91,853,708...92,172,435
Ensembl chr15:91,853,708...92,172,435 		JBrowse link
G SLCO4A1 solute carrier organic anion transporter family member 4A1 increases expression EXP zoledronic acid results in increased expression of SLCO4A1 mRNA CTD PMID:24714768 NCBI chr20:62,642,503...62,690,740
Ensembl chr20:62,642,503...62,685,785 		JBrowse link
G SLCO4C1 solute carrier organic anion transporter family member 4C1 decreases expression EXP zoledronic acid results in decreased expression of SLCO4C1 mRNA CTD PMID:24714768 NCBI chr 5:102,233,986...102,296,284
Ensembl chr 5:102,233,986...102,296,284 		JBrowse link
G SLF2 SMC5-SMC6 complex localization factor 2 decreases expression EXP zoledronic acid results in decreased expression of SLF2 mRNA CTD PMID:24714768 NCBI chr10:100,912,963...100,965,134
Ensembl chr10:100,912,963...100,965,134 		JBrowse link
G SLFN5 schlafen family member 5 increases expression EXP zoledronic acid results in increased expression of SLFN5 mRNA CTD PMID:24714768 NCBI chr17:35,243,072...35,273,655
Ensembl chr17:35,243,071...35,273,655 		JBrowse link
G SLITRK4 SLIT and NTRK like family member 4 decreases expression EXP zoledronic acid results in decreased expression of SLITRK4 mRNA CTD PMID:24714768 NCBI chr  X:143,622,790...143,636,101
Ensembl chr  X:143,622,790...143,636,101 		JBrowse link
G SLMAP sarcolemma associated protein increases expression EXP zoledronic acid results in increased expression of SLMAP mRNA CTD PMID:20977926 NCBI chr 3:57,756,309...57,930,013
Ensembl chr 3:57,755,450...57,930,003 		JBrowse link
G SLPI secretory leukocyte peptidase inhibitor increases expression EXP zoledronic acid results in increased expression of SLPI mRNA; zoledronic acid results in increased expression of SLPI protein CTD PMID:24714768 PMID:28871336 NCBI chr20:45,252,239...45,254,564
Ensembl chr20:45,252,239...45,254,564 		JBrowse link
G SMAD3 SMAD family member 3 increases expression
multiple interactions
increases phosphorylation 		EXP
ISO 		zoledronic acid results in increased expression of SMAD3 mRNA
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [zoledronic acid results in increased phosphorylation of SMAD3 protein] 		CTD PMID:24714768 PMID:28871336 NCBI chr15:67,065,602...67,195,169
Ensembl chr15:67,063,763...67,195,173 		JBrowse link
G SMCO4 single-pass membrane protein with coiled-coil domains 4 decreases expression EXP zoledronic acid results in decreased expression of SMCO4 mRNA CTD PMID:24714768 NCBI chr11:93,478,472...93,553,979
Ensembl chr11:93,478,472...93,543,391 		JBrowse link
G SMIM24 small integral membrane protein 24 decreases expression EXP zoledronic acid results in decreased expression of SMIM24 mRNA CTD PMID:24714768 NCBI chr19:3,473,986...3,480,525
Ensembl chr19:3,473,986...3,480,525 		JBrowse link
G SMOC2 SPARC related modular calcium binding 2 increases expression EXP zoledronic acid results in increased expression of SMOC2 mRNA CTD PMID:24714768 NCBI chr 6:168,441,184...168,667,992
Ensembl chr 6:168,441,151...168,673,445 		JBrowse link
G SMOX spermine oxidase decreases expression EXP zoledronic acid results in decreased expression of SMOX mRNA CTD PMID:24714768 NCBI chr20:4,148,828...4,187,727
Ensembl chr20:4,120,980...4,187,747 		JBrowse link
G SMTN smoothelin decreases expression EXP zoledronic acid results in decreased expression of SMTN mRNA CTD PMID:24714768 NCBI chr22:31,064,118...31,104,624
Ensembl chr22:31,064,105...31,104,757 		JBrowse link
G SNAP25 synaptosome associated protein 25 increases expression EXP zoledronic acid results in increased expression of SNAP25 mRNA CTD PMID:24714768 NCBI chr20:10,218,830...10,307,418
Ensembl chr20:10,172,395...10,308,258 		JBrowse link
G SNHG12 small nucleolar RNA host gene 12 increases expression EXP zoledronic acid results in increased expression of SNHG12 mRNA CTD PMID:20977926 NCBI chr 1:28,578,538...28,582,983
Ensembl chr 1:28,578,536...28,583,132 		JBrowse link
G SNPH syntaphilin increases expression EXP zoledronic acid results in increased expression of SNPH mRNA CTD PMID:24714768 NCBI chr20:1,266,294...1,309,327
Ensembl chr20:1,266,280...1,309,328 		JBrowse link
G SOCS1 suppressor of cytokine signaling 1 increases expression EXP zoledronic acid results in increased expression of SOCS1 mRNA CTD PMID:24714768 NCBI chr16:11,254,417...11,256,204
Ensembl chr16:11,254,417...11,256,204 		JBrowse link
G SOD2 superoxide dismutase 2 increases expression EXP zoledronic acid results in increased expression of SOD2 mRNA CTD PMID:24714768 NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529 		JBrowse link
G SOD3 superoxide dismutase 3 increases expression EXP zoledronic acid results in increased expression of SOD3 mRNA CTD PMID:24714768 NCBI chr 4:24,795,573...24,800,842
Ensembl chr 4:24,789,912...24,800,842 		JBrowse link
G SORCS3 sortilin related VPS10 domain containing receptor 3 decreases expression EXP zoledronic acid results in decreased expression of SORCS3 mRNA CTD PMID:24714768 NCBI chr10:104,641,290...105,265,242
Ensembl chr10:104,641,290...105,265,242 		JBrowse link
G SOS2 SOS Ras/Rho guanine nucleotide exchange factor 2 multiple interactions EXP [zoledronic acid co-treated with fluvastatin] results in increased expression of SOS2 mRNA CTD PMID:16996129 NCBI chr14:50,117,130...50,231,882
Ensembl chr14:50,117,130...50,231,578 		JBrowse link
G SOSTDC1 sclerostin domain containing 1 increases expression EXP zoledronic acid results in increased expression of SOSTDC1 mRNA CTD PMID:24714768 NCBI chr 7:16,461,481...16,465,738
Ensembl chr 7:16,461,481...16,530,580 		JBrowse link
G SOWAHC sosondowah ankyrin repeat domain family member C decreases expression EXP zoledronic acid results in decreased expression of SOWAHC mRNA CTD PMID:24714768 NCBI chr 2:109,614,364...109,618,990
Ensembl chr 2:109,614,364...109,618,990 		JBrowse link
G SOX13 SRY-box transcription factor 13 increases expression EXP zoledronic acid results in increased expression of SOX13 mRNA CTD PMID:20977926 NCBI chr 1:204,073,115...204,127,743
Ensembl chr 1:204,073,115...204,127,743 		JBrowse link
G SOX17 SRY-box transcription factor 17 increases expression EXP zoledronic acid results in increased expression of SOX17 mRNA CTD PMID:24714768 NCBI chr 8:54,457,935...54,460,892
Ensembl chr 8:54,457,935...54,460,892 		JBrowse link
G SOX2 SRY-box transcription factor 2 increases expression EXP zoledronic acid results in increased expression of SOX2 mRNA CTD PMID:24714768 NCBI chr 3:181,711,925...181,714,436
Ensembl chr 3:181,711,925...181,714,436 		JBrowse link
G SOX4 SRY-box transcription factor 4 decreases expression EXP zoledronic acid results in decreased expression of SOX4 mRNA CTD PMID:24714768 NCBI chr 6:21,593,751...21,598,619
Ensembl chr 6:21,593,751...21,598,619 		JBrowse link
G SOX9 SRY-box transcription factor 9 decreases expression EXP zoledronic acid results in decreased expression of SOX9 mRNA CTD PMID:24714768 NCBI chr17:72,121,020...72,126,416
Ensembl chr17:72,121,020...72,126,416 		JBrowse link
G SP1 Sp1 transcription factor increases expression EXP zoledronic acid results in increased expression of SP1 mRNA CTD PMID:20977926 NCBI chr12:53,380,176...53,416,446
Ensembl chr12:53,380,176...53,416,446 		JBrowse link
G SPART spartin decreases expression EXP Zoledronic Acid results in decreased expression of SPART protein CTD PMID:28871336 NCBI chr13:36,301,638...36,370,180
Ensembl chr13:36,301,638...36,370,180 		JBrowse link
G SPATA7 spermatogenesis associated 7 increases expression EXP zoledronic acid results in increased expression of SPATA7 mRNA CTD PMID:20977926 NCBI chr14:88,385,657...88,470,350
Ensembl chr14:88,384,924...88,470,350 		JBrowse link
G SPC24 SPC24 component of NDC80 kinetochore complex decreases expression EXP zoledronic acid results in decreased expression of SPC24 mRNA CTD PMID:24714768 NCBI chr19:11,145,493...11,155,782
Ensembl chr19:11,131,520...11,155,807 		JBrowse link
G SPDYE1 speedy/RINGO cell cycle regulator family member E1 increases expression EXP zoledronic acid results in increased expression of SPDYE1 mRNA CTD PMID:24714768 NCBI chr 7:43,997,897...44,010,124
Ensembl chr 7:43,997,897...44,010,124 		JBrowse link
G SPIN2A spindlin family member 2A multiple interactions EXP [zoledronic acid co-treated with fluvastatin] results in increased expression of SPIN2A mRNA CTD PMID:16996129 NCBI chr  X:57,134,265...57,147,180
Ensembl chr  X:57,134,530...57,137,523 		JBrowse link
G SPINK1 serine peptidase inhibitor Kazal type 1 increases expression EXP zoledronic acid results in increased expression of SPINK1 mRNA CTD PMID:24714768 NCBI chr 5:147,824,582...147,839,196
Ensembl chr 5:147,824,572...147,831,671 		JBrowse link
G SPOCK1 SPARC (osteonectin), cwcv and kazal like domains proteoglycan 1 decreases expression EXP zoledronic acid results in decreased expression of SPOCK1 mRNA CTD PMID:24714768 NCBI chr 5:136,975,298...137,499,326
Ensembl chr 5:136,975,298...137,598,379 		JBrowse link
G SPRR2A small proline rich protein 2A increases expression EXP zoledronic acid results in increased expression of SPRR2A mRNA CTD PMID:24714768 NCBI chr 1:153,056,120...153,057,512
Ensembl chr 1:153,056,120...153,057,512 		JBrowse link
G SPRR2F small proline rich protein 2F increases expression EXP zoledronic acid results in increased expression of SPRR2F mRNA CTD PMID:24714768 NCBI chr 1:153,112,121...153,119,468
Ensembl chr 1:153,112,121...153,113,516 		JBrowse link
G SPRYD3 SPRY domain containing 3 decreases expression EXP zoledronic acid results in decreased expression of SPRYD3 mRNA CTD PMID:20977926 NCBI chr12:53,064,316...53,079,390
Ensembl chr12:53,064,316...53,079,404 		JBrowse link
G SPTAN1 spectrin alpha, non-erythrocytic 1 decreases expression EXP zoledronic acid results in decreased expression of SPTAN1 protein CTD PMID:28871336 NCBI chr 9:128,552,587...128,633,662
Ensembl chr 9:128,552,558...128,633,662 		JBrowse link
G SPTLC3 serine palmitoyltransferase long chain base subunit 3 decreases expression EXP zoledronic acid results in decreased expression of SPTLC3 mRNA CTD PMID:24714768 NCBI chr20:13,008,972...13,169,103
Ensembl chr20:13,008,972...13,169,103 		JBrowse link
G SPX spexin hormone increases expression EXP zoledronic acid results in increased expression of SPX mRNA CTD PMID:24714768 NCBI chr12:21,526,296...21,532,947
Ensembl chr12:21,526,296...21,541,249 		JBrowse link
G SQLE squalene epoxidase increases expression EXP
ISO 		zoledronic acid results in increased expression of SQLE mRNA CTD PMID:18325729 PMID:20977926 PMID:24714768 NCBI chr 8:124,998,505...125,022,283
Ensembl chr 8:124,998,497...125,022,283 		JBrowse link
G SQOR sulfide quinone oxidoreductase increases expression EXP zoledronic acid results in increased expression of SQOR mRNA CTD PMID:24714768 NCBI chr15:45,631,148...45,691,281
Ensembl chr15:45,631,148...45,691,281 		JBrowse link
G SRD5A2 steroid 5 alpha-reductase 2 increases expression EXP zoledronic acid results in increased expression of SRD5A2 mRNA CTD PMID:24714768 NCBI chr 2:31,522,480...31,663,009
Ensembl chr 2:31,522,480...31,580,938 		JBrowse link
G SRD5A3 steroid 5 alpha-reductase 3 increases expression EXP zoledronic acid results in increased expression of SRD5A3 mRNA CTD PMID:25596134 NCBI chr 4:55,346,242...55,373,100
Ensembl chr 4:55,346,213...55,373,100 		JBrowse link
G SRGAP3 SLIT-ROBO Rho GTPase activating protein 3 increases expression EXP zoledronic acid results in increased expression of SRGAP3 mRNA CTD PMID:24714768 NCBI chr 3:8,980,591...9,363,027
Ensembl chr 3:8,980,591...9,363,053 		JBrowse link
G SRSF11 serine and arginine rich splicing factor 11 decreases expression EXP zoledronic acid results in decreased expression of SRSF11 mRNA CTD PMID:20977926 NCBI chr 1:70,205,696...70,253,052
Ensembl chr 1:70,205,682...70,253,052 		JBrowse link
G SS18 SS18 subunit of BAF chromatin remodeling complex increases expression EXP zoledronic acid results in increased expression of SS18 mRNA CTD PMID:20977926 NCBI chr18:26,016,253...26,091,219
Ensembl chr18:26,016,253...26,091,217 		JBrowse link
G SSH2 slingshot protein phosphatase 2 decreases expression EXP zoledronic acid results in decreased expression of SSH2 mRNA CTD PMID:24714768 NCBI chr17:29,625,938...29,930,228
Ensembl chr17:29,625,938...29,930,276 		JBrowse link
G SSTR1 somatostatin receptor 1 decreases expression EXP zoledronic acid results in decreased expression of SSTR1 mRNA CTD PMID:24714768 NCBI chr14:38,207,904...38,213,067
Ensembl chr14:38,207,904...38,213,067 		JBrowse link
G SSTR5-AS1 SSTR5 antisense RNA 1 decreases expression EXP zoledronic acid results in decreased expression of SSTR5-AS1 mRNA CTD PMID:24714768 NCBI chr16:1,064,081...1,078,731
Ensembl chr16:1,064,081...1,078,731 		JBrowse link
G SSX2IP SSX family member 2 interacting protein increases expression EXP zoledronic acid results in increased expression of SSX2IP mRNA CTD PMID:20977926 NCBI chr 1:84,643,706...84,690,745
Ensembl chr 1:84,643,706...84,690,803 		JBrowse link
G ST6GAL1 ST6 beta-galactoside alpha-2,6-sialyltransferase 1 increases expression EXP zoledronic acid results in increased expression of ST6GAL1 mRNA CTD PMID:20977926 NCBI chr 3:186,930,526...187,078,553
Ensembl chr 3:186,930,325...187,078,553 		JBrowse link
G ST6GALNAC1 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 increases expression EXP zoledronic acid results in increased expression of ST6GALNAC1 mRNA CTD PMID:24714768 NCBI chr17:76,617,407...76,643,757
Ensembl chr17:76,624,761...76,643,786 		JBrowse link
G STAG2 STAG2 cohesin complex component decreases expression EXP zoledronic acid results in decreased expression of STAG2 protein CTD PMID:28871336 NCBI chr  X:123,960,560...124,102,656
Ensembl chr  X:123,960,212...124,422,664 		JBrowse link
G STARD13 StAR related lipid transfer domain containing 13 decreases expression EXP zoledronic acid results in decreased expression of STARD13 mRNA CTD PMID:24714768 NCBI chr13:33,103,137...33,676,794
Ensembl chr13:33,103,137...33,350,630 		JBrowse link
G STARD8 StAR related lipid transfer domain containing 8 decreases expression EXP zoledronic acid results in decreased expression of STARD8 mRNA CTD PMID:24714768 NCBI chr  X:68,647,666...68,725,836
Ensembl chr  X:68,647,666...68,725,842 		JBrowse link
G STAT1 signal transducer and activator of transcription 1 increases expression EXP zoledronic acid results in increased expression of STAT1 mRNA CTD PMID:24714768 NCBI chr 2:190,969,149...191,014,171
Ensembl chr 2:190,908,460...191,020,960 		JBrowse link
G STAT3 signal transducer and activator of transcription 3 increases expression EXP zoledronic acid results in increased expression of STAT3 mRNA CTD PMID:24714768 NCBI chr17:42,313,324...42,388,442
Ensembl chr17:42,313,324...42,388,568 		JBrowse link
G STAT5A signal transducer and activator of transcription 5A increases expression EXP zoledronic acid results in increased expression of STAT5A mRNA CTD PMID:24714768 NCBI chr17:42,287,439...42,311,943
Ensembl chr17:42,287,547...42,311,943 		JBrowse link
G STC1 stanniocalcin 1 increases expression EXP zoledronic acid results in increased expression of STC1 protein CTD PMID:28871336 NCBI chr 8:23,841,929...23,854,806
Ensembl chr 8:23,841,929...23,854,806 		JBrowse link
G STC2 stanniocalcin 2 increases expression EXP zoledronic acid results in increased expression of STC2 mRNA CTD PMID:24714768 NCBI chr 5:173,314,723...173,328,414
Ensembl chr 5:173,314,723...173,328,447 		JBrowse link
G STEAP1 STEAP family member 1 increases expression EXP zoledronic acid results in increased expression of STEAP1 mRNA CTD PMID:24714768 NCBI chr 7:90,154,469...90,164,827
Ensembl chr 7:90,154,456...90,164,829 		JBrowse link
G STING1 stimulator of interferon response cGAMP interactor 1 increases expression EXP Zoledronic Acid results in increased expression of STING1 mRNA CTD PMID:24714768 NCBI chr 5:139,475,533...139,482,758
Ensembl chr 5:139,475,533...139,482,935 		JBrowse link
G STK17A serine/threonine kinase 17a multiple interactions EXP [zoledronic acid co-treated with fluvastatin] results in increased expression of STK17A mRNA CTD PMID:16996129 NCBI chr 7:43,583,108...43,627,379
Ensembl chr 7:43,582,758...43,650,713 		JBrowse link
G STK32A serine/threonine kinase 32A decreases expression EXP zoledronic acid results in decreased expression of STK32A mRNA CTD PMID:24714768 NCBI chr 5:147,235,026...147,401,990
Ensembl chr 5:147,234,963...147,387,855 		JBrowse link
G STK32B serine/threonine kinase 32B decreases expression EXP zoledronic acid results in decreased expression of STK32B mRNA CTD PMID:24714768 NCBI chr 4:5,019,386...5,500,989
Ensembl chr 4:5,051,480...5,500,994 		JBrowse link
G STK40 serine/threonine kinase 40 decreases expression EXP zoledronic acid results in decreased expression of STK40 mRNA CTD PMID:20977926 NCBI chr 1:36,339,628...36,385,924
Ensembl chr 1:36,339,624...36,385,924 		JBrowse link
G STMN1 stathmin 1 decreases expression EXP zoledronic acid results in decreased expression of STMN1 mRNA CTD PMID:24714768 NCBI chr 1:25,884,179...25,906,880
Ensembl chr 1:25,884,181...25,906,991 		JBrowse link
G STOML1 stomatin like 1 increases expression EXP zoledronic acid results in increased expression of STOML1 mRNA CTD PMID:24714768 NCBI chr15:73,978,926...73,994,622
Ensembl chr15:73,978,926...73,994,622 		JBrowse link
G STX16 syntaxin 16 increases expression EXP zoledronic acid results in increased expression of STX16 mRNA CTD PMID:20977926 NCBI chr20:58,651,283...58,679,526
Ensembl chr20:58,651,272...58,679,526 		JBrowse link
G STX17 syntaxin 17 increases expression EXP zoledronic acid results in increased expression of STX17 mRNA CTD PMID:20977926 NCBI chr 9:99,906,654...99,974,534
Ensembl chr 9:99,906,654...99,974,534 		JBrowse link
G STXBP4 syntaxin binding protein 4 decreases expression EXP zoledronic acid results in decreased expression of STXBP4 mRNA CTD PMID:24714768 NCBI chr17:54,968,765...55,213,273
Ensembl chr17:54,968,727...55,173,632 		JBrowse link
G SUCNR1 succinate receptor 1 decreases expression EXP zoledronic acid results in decreased expression of SUCNR1 mRNA CTD PMID:24714768 NCBI chr 3:151,873,643...151,884,619
Ensembl chr 3:151,873,643...151,884,619 		JBrowse link
G SUGCT succinyl-CoA:glutarate-CoA transferase increases expression EXP zoledronic acid results in increased expression of SUGCT mRNA CTD PMID:24714768 NCBI chr 7:40,135,005...41,038,816
Ensembl chr 7:40,135,005...40,860,763 		JBrowse link
G SULF2 sulfatase 2 increases expression EXP zoledronic acid results in increased expression of SULF2 mRNA CTD PMID:25596134 NCBI chr20:47,657,406...47,786,627
Ensembl chr20:47,656,197...47,786,616 		JBrowse link
G SULT1C5P sulfotransferase family 1C member 5, pseudogene increases expression EXP Zoledronic Acid results in increased expression of SULT1C5P mRNA CTD PMID:24714768 NCBI chr 2:108,322,238...108,353,799
Ensembl chr 2:108,322,238...108,353,799
Ensembl chr 2:108,322,238...108,353,799 		JBrowse link
G SVIL supervillin increases expression EXP zoledronic acid results in increased expression of SVIL mRNA CTD PMID:24714768 NCBI chr10:29,457,338...29,736,936
Ensembl chr10:29,457,338...29,736,959 		JBrowse link
G SVIL2P supervillin family member 2, pseudogene increases expression EXP zoledronic acid results in increased expression of SVIL2P mRNA CTD PMID:24714768 NCBI chr10:30,692,274...30,717,013
Ensembl chr10:30,655,651...30,717,266 		JBrowse link
G SYBU syntabulin decreases expression EXP Zoledronic Acid results in decreased expression of SYBU mRNA CTD PMID:24714768 NCBI chr 8:109,573,978...109,691,600
Ensembl chr 8:109,573,978...109,691,791 		JBrowse link
G SYNJ1 synaptojanin 1 increases expression EXP zoledronic acid results in increased expression of SYNJ1 mRNA CTD PMID:20977926 NCBI chr21:32,628,759...32,728,394
Ensembl chr21:32,628,759...32,728,040 		JBrowse link
G SYT13 synaptotagmin 13 decreases expression EXP zoledronic acid results in decreased expression of SYT13 mRNA CTD PMID:24714768 NCBI chr11:45,240,302...45,286,341
Ensembl chr11:45,240,302...45,286,341 		JBrowse link
G SYTL2 synaptotagmin like 2 decreases expression EXP zoledronic acid results in decreased expression of SYTL2 mRNA CTD PMID:24714768 NCBI chr11:85,694,229...85,854,870
Ensembl chr11:85,694,224...85,811,159 		JBrowse link
G TAB2 TGF-beta activated kinase 1 (MAP3K7) binding protein 2 increases expression EXP zoledronic acid results in increased expression of TAB2 mRNA CTD PMID:20977926 NCBI chr 6:149,217,926...149,411,607
Ensembl chr 6:149,218,641...149,411,613 		JBrowse link
G TACC3 transforming acidic coiled-coil containing protein 3 decreases expression EXP zoledronic acid results in decreased expression of TACC3 mRNA CTD PMID:24714768 NCBI chr 4:1,721,521...1,745,171
Ensembl chr 4:1,712,858...1,745,171 		JBrowse link
G TAF9B TATA-box binding protein associated factor 9b increases expression EXP zoledronic acid results in increased expression of TAF9B mRNA CTD PMID:20977926 NCBI chr  X:78,129,748...78,139,650
Ensembl chr  X:78,129,748...78,139,650 		JBrowse link
G TAPBP TAP binding protein increases expression EXP zoledronic acid results in increased expression of TAPBP mRNA CTD PMID:24714768 NCBI chr 6:33,299,694...33,314,078
Ensembl chr 6:33,299,694...33,314,284 		JBrowse link
G TBC1D16 TBC1 domain family member 16 increases expression EXP zoledronic acid results in increased expression of TBC1D16 mRNA CTD PMID:24714768 NCBI chr17:79,932,343...80,035,872
Ensembl chr17:79,932,343...80,035,872 		JBrowse link
G TBC1D2B TBC1 domain family member 2B increases expression EXP zoledronic acid results in increased expression of TBC1D2B mRNA CTD PMID:24714768 NCBI chr15:77,994,985...78,077,711
Ensembl chr15:77,984,036...78,077,724 		JBrowse link
G TBC1D4 TBC1 domain family member 4 decreases expression EXP zoledronic acid results in decreased expression of TBC1D4 mRNA CTD PMID:24714768 NCBI chr13:75,283,503...75,482,169
Ensembl chr13:75,283,503...75,482,169 		JBrowse link
G TBC1D8 TBC1 domain family member 8 increases expression EXP zoledronic acid results in increased expression of TBC1D8 mRNA CTD PMID:24714768 NCBI chr 2:101,007,228...101,151,382
Ensembl chr 2:101,007,228...101,252,866 		JBrowse link
G TBL1XR1 TBL1X/Y related 1 increases expression EXP zoledronic acid results in increased expression of TBL1XR1 mRNA CTD PMID:20977926 NCBI chr 3:177,019,344...177,201,800
Ensembl chr 3:177,019,340...177,228,000 		JBrowse link
G TCAF2P1 TRPM8 channel associated factor 2 pseudogene 1 increases expression EXP zoledronic acid results in increased expression of TCAF2P1 mRNA CTD PMID:24714768 NCBI chr 7:143,809,990...143,815,389
Ensembl chr 7:143,800,732...143,817,973 		JBrowse link
G TCAIM T cell activation inhibitor, mitochondrial increases expression EXP zoledronic acid results in increased expression of TCAIM mRNA CTD PMID:20977926 NCBI chr 3:44,338,129...44,409,448
Ensembl chr 3:44,338,119...44,409,451 		JBrowse link
G TCIM transcriptional and immune response regulator increases expression EXP zoledronic acid results in increased expression of TCIM mRNA CTD PMID:24714768 NCBI chr 8:40,153,482...40,155,310
Ensembl chr 8:40,153,482...40,155,310 		JBrowse link
G TCN1 transcobalamin 1 increases expression EXP zoledronic acid results in increased expression of TCN1 mRNA CTD PMID:24714768 NCBI chr11:59,852,808...59,866,487
Ensembl chr11:59,852,800...59,866,489 		JBrowse link
G TCP1 t-complex 1 decreases expression EXP zoledronic acid results in decreased expression of TCP1 mRNA CTD PMID:24714768 NCBI chr 6:159,778,498...159,789,602
Ensembl chr 6:159,778,498...159,789,703 		JBrowse link
G TEAD2 TEA domain transcription factor 2 decreases expression EXP zoledronic acid results in decreased expression of TEAD2 mRNA CTD PMID:24714768 NCBI chr19:49,340,595...49,362,416
Ensembl chr19:49,340,595...49,362,457 		JBrowse link
G TENM4 teneurin transmembrane protein 4 increases expression EXP zoledronic acid results in increased expression of TENM4 mRNA CTD PMID:24714768 NCBI chr11:78,652,829...79,441,030
Ensembl chr11:78,652,829...79,441,030 		JBrowse link
G TENT5B terminal nucleotidyltransferase 5B decreases expression EXP zoledronic acid results in decreased expression of TENT5B mRNA CTD PMID:24714768 NCBI chr 1:27,005,020...27,012,850
Ensembl chr 1:27,005,020...27,012,850 		JBrowse link
G TESC tescalcin decreases expression EXP zoledronic acid results in decreased expression of TESC mRNA CTD PMID:24714768 NCBI chr12:117,038,923...117,099,416
Ensembl chr12:117,038,923...117,099,479 		JBrowse link
G TESPA1 thymocyte expressed, positive selection associated 1 decreases expression EXP zoledronic acid results in decreased expression of TESPA1 mRNA CTD PMID:20977926 NCBI chr12:54,948,015...54,985,188
Ensembl chr12:54,948,015...54,984,762 		JBrowse link
G TFAP2B transcription factor AP-2 beta decreases expression EXP zoledronic acid results in decreased expression of TFAP2B mRNA CTD PMID:24714768 NCBI chr 6:50,818,355...50,847,619
Ensembl chr 6:50,818,723...50,847,619 		JBrowse link
G TFCP2L1 transcription factor CP2 like 1 decreases expression EXP zoledronic acid results in decreased expression of TFCP2L1 mRNA CTD PMID:24714768 NCBI chr 2:121,216,587...121,285,202
Ensembl chr 2:121,216,587...121,285,202 		JBrowse link
G TFIP11 tuftelin interacting protein 11 decreases expression EXP zoledronic acid results in decreased expression of TFIP11 mRNA CTD PMID:20977926 NCBI chr22:26,491,240...26,512,473
Ensembl chr22:26,491,225...26,512,505 		JBrowse link
G TFPI tissue factor pathway inhibitor increases expression EXP zoledronic acid results in increased expression of TFPI mRNA CTD PMID:24714768 NCBI chr 2:187,464,230...187,554,435
Ensembl chr 2:187,464,230...187,565,760 		JBrowse link
G TFPI2 tissue factor pathway inhibitor 2 increases expression EXP zoledronic acid results in increased expression of TFPI2 mRNA CTD PMID:24714768 NCBI chr 7:93,885,396...93,890,753
Ensembl chr 7:93,885,396...93,890,753 		JBrowse link
G TFRC transferrin receptor increases expression EXP zoledronic acid results in increased expression of TFRC mRNA CTD PMID:20977926 NCBI chr 3:196,049,284...196,082,090
Ensembl chr 3:196,012,511...196,082,153 		JBrowse link
G TGFB1 transforming growth factor beta 1 multiple interactions
increases expression 		ISO
EXP 		[Alendronate co-treated with zoledronic acid] results in increased expression of TGFB1 protein
zoledronic acid results in increased expression of and results in increased secretion of TGFB1 protein
zoledronic acid results in increased expression of TGFB1 mRNA
zoledronic acid results in increased expression of TGFB1 protein 		CTD PMID:18504149 PMID:28871336 NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922 		JBrowse link
G TGFB1I1 transforming growth factor beta 1 induced transcript 1 increases expression EXP zoledronic acid results in increased expression of TGFB1I1 protein CTD PMID:28871336 NCBI chr16:31,472,152...31,477,960
Ensembl chr16:31,471,585...31,477,960 		JBrowse link
G TGFB2 transforming growth factor beta 2 increases expression EXP zoledronic acid results in increased expression of TGFB2 mRNA CTD PMID:24714768 NCBI chr 1:218,345,336...218,444,619
Ensembl chr 1:218,345,336...218,444,619 		JBrowse link
G TGFBRAP1 transforming growth factor beta receptor associated protein 1 increases expression EXP zoledronic acid results in increased expression of TGFBRAP1 protein CTD PMID:28871336 NCBI chr 2:105,249,404...105,329,735
Ensembl chr 2:105,264,391...105,329,735 		JBrowse link
G TGM2 transglutaminase 2 increases expression EXP zoledronic acid results in increased expression of TGM2 mRNA CTD PMID:24714768 NCBI chr20:38,127,385...38,168,475
Ensembl chr20:38,127,385...38,166,578 		JBrowse link
G THBS1 thrombospondin 1 decreases expression EXP zoledronic acid results in decreased expression of THBS1 mRNA CTD PMID:24714768 NCBI chr15:39,581,079...39,599,466
Ensembl chr15:39,581,079...39,599,466 		JBrowse link
G TIFA TRAF interacting protein with forkhead associated domain increases expression EXP zoledronic acid results in increased expression of TIFA mRNA CTD PMID:24714768 NCBI chr 4:112,274,537...112,285,904
Ensembl chr 4:112,272,968...112,285,955 		JBrowse link
G TIGAR TP53 induced glycolysis regulatory phosphatase decreases expression EXP zoledronic acid results in decreased expression of TIGAR mRNA CTD PMID:25596134 NCBI chr12:4,321,213...4,360,028
Ensembl chr12:4,307,763...4,360,028 		JBrowse link
G TIMP1 TIMP metallopeptidase inhibitor 1 multiple interactions
increases expression 		ISO
EXP 		Fenofibrate inhibits the reaction [zoledronic acid results in increased expression of TIMP1 mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in increased expression of TIMP1 mRNA]
zoledronic acid results in increased expression of TIMP1 mRNA; zoledronic acid results in increased expression of TIMP1 protein 		CTD PMID:28871336 NCBI chr  X:47,582,436...47,586,789
Ensembl chr  X:47,582,408...47,586,789 		JBrowse link
G TIMP2 TIMP metallopeptidase inhibitor 2 multiple interactions
increases expression 		ISO
EXP 		Fenofibrate inhibits the reaction [zoledronic acid results in increased expression of TIMP2 mRNA]; SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in increased expression of TIMP2 mRNA]
zoledronic acid results in increased expression of TIMP2 mRNA; zoledronic acid results in increased expression of TIMP2 protein 		CTD PMID:28871336 NCBI chr17:78,852,977...78,925,387
Ensembl chr17:78,852,977...78,925,387 		JBrowse link
G TINAG tubulointerstitial nephritis antigen decreases expression EXP zoledronic acid results in decreased expression of TINAG mRNA CTD PMID:24714768 PMID:25596134 NCBI chr 6:54,307,862...54,390,142
Ensembl chr 6:54,307,859...54,390,142 		JBrowse link
G TIPARP TCDD inducible poly(ADP-ribose) polymerase increases expression EXP zoledronic acid results in increased expression of TIPARP mRNA CTD PMID:24714768 PMID:25596134 NCBI chr 3:156,674,590...156,706,770
Ensembl chr 3:156,673,235...156,706,770 		JBrowse link
G TLCD3A TLC domain containing 3A increases expression EXP Zoledronic Acid results in increased expression of TLCD3A mRNA CTD PMID:20977926 NCBI chr17:732,596...742,968
Ensembl chr17:732,412...742,968 		JBrowse link
G TLE4 TLE family member 4, transcriptional corepressor increases expression EXP zoledronic acid results in increased expression of TLE4 mRNA CTD PMID:24714768 NCBI chr 9:79,571,965...79,726,882
Ensembl chr 9:79,571,773...79,726,882 		JBrowse link
G TLR5 toll like receptor 5 increases expression EXP zoledronic acid results in increased expression of TLR5 mRNA CTD PMID:24714768 NCBI chr 1:223,109,404...223,143,248
Ensembl chr 1:223,109,404...223,143,292 		JBrowse link
G TM4SF4 transmembrane 4 L six family member 4 decreases expression EXP zoledronic acid results in decreased expression of TM4SF4 mRNA CTD PMID:24714768 NCBI chr 3:149,474,697...149,503,394
Ensembl chr 3:149,474,697...149,503,394 		JBrowse link
G TM7SF2 transmembrane 7 superfamily member 2 increases expression EXP zoledronic acid results in increased expression of TM7SF2 mRNA CTD PMID:24714768 NCBI chr11:65,111,872...65,116,230
Ensembl chr11:65,111,845...65,116,384 		JBrowse link
G TMC5 transmembrane channel like 5 increases expression EXP zoledronic acid results in increased expression of TMC5 mRNA CTD PMID:24714768 NCBI chr16:19,410,539...19,499,113
Ensembl chr16:19,410,496...19,499,113 		JBrowse link
G TMCC1 transmembrane and coiled-coil domain family 1 decreases expression EXP zoledronic acid results in decreased expression of TMCC1 mRNA CTD PMID:24714768 NCBI chr 3:129,647,792...129,893,711
Ensembl chr 3:129,647,792...129,893,711 		JBrowse link
G TMCO3 transmembrane and coiled-coil domains 3 increases expression EXP zoledronic acid results in increased expression of TMCO3 mRNA CTD PMID:20977926 NCBI chr13:113,491,021...113,550,229
Ensembl chr13:113,491,021...113,554,590 		JBrowse link
G TMEM125 transmembrane protein 125 decreases expression EXP zoledronic acid results in decreased expression of TMEM125 mRNA CTD PMID:24714768 NCBI chr 1:43,269,983...43,274,002
Ensembl chr 1:43,269,983...43,274,002 		JBrowse link
G TMEM132A transmembrane protein 132A increases expression EXP zoledronic acid results in increased expression of TMEM132A mRNA CTD PMID:24714768 NCBI chr11:60,924,460...60,937,159
Ensembl chr11:60,924,460...60,937,159 		JBrowse link
G TMEM154 transmembrane protein 154 decreases expression EXP zoledronic acid results in decreased expression of TMEM154 mRNA CTD PMID:24714768 NCBI chr 4:152,618,628...152,679,997
Ensembl chr 4:152,618,628...152,680,012 		JBrowse link
G TMEM171 transmembrane protein 171 increases expression EXP zoledronic acid results in increased expression of TMEM171 mRNA CTD PMID:24714768 NCBI chr 5:73,120,575...73,131,809
Ensembl chr 5:73,120,569...73,131,809 		JBrowse link
G TMEM213 transmembrane protein 213 decreases expression EXP zoledronic acid results in decreased expression of TMEM213 mRNA CTD PMID:24714768 NCBI chr 7:138,797,994...138,806,759
Ensembl chr 7:138,797,952...138,838,101 		JBrowse link
G TMEM259 transmembrane protein 259 increases expression EXP zoledronic acid results in increased expression of TMEM259 mRNA CTD PMID:20977926 NCBI chr19:1,009,653...1,021,123
Ensembl chr19:1,009,648...1,021,179 		JBrowse link
G TMEM267 transmembrane protein 267 increases expression EXP zoledronic acid results in increased expression of TMEM267 mRNA CTD PMID:24714768 NCBI chr 5:43,444,252...43,484,387
Ensembl chr 5:43,444,252...43,483,893 		JBrowse link
G TMEM30A transmembrane protein 30A increases expression EXP zoledronic acid results in increased expression of TMEM30A mRNA CTD PMID:20977926 NCBI chr 6:75,252,924...75,284,792
Ensembl chr 6:75,252,924...75,284,948 		JBrowse link
G TMEM37 transmembrane protein 37 decreases expression EXP zoledronic acid results in decreased expression of TMEM37 mRNA CTD PMID:24714768 NCBI chr 2:119,429,895...119,438,504
Ensembl chr 2:119,429,901...119,438,504 		JBrowse link
G TMEM52B transmembrane protein 52B decreases expression EXP zoledronic acid results in decreased expression of TMEM52B mRNA CTD PMID:24714768 NCBI chr12:10,170,513...10,191,804
Ensembl chr12:10,170,542...10,191,804 		JBrowse link
G TMEM72 transmembrane protein 72 decreases expression EXP zoledronic acid results in decreased expression of TMEM72 mRNA CTD PMID:24714768 NCBI chr10:44,911,337...44,937,010
Ensembl chr10:44,911,316...44,937,010 		JBrowse link
G TMEM74B transmembrane protein 74B increases expression EXP zoledronic acid results in increased expression of TMEM74B mRNA CTD PMID:24714768 NCBI chr20:1,180,570...1,189,409
Ensembl chr20:1,180,561...1,185,415 		JBrowse link
G TMEM86A transmembrane protein 86A decreases expression EXP zoledronic acid results in decreased expression of TMEM86A mRNA CTD PMID:24714768 NCBI chr11:18,698,779...18,704,785
Ensembl chr11:18,693,122...18,704,785 		JBrowse link
G TMEM87B transmembrane protein 87B increases expression EXP zoledronic acid results in increased expression of TMEM87B mRNA CTD PMID:20977926 NCBI chr 2:112,055,269...112,119,314
Ensembl chr 2:112,055,269...112,119,318 		JBrowse link
G TMEM97 transmembrane protein 97 increases expression EXP zoledronic acid results in increased expression of TMEM97 mRNA CTD PMID:24714768 NCBI chr17:28,319,200...28,328,685
Ensembl chr17:28,319,200...28,328,685 		JBrowse link
G TMOD1 tropomodulin 1 increases expression EXP zoledronic acid results in increased expression of TMOD1 mRNA CTD PMID:24714768 NCBI chr 9:97,501,180...97,601,743
Ensembl chr 9:97,501,180...97,601,743 		JBrowse link
G TMPRSS2 transmembrane serine protease 2 increases expression EXP Zoledronic Acid results in increased expression of TMPRSS2 mRNA CTD PMID:24714768 NCBI chr21:41,464,305...41,508,158
Ensembl chr21:41,464,300...41,531,116 		JBrowse link
G TMPRSS3 transmembrane serine protease 3 increases expression EXP zoledronic acid results in increased expression of TMPRSS3 mRNA CTD PMID:24714768 NCBI chr21:42,371,890...42,396,052
Ensembl chr21:42,371,887...42,396,091 		JBrowse link
G TMSB10 thymosin beta 10 decreases expression EXP zoledronic acid results in decreased expression of TMSB10 protein CTD PMID:28871336 NCBI chr 2:84,905,656...84,906,671
Ensembl chr 2:84,905,656...84,906,671 		JBrowse link
G TMSB15A thymosin beta 15A decreases expression EXP zoledronic acid results in decreased expression of TMSB15A mRNA CTD PMID:24714768 NCBI chr  X:102,513,682...102,516,739
Ensembl chr  X:102,513,682...102,516,739 		JBrowse link
G TMSB15B thymosin beta 15B decreases expression EXP zoledronic acid results in decreased expression of TMSB15B mRNA CTD PMID:24714768 NCBI chr  X:103,919,155...103,974,426
Ensembl chr  X:103,918,896...103,966,712
Ensembl chr  X:103,918,896...103,966,712 		JBrowse link
G TMSB4X thymosin beta 4 X-linked decreases expression EXP zoledronic acid results in decreased expression of TMSB4X protein CTD PMID:28871336 NCBI chr  X:12,975,110...12,977,223
Ensembl chr  X:12,975,110...12,977,227 		JBrowse link
G TMTC2 transmembrane O-mannosyltransferase targeting cadherins 2 increases expression EXP zoledronic acid results in increased expression of TMTC2 mRNA CTD PMID:20977926 NCBI chr12:82,686,906...83,134,866
Ensembl chr12:82,686,880...83,134,870 		JBrowse link
G TNC tenascin C increases expression EXP zoledronic acid results in increased expression of TNC mRNA CTD PMID:24714768 NCBI chr 9:115,019,575...115,118,157
Ensembl chr 9:115,019,575...115,118,207 		JBrowse link
G TNF tumor necrosis factor increases expression
multiple interactions 		EXP
ISO 		Zoledronic Acid results in increased expression of TNF mRNA; Zoledronic Acid results in increased expression of TNF protein
SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in increased expression of TNF mRNA]
zoledronic acid promotes the reaction [TNF protein results in increased phosphorylation of MAPK8 protein] 		CTD PMID:9351880 PMID:17059425 PMID:19036117 PMID:24714768 PMID:28871336 More... NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336 		JBrowse link
G TNFAIP2 TNF alpha induced protein 2 increases expression EXP zoledronic acid results in increased expression of TNFAIP2 mRNA CTD PMID:24714768 NCBI chr14:103,121,469...103,137,439
Ensembl chr14:103,121,476...103,137,439 		JBrowse link
G TNFAIP3 TNF alpha induced protein 3 increases expression EXP zoledronic acid results in increased expression of TNFAIP3 mRNA CTD PMID:24714768 NCBI chr 6:137,866,349...137,883,312
Ensembl chr 6:137,867,214...137,883,314 		JBrowse link
G TNFAIP6 TNF alpha induced protein 6 increases expression EXP zoledronic acid results in increased expression of TNFAIP6 mRNA CTD PMID:20977926 NCBI chr 2:151,357,592...151,381,340
Ensembl chr 2:151,357,592...151,380,046 		JBrowse link
G TNFAIP8 TNF alpha induced protein 8 increases expression EXP zoledronic acid results in increased expression of TNFAIP8 mRNA CTD PMID:24714768 PMID:25596134 NCBI chr 5:119,268,759...119,399,688
Ensembl chr 5:119,268,692...119,399,688 		JBrowse link
G TNFRSF10A TNF receptor superfamily member 10a multiple interactions
increases expression 		EXP [zoledronic acid co-treated with fluvastatin] results in increased expression of TNFRSF10A mRNA
zoledronic acid results in increased expression of TNFRSF10A mRNA 		CTD PMID:16996129 PMID:19036117 NCBI chr 8:23,190,452...23,225,102
Ensembl chr 8:23,190,452...23,225,102 		JBrowse link
G TNFRSF10B TNF receptor superfamily member 10b multiple interactions EXP [Tretinoin co-treated with zoledronic acid] results in increased expression of TNFRSF10B mRNA CTD PMID:20349282 NCBI chr 8:23,020,133...23,069,031
Ensembl chr 8:23,020,133...23,069,031 		JBrowse link
G TNFRSF11B TNF receptor superfamily member 11b affects expression
increases expression
multiple interactions
increases secretion 		EXP
ISO 		zoledronic acid affects the expression of TNFRSF11B protein
zoledronic acid results in increased expression of TNFRSF11B mRNA; zoledronic acid results in increased expression of TNFRSF11B protein
TNFRSF11B protein affects the reaction [zoledronic acid results in decreased activity of ALPL protein]
zoledronic acid results in increased secretion of TNFRSF11B protein
Zoledronic Acid results in increased expression of TNFRSF11B mRNA; Zoledronic Acid results in increased expression of TNFRSF11B protein
zoledronic acid inhibits the reaction [Dexamethasone results in decreased expression of TNFRSF11B mRNA]; zoledronic acid inhibits the reaction [Dexamethasone results in decreased expression of TNFRSF11B protein] 		CTD PMID:11855844 PMID:14753746 PMID:16121404 PMID:17041912 PMID:18496637 More... NCBI chr 8:118,923,557...118,951,885
Ensembl chr 8:118,923,557...118,951,885 		JBrowse link
G TNFRSF12A TNF receptor superfamily member 12A multiple interactions EXP [Tretinoin co-treated with zoledronic acid] results in increased expression of TNFRSF12A mRNA CTD PMID:20349282 NCBI chr16:3,020,368...3,022,383
Ensembl chr16:3,018,445...3,022,383 		JBrowse link
G TNFRSF14 TNF receptor superfamily member 14 increases expression EXP zoledronic acid results in increased expression of TNFRSF14 mRNA CTD PMID:24714768 NCBI chr 1:2,554,234...2,563,829
Ensembl chr 1:2,555,639...2,565,382 		JBrowse link
G TNFRSF1A TNF receptor superfamily member 1A increases expression
multiple interactions 		EXP zoledronic acid results in increased expression of TNFRSF1A mRNA
[Tretinoin co-treated with zoledronic acid] results in increased expression of TNFRSF1A mRNA 		CTD PMID:19036117 PMID:20349282 NCBI chr12:6,328,771...6,342,076
Ensembl chr12:6,328,757...6,342,114 		JBrowse link
G TNFRSF1B TNF receptor superfamily member 1B increases expression EXP zoledronic acid results in increased expression of TNFRSF1B mRNA CTD PMID:24714768 NCBI chr 1:12,166,991...12,209,220
Ensembl chr 1:12,166,991...12,209,228 		JBrowse link
G TNFRSF21 TNF receptor superfamily member 21 decreases expression
increases expression 		EXP zoledronic acid results in decreased expression of TNFRSF21 mRNA
zoledronic acid results in increased expression of TNFRSF21 mRNA 		CTD PMID:19036117 PMID:25596134 NCBI chr 6:47,231,532...47,309,905
Ensembl chr 6:47,231,532...47,309,905 		JBrowse link
G TNFRSF25 TNF receptor superfamily member 25 decreases expression EXP zoledronic acid results in decreased expression of TNFRSF25 mRNA CTD PMID:19036117 NCBI chr 1:6,460,786...6,466,173
Ensembl chr 1:6,460,786...6,466,175 		JBrowse link
G TNFRSF9 TNF receptor superfamily member 9 decreases expression
increases expression 		EXP zoledronic acid results in decreased expression of TNFRSF9 mRNA
zoledronic acid results in increased expression of TNFRSF9 mRNA 		CTD PMID:19036117 PMID:24714768 NCBI chr 1:7,915,871...7,940,839
Ensembl chr 1:7,915,871...7,943,165 		JBrowse link
G TNFSF11 TNF superfamily member 11 multiple interactions
decreases expression
affects expression 		EXP ADAM17 protein promotes the reaction [zoledronic acid results in decreased expression of TNFSF11 protein]; TAPI-2 inhibits the reaction [zoledronic acid results in decreased expression of TNFSF11 protein]
zoledronic acid affects the expression of TNFSF11 protein 		CTD PMID:14753746 PMID:17041912 NCBI chr13:42,562,736...42,608,013
Ensembl chr13:42,562,736...42,608,013 		JBrowse link
G TNFSF15 TNF superfamily member 15 increases expression EXP zoledronic acid results in increased expression of TNFSF15 mRNA CTD PMID:24714768 NCBI chr 9:114,784,635...114,806,039
Ensembl chr 9:114,784,652...114,806,039 		JBrowse link
G TNFSF8 TNF superfamily member 8 increases expression EXP zoledronic acid results in increased expression of TNFSF8 mRNA CTD PMID:20977926 NCBI chr 9:114,893,343...114,930,595
Ensembl chr 9:114,893,343...114,930,595 		JBrowse link
G TNFSF9 TNF superfamily member 9 increases expression EXP zoledronic acid results in increased expression of TNFSF9 mRNA CTD PMID:25596134 NCBI chr19:6,531,026...6,535,924
Ensembl chr19:6,531,026...6,535,924 		JBrowse link
G TNIP1 TNFAIP3 interacting protein 1 increases expression EXP zoledronic acid results in increased expression of TNIP1 mRNA CTD PMID:24714768 NCBI chr 5:151,029,943...151,087,685
Ensembl chr 5:151,029,945...151,093,577 		JBrowse link
G TNIP3 TNFAIP3 interacting protein 3 increases expression EXP zoledronic acid results in increased expression of TNIP3 mRNA CTD PMID:24714768 NCBI chr 4:121,131,408...121,227,483
Ensembl chr 4:121,131,408...121,227,466 		JBrowse link
G TNKS1BP1 tankyrase 1 binding protein 1 increases expression EXP zoledronic acid results in increased expression of TNKS1BP1 mRNA CTD PMID:24714768 NCBI chr11:57,299,642...57,324,952
Ensembl chr11:57,299,638...57,324,952 		JBrowse link
G TNPO3 transportin 3 decreases expression EXP zoledronic acid results in decreased expression of TNPO3 mRNA CTD PMID:20977926 NCBI chr 7:128,954,185...129,056,193
Ensembl chr 7:128,954,180...129,055,173 		JBrowse link
G TOB1 transducer of ERBB2, 1 increases expression EXP zoledronic acid results in increased expression of TOB1 mRNA CTD PMID:20977926 NCBI chr17:50,862,223...50,867,978
Ensembl chr17:50,862,223...50,867,978 		JBrowse link
G TOLLIP toll interacting protein increases expression EXP zoledronic acid results in increased expression of TOLLIP mRNA CTD PMID:20977926 NCBI chr11:1,274,371...1,309,632
Ensembl chr11:1,274,371...1,309,654 		JBrowse link
G TOP2A DNA topoisomerase II alpha decreases expression EXP zoledronic acid results in decreased expression of TOP2A mRNA CTD PMID:24714768 NCBI chr17:40,388,525...40,417,896
Ensembl chr17:40,388,525...40,417,896 		JBrowse link
G TOR2A torsin family 2 member A decreases expression EXP zoledronic acid results in decreased expression of TOR2A mRNA CTD PMID:24714768 NCBI chr 9:127,731,524...127,735,294
Ensembl chr 9:127,731,524...127,735,313 		JBrowse link
G TOX4 TOX high mobility group box family member 4 increases expression EXP zoledronic acid results in increased expression of TOX4 mRNA CTD PMID:20977926 NCBI chr14:21,477,195...21,499,170
Ensembl chr14:21,476,597...21,499,175 		JBrowse link
G TP53 tumor protein p53 affects activity
increases expression
multiple interactions 		EXP zoledronic acid affects the activity of TP53 protein
Zoledronic Acid results in increased expression of TP53 mRNA
[Tretinoin co-treated with zoledronic acid] results in decreased expression of TP53 protein 		CTD PMID:20349282 PMID:25596134 PMID:35587103 NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,546 		JBrowse link
G TP53INP1 tumor protein p53 inducible nuclear protein 1 multiple interactions EXP [zoledronic acid co-treated with fluvastatin] results in increased expression of TP53INP1 mRNA CTD PMID:16996129 NCBI chr 8:94,925,972...94,949,378
Ensembl chr 8:94,925,972...94,949,378 		JBrowse link
G TPCN1 two pore segment channel 1 increases expression EXP zoledronic acid results in increased expression of TPCN1 mRNA CTD PMID:25596134 NCBI chr12:113,221,464...113,298,585
Ensembl chr12:113,221,050...113,298,585 		JBrowse link
G TPD52L1 TPD52 like 1 decreases expression EXP zoledronic acid results in decreased expression of TPD52L1 mRNA CTD PMID:24714768 PMID:25596134 NCBI chr 6:125,153,773...125,264,407
Ensembl chr 6:125,119,049...125,264,407 		JBrowse link
G TPM2 tropomyosin 2 decreases expression EXP zoledronic acid results in decreased expression of TPM2 protein CTD PMID:28871336 NCBI chr 9:35,681,993...35,690,056
Ensembl chr 9:35,681,992...35,690,056 		JBrowse link
G TPRA1 transmembrane protein adipocyte associated 1 increases expression EXP zoledronic acid results in increased expression of TPRA1 mRNA CTD PMID:24714768 NCBI chr 3:127,571,232...127,598,231
Ensembl chr 3:127,571,232...127,598,267 		JBrowse link
G TPST2 tyrosylprotein sulfotransferase 2 decreases expression EXP zoledronic acid results in decreased expression of TPST2 mRNA CTD PMID:24714768 NCBI chr22:26,521,996...26,590,132
Ensembl chr22:26,521,996...26,596,717 		JBrowse link
G TPT1 tumor protein, translationally-controlled 1 decreases expression EXP zoledronic acid results in decreased expression of TPT1 protein CTD PMID:28871336 NCBI chr13:45,333,471...45,341,183
Ensembl chr13:45,333,471...45,341,284 		JBrowse link
G TPT1P9 TPT1 pseudogene 9 increases expression EXP zoledronic acid results in increased expression of TPT1P9 mRNA CTD PMID:24714768 NCBI chr 9:118,082,693...118,083,496
Ensembl chr 9:118,082,869...118,083,382 		JBrowse link
G TPX2 TPX2 microtubule nucleation factor decreases expression EXP zoledronic acid results in decreased expression of TPX2 mRNA CTD PMID:24714768 NCBI chr20:31,739,290...31,801,800
Ensembl chr20:31,739,271...31,801,805 		JBrowse link
G TRADD TNFRSF1A associated via death domain increases expression EXP zoledronic acid results in increased expression of TRADD mRNA CTD PMID:19036117 NCBI chr16:67,154,185...67,159,909
Ensembl chr16:67,154,185...67,159,909 		JBrowse link
G TRAF2 TNF receptor associated factor 2 increases expression EXP zoledronic acid results in increased expression of TRAF2 mRNA CTD PMID:19036117 NCBI chr 9:136,881,958...136,926,607
Ensembl chr 9:136,881,912...136,926,607 		JBrowse link
G TRAF3 TNF receptor associated factor 3 increases expression EXP zoledronic acid results in increased expression of TRAF3 mRNA CTD PMID:19036117 PMID:24714768 NCBI chr14:102,777,449...102,911,500
Ensembl chr14:102,777,449...102,911,500 		JBrowse link
G TRAIP TRAF interacting protein increases expression EXP zoledronic acid results in increased expression of TRAIP mRNA CTD PMID:20977926 NCBI chr 3:49,828,601...49,856,564
Ensembl chr 3:49,828,601...49,856,574 		JBrowse link
G TRERF1 transcriptional regulating factor 1 increases expression EXP zoledronic acid results in increased expression of TRERF1 mRNA CTD PMID:24714768 NCBI chr 6:42,224,931...42,452,224
Ensembl chr 6:42,224,931...42,452,051 		JBrowse link
G TRHDE-AS1 TRHDE antisense RNA 1 increases expression EXP zoledronic acid results in increased expression of TRHDE-AS1 mRNA CTD PMID:24714768 NCBI chr12:72,253,507...72,273,509
Ensembl chr12:72,249,964...72,276,954 		JBrowse link
G TRIB3 tribbles pseudokinase 3 increases expression EXP zoledronic acid results in increased expression of TRIB3 mRNA CTD PMID:20977926 NCBI chr20:380,760...397,559
Ensembl chr20:362,835...397,559 		JBrowse link
G TRIM16 tripartite motif containing 16 increases expression EXP zoledronic acid results in increased expression of TRIM16 mRNA CTD PMID:24714768 NCBI chr17:15,627,966...15,684,311
Ensembl chr17:15,627,960...15,684,311 		JBrowse link
G TRIM22 tripartite motif containing 22 increases expression EXP zoledronic acid results in increased expression of TRIM22 mRNA CTD PMID:20977926 NCBI chr11:5,689,790...5,710,863
Ensembl chr11:5,689,610...5,737,089 		JBrowse link
G TRIM37 tripartite motif containing 37 increases expression EXP zoledronic acid results in increased expression of TRIM37 mRNA CTD PMID:24714768 NCBI chr17:58,967,201...59,106,880
Ensembl chr17:58,982,638...59,106,921 		JBrowse link
G TRIM55 tripartite motif containing 55 increases expression EXP zoledronic acid results in increased expression of TRIM55 mRNA CTD PMID:24714768 NCBI chr 8:66,113,351...66,175,485
Ensembl chr 8:66,126,896...66,175,485 		JBrowse link
G TRIP13 thyroid hormone receptor interactor 13 decreases expression EXP zoledronic acid results in decreased expression of TRIP13 mRNA CTD PMID:24714768 NCBI chr 5:892,884...919,348
Ensembl chr 5:892,884...919,357 		JBrowse link
G TRIQK triple QxxK/R motif containing increases expression EXP zoledronic acid results in increased expression of TRIQK mRNA CTD PMID:20977926 NCBI chr 8:92,883,534...93,017,665
Ensembl chr 8:92,883,532...93,017,673 		JBrowse link
G TRNP1 TMF1 regulated nuclear protein 1 decreases expression EXP zoledronic acid results in decreased expression of TRNP1 mRNA CTD PMID:24714768 NCBI chr 1:26,993,692...27,000,886
Ensembl chr 1:26,993,692...27,001,912 		JBrowse link
G TRPV2 transient receptor potential cation channel subfamily V member 2 decreases expression EXP zoledronic acid results in decreased expression of TRPV2 mRNA CTD PMID:24714768 NCBI chr17:16,415,571...16,437,003
Ensembl chr17:16,415,571...16,437,003 		JBrowse link
G TSC22D1 TSC22 domain family member 1 increases expression EXP zoledronic acid results in increased expression of TSC22D1 mRNA CTD PMID:24714768 NCBI chr13:44,432,143...44,577,344
Ensembl chr13:44,432,143...44,577,147 		JBrowse link
G TSC22D3 TSC22 domain family member 3 increases expression EXP zoledronic acid results in increased expression of TSC22D3 mRNA CTD PMID:20977926 NCBI chr  X:107,713,221...107,775,988
Ensembl chr  X:107,713,221...107,777,342 		JBrowse link
G TSPAN15 tetraspanin 15 increases expression EXP zoledronic acid results in increased expression of TSPAN15 mRNA CTD PMID:24714768 NCBI chr10:69,451,465...69,549,508
Ensembl chr10:69,451,465...69,507,666 		JBrowse link
G TSPAN18 tetraspanin 18 increases expression EXP zoledronic acid results in increased expression of TSPAN18 mRNA CTD PMID:24714768 NCBI chr11:44,726,310...44,932,423
Ensembl chr11:44,726,465...44,932,423 		JBrowse link
G TSPAN7 tetraspanin 7 decreases expression EXP zoledronic acid results in decreased expression of TSPAN7 mRNA CTD PMID:24714768 NCBI chr  X:38,561,542...38,688,918
Ensembl chr  X:38,561,542...38,688,920 		JBrowse link
G TTC29 tetratricopeptide repeat domain 29 increases expression EXP zoledronic acid results in increased expression of TTC29 mRNA CTD PMID:24714768 NCBI chr 4:146,706,617...146,945,864
Ensembl chr 4:146,706,617...146,945,882 		JBrowse link
G TTC39C tetratricopeptide repeat domain 39C increases expression EXP zoledronic acid results in increased expression of TTC39C mRNA CTD PMID:24714768 NCBI chr18:23,992,887...24,135,600
Ensembl chr18:23,992,773...24,135,970 		JBrowse link
G TTC9 tetratricopeptide repeat domain 9 increases expression EXP zoledronic acid results in increased expression of TTC9 mRNA CTD PMID:24714768 NCBI chr14:70,641,916...70,675,366
Ensembl chr14:70,641,916...70,675,366 		JBrowse link
G TTK TTK protein kinase decreases expression EXP zoledronic acid results in decreased expression of TTK mRNA CTD PMID:24714768 NCBI chr 6:80,004,649...80,042,527
Ensembl chr 6:80,003,887...80,042,527 		JBrowse link
G TTTY4B testis expressed transcript, Y-linked 4B decreases expression EXP zoledronic acid results in decreased expression of TTTY4B mRNA CTD PMID:24714768 NCBI chr  Y:24,570,202...24,607,025
Ensembl chr  Y:24,570,202...24,607,025 		JBrowse link
G TTTY4C testis expressed transcript, Y-linked 4C decreases expression EXP zoledronic acid results in decreased expression of TTTY4C mRNA CTD PMID:24714768 NCBI chr  Y:25,063,083...25,099,892
Ensembl chr  Y:25,063,083...25,099,892 		JBrowse link
G TUBA1A tubulin alpha 1a decreases expression EXP zoledronic acid results in decreased expression of TUBA1A mRNA CTD PMID:24714768 NCBI chr12:49,184,795...49,189,080
Ensembl chr12:49,184,686...49,189,324 		JBrowse link
G TUBA1B tubulin alpha 1b decreases expression EXP zoledronic acid results in decreased expression of TUBA1B mRNA CTD PMID:24714768 NCBI chr12:49,127,782...49,131,395
Ensembl chr12:49,127,782...49,131,397 		JBrowse link
G TUBA1C tubulin alpha 1c decreases expression EXP zoledronic acid results in decreased expression of TUBA1C mRNA CTD PMID:24714768 NCBI chr12:49,227,926...49,274,600
Ensembl chr12:49,188,736...49,274,600 		JBrowse link
G TUBA3D tubulin alpha 3d decreases expression EXP zoledronic acid results in decreased expression of TUBA3D mRNA CTD PMID:24714768 NCBI chr 2:131,476,119...131,482,934
Ensembl chr 2:131,476,119...131,482,934 		JBrowse link
G TUBA4A tubulin alpha 4a decreases expression EXP zoledronic acid results in decreased expression of TUBA4A mRNA CTD PMID:24714768 NCBI chr 2:219,249,710...219,254,740
Ensembl chr 2:219,249,710...219,277,902 		JBrowse link
G TUBAP2 tubulin alpha pseudogene 2 decreases expression EXP zoledronic acid results in decreased expression of TUBAP2 mRNA CTD PMID:24714768 NCBI chr11:90,282,563...90,284,173
Ensembl chr11:90,282,560...90,284,172 		JBrowse link
G TUBB tubulin beta class I decreases expression EXP zoledronic acid results in decreased expression of TUBB mRNA CTD PMID:24714768 NCBI chr 6:30,720,352...30,725,422
Ensembl chr 6:30,717,435...30,725,538 		JBrowse link
G TUBB1 tubulin beta 1 class VI increases expression EXP zoledronic acid results in increased expression of TUBB1 protein CTD PMID:28871336 NCBI chr20:59,016,438...59,026,654
Ensembl chr20:59,019,429...59,026,654 		JBrowse link
G TUBB2B tubulin beta 2B class IIb decreases expression EXP zoledronic acid results in decreased expression of TUBB2B mRNA CTD PMID:24714768 NCBI chr 6:3,224,277...3,227,653
Ensembl chr 6:3,223,324...3,231,730 		JBrowse link
G TUBB3 tubulin beta 3 class III decreases expression EXP zoledronic acid results in decreased expression of TUBB3 mRNA CTD PMID:24714768 NCBI chr16:89,921,925...89,936,097
Ensembl chr16:89,921,392...89,938,761 		JBrowse link
G TUBB4A tubulin beta 4A class IVa decreases expression EXP zoledronic acid results in decreased expression of TUBB4A mRNA CTD PMID:24714768 NCBI chr19:6,494,319...6,502,848
Ensembl chr19:6,494,319...6,502,848 		JBrowse link
G TUBB4B tubulin beta 4B class IVb decreases expression EXP zoledronic acid results in decreased expression of TUBB4B mRNA CTD PMID:24714768 NCBI chr 9:137,241,287...137,243,707
Ensembl chr 9:137,241,287...137,243,707 		JBrowse link
G TUBB7P tubulin beta 7 pseudogene decreases expression EXP zoledronic acid results in decreased expression of TUBB7P mRNA CTD PMID:24714768 NCBI chr 4:189,982,335...189,984,929
Ensembl chr 4:189,982,523...189,984,871 		JBrowse link
G TUBBP1 tubulin beta pseudogene 1 decreases expression EXP zoledronic acid results in decreased expression of TUBBP1 mRNA CTD PMID:24714768 NCBI chr 8:30,351,857...30,353,521
Ensembl chr 8:30,352,008...30,353,342 		JBrowse link
G TUBBP2 tubulin beta pseudogene 2 decreases expression EXP zoledronic acid results in decreased expression of TUBBP2 mRNA CTD PMID:24714768 NCBI chr13:41,383,682...41,385,076
Ensembl chr13:41,384,773...41,385,183 		JBrowse link
G TXNIP thioredoxin interacting protein increases expression EXP zoledronic acid results in increased expression of TXNIP mRNA CTD PMID:20977926 NCBI chr 1:145,992,435...145,996,579
Ensembl chr 1:145,992,435...145,996,579 		JBrowse link
G TYMP thymidine phosphorylase increases expression
multiple interactions 		EXP zoledronic acid results in increased expression of TYMP mRNA
Gossypol inhibits the reaction [zoledronic acid results in increased expression of TYMP mRNA] 		CTD PMID:19825521 NCBI chr22:50,525,752...50,530,085
Ensembl chr22:50,525,752...50,530,032 		JBrowse link
G UBD ubiquitin D increases expression EXP zoledronic acid results in increased expression of UBD mRNA CTD PMID:24714768 NCBI chr 6:29,555,515...29,559,732
Ensembl chr 6:29,555,515...29,559,732 		JBrowse link
G UBE2C ubiquitin conjugating enzyme E2 C decreases expression EXP zoledronic acid results in decreased expression of UBE2C mRNA CTD PMID:24714768 NCBI chr20:45,812,644...45,816,952
Ensembl chr20:45,812,576...45,816,957 		JBrowse link
G UBQLN1 ubiquilin 1 increases expression EXP zoledronic acid results in increased expression of UBQLN1 protein CTD PMID:28871336 NCBI chr 9:83,659,968...83,707,958
Ensembl chr 9:83,659,968...83,707,958 		JBrowse link
G UGT1A6 UDP glucuronosyltransferase family 1 member A6 decreases expression EXP zoledronic acid results in decreased expression of UGT1A6 mRNA CTD PMID:24714768 NCBI chr 2:233,691,702...233,773,300
Ensembl chr 2:233,691,607...233,773,300 		JBrowse link
G UGT8 UDP glycosyltransferase 8 decreases expression EXP zoledronic acid results in decreased expression of UGT8 mRNA CTD PMID:24714768 NCBI chr 4:114,598,402...114,678,225
Ensembl chr 4:114,598,770...114,678,588 		JBrowse link
G UHRF1 ubiquitin like with PHD and ring finger domains 1 decreases expression EXP zoledronic acid results in decreased expression of UHRF1 mRNA CTD PMID:24714768 NCBI chr19:4,903,080...4,962,154
Ensembl chr19:4,903,080...4,962,154 		JBrowse link
G ULK2 unc-51 like autophagy activating kinase 2 increases expression EXP zoledronic acid results in increased expression of ULK2 mRNA CTD PMID:20977926 NCBI chr17:19,770,830...19,867,936
Ensembl chr17:19,770,829...19,867,936 		JBrowse link
G UNC13D unc-13 homolog D increases expression EXP zoledronic acid results in increased expression of UNC13D mRNA CTD PMID:20977926 NCBI chr17:75,827,225...75,844,404
Ensembl chr17:75,827,225...75,844,785 		JBrowse link
G UNC5A unc-5 netrin receptor A increases expression EXP zoledronic acid results in increased expression of UNC5A mRNA CTD PMID:24714768 NCBI chr 5:176,810,559...176,880,898
Ensembl chr 5:176,810,519...176,880,898 		JBrowse link
G UPP1 uridine phosphorylase 1 decreases expression EXP zoledronic acid results in decreased expression of UPP1 mRNA CTD PMID:24714768 NCBI chr 7:48,088,704...48,108,736
Ensembl chr 7:48,088,628...48,108,736 		JBrowse link
G UQCRC1 ubiquinol-cytochrome c reductase core protein 1 decreases expression EXP zoledronic acid results in decreased expression of UQCRC1 protein CTD PMID:28871336 NCBI chr 3:48,599,002...48,609,646
Ensembl chr 3:48,599,002...48,610,976 		JBrowse link
G UQCRH ubiquinol-cytochrome c reductase hinge protein decreases expression EXP zoledronic acid results in decreased expression of UQCRH protein CTD PMID:28871336 NCBI chr 1:46,303,698...46,316,776
Ensembl chr 1:46,303,698...46,316,776 		JBrowse link
G USP13 ubiquitin specific peptidase 13 decreases expression EXP zoledronic acid results in decreased expression of USP13 mRNA CTD PMID:24714768 NCBI chr 3:179,653,040...179,789,401
Ensembl chr 3:179,653,032...179,804,366 		JBrowse link
G USP24 ubiquitin specific peptidase 24 decreases expression EXP zoledronic acid results in decreased expression of USP24 mRNA CTD PMID:20977926 NCBI chr 1:55,066,359...55,215,364
Ensembl chr 1:55,066,359...55,215,378 		JBrowse link
G USP31 ubiquitin specific peptidase 31 increases expression EXP zoledronic acid results in increased expression of USP31 mRNA CTD PMID:20977926 NCBI chr16:23,061,406...23,149,452
Ensembl chr16:23,061,406...23,149,452 		JBrowse link
G UVRAG UV radiation resistance associated increases expression EXP zoledronic acid results in increased expression of UVRAG mRNA CTD PMID:24714768 NCBI chr11:75,815,210...76,144,232
Ensembl chr11:75,815,210...76,144,232 		JBrowse link
G VAMP2 vesicle associated membrane protein 2 increases expression EXP zoledronic acid results in increased expression of VAMP2 protein CTD PMID:28871336 NCBI chr17:8,159,147...8,162,948
Ensembl chr17:8,159,149...8,163,546 		JBrowse link
G VAMP3 vesicle associated membrane protein 3 increases expression EXP zoledronic acid results in increased expression of VAMP3 mRNA CTD PMID:20977926 NCBI chr 1:7,771,296...7,781,432
Ensembl chr 1:7,771,296...7,781,432 		JBrowse link
G VANGL1 VANGL planar cell polarity protein 1 decreases expression EXP zoledronic acid results in decreased expression of VANGL1 mRNA CTD PMID:20977926 NCBI chr 1:115,641,970...115,698,221
Ensembl chr 1:115,641,970...115,698,224 		JBrowse link
G VARS1 valyl-tRNA synthetase 1 increases expression EXP Zoledronic Acid results in increased expression of VARS1 mRNA CTD PMID:20977926 NCBI chr 6:31,777,518...31,795,752
Ensembl chr 6:31,777,518...31,795,752 		JBrowse link
G VASH1 vasohibin 1 increases expression EXP zoledronic acid results in increased expression of VASH1 mRNA CTD PMID:20977926 NCBI chr14:76,761,468...76,783,015
Ensembl chr14:76,761,468...76,783,015 		JBrowse link
G VEGFA vascular endothelial growth factor A increases expression EXP zoledronic acid results in increased expression of VEGFA mRNA CTD PMID:20977926 NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487 		JBrowse link
G VIM vimentin multiple interactions
increases expression 		ISO
EXP 		SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in increased expression of VIM mRNA] CTD PMID:28871336 NCBI chr10:17,228,241...17,237,593
Ensembl chr10:17,228,241...17,237,593 		JBrowse link
G VIPR1 vasoactive intestinal peptide receptor 1 increases expression EXP zoledronic acid results in increased expression of VIPR1 mRNA CTD PMID:25596134 NCBI chr 3:42,489,299...42,537,568
Ensembl chr 3:42,489,299...42,537,573 		JBrowse link
G VNN1 vanin 1 increases expression EXP zoledronic acid results in increased expression of VNN1 mRNA CTD PMID:24714768 NCBI chr 6:132,680,849...132,714,055
Ensembl chr 6:132,680,849...132,714,055 		JBrowse link
G VNN2 vanin 2 increases expression EXP zoledronic acid results in increased expression of VNN2 mRNA CTD PMID:24714768 NCBI chr 6:132,743,870...132,763,455
Ensembl chr 6:132,743,870...132,763,459 		JBrowse link
G VNN3P vanin 3, pseudogene increases expression EXP Zoledronic Acid results in increased expression of VNN3P mRNA CTD PMID:24714768 NCBI chr 6:132,722,787...132,734,765
Ensembl chr 6:132,722,784...132,736,935
Ensembl chr 6:132,722,784...132,736,935 		JBrowse link
G VPS13A vacuolar protein sorting 13 homolog A increases expression EXP zoledronic acid results in increased expression of VPS13A protein CTD PMID:28871336 NCBI chr 9:77,177,534...77,421,537
Ensembl chr 9:77,177,445...77,421,537 		JBrowse link
G VPS53 VPS53 subunit of GARP complex decreases expression EXP zoledronic acid results in decreased expression of VPS53 protein CTD PMID:28871336 NCBI chr17:508,668...714,839
Ensembl chr17:508,503...721,717 		JBrowse link
G VTCN1 V-set domain containing T cell activation inhibitor 1 increases expression EXP zoledronic acid results in increased expression of VTCN1 mRNA CTD PMID:24714768 PMID:25596134 NCBI chr 1:117,143,587...117,210,927
Ensembl chr 1:117,143,587...117,210,960 		JBrowse link
G VWA3B von Willebrand factor A domain containing 3B increases expression EXP zoledronic acid results in increased expression of VWA3B mRNA CTD PMID:24714768 NCBI chr 2:98,087,167...98,330,616
Ensembl chr 2:98,087,116...98,313,299 		JBrowse link
G VWF von Willebrand factor increases expression EXP zoledronic acid results in increased expression of VWF mRNA CTD PMID:24714768 NCBI chr12:5,948,877...6,124,670
Ensembl chr12:5,948,877...6,124,770 		JBrowse link
G WDR1 WD repeat domain 1 increases expression EXP zoledronic acid results in increased expression of WDR1 mRNA CTD PMID:20977926 NCBI chr 4:10,074,339...10,116,799
Ensembl chr 4:10,068,089...10,116,972 		JBrowse link
G WDR72 WD repeat domain 72 decreases expression EXP zoledronic acid results in decreased expression of WDR72 mRNA CTD PMID:24714768 NCBI chr15:53,513,741...53,762,878
Ensembl chr15:53,513,741...53,762,878 		JBrowse link
G WDTC1 WD and tetratricopeptide repeats 1 increases expression EXP zoledronic acid results in increased expression of WDTC1 mRNA CTD PMID:20977926 NCBI chr 1:27,234,441...27,308,636
Ensembl chr 1:27,234,632...27,308,636 		JBrowse link
G WFDC21P WAP four-disulfide core domain 21, pseudogene increases expression EXP zoledronic acid results in increased expression of WFDC21P mRNA CTD PMID:24714768 NCBI chr17:60,083,566...60,088,467
Ensembl chr17:60,085,109...60,088,286
Ensembl chr17:60,085,109...60,088,286 		JBrowse link
G WFDC5 WAP four-disulfide core domain 5 increases expression EXP zoledronic acid results in increased expression of WFDC5 mRNA CTD PMID:24714768 NCBI chr20:45,109,463...45,116,319
Ensembl chr20:45,109,452...45,115,174 		JBrowse link
G WHAMM WASP homolog associated with actin, golgi membranes and microtubules increases expression EXP zoledronic acid results in increased expression of WHAMM mRNA CTD PMID:20977926 NCBI chr15:82,809,628...82,836,108
Ensembl chr15:82,809,628...82,836,108 		JBrowse link
G WLS Wnt ligand secretion mediator decreases expression EXP zoledronic acid results in decreased expression of WLS mRNA CTD PMID:24714768 NCBI chr 1:68,098,459...68,232,546
Ensembl chr 1:68,098,473...68,233,120 		JBrowse link
G WNK1 WNK lysine deficient protein kinase 1 decreases expression EXP zoledronic acid results in decreased expression of WNK1 mRNA CTD PMID:20977926 NCBI chr12:752,579...911,452
Ensembl chr12:752,579...911,452 		JBrowse link
G WNT11 Wnt family member 11 multiple interactions EXP [zoledronic acid co-treated with fluvastatin] results in increased expression of WNT11 mRNA CTD PMID:16996129 NCBI chr11:76,186,325...76,210,761
Ensembl chr11:76,186,325...76,210,736 		JBrowse link
G WNT5A Wnt family member 5A increases expression EXP zoledronic acid results in increased expression of WNT5A mRNA CTD PMID:24714768 NCBI chr 3:55,465,715...55,505,263
Ensembl chr 3:55,465,715...55,490,539 		JBrowse link
G WSCD1 WSC domain containing 1 decreases expression EXP zoledronic acid results in decreased expression of WSCD1 mRNA CTD PMID:24714768 NCBI chr17:6,069,116...6,124,427
Ensembl chr17:6,057,807...6,124,427 		JBrowse link
G WTAP WT1 associated protein increases expression EXP zoledronic acid results in increased expression of WTAP mRNA CTD PMID:24714768 NCBI chr 6:159,726,693...159,756,319
Ensembl chr 6:159,725,585...159,756,319 		JBrowse link
G XDH xanthine dehydrogenase increases expression EXP zoledronic acid results in increased expression of XDH mRNA CTD PMID:24714768 NCBI chr 2:31,334,321...31,414,742
Ensembl chr 2:31,334,321...31,414,742 		JBrowse link
G XIAP X-linked inhibitor of apoptosis decreases expression EXP zoledronic acid results in decreased expression of XIAP mRNA CTD PMID:19036117 NCBI chr  X:123,859,708...123,913,972
Ensembl chr  X:123,859,712...123,913,972 		JBrowse link
G XPO6 exportin 6 increases expression EXP zoledronic acid results in increased expression of XPO6 protein CTD PMID:28871336 NCBI chr16:28,097,976...28,211,965
Ensembl chr16:28,097,976...28,211,965 		JBrowse link
G YARS1 tyrosyl-tRNA synthetase 1 decreases expression EXP Zoledronic Acid results in decreased expression of YARS1 mRNA CTD PMID:25596134 NCBI chr 1:32,775,239...32,817,358
Ensembl chr 1:32,775,237...32,818,031 		JBrowse link
G YTHDF3 YTH N6-methyladenosine RNA binding protein F3 increases expression EXP zoledronic acid results in increased expression of YTHDF3 mRNA CTD PMID:20977926 NCBI chr 8:63,168,553...63,212,788
Ensembl chr 8:63,168,553...63,212,786 		JBrowse link
G YWHAZ tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta decreases expression EXP zoledronic acid results in decreased expression of YWHAZ protein CTD PMID:28871336 NCBI chr 8:100,916,523...100,953,382
Ensembl chr 8:100,916,523...100,953,388 		JBrowse link
G ZBTB4 zinc finger and BTB domain containing 4 decreases expression EXP zoledronic acid results in decreased expression of ZBTB4 mRNA CTD PMID:20977926 NCBI chr17:7,459,378...7,484,249
Ensembl chr17:7,459,366...7,484,263 		JBrowse link
G ZC3H12A zinc finger CCCH-type containing 12A increases expression EXP zoledronic acid results in increased expression of ZC3H12A mRNA CTD PMID:24714768 NCBI chr 1:37,474,580...37,484,377
Ensembl chr 1:37,474,580...37,484,377 		JBrowse link
G ZC3H12C zinc finger CCCH-type containing 12C increases expression EXP zoledronic acid results in increased expression of ZC3H12C mRNA CTD PMID:24714768 NCBI chr11:110,093,392...110,171,841
Ensembl chr11:110,093,392...110,171,841 		JBrowse link
G ZC3HAV1 zinc finger CCCH-type containing, antiviral 1 increases expression EXP zoledronic acid results in increased expression of ZC3HAV1 mRNA CTD PMID:20977926 NCBI chr 7:139,043,515...139,109,720
Ensembl chr 7:139,043,515...139,132,122 		JBrowse link
G ZFP36L2 ZFP36 ring finger protein like 2 increases expression EXP zoledronic acid results in increased expression of ZFP36L2 mRNA CTD PMID:20977926 NCBI chr 2:43,222,402...43,226,606
Ensembl chr 2:43,222,402...43,226,606 		JBrowse link
G ZNF146 zinc finger protein 146 increases expression EXP zoledronic acid results in increased expression of ZNF146 mRNA CTD PMID:20977926 NCBI chr19:36,214,723...36,238,768
Ensembl chr19:36,214,602...36,238,771 		JBrowse link
G ZNF365 zinc finger protein 365 decreases expression EXP Zoledronic Acid results in decreased expression of ZNF365 mRNA CTD PMID:24714768 NCBI chr10:62,374,369...62,480,285
Ensembl chr10:62,374,192...62,480,288 		JBrowse link
G ZNF385B zinc finger protein 385B decreases expression EXP zoledronic acid results in decreased expression of ZNF385B mRNA CTD PMID:24714768 NCBI chr 2:179,441,982...179,861,612
Ensembl chr 2:179,441,982...179,861,612 		JBrowse link
G ZNF436 zinc finger protein 436 increases expression EXP zoledronic acid results in increased expression of ZNF436 mRNA CTD PMID:20977926 NCBI chr 1:23,359,448...23,369,836
Ensembl chr 1:23,359,448...23,369,836 		JBrowse link
G ZNF467 zinc finger protein 467 increases expression EXP zoledronic acid results in increased expression of ZNF467 mRNA CTD PMID:20977926 NCBI chr 7:149,764,182...149,776,530
Ensembl chr 7:149,764,182...149,773,588 		JBrowse link
G ZNF485 zinc finger protein 485 decreases expression EXP zoledronic acid results in decreased expression of ZNF485 mRNA CTD PMID:20977926 NCBI chr10:43,606,438...43,617,904
Ensembl chr10:43,606,419...43,617,904 		JBrowse link
G ZNF644 zinc finger protein 644 increases expression EXP zoledronic acid results in increased expression of ZNF644 mRNA CTD PMID:20977926 NCBI chr 1:90,915,304...91,022,035
Ensembl chr 1:90,915,298...91,022,272 		JBrowse link
G ZNF684 zinc finger protein 684 decreases expression EXP zoledronic acid results in decreased expression of ZNF684 mRNA CTD PMID:24714768 NCBI chr 1:40,531,637...40,548,167
Ensembl chr 1:40,531,573...40,548,167 		JBrowse link
G ZNF74 zinc finger protein 74 increases expression EXP zoledronic acid results in increased expression of ZNF74 mRNA CTD PMID:20977926 NCBI chr22:20,394,151...20,408,455
Ensembl chr22:20,394,115...20,408,461 		JBrowse link
G ZNF775 zinc finger protein 775 increases expression EXP zoledronic acid results in increased expression of ZNF775 mRNA CTD PMID:24714768 NCBI chr 7:150,379,330...150,398,630
Ensembl chr 7:150,368,790...150,398,630 		JBrowse link
G ZNF827 zinc finger protein 827 increases expression EXP zoledronic acid results in increased expression of ZNF827 mRNA CTD PMID:24714768 NCBI chr 4:145,757,627...145,938,823
Ensembl chr 4:145,757,627...145,938,823 		JBrowse link
G ZNRF3 zinc and ring finger 3 decreases expression EXP zoledronic acid results in decreased expression of ZNRF3 mRNA CTD PMID:24714768 NCBI chr22:28,883,572...29,057,488
Ensembl chr22:28,883,572...29,057,488 		JBrowse link
G ZSCAN25 zinc finger and SCAN domain containing 25 increases expression EXP zoledronic acid results in increased expression of ZSCAN25 mRNA CTD PMID:20977926 NCBI chr 7:99,616,946...99,738,035
Ensembl chr 7:99,616,946...99,632,408 		JBrowse link
Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 26798
    role 26626
      application 25640
        pharmaceutical 25062
          drug 25059
            bone density conservation agent 6301
              zoledronic acid 1598
Path 2
Term Annotations click to browse term
  CHEBI ontology 26798
    subatomic particle 26774
      composite particle 26774
        hadron 26774
          baryon 26774
            nucleon 26774
              atomic nucleus 26774
                atom 26774
                  main group element atom 26525
                    p-block element atom 26525
                      carbon group element atom 26002
                        carbon atom 25965
                          organic molecular entity 25965
                            organic molecule 25720
                              organic cyclic compound 24809
                                organic heterocyclic compound 22904
                                  heteroarene 18843
                                    monocyclic heteroarene 16334
                                      azole 15880
                                        diazole 11546
                                          imidazoles 10748
                                            zoledronic acid 1598
paths to the root